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Abstract 
Background: Vaccine-preventable diseases are easily transmitted in healthcare and military 
facilities. Despite deliberate efforts being instigated, vaccine preventable diseases in KSA 
remain the most commonly reported infectious diseases among adults. This study aimed to 
enhance understanding of the epidemiological pattern, seroimmunity, associated knowledge, 
and concerns on Hepatitis B virus (HBV), measles and varicella infections; investigating 
barriers to vaccine compliance among newly recruited health care workers (HCWs) and 
soldiers. 
Methods: A mixed methods model of analysis was performed: (1) A quantitative analysis 
through a cross-sectional survey and gathering results of blood samples and (2) a qualitative 
analysis through in-depth interviews and focus group discussions. 
Results: 315 multinational HCWs and 426 male Saudi soldiers completed similar 
questionnaires. The HCWs scored an intermediate median knowledge level of 43 HBV, 27 
measles and 33 varicella questions, 32, 15 and 19 respectively, with the soldiers scoring a low 
median knowledge level 8, 4 and 7 respectively. Blood samples of 4,328 multinational HCWs 
and 1,030 male Saudi soldiers were screened. The HBsAg seroprevalence among HCWs was 
0.4% and among soldiers 0.2%. The HBcAb positive seroimmunity was 6.7% and 0.8% 
respectively, and HBsAb positive seroimmunity 68.3%, and 29.4% respectively. Among HCWs 
IgG measles positive seroimmunity was 64.3% and for soldiers 31.2%, IgG varicella positive 
seroimmunity was 85.2% and 68.3% respectively. Vaccine barriers and acceptability for the 
vaccination were identified, comprising five main barriers related to: individual, vaccine, 
HCWs providing vaccine, organisation, and social and cultural factors. 
Conclusion: Low and intermediate levels of awareness among military and HCWs respectively 
confirm the need for educational campaigns to reduce infection transmission and increase 
vaccine compliance. The rate of HBV, measles and varicella immunity was low indicating the 
need to vaccinate susceptible groups. 
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Chapter 1. Introduction 
1.1 : Saudi Ministry of National Guard  
The Saudi Armed Forces in the Kingdom of Saudi Arabia (KSA) comprise various forces 
including the Saudi Arabian National Guard (SANG) an operational front-line force, uniquely 
independent of the Ministry of Defence(1), acting against external and internal threats in 
protecting strategic facilities and resources, such as oil installations(2). The Ministry of National 
Guard - Health Affairs (MNG-HA) provides health care to SANG personnel and their families, 
including soldiers and health care workers (HCWs)(3). It depends on expatriate clinical staff 
recruited from (in descending order of percentage representation): the Middle East, the Far East, 
Africa, Europe and North America(4). 
1.2 : Infection Prevention and Control Department in Ministry of National Guard - 
Health Affairs 
HCWs recruited from over 50 countries, each differing in epidemiological patterns of infectious 
disease, create a unique infection control management challenge(4) MNG-HA established and 
maintain a comprehensive program, the Infection Prevention and Control Programme (IPCP), 
according to Joint Commission International (USA) standards, recommendations of the Centres 
for Disease Control and Prevention (CDC) and Saudi Ministry of Health (SMOH) 
guidelines(3). IPCPs aim to develop policies and procedures to guide and instruct HCWs and 
soldiers on practices to prevent and control health care associated and work related 
infections(5), additionally, providing a healthy, safe, supportive, and effective environment of 
care for all. 
Standard precautions are adapted, emphasising the need to consider all body substances as 
potentially infectious. The Infection Prevention and Control Department (IPCD) in the western 
region (WR), Jeddah, supervises and handles all of its services in MNG-HA facilities and 
military units in the region (MNG-HA-WR), comprising three main sections (public health, 
hospital infection control, and environmental and occupational health and safety), each 
providing specific services to the King Abdul-Aziz Medical City (KAMC), affiliated clinics 
and/or communities of the SANG-WR(5). 
Designated communicable diseases such as HBV, measles and varicella are reported by IPCP- 
MNG-HA to the SMOH to provide timely and accurate information, necessary for appropriate 
epidemiological protocols, monitoring and institutional control(5). 
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1.2.1 The public health section in the infection prevention and control programme 
The Public Health section focuses on early detection of infectious diseases promoting health 
awareness, and preventing infection spread. It aims to measure indicators of communicable 
disease prevention and control in the SANG population through conducting communicable 
disease outbreak investigations, organising, running, and evaluating a reportable disease 
surveillance system, identifying risk factors and populations at risk of communicable diseases, 
providing preventive measures against communicable diseases such as vaccines, identification 
of and response to emerging threats of public health interests, increasing the patient and family 
awareness of communicable illnesses and other related medical concerns, improving the system 
of follow-up for tuberculosis and hepatitis patients and other communicable diseases, and 
communicating the analysed and interpreted health information in a timely manner to policy-
makers and planners(5). Some services are provided through outpatient clinics, e.g. adult 
vaccination, public health and pre-employment health. 
1.3 : The Surveillance System for Communicable Diseases and Vaccination 
The SMOH and MNG-HA continuously upgrade their surveillance system, prevention and 
control programmes for infectious diseases aiming at elimination. Continuous effort during 
previous years has resulted in eliminating numerous incidents of other diseases, which have 
been reduced under this surveillance throughout KSA(6). CDC estimated that 40,000 to 50,000 
vaccine-preventable deaths occur annually in US at a health care burden of $10 billion each 
year(7). There is no similar study in the KSA on the cost burden. 
1.3.1 Hepatitis B virus, varicella and measles  
HCWs have one of the highest rates of occupational risk for HBV worldwide(8), associated 
with degree of contact with blood in the work place and needle stick exposure(9). Additionally, 
several behavioral factors are associated with increased risk of HBV infection among soldiers 
such as illicit injectable drugs(10); sexual contact(11); duty assignment to high-prevalence 
regions; occupational exposure to blood(12) and history of sexually transmitted disease 
(STD)(11,13). During the acute phase of HBV, manifestations range from subclinical or 
anicteric hepatitis to icteric hepatitis and fulminant hepatitis. During the chronic phase, 
manifestations range from asymptomatic carrier state to chronic hepatitis, cirrhosis, and 
hepatocellular carcinoma (HCC)(14). 
Moreover, HCWs have an 18.6-fold increased risk of acquiring measles compared with non-
HCWs; thus measles represents a high occupational risk(15). The evolution of nosocomial 
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outbreaks is highly facilitated by measles virus rapidly spreading within closed settings, e.g. 
waiting areas in emergency departments(16). Soldiers risk measles transmission because of the 
nature of military lifestyle, being in closed communities, conducting activities that enhance 
close contact and possible easy transmission(17-19). The following complications of measles 
may occur(20): Pulmonary , encephalitis(21), subacute sclerosing panencephalitis(22), acute 
disseminated encephalomyelitis, eye manifestations(21). 
Furthermore, studies of varicella zoster virus (VZV) exposure in health-care settings document 
how a single provider with unrecognised varicella can expose over 30 patients and 30+ more 
employees(23). Military personnel often face varicella in several settings; during training, 
deployments and war mobilisation when confined in barracks where respiratory pathogens can 
spread rapidly(24). Varicella complications include: Skin/soft tissue infections, neurologic 
complications, pneumonia, hepatitis, and otitis media(25), fever and constitutional 
manifestations, which may be severe among adults(26). 
Varicella was the most common (19.7%) of all reported communicable disease cases in the 
SANG in 2011(10). This was an annual 58.0% increase in the number of reported varicella 
cases. HBV ranked second, representing 19.4% of all reported communicable disease cases and 
measles 0.6% in 2011 ( a year-on-year 214% increase in reported cases)(27). 
Viral hepatitis remains a significant cause of morbidity and mortality, imposing a major burden 
on the country's health care system regardless of the significant decline in the prevalence of 
HBV. Recently published health statistics (2014) rank it the second most common viral disease 
following varicella. SMOH report 4,323 new cases diagnosed representing 14.05% of reported 
communicable disease cases, Jeddah alone accounting for one fifth of reported cases. 98% of 
HBV-infections occurred amongst over 15 year olds. Further, 154 new measles cases were 
diagnosed, just over a third (34.0%) of which were Jeddah based. One quarter of the measles-
infected were older than 15. Finally, 8,204 new varicella cases were diagnosed (the highest 
reported communicable disease in the KSA) representing 26.6% of all reported communicable 
disease, 34.0% were older than 15(6). 
HBV, measles and varicella cases reported in the last four years before collection of data among 
MNG-HA population are shown at Figure 1-1. Vaccines are provided to the targets for these 
three diseases, considered to be the most commonly reported vaccine preventable diseases. 
However, reporting of disease incidence is inconsistent indicating the need for deeper 
investigation into the underlying reasons for this poor level of reporting. 
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Figure 1-1 : HBV, measles and varicella cases reported in the last four years among MNG-
HA population 
 
Education, especially for young individuals, is an effective tool in reducing the spread of 
infectious diseases within a population(28). An important starting point for designing 
appropriate prevention tools is to assess knowledge of a disease, amongst those with a higher 
education level or those at risk, e.g. HCWs and soldiers. Knowledge can be established within 
the community as a whole. Although an effective vaccine is now available, not everyone can 
access it. Therefore, public health education remains optimum in disease combating. IPCD acts 
in prevention through different channels including public awareness campaigns. As far as is 
known, no studies have assessed knowledge levels or attitudes of the newly recruited towards 
HBV, measles and varicella infection in MNG-HA. 
 
1.4 : Vaccination Programme among Health Care Workers and Soldiers 
Immunisation programs are an essential part of infection prevention and control for HCWs, 
soldiers, limiting the spread of vaccine-preventable diseases such as HBV, measles, varicella 
and maintaining high levels of readiness. 
The Advisory Committee on Immunisation Practice (ACIP) and the Hospital Infection Control 
Practice Advisory Committee (HICPAC) strongly recommend vaccination of all 
HCWs susceptible to vaccine preventable diseases such as HBV, measles and varicella(29). 
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Additionally, the Occupational Safety and Health Administration (OSHA) considers soldiers to 
be a peculiar community having a number of features that differentiate them from other social 
groups, namely, their lifestyle, nature of work and training that ultimately renders them at 
increased risk of acquiring infections through their various transmission routes(30). 
Therefore, optimal use of recommended vaccines maintains immunity and safeguards against 
infection, helping HCWs protect patients from infection and enabling military personnel to 
maintain high levels of readiness(24,31). 
MNG-HA’s immunisation policy follows CDC and ACIP recommendations, every HCW 
having valid completion documentation of the required immunisations(5). Additionally, all new 
SANG military recruits (officer, enlisted) and other military personnel are vaccinated during 
training, as adapted from US army practice(32). These immunisations include those protecting 
against pathogens posing imminent risk in closed communities (meningococcal; measles, 
mumps, rubella; varicella), and against pathogens posing a later threat (hepatitis A virus (HAV), 
HBV, tetanus-diphtheria-pertussis). Influenza vaccine is provided to all newly recruited HCWs 
during the influenza season (September-April annually). Those assigned for work during Hajj 
are required to receive influenza and meningococcal vaccines(5). These immunising agents 
should be licensed by the food and drug administration and Saudi National official 
organisations. In addition, staff members adhere to cold chain management principles. An 
employee immunisation program has been applied since 2001 among HCWs and 2004 among 
soldiers(5). 
IPCP uses a secure, computerised system to manage vaccination records for all HCWs, each 
record reflecting immunity status for the target vaccine-preventable diseases (i.e., documented 
disease, vaccination history, or serology results), and vaccinations administered during 
employment plus documented episodes of adverse events after vaccination. Such a system does 
not exist for the military(5). 
1.4.1 Vaccine compliance among new employees 
Completion of the required immunisations among newly recruited employees is mandatory 
(100%) for both HCWs and soldiers. However, there is low compliance among soldiers whose 
training centre periods are shorter than three months. Campaigns target those soldiers, with the 
third HBV vaccine dose possibly being given elsewhere (recommended at six months after first 
dose)(14,33). No available data for soldiers completing the third dose exists.  
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Low compliance rates are reported among HCWs, 44.1% of physicians and 36.0% of 
paramedics had received the flu vaccine compared to 95.0% of nurses. Only 75.0% of HCWs 
completed vaccine doses for HBV, measles and varicella(27). 
Barriers to immunisation are a significant factor in the rising incidence rates of some vaccine-
preventable diseases. These could be grouped as system barriers (e.g., involving health care 
system organisation and economics), health care provider barriers (e.g., inadequate clinician 
knowledge and contraindications to their use), and patient barriers (e.g., fear related adverse 
events). These affect immunisation rates and increase societal burdens of preventable 
diseases(34). Better understanding of immunisation barriers could enhance coverage levels 
affecting improved strategies on immunisation. 
 
1.5 : Occupational Infections in Healthcare and Military Work Settings 
A health care facility is a workplace and care centre, exposed to health and safety hazards daily, 
including exposure to infections. Military barracks present unique living arrangements with 
many recruits living in close physical proximity, which can lead to rapid infection 
transmission(35). 
IPCP initiated specific screening programs for HCWs and soldiers to monitor their health and 
immunity, providing appropriate curative treatment with, additionally, relatives of the infected 
also being treated. 
1.5.1 Newly recruited health care worker screening programme  
All international and local employees are required to provide results of serological testing for 
HAV, HBV, hepatitis C virus (HCV), and the human immunodeficiency virus (HIV) before 
recruitment is confirmed. They are required to complete medical screening including declaring 
any history of infectious diseases before and on arrival in KSA. Only applicants who test 
negative for antibodies to HBV, HCV, and HIV are processed for future employment(4). These 
tests are repeated in KAMC on arrival at pre-employment health clinic. Over and above national 
requirements, applicants are tested for antibodies to measles, rubella, and varicella viruses, to 
optimise the vaccination program conducted by IPCP. Only applicants testing negative for 
HBV, HCV, and HIV are allowed to work. A prior history of infections due to measles, rubella, 
or varicella viruses or HAV or HBV is not considered evidence of immunity(4). 
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1.5.2 Newly recruited soldiers screening programme 
All soldiers undergo a pre-entrance medical screening before military service, including 
serological testing for HBV, HCV, and HIV. There is no current routine testing for antibodies 
to HAV, HBV, measles, rubella, and varicella viruses. Only applicants who test negative for 
HBV, HCV, and HIV are allowed to work. 
 
1.6 : Rationale of the Study 
As discussed above, the following are summarised rationale for this study: 
1- Despite the deliberate efforts undertaken by health sectors for prevention and control of 
communicable diseases, vaccine preventable diseases such as HBV, measles and varicella are 
still considered the most commonly reported infectious diseases among adults in KSA for 
Saudis and non-Saudis, at the level of SMOH and MNG-HA(6,27,36). 
2- HCWs and military communities possess a number of factors determining their lifestyle 
placing them at increased risk of acquiring HBV, measles and varicella(7,29-31). 
3- Many studies recommended wider scale studies to identify the seroprevalence of HBV, 
measles and varicella seroimmunity, associated knowledge identifying the risk factors 
responsible for transmission(37-41).  
4- Appropriate education is effective in reducing the spread of infectious diseases(28). An 
important starting point for designing such tools is to assess people’s knowledge of a disease. 
5- Although vaccines are available, the incidence of infections is not decreasing - as 
evidenced in episodes of HBV, measles and varicella. The uptake of complete vaccine doses: 
entailing more than one dose, such as, HBV, measles and varicella or one dose, such as Flu, is 
not optimised. Perceptions of vaccine compliance barriers and preventive measures could be 
contributing factors and, therefore, require further investigation. 
6- No scientific data is available to understand the effectiveness and functionality of 
immunisation practice and work environments or vaccine reactions. This is particularly relevant 
to the local military immunisation programs in MNG-HA. 
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1.7 : Hypotheses of the Study 
1. The immunity status towards HBV, measles and varicella among new HCWs will be 
higher than among newly recruited soldiers. 
2. The immunity status towards HBV, measles and varicella among new HCWs will differ 
according to nationality, education level, type of work and duration of work. 
3. The immunity status towards HBV, measles and varicella among newly recruited 
soldiers will differ according to place of residence and educational level. 
4. Knowledge pass score towards HBV, measles and varicella among new HCWs will be 
higher than newly recruited soldiers. 
5. Knowledge pass score towards HBV, measles and varicella among new HCWs will 
differ according to education level, type of work and duration of work. 
6. Knowledge pass score towards HBV, measles and varicella among newly recruited 
soldiers will differ according to educational level. 
1.8 : Significance of the Study 
The significance of this study may be in its contribution to elaborating the epidemiological 
pattern of HBV, measles and varicella; exploring barriers of vaccine compliance among 
employees, each of these may assist in proper planning for prevention and control of these 
diseases. 
1.9 : Aims of the Study 
This is a mixed methods study, providing a comprehensive picture, to achieve a greater 
understanding than that gathered from evidence generated by one methodology alone(42,43). 
The study utilises mixed methods in order to obtain quantitative and qualitative data which 
explore newly employed soldiers’ and HCWs’ perspectives. 
It has two broad aims: 
1- To study the epidemiological pattern, seroimmunity and associated knowledge, 
concern, on HBV, measles and varicella infections among employees in the SANG. 
2- To explore barriers of vaccine compliance among the vaccine providers and service 
users (HCWs and soldiers). 
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1.10 : Objectives of the Study 
Quantitative Part:  
1- To estimate the seroprevalence of hepatitis B surface antigen and hepatitis B core 
antibody among newly recruited HCW employees and newly recruited soldiers of Saudi 
National Guard at Jeddah in 2013- 2014. 
2- To assess the immunity status by estimating hepatitis B surface antibody and IgG 
antibodies of measles and varicella among newly HCWs and military employees of SANG at 
Jeddah in 2013- 2014. 
3- To assess epidemiological characteristics, knowledge and concern of the study 
participants towards HBV, measles and varicella infections among newly HCWs and military 
employees of SANG at Jeddah in 2013- 2014. 
4- To assess determinants of immune status, knowledge and concern with special emphasis 
on nationality, education level, type of work and duration of work among newly recruited 
HCWs. 
5- To assess determinants of immune status and knowledge with special emphasis on place 
of residence and educational level among newly recruited soldiers. 
 
Qualitative Part: 
6- To explore vaccine compliance barriers among new HCWs and military employees of 
SANG at Jeddah in 2013-2014. 
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1.11 Mixed methods approach 
A mixed methods approach is deemed necessary to achieve the objectives of the study. 
Qualitative or quantitative data alone may not yield sufficient information to allow us to 
understand fully the social process under scrutiny, and qualitative and quantitative methods 
should be combined to allow adequate explanation of the phenomena under study, as suggested 
by Tashakkori and Teddlie(44).Using a combination of qualitative and quantitative data can 
improve an evaluation by ensuring that the limitations of one type of data are balanced by the 
strengths of another, each approach could potentially achieve the study aim based on available 
resources and study objectives. 
Nevertheless, the complementarity model is not a good general methodological concept for the 
integration of quantitative and qualitative methods because, once again as is suggested by  
Tashakkori and Teddlie(44), the triangulation of research results often leads to a situation in 
which the different findings do not align. Therefore, qualitative and quantitative data will be 
gathered simultaneously yet independently before separate analysis and overall interpretation 
to avoid any divergent empirical results (44). 
For this reason, both quantitative and qualitative approaches will take place concurrently in 
order to identify related aspects of the HBV, measles and varicella seroimmunity and vaccine 
compliance in the healthcare and military settings. The results of the qualitative approach, 
which investigate underlying reasons for the pattern of local variables and barriers regarding 
low vaccine compliance, and of the quantitative findings, that investigate knowledge and sero-
immunity rates of the HBV, measles and varicella, provide an important comprehensive 
assessment of the research aims. In summary, the findings of both the quantitative and 
qualitative components of the mixed method approach will aid understanding and provide 
explanations of vaccine compliance patterns and immunity rates among both groups, also 
facilitating the development of an appropriate preventive tool for better public health 
interventions. Gathering sufficient quantitative data exclusively would be costly both 
financially and in time would require a large sample size compared to qualitative data. 
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1.12 Diagrammatic presentation of the study design 
A diagrammatic presentation of the study design and participants is shown in Figure 1-2 
 
Figure 1-2 : A mixed method model of analysis used in parallel to achieve the study 
objectives 
 
 
1.13 : Thesis Structure 
The study is presented in 10 chapters, including this introduction (Chapter one). 
Chapter two presents a literature review on HBV, measles and varicella, describing clinical 
manifestation, diagnosis and management in local and international epidemiology terms for 
each disease and risk factors. The literature regarding the effects of each disease among HCWs 
and the military community are also critically reviewed. It ends with an extensive literature 
discussion of compliance and barriers to vaccination in developed and developing countries. 
Chapter three describes research design, the approach adopted in answering research questions, 
and procedures pursued. 
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The fourth and fifth chapters present the results derived from analysis of quantitative data for 
HCWs and soldiers, based on cross-sectional survey and gathered results of blood samples to 
determine seroprevalence, seroimmunity and epidemiological characteristics, knowledge and 
concern about HBV, measles and varicella infections for newly recruited HCWs or soldiers. 
The sixth chapter presents results derived from analysis of qualitative data for HCWs and 
soldiers investigating views on vaccine compliance, effectiveness and functionality of 
immunisation practice, among the vaccine providers and service users. 
The seventh and eighth chapters present the overall discussion through analysis of thesis 
strengths and limitations, summarising the main findings, explaining how the results relate to 
expectations and to the literature, clearly stating why they are acceptable and how they are 
consistent or fit previously published knowledge on the topic. 
Chapter nine offers overall conclusions, comprising a summary of the main findings, interaction 
of qualitative and quantitative research, implications of the results, and recommendations for 
policy action and further research.  
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Chapter 2. Literature Review 
This chapter discusses two main topics, firstly describing clinical manifestations, diagnosis and 
management of HBV, measles and varicella, and epidemiological terms for each disease and 
its risk factors, and secondly discussing vaccination compliance and barriers. 
2.1 : Hepatitis B Virus  
2.1.1 Introduction 
The HBV is a virus within the family hepadnavirus being a serious infectious liver disease of 
42 nm double stranded Deoxyribonucleic acid (DNA) virus(14,45-47). Its structure is shown in 
Figure 2-1. 
 
Figure 2-1: Structure of HBV 
Source: http://goo.gl/JkZMVt(48) 
An estimated more than two billion people today have serological evidence of past or present 
infection. Of these, about 350 million remain infected chronically and are virus 
carriers(14,49,50). Each year there are over four million acute clinical cases about 5-10% 
becoming chronic carriers (defined as hepatitis B surface antigen positive for at least 6 months). 
At least one million of the chronically infected die annually from the severe pathological 
consequences of persistent HBV infections(51,52), pointing to the seriousness of the disease 
and its heavy burden on the global health systems representing significant morbidity and 
mortality(51). 
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Mode of transmission 
Although the source of infection cannot be identified in about 35.0% of cases, there are four 
recognised modes of transmission: Mother to child at birth (peri-natal); contact with an infected 
person (horizontal); sexual contact; parenteral exposure to blood or other infected fluids (blood-
to-blood)(14,47). Percutaneous exposures occur through transfusion of unscreened blood or 
blood products, direct exposure to infected blood and blood products, sharing unsterilised 
injection needles (e.g. amongst injecting drug users), acupuncture, tattooing, and body 
piercing(14,45,53,54). The transmission could ensue following injuries from contaminated 
sharp instruments [surgical, dental instruments and dental manipulation, circumcision, cupping 
(Hijama)] and among haemodialysis patients(14,47,55,56). Permucosal could occur through 
sexual contact with hepatitis carriers (14,45,47,53,54). Transmission of HBV in a household 
primarily occurs from close household contact with an infective person; commonly used razors 
and toothbrushes have been implicated in this setting(54). 
Diagnosis 
Diagnosis of HBV is made by biochemical assessment of liver function. Initial laboratory 
evaluation should include liver function test(LFT): total and direct bilirubin, alanine 
aminotransferase(ALT), aspartate aminotransferase(AST),alkaline phosphatase(ALK),total 
protein, albumin, globulin(14,47). Diagnosis is confirmed by demonstration in sera of specific 
antigens and antibodies. Three clinical useful antigen-antibody systems have been identified 
for HBV: a)Hepatitis B surface antigen(HBsAg) and antibody to HBsAg(HBsAb), b)Antibody 
(HBcAb IgM and HBcAb IgG) to hepatitis B core antigen (HBcAg) and c)Hepatitis B e antigen 
(HBeAg) and antibody to HBeAg (HBeAb). Serological results interpretation is shown in 
Table 2.1 and Table 2.2 and serological and clinical patterns of HBV infections in 
Table 2.3(14,45,47,57,58).  
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Interpretation Result Test 
Never exposed, never vaccinated, susceptible for 
infection, vaccination of HBV required. 
Negative HBsAg 
Negative HBcAb 
Negative HBsAb 
1-Might be recovering from acute HBV infection 
not resolved completely (most common). 
2-Might be time span between disappearance of 
HBsAg and appearance of HBsAb (window 
period). 
3.Might be distantly immune and test not sensitive 
enough to detect very low level of HBsAb in 
serum. 
4.Might be undetectable level of HBsAg present in 
the serum and the person is actually chronically 
infected. 
5.Might be false-positive HBcAb. 
6-Might be suppression of HBV replication by a 
simultaneous HCV co-infection (59). 
Negative HBsAg 
Positive HBcAb IgG 
Negative HBcAb IgM 
Negative HBsAb 
Negative HBV DNA 
Immune due to natural infection Negative HBsAg 
Positive HBcAb IgG 
Negative HBcAb IgM 
Positive HBsAb 
Negative HBeAg 
Negative HBeAb 
Negative HBV DNA 
Normal LFT 
Mostly acute infection 
 
Positive HBsAg 
Positive HBcAb IgG 
Positive HBcAb IgM 
Negative HBsAb 
Positive/ Negative HBeAg 
Positive/ Negative HBeAb 
Positive/ Negative HBV DNA 
Marked increased LFT 
Table 2.1: Serological tests interpretation for HBV markers(a) 
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Interpretation Result Test 
1-Might be during incubation period before onset of 
symptoms. 
2-Might be HBeAg-negative active Chronic hepatitis B; 
(“pre-core/ core “HBV mutant) (HBeAg-negative chronic 
hepatitis). 
3-Might be early acute HBV infection. 
4-Might be inactive HBsAg carrier state. 
Positive HBsAg 
Negative HBcAb IgG 
Negative HBcAb IgM 
Negative HBeAg 
Negative HBsAb 
Negative HBeAb 
Positive HBV DNA 
Normal LFT 
1-Most probably immune due to HB vaccination. 
2-Might be repeated exposure to antigen without infection. 
3-Might be recovery from infection with loss of detectable 
HBcAb. 
Routine follow up it depends on risk factors. 
Negative HBsAg 
 
Negative HBcAb 
 
Positive HBsAb 
Inactive chronic carrier infection Positive HBsAg 
Positive HBcAb 
Negative HBeAg 
Negative HBsAb 
Positive HBeAb 
Positive/Negative HBV DNA 
Normal-mild 
increased 
LFT 
Active chronic carrier infection 
(HBeAg-positive chronic hepatitis) 
Positive HBsAg 
Positive HBcAb 
Positive HBeAg 
Negative HBsAb 
Negative HBeAb 
Positive HBV DNA 
Mild- Marked 
increased 
LFT 
Table 2.2: Serological tests interpretation for HBV markers(b) 
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HBsAg HBeAg IgM  
HBcAb 
IgG 
HBcAb 
HBsAb HBeAb HBV 
DNA 
Interpretation 
Acute HBV infection 
+ + +    +++ Early phase 
  +    + Window phase 
   + + +   Recovery phase 
Chronic HBV infection 
+ +  +   +++ Replicative phase 
+   +  +   Low, nonreplicative 
phase 
+   + +   + Flare of chronic HBV 
+   +  + ++ Precore/core promoter 
mutants 
Table 2.3: Serologic markers for the different phases of acute and chronic HBV 
2.1.2 Prevention measures of hepatitis B virus 
Vaccine 
HBV vaccine has been available since 1982, being effective in preventing transmission and 
consequences(14,45). Vaccines are composed of HBsAg, being produced by two different 
methods: plasma derived or recombinant DNA. When administered properly, they induce 
protection in about 95.0% of recipients(14). 
HBV vaccine schedules are flexible; thus, offering multiple options for adding the vaccine to 
existing national immunisation schedules without requiring additional visits for immunisation. 
HBV vaccine for adults is given in the following option doses: (0,1 month and 6 months); (0,1 
month and 4 months); and (0,2 month and 4 months)(14). Although the initial HBsAb titre is 
followed by a decline of antibodies, a rapid anamnesis response develops after exposure to the 
virus(14,22,45). An initial HBsAb titre of more or equal to 10 IU/l is regarded as being 
protective, however, the duration of vaccine-induced immunity is uncertain but it is definitely 
long term (>15 years). 
Research supported by Glasxosmith Kline Biological, producer of HBV vaccine, indicates the 
vaccine is effective in achieving early seroprotection when given as recommended in a 3-dose 
vaccination schedule to normal, healthy subjects. It was claimed that the explanation for 
occurrences of new cases among vaccinated individuals was unclear(60). Factors that may 
reduce the immunogenicity of HBV vaccines include age (>40 years), male gender, overweight, 
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genetics, haemo-dialysis, HIV infection, immune-suppression, tobacco smoking, subcutaneous 
injection, vaccine injection into the buttocks, freezing of vaccine, and accelerated 
schedule(14,47). 
In 1989, the HBV vaccine was initiated in the KSA, and researchers tried to determine the 
vaccine’s impact. Tamimi et al., (2004) found that the prevalence of HBV among Saudi blood 
donors declined from 4.0% to 1.7%(55). In another study among 13,443 blood donors in the 
Eastern region of the KSA, HBsAg prevalence was 2.58% in 1998 and 1.67% in 2001(61). 
 
Hepatitis B Immunoglobulin  
Hepatitis B immunoglobulin (HBIG) protects by passive immunisation if given shortly before 
or soon after exposure to HBV. It is administered in combination with HBV vaccines to 
newborns of HBsAg positive mothers. The protection is immediate, but of short 
duration(14,47). 
 
2.1.3 Epidemiology  
Globally, HBV carriage rate varies between 1.0% and 20.0%. This variation is related to 
differences in the mode of transmission and age at infection. In terms of HBV distribution, the 
world is divided into three where the prevalence of chronic HBV infection is high (> 8.0%), 
intermediate (2.0-8.0%), and low (< 2.0%)(14,45). Table 2.4 and Figure 2-2 show regional 
prevalences. 
High endemicity areas include south-east Asia Region(SEAR) such as Indonesia and the 
Western Pacific Region(WPR) (excluding Japan, Australia, and New Zealand), sub-Saharan 
Africa, parts of the Middle East Region(MER), and some countries in Eastern Europe(14). 
These are regions of non-Saudi recruitment for HCWs in the MNG-HA(62). 
Although global control of HBV is achievable, it has not been attained yet. In fact, for a large 
pool of carriers the burden of the disease remains, and vaccine coverage in rural areas of many 
HBV high endemicity countries faces logistical and economic challenges, necessitating efforts 
to continue to treat the various stage(14,45). Since 1994, the United Nations Children's Fund 
(UNICEF), World Health Organisation (WHO), and several other international donor agencies 
assisted developing countries to obtain HB vaccine and implement national programs(14).  
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 High Intermediate Low 
HBsAg Carrier 
rate, percent 
8.0% 2.0-7.0% 1.0% 
HBsAb 70.0-95.0% 20.0-55.0% 4.0-6.0% 
Geographic 
distribution 
Southeast Asia; 
China; Pacific 
islands; sub-Saharan 
Africa; Alaska 
(Eskimos) 
Mediterranean basin; 
Eastern Europe; 
central Asia; Japan; 
Latin and South 
America; MER 
United States and 
Canada; western 
Europe; Australia; 
New Zealand 
Predominant age at 
infection 
Perinatal and early 
childhood 
Early childhood Adult 
Predominant mode 
of infection 
Maternal-infant; 
percutaneous 
Percutaneous; sexual Sexual; percutaneous 
Table 2.4 : Prevalence of HBV in various areas 
 
 
Figure 2-2: World distribution map of HbsAg 
Source: http://goo.gl/SAatKj(63) 
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A local study, conducted into HBV seroprevalence among 4,575 Saudi children in December 
1989 and January 1990, revealed 6.7% of children to be positive for HBsAg(64). Another local 
study in 1998 reported the average positivity for HBsAg for 1992 to 1994 in blood bank donors 
from a tertiary hospital was 4.0%(65). In 2001, Qirbi reported that prevalence in KSA regions 
and provinces among different population groups such as healthy ambulatory men, blood 
donors, school children and pregnant women in hospitals and community based studies ranged 
from 7.4% to 17.0%. Though, in this study, carrier status and risk factors of HBV have not been 
investigated(66). 
Memish et al (2003) investigated the pattern of hepatitis among SANG personnel and their 
extended families in the central region. The most dominant type of hepatitis infection was HBV, 
in a prevalence of 4.9%, 5.8% and 3.8% for 1990, 2000, and 2001 respectively. However, this 
study does not investigate risk factors related to HBV(67). This was contrary to the figures from 
England and Wales where the most common hepatitis infection was HCV, followed by HAV, 
and finally HBV(68). This could be related to differences in socioeconomic status, wherein 
developed countries’ good infrastructure and numerous awareness programmes minimise risks 
of infection. Another interesting study result suggested HBV might be acquired as a result of 
injecting drug users, poor health practices and the use of traditional medicine such as "Hijama" 
or bloodletting(67). 
 
Risk of hepatitis B virus among health care workers 
HCWs have one of the highest rates of occupational risk for HBV worldwide(8) associated with 
degree of contact with blood in the work place and with the hepatitis B e-antigen status of 
patients(9). HBV transmission from needle stick exposure is up to 100 times more likely to 
expose HBeAg positive blood than HIV-positive blood(69). HBV is passed through the 
exchange of body fluids, such as semen, vaginal fluids, and blood(70). A survey of New York 
surgeons in 1988 revealed that 86.0% had at least one puncture injury(71). A similar study at a 
tertiary hospital in Riyadh reviewed reports from 1996 to 2000 and revealed that 33 needle stick 
injuries had occurred per 1,000 HCWs. However, in this study there was significant under-
reporting of needle stick and sharps injuries among HCWs, which influences the accuracy of 
the data and is recognized as a universal occurrence(40). 
The risk of acquiring HBV from medical occupational exposures depends on the frequency of 
percutaneous and mucosal exposures to blood or body fluids containing HBV, particularly 
fluids containing HBeAg(31). This risk is highest during professional training(31). There are a 
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variety of sources of HBV, other than blood-containing specimens, such as contaminated 
medical instruments, environmental surfaces, and contaminated file cards among laboratory 
technicians(72). Additionally, infected HCWs have been responsible for numerous outbreaks 
in patients, such that as a practical regulation in the US and UK, HCWs who are HBeAg-
positive are restricted from performing invasive procedures(72). 
In December 1991, a US federal standard mandated that the hepatitis B vaccine be made 
available at employer's expense to all HCWs exposed occupationally to blood or other 
potentially infectious materials(73). ACIP recommends HCWs and trainees in certain 
populations at high risk for chronic HBV be evaluated when first presenting in a healthcare 
facility and immunised(31,72,74). In 1982 about 10,000 HBV infections occurred among 
HCWs in the USA and by 2004 decreased to 304, largely resulting from the implementation of 
routine pre-exposure vaccination and improved infection-control precautions(72). 
KSA is an endemic area for HBV, suggesting that HCWs there who come into contact with 
blood and bloody fluids are at substantial risk of HBV infection(75). Additionally, HCWs from 
the multinational workforce originating from either high or medium endemicity HBV countries 
present another challenge to health affairs(40). In KSA in 1988, according to a study exploring 
the HBV profile among 289 HCWs, the HBsAg carrier rate in males and females from the 
Philippines was 33.3% and 8.0%, respectively. Moreover, no details about inclusion or 
otherwise of Saudis carrying out different hospital activities were presented. Philippines is 
considered a main source of HCW recruitment to Arabian Gulf countries and especially 
KSA(4,76).  
In 1998, MNG-HA started to check for HBV immunity status of all new employees working in 
patient care areas before their initial assignment, HB vaccine being given depending on 
antibody status(75). A local survey was conducted in 2004 to screen a total of 4,006 new hires 
(international and local ) revealing the highest rate of susceptibility among HCWs to HBV was 
for Middle Eastern men, 43.0% of the sample had negative IgG antibody test results for HBV. 
However, the survey uncovered some pertinent epidemiological findings invaluable in the 
management of a multinational workforce. Additionally, the survey does not identify the 
specific occupations of 46% of HCWs assessed. This is of concern, because certain occupations 
are more at risk for disease acquisition. Thus, the effect of occupation on the rates of 
susceptibility to these vaccine-preventable diseases was not analysed(4). 
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Risk of hepatitis B virus among military soldiers 
Military personnel are at increased risk of acquiring HBV infection(77,78). Incidence of HBV 
infection is different among armies in various countries (0.3-3.9%), being higher where there 
are generally no vaccination programs(79,80). The large majority of military personnel can be 
considered as young and healthy. This can significantly contribute to reducing the impact of 
HBV, but even a simple infection can impact on combat-readiness and prevention is 
preferential(81). Recruitment into the army is a risk factor in itself for some diseases, these risks 
being linked to specificities of function, as combatants may be exposed to blood and blood-
borne disease and during combat, blood-borne infections are a real threat(24,81). Any decline 
in uptake of HBV vaccine in the general population could lead to a reservoir of unprotected 
adults in military populations, which could cause outbreaks (81). At particular risk is the soldier 
providing emergency care to combat causalities(82), any soldier administering first aid may 
become infected while treating bleeding wounds or providing other life-support measures(82). 
Several behavioral factors have been associated with increased risk of HBV infection in the US 
Army(10-13,83). Although difficult to determine the relative importance of these factors 
between studies, suggested risk factors include: use of illicit injectable drugs;(10) number of 
sexual contacts;(11) duty assignment to a high-prevalence region;(12) STD history;(11,13) 
occupational exposure to blood(12). 
A study conducted to assess occupational and geographic risk factors for HBV among US army 
personnel showed that the principal route of transmission of HBV among conscripted personnel 
is not through occupational exposure to blood or blood products, but through behavioural risk 
factors of sexual activity, parenteral drug use, and perhaps other unknown etiologic factors. 
However, a detailed classification of blood-exposure for hospital personnel was preferable for 
occupational analyses. This level of occupational detail was not possible with the present data, 
and consequently some of the risk contrast between personnel handling blood and those not, 
will have been obscured. Additionally, data do not reflect a longer time-in-job for blood-
exposure compared to non-exposed personnel. Moreover, this data was not presented with a 
reliable estimate of the annual incidence of HB infection in the US Army because of the 
underreporting inherent in records restricted to inpatients(12). 
Vasilios’s study among military recruits in Greece (2004-2005) after the HBV vaccination 
programs were implemented in 1993 revealed of 1840 participating recruits, 62.0% had 
antibodies against HBsAg, while 36.0% had undetectable HBsAb levels. HBcAb was found in 
1.68%, among them 1.1% were HBsAb positive, and 0.2% were HBsAb negative. The overall 
prevalence of HBsAg carriage was 0.32%. However, the recruits' vaccination records were not 
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available for further analysis and this renders it difficult to effectively interpret the HBV 
serologic profile in some of the recruits(84). 
A cross-sectional study was performed to estimate the seroprevalence of HBV and the risk of 
exposure among 400 male SANG soldiers working in Jeddah in January 2009(37). A total 4.0% 
soldiers were positive for HBsAg, 13.2% positive for HBcAb, and 57.5% for HBsAb (immune 
to HBV infection) primarily(84.3%) due to HBV vaccination. A total of 38.0% were susceptible 
to HBV infection. Older age, presence of a household member with HBV disease and previous 
endoscopy were considered as independent predictors of HBV exposure. The study concluded 
that HBV prevalence was higher than in the general population and military populations from 
Western countries. Both work-related and community-related risk factors for exposure are 
suggested. However, self-reported data were susceptible to recall bias. Additionally, the cross-
sectional design does not allow the determination of causality and the small number of those 
with HBV infection (15 out of 400) made it difficult to examine the risk factors of infection(37). 
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2.2 : Measles 
2.2.1 Introduction 
Measles is an acute, highly communicable viral disease(85,86), more severe in infants and 
adults than children(85). It is of the genus Morbillivirus of the family Paramyxoviridae(85,87), 
humans being the only known natural host(85,87). It spreads by airborne droplets or by direct 
contact with nasal or throat secretions of infected people being less commonly spread by articles 
freshly soiled with nose and throat secretions(85,87). Person- flight transmission occurs(88). 
The attack rate in a susceptible individual exposed to measles is 75.0%(89) with those not 
previously having the disease or being successfully immunised being susceptible(85,87). 
Incubation is about 10 days (range,7–18) from exposure to fever onset(85,87) but extend when 
immune globulin (IG) is given. Infected people are usually contagious from day one, before the 
beginning of the prodromal period to four days after rash appearance(85,87). 
Diagnosis 
The WHO clinical case-definition for measles is “any person with fever and maculopapular 
rash and cough/coryza/conjunctivitis”(85). A confirmed case is one that either meets the clinical 
case definition, and is epidemiologically linked to a confirmed case, or laboratory-confirmed 
(not needing to meet the clinical case definition)(85,87). The detection of measles-specific IgM 
antibodies presents 3–4 days after rash onset, or a significant rise in antibody concentrations 
between acute and convalescent sera confirms the diagnosis(85). The diagnosis of measles can 
be made by culturing the virus from blood, respiratory secretions, conjunctival swabs, or urine, 
however, culturing the virus is difficult, requires special facilities, and is performed rarely(20). 
2.2.2 Measles vaccination 
The vaccine strain currently in use globally is Enders-Edmonston; a live attenuated vaccine 
licensed in 1968, available in combination as a measles-mumps-rubella (MMR) vaccine, and a 
quadrivalent MMRV vaccine (measles, mumps, rubella, and varicella). Other vaccines, derived 
from attenuated measles virus, are in use around the world(90). 
To achieve immunity, two doses of MMR to all children should be administrated. ACIP (US) 
recommends children without evidence of measles immunity not be admitted to school until the 
first dose of MMR has been administered(91). The rationale for the second dose of the measles 
vaccine was not to serve as a booster but rather to immunise the five to 20.0% of people who 
had not responded to the first dose(92,93). 
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Anti-measles antibody develops in 95.0% of individuals vaccinated at age 12 months, and 
98.0% vaccinated at 15 months(91). The WHO recommends that in high-prevalence settings, 
the first dose of MMR be administered at nine months (given high risk of transmission and the 
persistence of maternal antibodies in the infant and the increased risk of exposure to measles at 
a younger age)(85). Great efforts have been made in measles immunisation in KSA from the 
control to elimination phases, mandatory measles vaccination with one-dose Schwartz vaccine 
being introduced in 1982, but in 1991 a two-dose schedule was implemented using Edmonston-
Zagreb measles vaccine. Evaluation of the MMR campaign and surveillance data was reflected 
in the measles immunisation policy by shifting the immunisation age to 12 months and to 
preschool using the two-dose MMR schedule(94). Measles vaccination usually leads to long-
term immunity; more than 90.0% of recipients develop anti-measles antibodies if the first dose 
of the two-dose series is given no sooner than 12 months of age(91). In adults, the following 
groups are at increased risk of exposure to morbidity from measles if not vaccinated: Women 
who could become pregnant, college students, HCWs, international travellers, individuals 
involved in outbreaks and military soldiers(17-19). Acceptable documentation of previous 
immunisation is by: clinical measles diagnosis by a physician, laboratory evidence of immunity 
and documentation of measles vaccination(22). 
In the setting of measles exposure, individuals with contraindications to vaccination should 
receive IG. The following cases are contraindicated for vaccinations: Pregnancy, 
immunocompromised patients, thrombocytopenia, recent blood products or immunoglobulin, 
allergy, and concurrent illness(91). Evidence does not support a link between MMR vaccination 
and any of the following: retinopathy, optic neuritis, ocular palsies, Guillain-Barre syndrome, 
cerebellar ataxia or autism(22). Concern has been raised periodically about a possible link 
between receipt of MMR and autism, but several studies have now been performed which fail 
to demonstrate any such association and the original study that prompted these fears has now 
been shown to be fraudulent(22,95). 
2.2.3 Epidemiology  
Seroimmunity status of measles 
Measles occurs worldwide with control efforts substantially altering the global distribution(92), 
summarised in Table 2.5 below. In temperate climates, it occurs primarily in late winter and 
early spring, while in tropical climates primarily in the dry season(85,96). Its incidence has 
decreased substantially in regions where vaccination has been established; the high number of 
cases in the developing world has been attributed to low vaccination rates(96).  
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Region Achievement 
The 
Americas 
1990-2008, cases fell from approximately 250,000 to 203 cases (97). In 2000, 
elimination of measles was declared in US; however, imported cases continue 
to occur and emphasise the importance of routine vaccination to maintain 
immunity(98). 
European 
Region 
In late 2009, a sharp increase in measles cases in the region began, primarily in 
Western Europe in 2011. Of the approximately 26,000 cases reported for 2011, 
an estimated 54%occurred in France(99).  
African 
Region 
Improved vaccination rates were associated with a 93.0% reduction in measles 
cases, from 492,116 (2001) to 32,278 (2008)(100). 
WPR Japan had a measles epidemic in 2007/8, which led to secondary imported cases 
in Canada & US(101). The region is estimated to have had 147,986 cases in 
2008(97). 
MER KSA included; implementing measles control has been a challenge due to civil 
unrest, natural disasters, and inadequate public health systems(98),(101). Cases 
have declined; early 1980s approximately 200,000 cases identified annually 
(101), 2008, 12,120 cases identified(97).  
SEAR Region had approximately 126,000 measles deaths in 2008, representing the 
majority of all measles deaths in the world in year(77.0%). India is identified as 
the only WHO-designated “priority country” not implementing WHO measles-
control strategies(97,98,102). 
Table 2.5: Achievements in global measles control 
 
In the pre-vaccine era, there was an estimated 100 million cases and six million measles deaths 
per year(85). By 2000, measles was estimated to cause approximately 31 to 39.9 million 
illnesses worldwide with an estimated 733,000 to 777,000 deaths, making it the fifth most 
common cause of death in children under five(103). Figure 2-3 shows globally reported cases 
in 2015. 
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Figure 2-3: Reported measles cases on 2015 
Source: http://goo.gl/LzxciF(104) 
Measles vaccination has markedly reduced incidence throughout the developed world, 
however, cases still occur in low-incidence countries via importation by travellers not 
vaccinated(92). Therefore, maintenance of immunity is important even in low incidence 
countries, since a single imported case can result in large outbreaks in the setting of waning 
immunity(92). Strategies to update immunisations in foreign-born adults are an important 
component of a comprehensive vaccine program in any country. This is supported by a 
serologic study of recently arrived immigrants and refugees to Canada, in which 36.0% of 
participants were not immune to at least one of three vaccine-preventable diseases (e.g., 
measles, mumps, or rubella)(105). 
The World Health Assembly adopted the WHO/UNICEF global immunisation vision and 
strategy including the goal of a 90.0% reduction in global measles mortality between 2000 and 
2010(96). The WHO identified 47 “priority countries” to focus measles mortality reduction 
efforts; these nations jointly account for approximately 98.0% of measles deaths. The strategy 
in these nations includes the following measures: (1)Immunisation with a goal of more than 
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90.0% national coverage and more than 80.0% per-district coverage with two doses; 
(2)Surveillance activities, including case investigation and laboratory testing in all suspected 
cases; and (3)Clinical management of cases, including administration of vitamin A(106). A 
model to estimate progress to reaching the above goals suggested that the estimated annual 
global measles incidence fell by 66.0% between 2000 and 2010, from 4.6 to 1.6 cases per 1000 
population(107). During the same period, estimated annual global mortality fell by 74.0%; most 
deaths occurred in Africa and India(108). 
Risk of measles among health care workers 
Health-care facilities are emerging as important sites for acquisition of measles(109) and 
nosocomial transmission may account for 14.0-45.0% of cases identified during epidemics, 
especially in countries where measles elimination is declared(15). Measles may be easily 
transmitted in hospitals and physicians' offices(88). The evolution of nosocomial outbreaks is 
highly facilitated by the fact that the virus spreads extremely quickly within closed settings, 
such as waiting areas in emergency departments, where numerous patients congregate in 
proximity and often for a long time, resulting in hundreds of contacts(16). 
Misdiagnosis or delayed diagnosis of a measles case in association with delays in contact 
tracing and inadequate implementation of control measures are common in almost all events of 
nosocomial spread. It has been estimated that HCWs have an 18.6-fold increased risk for 
acquisition of measles compared with adults in the community, and thus measles represents an 
occupational risk(15). Once exposed to measles, susceptible HCWs may pose themselves, their 
patients, or colleagues a risk, and when a case is suspected, respiratory isolation should be 
instigated: such as isolation of the suspect or confirmed index patient, negative air pressure 
rooms, masks for the index patient, proper use of personal protective equipment among HCWs 
such as masks and N95 respirators, eye protection, gloves, and gowns(109). 
Beyond serious morbidity and mortality, measles nosocomial outbreaks are associated with 
absenteeism of susceptible HCWs after exposure, disruption of health-care services, and 
considerable costs because of management of infected persons and containment purposes, 
including serology testing and extensive contact tracing(16,109). In a 2008 health-care-
associated measles outbreak that occurred in Arizona, US, a total of US $799,136 was spent 
responding to and containing seven cases in two hospitals, with 8,231 contacts traced and 
investigated(75). Similarly, in a hospital-based measles outbreak that occurred in Pennsylvania, 
US, in April 2009, one index case from India resulted in five additional measles cases and an 
extensive investigation of 4,000 contacts in the emergency department. However, some measles 
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cases appeared to be community acquired with no demonstrable epidemiological links. 
Moreover, HCWs measles serologic data analysis was based on information collected at two 
hospitals and, therefore, might not be representative. Also, birth year was not available for all 
HCWs, limiting ability to determine the proportion of all HCWs born before 1957 who were 
measles seronegative. Additionally, estimated outbreak costs quite possibly underestimate the 
true cost for the two hospitals(110). 
As HCWs are at higher risk(15), a strict and sufficient occupational immunisation program 
must be implemented for all who might come into contact with patients, including permanent, 
temporary, and contract staff; medical students; physician; and volunteers. Occupational 
vaccination programs must start as early as possible in the careers of trainees and students(109). 
All HCWs should have documented and easily retrievable evidence of measles immunity to 
ensure case management and rapid outbreak response(110). In countries where measles 
elimination is declared, a travel history to an endemic country taking into account the incubation 
period of measles should be considered(15). 
Almuneef et al (2006) investigated the prevalence of measles in SANG among multinational 
HCWs in KAMC- Riyadh from September 2001 to March 2005, indicating that among the 
4,006 HCWs, 13.0% had negative IgG antibody test results for measles virus, and susceptibility 
to measles was highest among HCWs from the MER. This survey does not identify the specific 
occupations of 46% of HCWs assessed. This is of concern, because certain occupations are 
more at risk for disease acquisition and thus the effect of occupation on the rates of 
susceptibility to these vaccine-preventable diseases in this study were not analysed(4). 
Risk of measles among military soldiers 
Military soldiers are at risk of measles transmission; possible explanations are the nature of 
military lifestyle, since they most often live in closed communities, and pursue activities that 
foster close contacts and therefore the transmission of the disease(17-19). Military recruits, as 
with other populations in school or camp settings, are placed in an environment particularly 
favourable to the rapid and efficient transmission of the virus in these high-risk settings(17). 
Table 2.6 displays study summaries of military personnel with measles infection; seronegativity 
against IgG measles ranged between 40.8% and 4.5%. 
  
  
30 
Author Date& place Method Results 
Kelley 
PW, et 
al(111) 
1989, US army 
recruits 
A questionnaire and 
serological survey 
Seronegativity rates were 20.7% 
susceptibility was less in females, 
blacks, and college-educated recruits.  
Duclos 
P, et 
al(112) 
1991,Canada 
among military  
recruits  
Two blood samples were 
collected from 399 
recruits enrolled prior to 
immunisation and 3 to 5 
weeks following 
immunisation. 
4.5% recruits had seronegativity rates 
on the first sample, All recruits had 
neutralisation titres on the second 
sample. 
Sibilev 
VI, et 
al(113) 
1994, Russian 
military units 
 Epidemic outbreaks that exposed to 
12.0% of personnel in Russian 
military units 
Peric D, 
et 
al(114) 
1996, recruits of 
the Croatian 
Army  
To estimate the 
transmission risk 
of measles viruses. 
Seronegativity rates measured 40.8%. 
However, the soldiers do not have any 
medical records on vaccination, and 
that anamnestic data on disease 
contraction and vaccination were 
unreliable. 
Gdalevic
h M,et 
al(115) 
1994, Israel 
military units 
A wide-scale 
vaccination campaign 
was launched. 
Abrupt cessation of morbidity in the 
military. In the civilian sector, no 
intervention was undertaken, the 
epidemic continued for another four 
months. However, this study had the 
absence of active case finding and the 
nonreliance on serological testing for 
the definition of measles. 
Vainio 
K, at 
al(116) 
2004,Norwegian 
military  
conscripts 
Level 
of measles immunity 
was measured among 
1,405 soldiers. 
Seroprevalence of measles antibodies 
was 89.3% 
Table 2.6: Studies about military personnel with measles 
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2.3 : Varicella (Chickenpox) 
2.3.1 Introduction 
VZV is one of eight herpes viruses causing human infection in two forms: varicella and herpes 
zoster (shingles)(25). It is (alpha) herpesvirus 3, a member of the Herpesvirus group , and the 
disease occurs only in humans(26,117). 
It is highly contagious, with secondary household attack rates of more than 90.0% in susceptible 
individuals(118,119), it is transmitted in susceptible hosts via contact with aerosolized droplets 
from nasopharyngeal secretions or direct cutaneous contact and inhalation with vesicle fluid 
from skin lesions(118). The average incubation period is 14 to 16 days, up to a range of 10-21 
days(120). The period of infectivity is from 48 hours prior to rash onset until skin lesions have 
fully crusted(25), prolonged after passive immunisation. Susceptible individuals are considered 
infectious for 10–21 days following exposure(26). 
 
Diagnosis 
VZV is clinically diagnosed but skin lesion specimens could be used for laboratory 
confirmation. Vesicular swabs or scraping and scabs from crusted lesions can be used to 
identify VZV by polymerase chain reaction (PCR) or direct fluorescent antibody (FA). In the 
absence of vesicles or scabs, scrapings of maculopapular lesions can be collected for 
testing(117). In the absence of skin lesions, a significant rise in serum varicella IgG from acute- 
and convalescent-phase samples by any standard serologic assay confirms diagnosis 
retrospectively and are useful in complicated cases and epidemiological studies(26,117), but 
may not be reliable in immunocompromised people(117). 
 
2.3.2 Varicella vaccination 
The introduction of the varicella vaccine in 1995 in the US was a major advance, leading to 
marked decline in associated morbidity and mortality. Initially, when only one dose was 
required, the incidence of varicella declined 43.0% between 2000 to 2005; after a second dose 
was added to the routine childhood schedule, the incidence of varicella declined 72.0% between 
2006 to 2010(121). 
Post-licensure experience demonstrated that one dose is usually 80.0 to 90.0% effective in 
preventing clinically diagnosed or laboratory-confirmed varicella showing 95.0 to 100% 
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effectiveness in preventing severe disease(22). The evidence of immunity in adults includes: 
documentation of two doses of varicella vaccine at least four weeks apart; laboratory 
confirmation of prior exposure to varicella infection; history of prior varicella infection or 
herpes zoster infection(22,117). 
Priority groups for adult immunisation of VZV include; close contacts of persons at high risk 
for serious complications, persons in environments where transmission of varicella is likely 
(e.g. day care employees, residents and staff in institutional settings), or where transmission can 
occur (e.g. college students, inmates and staff members of correctional institutions and military 
personnel), non-pregnant women of childbearing age(26). 
SMOH introduced mandatory childhood varicella vaccine as two doses in January 
2008(122).Varicella vaccine is composed of the Oka strain of live, attenuated VZV(123), of 
two live, attenuated VZV vaccines US licensed(123); a single-antigen varicella 
vaccine (VARIVAX, Merck) and a combination measles, mumps, rubella, and varicella 
vaccine (ProQuad, Merck); ProQuad is licensed for use in persons aged 12 months to 12 years 
produced to decrease the number of injections and to increase compliance, but because of 
manufacturing problems at is currently unavailable(124). 
Two doses are now recommended for those aged below 12 months who do not have 
contraindications to the vaccine. The first dose being administered at age 12–15 months and the 
second 4–6 years of age. A second catch-up dose of varicella vaccination is recommended for 
children, adolescents, and adults who have received only one dose. The minimum interval 
between doses for children less than 13 years is 3 months, and those aged 13 years or more can 
be vaccinated at an interval of 4–8 weeks. In doubt, prior varicella disease is not a 
contraindication to varicella vaccination(117). The following cases are contraindicated to the 
vaccine: People with severe allergy to gelatine or neomycin (hives, swelling of the mouth or 
throat, difficulty breathing, hypotension, and shock), people who have had a severe allergic 
reaction to a prior dose of vaccine, immunosuppression patients, women who are pregnant or 
attempting to become pregnant(117). 
2.3.3 Epidemiology 
Seroimmunity status of varicella 
Varicella occurs worldwide; in temperate climates, it tending to be a childhood disease, with 
peak incidence during late winter and early spring while in tropical climates, infection tends to 
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occur at older ages, resulting in a higher susceptibility among adults than in temperate climates 
(26,117). 
According to seroprevalence pre-vaccine data, more than 95.0% of those acquiring varicella in 
the US did so before age 20, and fewer than 2.0% of adults remained susceptible to 
infection(125). In the pre-vaccine era , the CDC estimated US yearly incidence at 
approximately four million cases, with nearly 11,000 admissions and 100 deaths(126). 
The Varicella Activity Surveillance Project was established in 1995 as a cooperative agreement 
between CDC and two US cities to monitor incidence after vaccine introduction. At the start of 
the national program, ACIP recommended one dose of varicella vaccine for children 12 to 18 
months old, older susceptible children (19 months through 12 years of age), and high-risk 
groups(127). This was followed by substantial declines in incidence and related hospitalizations 
within the first five years; in three surveillance sites, the incidence declined by greater than 
70.0% from 1995 to 2000 with vaccination rates ranging from 74.0 to 84.0%. Although a 
substantial reduction in the extent consequences of varicella was reported, varicella 
hospitalizations were a relatively rare event, and the data did not provide sufficient weight of 
evidence to detect a statistically significant decline. Regarding vaccine coverage, there were no 
estimates available for the study location from the national immunisation survey; coverage 
estimates for the state may not accurately reflect coverage in the study location(128). In 2006, 
ACIP recommended a second dose because of a number of varicella outbreaks in highly 
vaccinated populations of schoolchildren, continued monitoring being necessary to observe 
additional gains made in decreasing incidence(118).  
Although children were most commonly affected, adults and infants less than one year old were 
overrepresented among those who developing complications at relatively high rates of 
mortality(129), adults with varicella having a 25-fold higher risk of complications compared to 
children(130). A US review of age-specific data for varicella and encephalitis 1972 to 1978, 
demonstrated persons under 20 accounted for fewer than 2.0% of varicella cases, but 12.0 and 
28.0% of varicella encephalitis and deaths, respectively. However, conclusions based on these 
data must be made cautiously. First there was no information regarding underlying conditions. 
Second, under-reporting of cases was widely acknowledged and may be selective for particular 
age groups and may vary over time. Third, there probably was over-reporting of severe cases 
as well as complicated cases occurring in older individuals because of the relative infrequency 
of varicella in this age group(131). 
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Almuneef et al (2006) investigated complication rates in SANG over two-years, all reported 
cases of varicella at KAMC- Riyadh being followed for development of complications (June 
2001-December 2003. This study indicated that 3,802 cases were reported and followed during 
the acute illness phase with the majority (78.0%) occurring in children under 15, 2.0% required 
hospitalization, and 1.5% developed complications. Among those with complication were 
34.0% skin and soft tissue infections, 28.0% pneumonia, 10.0% bacteraemia, 7.0% encephalitis 
and necrotizing fasciitis. Complications were less common in children at 1.2% as compared to 
adults 1.7%. However, pneumonia and hospitalization were significantly more common in 
adults as compared to children. The overall fatality rate was 0.05%; two patients died, one aged 
two months, the other 28 years. Though, the reporting system in KSA is voluntary and only 
cases that seek medical attention were reported, and even this was dependent on the compliance 
of the physician. This may reflect an incomplete record of mild cases, which did not come to 
medical attention(41). 
Risk of varicella among health care workers 
Varicella may be introduced into a hospital by patients, staff, or visitors with either clinically 
evident infection or during the incubation phase of the disease(132). Studies of VZV exposure 
in health-care settings have documented that a single provider with unrecognised varicella can 
result in the exposure of more than 30 patients and more than 30 employees(23). 
Nosocomial varicella has also occurred among staff and patients who had no direct contact with 
the index case, supporting airborne transmission as a spread mode(132). Epidemiologic and 
tracer studies confirm exposure to airflow, from rooms occupied by patients with varicella, 
presents major risks of infection acquisition among susceptible hosts(132). 
An outbreak was described in a tertiary paediatric facility (oncology), over16 days being 
detected in seven children (index case, five secondary, one tertiary), of which, four appeared to 
represent "breakthrough disease" in previously vaccinated children. However, the data collected 
could not be applied to cases of likely breakthrough disease in terms of the number of varicella 
lesions present, and laboratory confirmation of VZV infection was carried out for only four of 
the children(133). In contrast, transmission in the hospital nursery is rare because of trans-
placental passage of protective maternal antibodies(123). Table 2.7 summarises some existing 
literature about varicella in an HCW setting. 
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Author Time /place Aim /Method Results 
Kubeyinje 
EP, at 
al(134) 
1992-1994, 
Arar Central 
Hospital, KSA,  
To assess 
ethnic 
differences in 
the severity  
Persistent fever, extensive skin eruptions and transient elevation of hepatic enzymes significantly more 
in non- Saudis than in Saudis.  
M mean illness duration in non- Saudis significantly different, +/-3.41 days compared to mean duration 
+/-3.52 in Saudis. Varicella infection runs a more severe course in non- Saudis from Asia.  
Almuneef 
M, et 
al(39) 
2003,Riyadh, 
KSA 
Questionnaire 
distributed, 
and varicella 
IgG antibody 
serology 
measured. 
64.0% had previous history of VZV infection, 13.0% a history of positive test, 2.0% a history 
of varicella vaccination, 36.0% negative or unknown history of VZV infection, 29.0% underwent 
antibody testing, 83.0% proved immune. 
A significance difference among staff from the West 81.0%, Far East 78.0%, and South Africa 59% 
reporting more histories of VZV infection compared to employees from MER 46% revealing history of 
positive antibodies in 13%, 18%, 17%, and 8%, respectively.  
Significance difference found among nurses reporting varicella infection history 75.0% and of 
positive varicella antibodies 16.0% more than physicians (54% and 8%, respectively).  
However, as a result of the poor documentation, it was impossible to determine retrospectively how 
many HCWs were lost where staff of uncertain immunity were removed from duty after exposure. 
Almuneef 
M,et 
al(135) 
2004,Riyadh, 
KSA 
Questionnaire 
and serology 
test to study 
immunity & 
varicella 
history 
1,058 new recruits, 84.0% were immune and 16.0% were susceptible.  
Susceptibility rate was 23.0% for Asian, 15.0% for South African, 13.0% for MER, and 9% for Western 
employees.  
Physicians were more likely to be immune 93.0% than were nurses 85.0%, medical technicians 75.0%, 
or administrative clerks 84%.0.  
Seropositivity was not associated with age or gender.  
Table 2.7: Studies about Health care workers with varicella 
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Risk of varicella among military soldiers 
Military personnel often face varicella in several settings as detailed earlier(24). Outbreaks are 
reported among adult populations in hospitals, military training facilities, refugee centres, 
immigration detention facilities, and cruise ships (123). Military outbreaks are disrupt training 
schedules, reduce readiness, and significantly increase medical care costs. Consequently, a 
vaccine program to protect is suggested as a potential strategy to avoid the associated costs and 
morbidity during training(136). Table 2.8 summarises some of the existing literature. 
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Author Time and place Aim and method Results 
Kelley PW, et 
al(111) 
1980s, U.S Army 
 
To identify antibody prevalence. 
Questionnaire and serological survey  
6.9% lacked sufficient antibody titres to provide protection against 
varicella disease. 
Herrin 
VE,(137) 
1981-1994,U.S 
Army 
Retrospectively for the years 1981-1994 3,705 cases of varicella disease were reported. Overall incidence was 87.9 
/ 100,000 soldiers / year. However, data were not available to examine 
temporal changes in susceptibility. 
Struewing JP, 
et al,(138) 
1989, US Navy 
and Marine Corps 
recruits.  
Assess risk of epidemic transmission. 
Questionnaire and the seroprevalence of 
antibody to varicella  
Seronegativity rates 6.7% . Higher among non-Whites and recruits from 
outside US, especially island territories. However, this study was a cross-
sectional study over a short period. A longer cross-sectional study carried 
out over a period of considerably longer is needed for seroprevalence trend 
Avrahami-
Heller Y, et 
al,(139) 
3 years (1985, 
1988, and 1992) , 
Israeli Army 
Determine rate of immunity to VZV 
About 900 sera samples were taken for 3 
years (1985, 1988, and 1992). 
98.0% tested positive for VZV antibodies. 
Immigrants having slightly lower immunity rates. 
Longfield 
JN,(140) 
October 1986  
November, US 
Investigation of two varicella outbreaks 
in military training centre. 
42.0% of 810 adult recruits were seronegative for VZV. 
 
Dashraath P, 
et al(141) 
From September 
2000 to October 
2005, Singapore 
Army 
Assess seroprevalence of VZV 
antibodies in recruits and ascertain 
predictive value of self-reported history 
pre-enlistment medical check-up, 
questionnaire and serological survey 
Prevalence of VZV seropositivity was 76.0% For reported history,73.7% 
Chinese,73.0% Malays,63.6% Indians reported previous varicella infection 
and/or vaccination. However, the study only covers Singapore Armed 
Forces enlistees, who are all young adult males, so cannot be generalised 
to the entire population of Singapore. The study also excluded participants 
from other races due to their small numbers and the representation by a 
variety of races. 
Table 2.8: Studies about military personnel with varicella 
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2.4 Knowledge assessment  
Several studies attempted to assess knowledge of vaccine preventable diseases, especially amongst the risk within communities. Table 2.9 shows results 
of knowledge prevalence about HBV, measles and varicella among different population. 
Author Time and place Aim and method Results 
Al-
Thaqafy , 
et al(38) 
2013, KSA Assess knowledge, attitude 
and practice of HBV- 400 
Saudi soldiers surveyed 
Low median and inter-quartile range of score (16, 6-26) to 58 questions. However, these 
findings cannot be projected to the general population as the military population is likely to 
have different exposures and is inherently more disciplined 
Khan; et 
al(142) 
2005, KSA Assess knowledge of HBV 
and vaccination status of 
expatriate ethnic groups of 
blue collar workers in 
KSA. 665 participants  
 41.6% or more correct answers- of 12 questions. However, the sampling frame was based 
on verbal advertisement in different places where expatriates usually gathered. This might 
have produced some selection bias. Additionally, it was based on males only and therefore, 
cannot be generalized to the whole population.  Moreover, the survey did not include 
questions on family history or carrier status, which might have played an important role. 
Strohfus 
PK, et 
al(143) 
2013, USA Assess HCWs’ knowledge 
about measles, mumps, and 
rubella vaccine. 340 
participants.  
61% achieved passing score of 80%. However, participants were not monitored while 
completing the examination making it possible for staff collaboration on answers; and 
actual scores may have been even lower. Additionally, it is possible that the 50% who did 
not return the survey may have performed much differently to the 50% who did. 
Hesham 
R, et 
al(144) 
2009, Malaysia Assess knowledge, attitude 
and vaccination status of 
varicella among students of 
University in Malaysia. 
206 Malay respondents 
60% achieved pass of 74 questions. However, only first and second year students were 
included in this survey, so the results might not represent all university students. 
Additionally, the bilingual questionnaires were quite lengthy and this may have caused the 
participants to be impatient in answering questions which could introduce inaccurate data. 
Table 2.9: Studies about knowledge assessment among different groups 
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2.5 Vaccine Compliance 
It is important for HCWs involved in patient care in endemic areas to have effective sero-
protection through vaccination. The HBV vaccine is offered free of cost in some developing 
and most developed countries, despite claims on compliance to HBV vaccination among HCWs 
which conflict. Table 2.10 shows studies that demonstrate compliance rates among HCWs to 
HBV vaccine dose(145-152). 
Author Year Country N % Physicians 
(%) 
Nurses 
(%) 
Technicians
/Paramedic 
staff (%) 
Jepsen et al (145) 1992 Denmark 830 44.0 35.0 - 35.0 
Murta et al(146) 1993 US 813 54.0 32.0 - - 
Stanford et al (147) 1995 Australia 1464 55.8 69.0 74.6 - 
Gyawali et al (148) 1998 UK 236 80.0 88.0 83 70.0 
Mayo Ferriero et al 
(149) 
1998 Spain 475 47.1 - - - 
Fatusi et al(150)  2000 Nigeria 2548 53.8 40.3 39.7 69.5 
Manso et al (152) 2003 Brazil 458 80.7 98.6 94.3 91.7 
Panhotra 
et al(151)  
2005 KSA 1302 71.6 52.9 79.4 78.3 
Table 2.10: Studies showing HBV vaccine compliance among various groups of HCW 
A study in US (2003) demonstrated that only 75.0% of HCWs received the 3-dose HBV 
vaccination series. However, HCW education and income levels, as well as length of practice, 
were not evaluated, and these are characteristics that may influence vaccination status(153). A 
2009 reported an equal to or more than one-dose coverage rate of 75.0%-and a less than or 
equal to three-dose rate of 67.0%(154). This low vaccination coverage is partially explained by 
negative attitudes toward the vaccine among HCWs, who are more knowledgeable about 
vaccine-preventable diseases than the general population and are perceived as role models for 
health behaviour. However, HB vaccination was not verified by medical records and thus may 
be subject to recall bias. Additionally, face-to-face interviews might lead to underreporting of 
sensitive risk behaviours(8). 
However, almost all nosocomial cases of measles were either incompletely vaccinated (one 
shot) or completely unvaccinated. Some possible reasons for this are fear of vaccine adverse 
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effects, opposition to vaccinations, or simply not vaccinated routinely; it is common among 
HCWs to be incompletely vaccinated or unknowledgeable about previous doses(16). 
2.5.1 Compliance to vaccination in developing countries 
Many qualitative studies explore barriers and staff compliance to programmes, however, to the 
investigator’s best knowledge, there is no available published data about military groups. 
From focus group discussions in Uganda in 2006, main themes identified relate to general lack 
of information among care takers about immunisation, perceived immunisation benefits, 
concerns about vaccine administration, immunisation services and safety, and other 
misconceptions which influence decisions to vaccinate(155). In addition, although HCWs 
demonstrated knowledge about adverse events following immunisation and their management, 
reported facilities were rare. Finally, there was apparent inadequate communication between 
HCWs and care takers. However, caretakers with minor or no vaccine safety concerns were 
purposely excluded and the study was limited in coverage to only two districts(155). 
A mixed method study two years into a Human Papilloma Virus (HPV) vaccination program 
in Vietnam with parents, revealed support for the vaccination. Participation of the National 
Expanded Program of Immunisation (EPI) in the project lent credibility to the HPV vaccine and 
contributed to high levels of acceptance. Parents who declined participation had concerns about 
side effects, the possibility that the vaccine was experimental, and the possible impact on future 
fertility. In terms of the decision-making process, many parents exhibited 'active decision-
making’ by consulting friends, family, and opinion leaders for guidance prior to making their 
decision. However, participant selection was criteria-based, not random and with no equal 
representation of mothers and fathers, so there could be selection bias(156). 
Measles outbreaks in the developing world have been attributed to low vaccination rates, where 
barriers to measles eradication additionally include, vaccination of limited age groups, political 
conflicts, limited vaccination coverage outside urban areas, malnutrition and displacement from 
conflicts. Nonetheless, measles can be controlled even in developing countries with vigilance 
and organised programs including mass vaccination and catch-up campaigns(96). 
A study in Lao to determine factors affecting compliance convenience sampled 13 persons in 
charge of the vaccination program from different levels of the health care structure and 
interviewed members of vaccination teams and 584 parents of children aged 9-23 months in the 
three provinces of low vaccination coverage. The main problems identified on the provision of 
services were lack of vaccine supply and diluent, a difficulty in maintaining the cold chain, lack 
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of availability and competence among HCWs, lack of coordination, limited capacity to assess 
needs and incoherent decision-making. However, the main major obstacles among consumers 
were found to be poor knowledge about measles immunisation and difficulties in accessing 
vaccination centres because of distance and cost, fear of side effects, fear of injections and 
poverty. In further analysis, a low education level of the father was a factor of non-
immunisation while the factors of good compliance were high incomes, spacing of pregnancies, 
a feeling that children must be vaccinated, knowledge about immunisation age, presenting to 
the hospital rather than expecting the mobile vaccination teams and last, immunisation of other 
family members or friends' children. The study findings suggest that in general, obtaining 
effective coverage requires upgrading/ training staff and a reinforcement of health education 
for target populations. However, the research was conducted on only three of the 18 provinces 
and deliberately chosen for their low immunisation coverage. Additionally, possible 
information bias must be considered, associated with poor recall of vaccination and medical 
history(157). 
2.5.2 Compliance to vaccination in developed countries 
Qualitative studies in developed countries attempt to elaborate reasons and barriers to 
vaccination either among employees or parents of children or other target groups. Table 2.11 
and Table 2.12 display these(158-162). 
A total of 125 measles cases from December 28, 2014–February 8, 2015 were confirmed in 
U.S. residents in a California outbreak in California. The source of the initial exposure was 
unidentified(163). Of these, 110 patients were state residents aged 6 weeks to 70; median age 
being 22. 35.0% visited one of two Disney theme parks, 34.0% having an unknown exposure 
source, and 31.0% secondary cases. Among the last, 6.4% were household or close contacts, 
and 23.6% were exposed in a community setting (163). 
Among the 110 California patients, 45.0% were unvaccinated; 5.0% had had one dose, 6.0% 
two, 1.0% three, and 43.0% unknown or undocumented vaccination status. 24.4% of the 
unvaccinated patients were infants too young to be vaccinated. Among the 37 remaining 
vaccine-eligible patients, 28(67%) were intentionally unvaccinated because of personal beliefs, 
and one was on an alternative plan for vaccination. Among the 28 intentionally unvaccinated 
patients, 18 were children (aged less than 18 years), and 10 were adults(163). This outbreak 
exposed the presence of gaps in immunisation services(164). 
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Author Location
/period 
Aim of study Themes/ barriers 
Evans M, et 
al(158) 
1998 
Bristol, 
UK.  
Parents' decisions 
to accept or refuse 
the primary 
(MMR) 
1-Risks and benefits of MMR compared with contracting the diseases, 2-Information from media 
and other sources about the safety of MMR, 3-Trust in the advice of HCWs and attitudes towards 
compliance with this advice. However, over half of the participants were highly educated and their 
mean age was 35 years, which could limit the generalisability of the results. 
Mills EJ, et 
al(159) 
2003,  
Canada 
Addressed 
parental barriers 
to vaccinating 
children 
1-Beliefs that vaccines cause diseases; are painful; distrust of medical community; communication 
problems with staff; memories of own or others adverse experiences; fear of long-term effects; 2-
Belief medical community does not understand vaccine adverse events; and parent’s own lack of 
knowledge about diseases. However, qualitative studies may not have studied similar populations 
at a similar time and publication bias may be limiting systematic review of qualitative studies. 
Okamoto S, 
et al(161) 
2007, 
Japan 
Why medical 
students do not 
undergo 
vaccination 
1-Individual level (such as anxiety regarding vaccination), 2-University and regional hospital level 
(such as treatment experience at university and regional hospitals), 3-Governmental level (such as 
inconsistent information on vaccination policy cost of vaccination, and awareness of vaccination). 
However, the sample of residents was small and non-representative and the study site was an urban 
private general hospital. Findings may differ in other facilities. 
Flaherty 
DK;(165) 
2011 
 
MMR and the 
regressive autism-
enterocolitis 
syndrome  
1-Wakefield claimed autism triggered by factors such as MMR vaccination. 2-Decreased parental 
confidence in vaccination and created public health crisis in England, questions about vaccine 
safety in North America. 10 years of investigation, Wakefield found guilty of ethical and scientific 
misconduct in this publication. Studies showed that the data presented were fraudulent. 
Table 2.11: Qualitative studies from developed countries showing possible barriers to vaccine(a) 
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Author Location/ period Aim of study Themes/ barriers 
Flaherty 
DK;(165) 
2011  Flaherty claimed that “Although the Wakefield paper has been debunked and the 
vaccine-autism connection totally discredited based on scientific evidence, it is unlikely 
that these events will change the opinions of the lay public”. 
Niederhauser 
VP, et al(160) 
2006 
(Oahu, Kauai, 
Maui, Hawaii) 
US 
Explore barriers to 
free-immunisations 
in parents whose 
children not fully 
immunised by age 
two among multi-
ethnic parents on 
four different islands 
1-Parental core (such as decisions made by parents, busy schedules, lack of personal 
organisation and motivation), 
2-Vaccine belief subthemes (such as immunisations are a choice, mistrust information 
and sources of information, risks are low, vaccine-preventable diseases are 
manageable, preference to alternate medicine or health care, religious beliefs), 
3-Knowledge sub-theme (such as lack of knowledge about schedules and 
misunderstanding importance of immunisations), 
4-Fear sub-theme (such as child could catch diseases from shots, of side effects, number 
of shots, trauma of the process and long-term impact), 
5-Child barriers ( such as childcare for other children in the family and child illness), 
6-Organisation barriers (such as availability of appointments and vaccines, no reminder 
systems, lack of availability of vaccines, provider’s differences of recommendations 
for shots), 
7-Other themes- lack of transportation and financial support. 
Table 2.12: Qualitative studies from developed countries showing possible barriers to vaccine(b)
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2.6 Search Strategy 
The search strategy in Medline use the following search strategy in the titles and keywords: 
[‘HBV OR measles OR varicella’ AND ‘seroprevalence OR seroimmunity OR knowledge OR 
concern’ AND ‘HCWs OR soldiers’ AND ‘Saudi Arabia OR multinational ’] and cross 
referencing of relevant articles. Articles were included if they used quantitative research. 
Additionally, in the qualitative research, the following search strategy for titles and keywords 
[‘vaccine compliance or vaccine barrier’ AND ‘developed countries OR developing countries’ 
AND ‘qualitative OR focus group discussion OR in depth interviews’ ] and cross referencing 
of relevant articles. 
The starting point for comprehensive search for all relevant studies is the major bibliographic 
databases (e.g., Medline, Cochrane, and EMBASE) but also include a search of reference lists 
from relevant studies, and contact with experts and IPCD staff, particularly to inquire about 
unpublished studies. The search was not limited to English language only and included both 
MESH terms and text words. The inclusion or exclusion of studies is defined, and the eligibility 
criteria used specified exposures and outcomes of interest. 
 
2.7 Chapter Summary  
Chapter two has presented a literature review on the subject of HBV, measles and varicella, and 
a description of clinical manifestation, diagnosis and management discussed in local and 
international epidemiology terms for each disease and its risk factors. The effects of each 
disease among HCWs and the military community are also reviewed. Finally, this chapter has 
discussed compliance of vaccination and barriers among developed and developing countries. 
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Chapter 3. Methodology 
This chapter explains the research design, the approach adopted in answering research 
questions, and procedures that have been pursued. An overview of the research design is 
presented, justifying why the mixed-methods approach was chosen, followed by illustration 
and rationalisation of the data collection instruments used. Information regarding the study 
procedure, including an overview of the study participants, the research context and the ethical 
considerations, is subsequently provided. This is followed by a description of the data analysis 
processes including both quantitative and qualitative analyses. The chapter concludes with 
some limitations faced and a chapter summary. 
 
3.1 : Study Design 
To achieve the study objectives, a mixed methods model of analysis was adopted, with two 
methodological designs used in parallel; 
1- Quantitative analysis through cross-sectional survey and gathering results of blood 
samples to determine the seroprevalence, seroimmunity and epidemiological characteristics, 
knowledge and concern about hepatitis B, measles and varicella infections for newly recruited 
multinational HCWs or Saudi soldiers in the SANG. Then, potential associations between data 
from the questionnaire and the blood laboratory results are explored. 
2- Qualitative analysis through in-depth interviews and focus group discussions to 
understand vaccine compliance, occupational infections in working settings, effectiveness and 
functionality of immunisation practice, work environment and vaccine among the HCWs, 
providers and service users(HCWs and soldiers). 
3.1.1 : Mixed method study  
Mixed methods research is a methodology for conducting research that involves collecting, 
analysing, and integrating (or mixing) quantitative and qualitative research (and data) in a single 
study or longitudinal program of inquiry(166). This approach facilitates understanding of 
‘what’ works and ‘why’ this works and for whom, as well as ‘how’ similar services may be 
modified to better meet needs. A mixed methods approach provides a more comprehensive 
picture of infection prevention and control among high risk groups and therefore can achieve a 
greater understanding than that from evidence generated by one methodology alone. For this 
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reason, mixed methods often have a broader focus than designs using only one method(167). 
In addition, the use of multi-method data collection was observed as being important for 
ensuring validity, enabling the minimisation of any possible limitations imposed by using only 
one method and to achieve broader and better results(42). 
There are two main reasons why a mixed methods approach, combining qualitative and 
quantitative methods, was used in this study. The first relates to suitability in answering the 
research questions regarding associated knowledge levels and concerns; second to obtaining 
different but complementary extension data to understand underlying reasons around vaccine 
compliance. 
Quantitative research includes a number of aspects, one of which is that it “consists of a 
systematic examination of specific factors and includes numerical information as data” (168). 
In this study, it was utilised to obtain broad data which provides general insights into new 
soldiers’ and HCWs knowledge by using a self-administered questionnaire providing 
assessment of knowledge, concerns, seroprevalence and seroimmunity epidemiology of HBV, 
measles and varicella. 
The qualitative approach is particularly useful in identifying possible determinants of 
acceptance, being important to gain in-depth understanding of the target groups’ values, 
opinions, behaviours, and social contexts regarding vaccines in SANG. Therefore, this study 
qualitatively explores perceived determinants (barriers and facilitators) of intention to accept 
vaccination in military and various groups of HCWs and professionals and describes differences 
between the groups interviewed(169,170). This was needed to identify local variable and 
underlying reasons explaining low vaccine compliance from service users’ (HCWs and 
soldiers) and service providers’ (staff providing vaccine) perspectives, to compare and contrast 
variables identified among new HCWs and soldiers within other parts of the world and to fill 
the gap in knowledge because there was no available local data about details to factors that 
contribute and effect vaccine barriers, occupational setting and vaccines safety. 
There are four characteristics of qualitative research which apply to this study, and these are 
namely: collecting words as data, analysing data, being concerned with the process, and 
obtaining meaning from participants(171). 
In summary, assessment of the knowledge investigated in the quantitative research is a first step 
in designing a health education programme, which can build knowledge, skills, and positive 
attitudes about vaccine preventable diseases particularly HBV, measles sand varicella. It 
motivates targets to improve and maintain their health, prevent disease, and reduce potential 
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risky behaviours(172). Additionally, the immunisation rate and benefits derived from vaccines 
and their potential risks, explored in the qualitative research, could be improved by increasing 
awareness to more effectively allay fears, understand underlying reasons of low compliance 
and build trust(173). 
3.1.2 : Study instruments 
In order to focus on aspects relating to the questioning practice undertaken and perceived by 
newly recruited HCWs, soldiers and staff providing vaccines in MNG-HA , the study sought to 
answer research questions. In addition, it utilised a number of research instruments, the 
relationship of which to the research questions is illustrated in Table 3.1. 
Research Question Instrument 
What is the immunity percentage of HBV, measles and varicella? Blood test 
1. What is the level of knowledge and concern about HBV, measles 
and varicella? 
2. Are there any potential associations between data from the 
questionnaire and the laboratory blood results?  
3. Is there any difference in knowledge, concern and immunity status 
towards HBV, varicella and measles? 
Questionnaires 
1. What are the barriers in vaccine compliance? 
2. How do you evaluate the immunisation program effectiveness?  
3. How you monitor and improve vaccine safety?  
Focus group 
discussion  
1. What is your experience in immunisation programs?  
2. What are the barriers in vaccine compliance?  
3. How do you evaluate the immunisation program effectiveness? 
4. How you monitor and improve vaccine safety? 
In depth 
Interview 
Table 3.1: Research questions and instruments 
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By addressing these questions, it is hoped to offer insights into how newly recruited HCWs or 
soldiers and staff providing vaccines in MNG-HA step towards further understanding of 
knowledge levels, seroprevalence and seroimmunity about HBV, measles and varicella and 
offer insights into and details of factors that contribute to and affect the vaccination program. 
3.2 : Study Setting 
The current study took place among SANG staff in Jeddah governorate, in the western region 
of the KSA. Jeddah is considered the primary Saudi seaport and the main port of entry for 
Makkah pilgrims, Figure 3-1. Its 2014 population was estimated to be 3.9 million, including 
2.06 million non-Saudis(174). Approximately 12,000 male SANG soldiers serve there and 
more than 4000 HCWs work in KAMC-Jeddah. They primarily receive health services 
provided by the MNG-HA through one tertiary hospital and five primary healthcare and 
preventive centres(37). 
KAMC-Jeddah is situated approximately 30 km south of Jeddah and 55 km from Makkah, the 
King Khalid Hospital (KKH) is a 531 bed modern facility providing hospital and health care 
services to SANG soldiers and their eligible dependents(175). 
 
Figure 3-1: Map of KSA (highlighting the location of the current research) 
Source: https://goo.gl/yJZDFW (176) 
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3.3 : Study Population  
The participants in the present study, at the time of data collection (August 2014-February 
2015), were newly recruited either as soldiers in SANG or as HCW professional in MNG-HA 
in Jeddah city. Soldiers join SANG from all over KSA having similar educations, mostly shared 
similar cultural backgrounds, having completing stringent pre-employment medical 
examination. However, HCWs join from KSA and globally, hence differing in education, 
cultural backgrounds, but completing stringent pre-employment medical examination. In 
addition, all public health staff recruited in the study in positions of responsibility had duties to 
organise, implement and demonstrate ample experience with immunisation programs within 
the IPCD–Jeddah. 
 
3.4 : Quantitative Study  
3.4.1 : Study participants 
Participants in the quantitative study, at data collection, were newly recruited either as soldiers, 
who were applying to be private ranks in military service, in SANG or as HCWs professional 
in MNG-HA in Jeddah city. 
3.4.2 : Sampling 
Sample size  
1. Questionnaires 
The sample size N sufficient to measure the prevalence P of disease with margin of error E, 
95% confidence (Z=1.96) and 80% of study power, assuming that the sample selection is by 
simple random sampling, is given by the formula (One population proportion calculation): 
𝑁 =  (
𝑍
𝐸
)
2
×  𝑃 (1 −  𝑃) 
According to similar literature on knowledge assessment, the lowest prevalence for knowledge 
above the median score value is 27%) (38,142-144), (Appendix A). Taking E= 0.05 and 
prevalence P= 0.27 gives N=303. Accordingly, 300 questionnaires were distributed for each 
group.  
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2. Blood samples 
According to similar literature on seroimmunity, the lowest value for prevalence of positive 
seroimmunity is (57%) (37,62,177-180), (Appendix A). 
Given assumption of confidence of level 95% (Z= 1.96), 80% of study power and using the 
same sample size formula with E= 0.03 and P= 0.57 gives N= 1046. 
𝑁 =  (
𝑍
𝐸
)
2
× 𝑃 (1 −  𝑃) 
Accordingly, 1,000 blood samples were analysed for each group to identify targeted markers 
300 of these being matched with questionnaires from each group. 
Inclusion and exclusion criteria 
For the questionnaire, those included were all newly recruited either as soldiers, who applied 
for private rank in military service, in SANG or as HCWs professional, who were involved in 
direct health care service, in MNG-HA in Jeddah city, at the time of the data collection (August 
2014-February 2015). For blood samples, included were all available serology data for newly 
recruited in either. 
For HCWs, excluded were the newly recruited not working as physicians, nurses, medical 
specialists or technician and health administration. For military, no exclusions applied. 
Sampling technique  
A proportional stratified quota-sampling method to recruit data was used in both groups to 
obtain a population-representative sample. Stratification among HCWs accorded to proportions 
of sex, nationality and occupation. For soldiers, stratification was to education level. It was 
based in both groups on what was recorded in recruitment records in 2013 (a year before 
collected data) to be representative of different sex, nationality and occupation among HCWs 
and levels of education among soldiers. 
For blood samples, the results of markers obtained from available samples on the first day of 
collecting data were worked backwards to achieve the target sample size for each stratified 
group. 
3.4.3 : Study location of quantitative study 
This study took place in a relaxed and easily accessible setting to maintain participants’ privacy 
at two different locations in Jeddah, KSA: For HCWs, pre-employment and public health clinic, 
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Staff Health Department, at KAMC-Jeddah. For soldiers, it was a military vaccination clinic at 
the military training centre-WR. 
3.4.4 : Materials and resources 
Questionnaires 
A self-administered questionnaire was developed to measure and assess participants’ 
knowledge about HBV; measles and varicella. Its items were based on an exploratory meeting 
with supervisors, key persons, and previously used and validated questionnaires from other 
studies undertaken across the world about communicable disease and preventive medicine 
references with similar objectives and modified according to the local setting (38,143,144,181-
203). 
In constructing the questionnaire, multiple-choice questions were developed for their 
appropriateness to the study group. In addition, this has the advantages of greater reliability, 
usefulness in measuring simple to complex knowledge levels, and reduces chances of guessing. 
The response options for the items were made as simple as possible. Specifically, with a few 
exceptions being: yes, no, and don't know/not sure. 
Respondents were asked to express their personal opinions and perceptions in an ordinal Likert 
scale by agreeing or disagreeing with statements on a 5-point scale: 5-strongly agree, 4-agree, 
3-neutral, 2-disagree and 1-strongly disagree. For quality assurance, a form was provided to the 
participants to guide them. 
It was subjected to validity testing after being translated into Arabic and back translated to 
ensure lexical equivalence. The final questionnaire was revised by a translator who masters 
both Arabic and English. In this regard the purpose of face validity ensured translation 
authority. Additionally, content validity was established by a panel of experts being reviewed 
for appropriateness in reading level, content, clarity, relevancy, simplicity, and consistency of 
each question with the questions set. Modifications were made based on the panel's 
recommendations. 
Some questions specific to the Arab and Muslim culture were asked. The first of these asked if 
they have undertaken cupping Hijamah; defined as applying cups to various points on the body 
by removing the air inside the cups to form a vacuum with incisions in order to remove blood 
which lies just beneath the skin surface(204). The second question asked if they would agree to 
a person infected with HBV marrying a relative. In Arabic culture, it is common that relatives 
have an integral and significant role in accepting or rejecting the potential marital relationship. 
  
52 
Testing the reliability of the Likert scale took place using Cronbach’s Alpha to assess the 
internal consistency of the items within each factor, the cut-off point for this value was 0.89, 
which was considered a good and acceptable value(205). In this stage, all the translation process 
and its cultural adjustment were prepared along with the final version.  
Ultimately, the questionnaire in its final edition comprised 191 items, categorised under four 
main headings with the first of 13 items describing the personal and socio-demographic 
characteristics such as age, sex, education and occupational level, and others. The second 
encompasses 46 items describing history related to exposure for HBV, measles, varicella and 
immunisation history such as immunity and vaccination status, number of doses and risk factors 
of HBV exposure. The third part was used to explore knowledge level, including of key facts 
of the diseases, likely and unlikely ways of transmission, prevention measures, attitude towards 
infected workers and outbreak response, assessed through 103 items. The fourth part was about 
concern assessment to determine behaviour and attitudes toward clinical aspects of the disease 
and toward patients which was assessed through 17 items using a five-point Likert scale. The 
questionnaires for both groups were similar in Sections Two, Three and Four to allow 
comparison (Appendix B). 
Serology blood tests 
The study included blood sampling for screening of the HBV, measles and varicella markers 
that was done routinely as part of the recruitment process to identify sero-immunity and sero-
prevalence among the study group. 
The blood sampling procedure took place under standard aseptic precautions(206,207). In total, 
ten millilitres of venous blood was collected in a plain vacutainer (without anticoagulant) test 
tube from each participant and transported in an ice box at 4℃ within two hours of collection 
to the serology section of the KAMC-Jeddah laboratory. Samples were allowed to clot for at 
least 30 minutes, then serum was separated by centrifuging the blood samples for five minutes 
at 3,000 RPM/min, with the serum being stored at -20℃ until tested. Samples found to be 
negative on the preliminary screening were considered seronegative, those initially tested 
borderline or positive were retested using the same assay in order to confirm these results. 
Hepatitis B 
Separated sera were tested for hepatitis serology markers using both an enzyme-linked 
immunosorbent assay (ELISA) and a chemiluminescent microparticle immunoassay (MIA) 
technology according to the manufacturer’s instructions, using an ABBOTT ARCHITECT 
machine(206). Hepatitis serology markers were assessed as follows: 
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a. HBsAg a marker of current hepatitis B infection. All positive samples were analysed 
twice with the same test, and confirmed by Axysm HBsAg confirmatory test based on 
chemiluminescent technique. 
b. IgG antibody to an HBcAb marker indicates current or past HBV infection. 
c. HBsAb marker of immune status against HBV. 
Measles and varicella 
Measles antibodies (IgG measles) and Varicella zoster antibodies (IgG varicella) were 
performed on DiaSoren LIAISON according to manufacturer instructions(207). These two 
markers of immune status against measles and varicella viruses respectively. 
The serology markers interpretation (Operational definition) 
The following borderlines were used to interpret serology markers according to the standard of 
the serology section at laboratory department in KAMC and CDC guidelines(208-210). 
1. HBsAg measured qualitatively as positive (reactive) or negative. 
2. HBcAb measured qualitatively as positive or negative. 
3. HBsAb can be measured quantitatively or qualitatively. A protective antibody titre 
response was reported quantitatively as 10 or more Milli International units (10 mIU/mL) or 
qualitatively as positive/reactive. 
4. IgG measles measured quantitatively or qualitatively. A protective antibody titer 
response was reported quantitatively as 12 or more Milli International units (12 mIU/mL) or 
qualitatively as positive. 
5. IgG varicella measured quantitatively or qualitatively. A protective antibody titer 
response was reported quantitatively as 12 or more Milli International units (12 mIU/mL) or 
qualitatively as positive. 
The following interpretation to serology markers were used according to the standard of the 
serology section at laboratory department in KAMC and CDC guidelines(208-210). 
a. The participants were considered never exposed, never vaccinated and susceptible for 
infection, if HBsAg negative, HBcAb negative and HBsAb negative. 
b. The participants were considered immune due to natural infection, if HBsAg negative, 
HBcAb positive and HBsAb positive. 
c. The participants were considered most probably immune due to HBV vaccination, 
which might be repeated exposure to antigen without infection or might be recovery from 
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infection with loss of detectable HBcAb if HBsAg negative, HBcAb negative and HBsAb 
positive. 
d. The participants were considered infected with HBV, if HBsAg positive, HBcAb 
positive, and HBsAb negative. 
e. If the participant’s result was: HBsAg negative, HBcAb positive and HBsAb negative, 
interpretation was unclear and might be either: 
i.Recovering from acute HBV infection (most common). 
ii.Distantly immune and test not sensitive enough to detect a very low level of HBsAb in 
serum. 
iii.Susceptible with a false positive HBcAb. 
iv.Undetectable level of HBsAg present in the serum, “low level” chronic infection. 
f. The participants were considered as possibly lacking a specific immune response to 
immunisation or might be no prior exposure to the measles virus, if IgG measles negative. 
g. The participants were considered exposed to the measles virus through infection or 
immunisation, if IgG measles positive. 
h. The participants were considered to possibly lack a specific immune response to 
immunisation or might be no prior exposure to the varicella zoster virus, if IgG varicella 
negative. 
i. The participants were considered exposed to the varicella zoster virus through infection 
or possible immunisation, if IgG varicella positive. 
3.4.5 : Pilot study 
Prior to actual data collection and travel to the KSA, a pilot study took place to improve the 
reliability and internal validity of the questionnaire, anticipate possible obstacles to procedure, 
collection, and data analysis and to reveal if and what modifications were required. The 
questionnaire was piloted on a small group of volunteers among Saudi soldiers and HCWs 
working in MNG-HA in the KSA (six soldiers and six HCWs) who were as similar as possible 
to the target population, and among Saudis and other nationality friends living in the UK before 
it was used in the field. The participants were asked for feedback to identify ambiguities and 
difficult questions, whether each question gives an adequate range of responses and in a logical 
order, to establish that replies can be interpreted in terms of the information that was required, 
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ensuring it was simple, non-misleading and to check that all questions were answered. In 
addition, time taken to complete the questionnaire was recorded and used to decide with the 
supervisory team whether it was reasonable.  
Following this pilot survey, a number of useful suggestions were evaluated critically and some 
modifications were accordingly made, being incorporated into the content. Some changes to 
the wording were made to clarify and reduce bias caused by the mediator’s presence influencing 
participants. Some questions were deleted because of ambiguity and cultural sensitivity, 
without affecting the research objectives. The average time was recorded for completion of the 
questionnaire; being 45 minutes for soldiers and 35 for HCWs, no data from the pilot study 
being used in the final analysis. 
3.4.6 : Data collection  
The quantitative data were collected in two phases: 
Phase one: Cross sectional questionnaire survey 
Data were collected between August 2014 and February 2015. The participants were 
approached on a one-to-one level and invited to participate. After verbally explaining the study 
purpose and procedures, to those who agreed and met the study criteria, a descriptive 
information document and consent forms (Appendix C) were given in English or Arabic 
depending on the comfort level of the participant. Before distributing questionnaires, 
participants were welcomed and confirmed that they had read and clearly understood the 
research information sheet by completing a paper consent form which was considered as a 
prerequisite to be enrolled in the study. 
For those who agreed to this and were willing to enrol, a unique study identifier code number 
was given. This was used as an identification number for questionnaires as well as being marked 
on the test tubes used for blood samples. The sampling technique ensured clarity and 
compatibility of each sample coding with the respondent's questionnaires after it was completed 
anonymously. The participants were assured that their answers and data would be anonymous 
and confidential, and their right of uncontested withdrawal was confirmed. 
Next, the self-administered questionnaire was distributed in English or Arabic with emphasis 
on the coding system, the investigator was available at each setting for supervision, monitoring 
and clarification, also collecting completed forms and checking for clarity and completeness. 
Each questionnaire was evaluated for missing data as soon as being received. If needed, the 
questionnaire was returned for completion. 
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When the participants completed and submitted; vouchers were presented. In addition, health 
education materials about HBV, measles and varicella were distributed providing information 
about risk factors, hazards to the general population and to work settings, misconceptions and 
misunderstandings, prevention tools and how to deal with infected persons (Appendix D). This 
information satisfied all questions asked in the questionnaire.  
Following this, a participant debriefing sheet as an appreciation letter was distributed on 
departure. This included information on what they had done, future contact, an update about 
research progress and what to do in the event of experiencing significant levels of stress, 
discomfort, or unease in relation to the research project (Appendix E). Finally, an open session 
with participants was conducted to answer and clarify any questions related to the study. 
Phase two: Gathering results of the blood sampling 
Data was gathered between August 2014 and February 2015. The given identification number 
was used to access laboratory blood test results related to HBV, measles and varicella that were 
done routinely as part of the recruitment process. There was a daily meeting and discussion in 
the laboratory medicine department with a microbiology consultant and technician about the 
serology blood results to check if blood results were available and to allow opportunity for 
further blood sampling if any results were not available or were insufficient or did not work, 
through the staff health clinic. 
Those who were discovered during blood screening to be infected with HBV (HBsAg positive) 
were informed about the serology result and reported confidentially to IPCD to complete a 
clinical evaluation and to receive further counselling, monitoring and to provide appropriate 
curative treatment, and relatives of the infected were offered preventive measure advice. 
3.4.7 : Data processing and entry 
Access software was used for data entry and several training sessions were taken in 
familiarisation. Participants’ responses to the questionnaire were coded by assigning a 
numerical value to each answer, designed in tables and forms, which were then technician tested 
prior to actual data entry. About 10 % of the collected data for HCWs and soldiers was entered 
twice and tested for reliability according to data type. For categorical data, Cohen's Kappa was 
used and for continuous data intra-class correlation with two way mixed models and absolute 
agreement was used. The results of these tests indicated excellent agreement between the first 
and second data entry runs, selected results are shown in Table 3.2. 
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Variable Variable type Method Result 
Sex Categorical Cohen's Kappa 1.00 
Age Continuous Intra-class correlation 1.00 
Have you ever been tested for immune 
status against HBV? 
Categorical Cohen's Kappa 1.00 
The average number of visits to the 
dental clinic/Year? Times 
Continuous Intra-class correlation 1.00 
Hepatitis B is a communicable 
infectious disease 
Categorical Cohen's Kappa 0.93 
Employee who was not infected by 
HBV should take the vaccine 
Categorical Cohen's Kappa 1.00 
Table 3.2 : Results of reliability test on selected variables 
Some variables were merged and others rebased forming new variables. This was to facilitate 
statistical analysis. Birth cities among military responders were classified based on those born 
in one of the main four regions as provided by the MNG-HA-WR health service. 
The speciality and position of HCWs were classified based on MNG-HA recruitment 
systems(211). Nationalities of HCWs in the serology results section were classified based on 
WHO classification of countries; HCWs are assigned to WHO Regional Offices which usually 
share similar health systems and health indicators(212). 
3.4.8 : Data analysis 
Statistical plan 
All raw data were entered into Access software then imported to Statistical Package for the 
Social Sciences software, SPSS software (release 21.0, SPSS Inc., Chicago, USA) used for all 
statistical analyses. The data were recoded, cleaned and checked for errors. All p-values were 
two tailed and p-values <0.05 were considered significant. Also, corresponding 95% confidence 
interval (CI) were used and reported throughout the study. Next, categorical data such as gender 
and occupational status were summarised using frequencies and percentages. Continuous data, 
such as age and years of experience were summarised using median and inter-quartile range 
(IQR) since this data was not normally distributed. Next, the seroprevalence and seroimmunity 
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of each disease were presented in the tables as frequencies and percentages together with 
confidence intervals(213). 
To investigate the effect on seroimmunity and immune status of sociodemographic, 
occupational characteristics and other factors, both seroprevalence and seromimumnity were 
cross-tabulated against categorical factors and the influence of such factors was assessed by 
means of a chi-square test or Monte Carlo method (that is an alternative test to chi square used 
when a table is larger than two by two table). When expected numbers in a two by two table 
were less than 5 the Fisher’s exact test was used. Furthermore univariate logistic regression was 
used to produce odds ratios with 95% CIs. 
Knowledge score was the sum of correct responses to the diseases’ questions; one point was 
given for the correct answer and zero if wrong or I do not know. The data related to level of 
knowledge and source of information, key facts of the disease, likely and unlikely ways of 
transmission, vaccine and immunity of each disease, behaviour towards someone infected with 
a disease, and outbreak response were presented using descriptive statistics in the form of 
frequencies and percentages for respondents providing correct answers. Those who scored 
below the median were classified less knowledgeable and those who scored above the median 
were classified knowledgeable in comparison to participants in each group. 
To determine the influence on knowledge scores of categorical factors, the Mann-Whitney U 
test was used when the factor had two levels and the Kruskal Wallis test was used when the 
factor had more than two levels (test’s for differences between distributions), when using Mann-
Whitney test for equality of medians, the Moses-Extremes test was used to verify the 
assumption. Spearman’s rho correlation was used to test the association with knowledge scores 
of continuous variables with a non-normal distribution. The Pearson product-moment 
correlation coefficient was similarly used for continuous variables with a normal 
distribution(214). 
The relationships between level of agreement and response about participants’ concern and 
attitude towards a disease and HBV-infected colleagues among HCWs with occupational 
characteristics were investigated. To determine the influence on level of agreement of 
categorical factors, the Mann-Whitney U test was used when the factor had two levels and the 
Kruskal Wallis test was used when the factor had more than two levels. Spearman’s rho 
correlation was used to test the association with level of agreement of continuous variables with 
a non-normal distribution. The Pearson product-moment correlation coefficient was similarly 
used for continuous variables with a normal distribution. Additionally, chi-square for continuity 
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correction test, Fisher's exact test and Monte Carlo method were used to test the significance of 
the differences between groups. 
To understand how seroimmunity varies and identify potential predicators of seroimmunity 
determinants of a disease, significant variables based on the univariable analyses or univariate 
logistic regression were constructed to determine the crude and independent predictors, 
respectively, in multivariable logistic regression models. 
A multivariable logistic regression model was constructed to model these predictors of HBsAg 
positivity, HBcAb positivity; HBsAb positivity; IgG measles positivity, and IgG varicella 
positivity. Independent predictors were identified using backward likelihood ratio selection of 
variables with p-values >0.10, and those variables with a p-value <0.05 were retained. When 
having less than two significant independent predictors, variables included in the model based 
on the univariable analyses or univariate logistic regression have a P value less than 0.2(214). 
The P-value was calculated for categorical variable with more than two levels using likelihood 
ratio test. Assessment of model fit has been measured by Hosmer and Lemeshow test. 
To understand and to assess how knowledge about the disease varies and identify potential 
predicators of knowledge determinants of a disease, significant variables based on the 
univariable analyses were tested as predicted variables for inclusion in the model and were used 
in a multiple linear regression model using backward selection of variables with p-values >0.10, 
and those variables with a p-value <0.05 were retained. When having less than two significant 
independent predictors, variables included in the model based on the univariable analyses or 
univariate logistic regression have a P value less than 0.2(214). To ensure no violation of 
assumptions of normality, regression diagnostics linearity, multicollinearity, and 
homoscedasticity were investigated. 
All independent variables used in testing the knowledge level determinants of a disease were 
selected from previous research studies and the related applied statistical analyses (38,142-
144,181,182,184,186,187,190,191,196,199,215-220), as was also the case in testing 
seroimmunity level (4,37,56,59,64,77,84,116,141,178-180,221-228). Included in the 
univariable analyses or univariate logistic regression are available variables pertaining to 
sociodemographic characteristics, potential risk factors, past history related to diseases 
exposure or vaccination, knowledge and seroimmunity level. Significant variables based on the 
univariable analyses or univariate logistic regression were constructed to determine the crude 
and independent predictors, respectively. 
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The results of multiple logistic or linear regression including independent significant factors 
have been adjusted and tested for potential confounders, unique variables not affected have 
been reported to determine knowledge and immunity of a disease(229). Then, interaction and 
direction between significant predictors were studied based on logistic or linear regression to 
produce the modelling framework and statistically significant interactions were reported.  
There was a knowledge variation among HCWs and soldiers that could lead to a potential 
selection bias, this bias to the knowledge difference was taken into consideration during 
questionnaire design by stratification data to different occupations, occupational positions and 
specialities among HCWs and by educational level among soldiers, and also considered during 
analysis of the study by using multiple regression analysis. 
3.5 : Qualitative Study  
Focus group discussion and in depth interviews aimed to explore participants' views about the 
vaccination programme in SANG. The interviews aimed to investigate newly recruited staff 
perspectives on the health care vaccine providers on evaluating the immunisation programme. 
In addition, all participants' views on the vaccination programme were investigated to obtain 
new soldiers’ and HCWs’ employee perspectives and awareness’s about the vaccination. 
Furthermore, all participants were asked about the reasons and barriers that cause low 
compliance with the vaccination process, and what approaches could be implemented to raise 
the ratio of compliance to vaccination. Finally, the issue of vaccine safety was explored. 
3.5.1 : Study participants 
The participants in the present study, at the time of the data collection (August to September 
2014), were newly recruited either as soldiers, who applied to be recruited as privates in military 
service, in SANG or as nurses in MNG-HA in Jeddah city. In addition, all public health staff in 
charge of organising and implementing and having ample experience with immunisation 
program at IPCD–Jeddah were invited to participate. 
3.5.2 : Selection of participants for interviews (Sampling) 
There were two focus group discussions and ten in-depth interviews altogether. In all, 26 
participants were interviewed over a two-month period. The data saturation were maximised as 
much as possible based on time and resources available. Interview participants were selected 
via purposive sampling (judgmental sampling)-based on type of interview and targets of 
discussion as follows: 
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1- (Focus group discussions–HCWs): The criteria were: Eight newly recruited HCWs 
(four male nurses; four female nurses; multinationals based on the questionnaire data). The 
reasons for recruiting nurses were to avoid any effect of seniority in discussion, avoid 
heterogeneity in occupation and related determinants such as different levels of education and 
to maintain homogeneity of the group during discussion. 
2- (Focus group discussions-soldiers): The criteria were: Eight newly recruited soldiers 
(all male with secondary level of education). This was necessary because only males are 
recruited as soldiers with most educated to secondary school. So, to avoid any effect of seniority 
in discussion, only those with secondary level of education were recruited. 
3- In depth interview: The criteria were as follows: Ten HCWs - five civilian HCWs 
working in the HCW immunisation programme and five HCWs working in the military 
immunisation programme. Those with little or no experience were excluded. 
3.5.3 : Location of interviews 
The interviews took place in a calm, convenient setting in a friendly atmosphere maintaining 
participants’ privacy at three different locations in Jeddah, KSA: the focus group discussions 
among HCWs were carried out in the main meeting room at KAMC while the focus group 
discussion among soldiers took place in the main meeting room at military training centre-WR 
and in depth interviews in the meeting room of IPCD. 
3.5.4 : Materials and resources 
It was decided that the combination of the focus group discussion and in depth interviews (one-
to-one interviews) were to be used for data collection. 
Interviews suited the research aims and objectives, particularly in trying to understand the HCW 
and military immunisation programme from two different perspectives. Interviews give greater 
significance to meaning and individual narratives as well as allowing related in-depth 
investigation of structures or contextual factors to capture lessons that can be used in future 
interventions. 
The interview's first set of questions aimed to investigate perspectives about communicable 
diseases in occupational settings. This was done with a special focus on why the staff's 
environment / workplace has more risk for causing infection, what were their sources of 
information about communicable diseases in work fields, and how those risks could be 
minimised. 
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The second topic was the perspective of the health care vaccine providers on evaluating the 
programme. In particular, the questions in this section sought to identify levels of staff 
knowledge and experience about vaccines and vaccination, the effectiveness of the team 
providing the vaccine, the cost-effectiveness of the programme, understanding the methods 
applied to maintain a cold chain, and then the co-ordination of other sectors in implementing 
the programme. 
Participants' views about the vaccination programme were investigated with special reference 
to new soldiers and HCWs’ awareness before the recruitment process, acceptance of the 
provided vaccines, and their responses about health education while conducting the programme. 
Furthermore, all participants were asked about the reasons and barriers that cause low staff 
compliance with the vaccination process, and what approaches should be implemented to raise 
this. The reasons why they decided for or against receiving a vaccine were explored using 
questions and prompts to encourage elaboration and improve insight into their attitudes and 
vaccination decision making. Finally, the issue of vaccine safety, including side effects, acute 
reactions, unpleasant vaccine experiences, and adverse events was explored. 
The qualitative tools of data collection were developed based on the findings derived from the 
available literature review and previously used qualitative tools from other 
studies(155,159,230-236), team members’ knowledge of the topic, understanding of the local 
vaccine scenes and field experience. 
The interviews were designed in the format of a semi-structured interview guide, encouraging 
depth to be achieved by providing the opportunity on the part of the interviewer, [through 
following a set agenda], to probe and expand the interviewee's responses,(237) and also to 
ensure that the same questions were used(238). The same interview guide was used for focus 
groups and in depth interviews. 
The interview guides were subjected to validity testing as detailed earlier.Content validity was 
reviewed by a panel of experts and the questions revised for appropriateness in discussion level. 
Modifications were made to the questions based on the panel's recommendations. 
Why was a mix of in depth interview and focus group discussions used? 
The decision to use a combination of in depth interviews and focus group discussions for data 
collection was necessitated by the need to capture how people respond and react to vaccines 
and vaccination programme issues at individual and group levels. This offered both depth and 
breadth providing more robust results. Furthermore, it was easier to probe specific variables or 
ideas and obtain greater detail and personal experience through in-depth interviews whereas the 
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focus group discussions were better for scoping for and exploring new ideas, and through this 
interaction hidden attitudes and any disagreements are revealed(169,239). It was also, however, 
difficult to explore some topics of interest in group discussion, especially evaluation and 
assessment of proficiency of staff and departments generally in their abilities to provide 
vaccines to specific groups reluctant to be vaccinated(240). Thus, the triangulation was adopted 
- using two different qualitative tools and among two different populations, HCWs and soldiers. 
The aim of triangulation in this study was to enhance validity by both highlighting inconsistency 
and contradiction between qualitative and quantitative findings and to provide a 
‘complementary extension’. This is, the comparing and integrating of findings from different 
methods in a mixed method approach can provide a more comprehensive picture of the social 
world and achieve a greater understanding than that from evidence generated by one 
methodology. 
In depth interview 
A total of 10 in-depth interviews were carried out to obtain information; on policy and program 
issues, immunisation services in general, and vaccine compliance. Interviews took place either 
in English or Arabic, each lasting an average of 60 minutes (range 45–90 minutes). The in depth 
interview in its final edition comprises 22 items, categorised under four headings, the first, 
included nine items describing personal experiences about the immunisation program with the 
second encompassing five items which cover the vaccines barriers. The third part is about 
vaccine administration and adverse events discussed through three items, the fourth part 
covering administration of the immunisation program, discussed through five items (Appendix 
F). 
Focus group discussion 
Two focus group discussions obtained information on policy and program issues, information 
on immunisation services in general, and vaccine compliance either in English or Arabic, 
lasting an average of 60 minutes (range 45–90 minutes). 
The focus group discussion in its final edition comprises 22 items categorised under four 
headings, the first includes four items describing personal occupational experience about 
communicable disease, the second encompasses seven items describing experiences about 
immunisation. The third part, about vaccine barriers, through five items and the fourth part, 
about vaccine safety and adverse events, through six (Appendix G). 
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3.5.5 : Pilot study 
A pre-pilot study had been undertaken in the UK and KSA, to test the focus group discussion 
and in depth interviews piloted on a small group of volunteers, to test the in-depth interview 
guide, on two HCWs in the immunisation team working in MNG-HA interviewed using 
Skype®. In addition, to test the focus group discussion form, three pilot studies took place in 
Newcastle with three Saudi HCWs and five Saudi soldiers who were as similar as possible to 
the target population to improve the reliability and the internal validity of the tools, invited to 
and interviewed discretely. 
The participants were asked for feedback to identify ambiguities and difficult questions, 
whether all interview questions were clear, if the interview length was acceptable, and to check 
that all questions were answered. In addition, time taken to complete the interview was recorded 
and used to decide, with the supervisory team, whether it is reasonable. 
Following the pilot survey some changes to the wording were made to increase clarity and to 
reduce mediator presence bias, as before. Some questions were deleted for ambiguity and 
cultural sensitivity without affecting research objectives and all comments made by 
interviewees in the pilot study were considered. The average time was recorded; focus group 
discussions were about 65 minutes among soldiers and 62 minutes among HCWs. The in depth 
interview lasted 120 minutes. When the pilot study was repeated with another group of soldiers 
after modifications, it lasted 72 minutes, no data from the pilot study being used in the final 
analysis. 
3.5.6 : The interview process 
Participants were approached on a one-to-one level explaining the study purpose and 
procedures, a letter in English or Arabic being distributed in invitation with the research aims 
confirmed and content clarified. An information sheet was enclosed with this letter detailing 
what taking part in the research would involve (Appendix H, Appendix I). 
In two focus group discussions, the first eight participants from each group who replied and 
satisfied the sampling criteria were recruited. For the in-depth interview, the first to reply and 
satisfy the sampling criteria were recruited. Next, another letter was sent to interviewees with 
logistic arrangements and a project consent form (Appendix J, Appendix K). 
Before the interviews, the participants were welcomed and confirmed that they had read and 
clearly understood the research information sheet by completing a paper consent form which 
was considered to be a prerequisite. 
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Participants were also informed that the discussion was to be digitally audio recorded and held 
in strict confidence as were notes taken during the session so as it would not be possible for 
anyone to be identified. Each participant enrolled in the in-depth interview was given a unique 
identifier number used for identifying them during the discussion. Participants were also 
allowed time to ask questions if they needed further clarifications before starting the interviews. 
Interviews took place either in English or Arabic and typically lasted between 60 minutes to 
one hour and 30 minutes. In the focus group discussion, the investigator acted as a facilitator 
and supervising group manager. 
When the interviews were completed vouchers were distributed. Following that, participants 
were “debriefed”- which entailed correcting any misconceptions observed during the course of 
the interview, some information about what had been done, future contact, updates about 
research progress, each aimed to reduce any experienced significant levels of stress, discomfort, 
or unease in relation to the research project (Appendix L) A question and answer session with 
participants took place related to the study as appropriate. 
3.5.7 : Qualitative interview transcription and translation 
The interview was tape recorded before being checked and transcribed verbatim. The Arabic 
interviews were transcribed by the investigator and translated by a professional translator group, 
the English interviews through a professional transcription group in the UK. 
Prior to analysing the interview data, the transcripts were reviewed for accuracy. Translation 
was checked for accuracy by asking a professional linguist and translator to translate and back-
translate a limited number of phrases to ensure equivalent meanings. The investigator 
purposively selected sentences that were judged to have the potential to create disagreement in 
translation. 
3.5.8 : Data analysis 
The analysis of qualitative data used both manual analysis and NVivo software (QSR 
International Pty Ltd, 10) for analysis transcript data. Thematic analysis technique was used in 
identifying, analysing, and reporting patterns (themes) within the transcripts (data), as it 
minimally organises and describes data set in detail. However, it also often goes further than 
this, and interprets various aspects of the research topic (241-243). Data analysis was carried 
out using Braun and Clarke’s thematic analysis process to explore the data for emerging themes 
linked to the research question (243) as follows: 
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To begin this process, the transcripts were read and re-read to full data familiarisation. Next, an 
initial list of ideas generated data analysis with interesting aspects collated and coded into 
potential themes. During this stage, the material was broken into more manageable portions, 
identifying elements of the data that related to the research question, feature coded as relevant. 
A mixture of inductive (themes were derived from the data) and deductive (pre-supposed 
themes) data analyses were used to extract main themes. This pragmatic approach linked codes 
(key themes) to the study's research questions. 
A coding frame was used that built on an a priori framework in the deductive approach. This 
involved determining categories or concepts under which the data were searched, labelled, 
sorted and compared. Two coding indices were developed, one for analysing the interviews 
with new recruits, either nurses or soldiers (customers), and the second for analysing staff 
providing vaccines’ interviews (providers). This process of coding was guided by the research 
question and objectives using manual analysis and NVivo version 10 software to assist with 
data management. 
The themes were reviewed in relation to coded extracts and the entire data generated a thematic 
‘map’ of the analysis. Post-analysis discussion and confirmation of the themes were carried out. 
Data were re-read by three members of the research team to examine how the codes could be 
linked to form coherent themes before being refined, generating definitions and identifying the 
content of each preliminary category, differences in coding being settled by consensus 
agreement. This was to maximise analytic validity. 
Finally, ongoing analysis to refine each theme took place with ascribed clear definitions and 
names for themes to produce a report of the analysis. This iterative process continued until full 
consensus was reached, resulting in the final formulation of the answer to the questions. In 
order to ensure the reliability of these themes, this final set of themes was analysed to verify 
the extent of representation of the transcribed data.  
3.5.9 : Reflexivity 
The role of the researcher and his/her relationship with the research design are very important 
factors in qualitative research(244). The researcher’s role revolved between an insider’s 
perspective and an outsider’s. Being born and bred in KSA offered an insider’s perspective, and 
the ability to investigate with a native eye, in a setting in which much personal professional 
experience was relevant. An advantage of this was that participating HCWs and soldiers may 
have felt more able to express their views freely, as they appeared to appreciate fellow 
understanding of their concerns. It also offered further insight into interviewees’ perspectives, 
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having once been a medical trainee and a military officer trainee at different periods in SANG. 
This was particularly important as regards interpreting the research data. However, there may 
have been some disadvantages to being an insider. Familiarity with the people and system, may 
have unintentionally led to overlooking some data, which could have been of importance to the 
research, on the grounds that they were too obvious to be worth mentioning. Through being 
accurate and rigorous in research procedures, any ethical bias was avoided. Furthermore, 
although having been a staff member at MNG-HA (prior to the carrying out of this research), 
the subjects were unknown. This and the fact that Newcastle University is the research home 
may have added to the position of being an outsider. 
3.6 : Administration Aspects and Ethical Considerations 
Ethical approval was obtained from Faculty of Medical Science, Ethics Committee, Newcastle 
University No. (00762/2014) (Appendix M). The research was approved by the research 
committee and the ethics committee of the MNG-HA, (represented by King Abdullah 
International Medical Research Centre (KAIMRC)), being KAIMRC No. (RJ13/038/J). 
(Appendix N) Also, the data project was supported by a letter from the head of department of 
IPCD-Jeddah which required access and authority to obtain and collect all required data and 
supervise immunisation programs among newly recruited HCWs and military personnel in 
MNG-HA. 
The participant information sheets, consent forms and debriefing sheets were provided to 
participants in English or Arabic. Military cadre were excluded from the subject recruitment 
and encounters in order to prevent any commander influence on participants’ informed consent. 
Participants and staff were offered appropriate guarantees of confidentiality and anonymity. All 
of the various information collected (whether audio or paper-based) was treated confidentially, 
with no use of names of subjects participating in the study. 
The investigator prepared sitting areas and booked meeting rooms and other logistic 
preparations such as obtaining stationery items (pens, notebooks and files), printing 
questionnaires and health education materials, designing and purchasing vouchers, and 
provisioning refreshments. 
3.7 : Limitations 
It was difficult to recruit 300 HCWs during the two month data collection period, however, 
90% of the sample for HCWs was collected, prior to training of a public health nurse with two 
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weeks to collect the remaining 10%. Most of those were physicians, well-known to be difficult 
to recruit for such studies due to their demanding schedules(245). By the second week of 
February all remaining data were collected and sent to the investigator. 
3.8 : Chapter Summary  
This chapter has covered a discussion of issues that relate to the process of data collection and 
analysis. It has defined the methodological journey undertaken during this research and 
presented an overall account of the data collection approach used in this study. The mixed-
method approach chosen was justified and the study instruments and procedure were 
highlighted.  
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Chapter 4. Results-Quantitative Research-Health Care Workers 
Findings about HBV, measles, and varicella among HCWs are presented in this chapter. 
Characteristics of the study group (HCWs), their previous health histories in relation to the 
aforementioned diseases, their knowledge about each disease, as well as their concerns and 
perspectives towards such diseases and people infected by them are also reported in this section. 
This chapter includes each of the above diseases' seroprevalence among participants who 
completed the questionnaire and those who did not. Each of this chapter's sub sections first 
describes the participants' characteristics and their response rate before it moves on to detail 
results for each of this study's phases. 
4.1 Characteristics of the Studied Health Care Workers Who Completed the 
Questionnaire 
4.1.1 Sociodemographic characteristics 
A total of 315 HCWs were enrolled into the study (Table 4.1). The median age of the 
respondents was 27 (inter-quartile range 25-31) with an age range of (21-71). The median time 
spent in formal education was 17 years (inter-quartile range 16-18 years) with range of (12- 30 
years), and the median of experience years in health care institutions was 3 (inter-quartile range 
1-6) with a range of (0-44). 
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Characteristics  N %  
 Age(Years)   
<25  75 23.8 
25-30  150 47.6 
>30  90 28.6 
Time spent in formal education(Years)   
≤16 156 49.5 
17-18 91 28.9 
≥19 68 21.6 
Experience in health care institutions(Years)   
<1 75 23.8 
1-3 95 30.2 
4-6 72 22.9 
> 6 73 23.2 
Table 4.1: Sociodemographic characteristics-HCWs-(N=315)(a) 
 
Socio-demographically, as Table 4.2 shows, females accounted for three fifths of the study 
participants, more than half of whom were Saudis, a quarter Filipinos, and a similar proportion 
were other nationals. Furthermore, three quarters of the participants were Muslims, and two 
thirds of them single. About two thirds of participants were recruited in KKH, the others King 
Saud bin Abdu Aziz University for Health Science (KSAU-HS) or in peripheral health centres 
(PHCs) including renal dialysis and primary health care centres. 
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Characteristics  N % 
Sex  
  
Female 191 60.6 
Male 124 39.3 
Nationality/Origin  
  
Saudi 165 52.3 
Philippines 73 23.1 
Malaysian 15 4.7 
Pakistani 13 4.1 
Sudanese 11 3.4 
Indian 9 2.8 
Egyptian 7 2.2 
North American 5 1.5 
Others* 17 5.3 
Religion    
Muslim 223 70.8 
Christian 82 26.0 
Hindu 4 1.3 
Did not wish to answer this question 6 1.9 
Marital Status    
Single 198 62.9 
Married 101 32.1 
Divorced 14 4.4 
Widowed 2 0.6 
Practise location   
KKH 191 60.6 
KSAU-HS 66 21.0 
PHC  58 18.4 
Table 4.2: Sociodemographic characteristics-HCWs(N=315)(b) 
*Others(N): Jordanian(4), European(3), Palestinian(3), South African(3), Cameroonian(1), Eritrean(1), Syrian(1), 
Yemeni(1) 
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Nearly half the recruited HCWs were born in WR of KSA, majority Jeddah born. The largest 
group of those born outside of KSA were Philippino (Table 4.3).  
Birth Country N % 
KSA 169 53.65% 
Philippines 73 23.17% 
Malaysia 14 4.44% 
Pakistan 14 4.44% 
India 10 3.17% 
Egypt 8 2.54% 
Sudan 7 2.22% 
Others* 20 6.37% 
Table 4.3 : Places of birth among HCWs(N=315) 
*Others(N): USA(4), Jordan(3), South Africa(3),Canada(2), Algeria(1), Cameroon(1),Czech(1), Eritrea(1), 
Germany(1), Libya(1),Qatar(1),Syria(1). 
 
4.1.2 Occupational characteristics  
Two thirds of respondents were bachelor's degree holders, this fraction represented participants 
holding the highest level of qualification in this group. Four main categories of HCWs were 
recruited; physicians, nurses, medical specialists/technicians and administrators (Table 4.4). 
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Characteristics  N %  
Highest level of Education      
Bachelor 211 67.0 
Diploma 54 17.1 
Master 28 8.9 
Board certified 12 3.8 
Fellowship 4 1.2 
PhD 3 0.9 
Secondary school 3 0.9 
 Occupation     
Nurse 99 31.4 
Medical Specialist/Technician 75 23.8 
Admin 71 22.5 
Physician 70 22.2 
Speciality     
Clinical services 116 36.8 
Administrative services 64 20.3 
Nursing services 63 20.0 
Pathology/laboratory 42 13.3 
Ancillary medical services 25 7.9 
Technical support services 5 1.6 
Position     
Staff nurse 86 27.3 
Admin assistant 62 19.7 
Specialist 39 12.4 
Staff physician 35 11.1 
Technician 35 11.1 
Academic staff 33 10.5 
Specialist physician 25 7.9 
Table 4.4: Educational and job characteristics-HCWs(N=315) 
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4.2 Characteristics of the Studied Health Care Workers Who Were Not Given the 
Questionnaire 
 
4.2.1 Sociodemographic characteristics 
Over half of the retrieved blood samples were from females (Table 4.5), more than half being 
from KSA, a quarter Philippino and 25.5% from other countries. About three quarters were 
recruited to work in KKH, and the rest recruited to work in the medical city but not in the 
clinical sections or PHCs. 
 
Characteristics  N % 
Sex  
  
Female 2215 55.2 
Male 1798 44.8 
Nationality  
  
Saudi 2080 51.8 
Philippines 910 22.7 
Malaysian 276 6.9 
Arab-Non Saudi 245 6.1 
European 172 4.3 
South African 136 3.4 
Indian 86 2.1 
Pakistani 50 1.2 
North American 34 0.8 
Australia/New Zealand 19 0.5 
Africa 5 0.1 
Practise location   
KKH 3112 77.5 
Medical City not working in clinical sections 799 19.9 
PHCs 102 2.5 
Table 4.5: Sociodemographic characteristics-HCWs-not given the questionnaire (N=4013) 
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4.2.2 Occupational characteristics  
 
A third were nurses, almost all of them working in clinical services with over one quarter in 
nursing services. Concerning occupational positions, almost one third were staff nurses 
(Table 4.6). 
Characteristics  N %  
 Occupation     
Nurse 1438 35.8 
Physician 691 17.2 
Medical specialist 557 13.9 
Medical technician 559 13.9 
Admin 768 19.1 
Speciality     
Clinical services 1243 31.0 
Nursing services  1084 27.0 
Ancillary medical services 745 18.6 
Administrative services medicine 692 17.2 
Pathology/laboratory 147 3.7 
Technical support services 102 2.5 
Position     
Staff nurse 1276 31.8 
Technician 603 15.0 
Intern 417 10.4 
Specialist physician 383 9.5 
Admin assistant 315 7.8 
Specialist 307 7.7 
Assistant 279 7.0 
Staff physician 214 5.3 
Information Technology Technician 94 2.3 
Supervisory/leadership 79 2.0 
Patient care technician 46 1.1 
Table 4.6: Educational and job characteristics-HCWs-not given the 
questionnaire(N=4013) 
  
  
76 
4.3 Hepatitis B among Health Care Workers 
 
4.3.1 Previous hepatitis B related health history 
Previous investigation for HBV 
Almost three quarters were sure they had been previously investigated, the others responding 
that they had never been screened or were not sure. Of those unsure, nearly all indicated they 
had been informed that they were not carrying the disease and only four persons were uncertain. 
The investigations were mainly done in KSA and Philippines; however, more than a third of 
the non-Saudis were screened in KSA (Table 4.7). 
Investigation against HBV N %  
Previous investigation against HBV(N=315)     
Yes 237 75.2 
No 58 18.4 
Not sure 20 6.3 
Results of investigations against HBV(N=273)     
Not infected 233 98.3 
Not sure 4 1.6 
Place at which investigations were done(N=273)     
KSA 153 64.5 
Philippines 45 18.9 
Malaysia 13 5.4 
India 9 3.8 
Pakistan 5 2.1 
Others* 12 4.8 
Non-Saudis for whome investigations were done in KSA(N=141) 58 38.7 
Table 4.7: Investigations against HBV-HCWs 
*Others (N): Egypt(4), Jordan (2), USA(2), Czech Republic(1), Eritrea(1), Germany(1), Yemen(1) 
About half were sure they had done previous investigations for immune status against HBV, 
and the rest either had not been investigated or were unsure. Of the latter, over three quarters 
indicated they had been informed of immunity against HBV. Almost two thirds of the 
investigations were done in KKH and about a third of the non-Saudis screened against immune 
status in KSA (Table 4.8)   
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Investigation against immune status of HBV N %  
 Previous investigation against immune status of HBV(N=315)     
Yes 171 54.3 
No 81 25.7 
Not sure 63 20.0 
Results of investigations against HBV immune status(N=171)     
Immune 141 82.4 
Not Immune 16 9.4 
Not sure 14 8.2 
Place at which investigations were done(N=171)     
KSA 108 63.1 
Philippines 29 16.9 
Malaysia 12 7.0 
India 7 4.0 
Pakistan 5 2.9 
Others* 10 5.8 
Non-Saudis which investigations were done in KSA(N=108) 46 30.7 
Table 4.8: Investigations against immune status of HBV-HCWs 
*Others (N): Egypt(2), Sudan(2), USA(2), Czech(1), Eritrea(1), Germany(1), Yemen(1) 
HBV immunisation 
Over two fifths of recruits had received the three doses required for protection. Additionally, 
almost a fifth stated that they had received more than three doses. 18.1% did not know if they 
received HB vaccine, and only 16 HCWs had not been offered the HB vaccine (Table 4.9 and 
Table 4.10). Of those vaccinated against HB before, two thirds were during undergraduate 
study, and a fifth before primary school. For those vaccinated recently (within a year), 8.2%, 
the median was 4 months (inter-quartile range 2-7.2 months) and range of (1–10 months). For 
those vaccinated more than a year before, the median was 4 years (inter-quartile range 3-7 
years) and range of (1–20 years).  
About half of those recruited had been vaccinated in KSA and a quarter in Philippines. Mostly, 
reasons to be vaccinated were either for work requirement or doctor’s recommendations, only 
12.6% reported that self-motivation was the reason for vaccinating, and furthermore, two thirds 
received regular vaccine doses. 
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Characteristics N %  
HB vaccination status (N=315)   
Three doses  124 39.3 
More than three doses  58 18.4 
Two doses  34 10.7 
One dose  24 7.6 
HB vaccine not offered 16 5.0 
HB vaccine offered, but not taken 2 0.6 
I do not know 57 18.1 
Time of administration of HB vaccine(N=164)     
Before primary school 32 19.5 
During primary school 5 3.0 
During secondary school 7 4.2 
During undergraduate study 101 61.5 
I do not know 19 11.5 
Place of administration HB vaccine(N=246)     
KSA 122 49.5 
Philippines 62 25.2 
Malaysia 13 5.2 
Pakistan 11 4.4 
India 10 4.0 
Sudan 7 2.8 
Egypt 5 2.0 
Jordan 5 2.0 
Others* 11 4.4 
Table 4.9: History of immunisation with HBV vaccine-HCWs(a) 
*Others (N): USA(3), South Africa (2), Canada(1), Czech(1), Germany(1), Libya(1), Syria(1), UK(1) 
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Characteristics N % 
The reason for being vaccinated(N=246)     
Work requirement 161 65.4 
Doctor’s recommendation 65 26.4 
Immunisation campaigns 44 17.8 
Self-motivation 31 12.6 
School requirements 19 7.7 
Parent's recommendation 1 0.4 
Were the doses of HB vaccine regular*?(N=246)    
Regular 166 67.4 
Irregular 21 8.5 
I did not receive all three doses 29 11.7 
I do not know 30 12.2 
Table 4.10: History of immunisation with HBV vaccine(b) 
*The second dose from one to 2 months of 1st dose and the third dose from 4 to 6 months of 1st dose. Any other 
regimen is considered irregular. 
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The reasons why some of HCWs were not vaccinated against HBV are shown in Table 4.11. 
The reason why not vaccinated against HBV  N %  
I do not believe myself at risk 26 37.7 
I am concerned about the safety of the HB vaccine 9 13.1 
Difficulty to access the HB vaccine 6 8.6 
I do not know 23 33.3 
Others 16 23.1 
Table 4.11: The reason why not vaccinated against HBV-HCWs(N=69) 
Others (N): I cannot remember(4), No awareness(4), Natural HBV is preferable to vaccine(2), HBV is not a 
serious enough disease to warrant immunisation(1), I am concerned about the cost(1), I suffer from a medical 
condition(1), Not in need after the immune status testing(1) 
 
Self-reporting of the respondents who had positive or negative HBsAb about the history of 
immunisation 
Half of those had immunity against HBV, with only a minority not. Two thirds of the above 
received three or more doses, while a marginal minority were never vaccinated before. 
Meanwhile, more than a third of the self-reporting respondents were vaccinated during 
undergraduate studies, while almost half received the vaccine against HBV as a work 
prerequisite. Furthermore, about a quarter of positive-HBsAb-alone cases did not receive 
regular doses against HBV. However, 35 cases reported never being (Table 4.12 and 
Table 4.13). 
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HBsAb is positive  N % 
Tested for immune status against HBV and result was   
Immune 123 54.2 
Not Immune 8 3.5 
Not sure 10 4.4 
I was not tested for immune status 86 37.9 
HB vaccination status   
I have had more than three doses 50 22.0 
I have had three doses  100 44.1 
I have had two doses  22 9.7 
I have had one dose  15 6.6 
I was offered the vaccine, but I have not had it. 2 0.9 
I was not offered the vaccine. 10 4.4 
I do not know. 28 12.3 
HB vaccination time    
Before primary school 28 12.3 
During primary school 5 2.2 
During secondary school 5 2.2 
During undergraduate study 86 37.9 
I was vaccinated during 11 months ago 11 4.8 
I was vaccinated during last 1 -20 years ago 46 20.3 
I do not know 11 4.8 
I was not vaccinated 35 15.4 
Table 4.12: Self-reporting of the respondents who had positive HBsAb alone about the 
history of immunisation-HCWs(N=227)(a) 
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HBsAb is positive N % 
The reason to be vaccinated against HB   
Doctor’s recommendation 51 22.5 
Self-motivation 24 10.6 
Immunisation campaigns 40 17.6 
Work requirement 122 53.7 
Other 16 7.0 
I was not vaccinated 35 15.4 
Were the doses regular? 
 
Not regular 56 24.7 
Regular, on time 136 59.9 
I was not vaccinated 35 15.4 
Table 4.13: Self-reporting of the respondents who had positive HBsAb alone about the 
history of immunisation-HCWs(N=227)(b) 
 
Among those who had negative HBsAb alone, a fifth reported being immune against HBV and 
about a third reported receipt in three doses or more, with a quarter received HBV vaccine but 
not in a regular pattern. Nonetheless, more than a third were never vaccinated (Table 4.14). 
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HBsAb and other HBV markers are negative  N % 
Tested for immune status and result was   
Immune 18 20.9 
Not Immune 8 9.3 
Not sure 4 4.7 
I was not tested 56 65.1 
Statements describes about receiving the HB vaccination   
I have had more than three doses  8 9.3 
I have had three doses  24 27.9 
I have had two doses  12 14.0 
I have had one dose  9 10.5 
I was not offered the vaccine. 6 7.0 
I do not know 27 31.4 
I was vaccinated against HB    
Before primary school 4 4.7 
During secondary school 2 2.3 
During undergraduate study 15 17.4 
I was vaccinated during 11 months ago 15 17.4 
I was vaccinated during last 1-20 years ago 10 11.6 
I do not know 8 9.3 
I was not vaccinated 32 37.2 
Were the doses regular?   
Regular on time 30 34.9 
Not regular 24 27.9 
I was not vaccinated 32 37.2 
Table 4.14: Self-reporting of the respondents who had negative HBsAb and other HBV 
markers about the history of immunisation-HCWs(N=86) 
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Exposure to potential risks of acquiring HBV 
The frequency of exposure to potential risks that increase the likelihood of acquiring HBV 
among HCWs is shown in Table 4.15. Furthermore, over a quarter had undergone surgical 
operations once or more and 6.1% reported that they had undergone "Hijamah" once or more. 
Potential exposure risk Response N % 
Previous surgery Yes, once 59 18.7 
Yes, more than once 31 9.8 
Past 'Hijamah' (cupping) Yes, once 11 3.4 
Yes, more than once 8 2.5 
Previous endoscopy Yes, once 18 5.7 
Yes, more than once 1 0.3 
Previous blood transfusion Yes, once 6 1.9 
Yes, more than once 4 1.2 
Past dental treatment Yes 288 91.4 
Previous syringe use Yes 17 5.4 
Family member infected with HBV Yes 15 4.7 
Previous acupuncture Yes 15 4.7 
Past use of others' tooth brush Yes 13 4.1 
Previous tattoos Yes 5 1.5 
Suffered from yellow discolouration in eyes or skin Yes 5 1.5 
Previous renal analysis Yes 1 0.3 
Table 4.15: Exposure to potential risks of acquiring HBV-HCWs(N=315) 
 
Moreover, 23 HCWs (7.3%) encountered HBV-positive friends or neighbours, and 156 HCWs 
(49.5%) heard of one or more patients being hospitalised for HBV- related conditions. 
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4.3.2 HBV knowledge 
Self-reporting of the respondents about their level of knowledge and sources of their 
information 
Almost all expressed having HBV knowledge, more than half describing their knowledge as 
inadequate, and the rest that it was adequate (Table 4.16). 
HBV-Knowledge level and source of information N % 
Do you have information?(N=315)     
Yes, enough 129 41.0 
Yes, but it is not enough 177 56.2 
No 9 2.9 
The main source of knowledge(N=306)     
Education 238 77.7 
Internet 159 51.9 
Colleagues 91 29.7 
Newspapers/Magazines 59 19.2 
TV/Radio 54 17.6 
Family/relatives 30 9.8 
Others* 3 0.9 
Table 4.16: Respondents’ self-reported HBV knowledge level and source of information-
HCWs. 
*Others(N): Books(2), self-experience(1). 
Knowledge about HBV key facts 
The highest percentage of correct answers was recorded for those who knew that HCWs may 
have an increased risk of becoming infected with HBV while the lowest percentage was 
recorded for knowledge that most primary liver tumours are caused by the HBV (Table 4.17). 
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Key facts of HBV N* % 
HCWs may have an increased risk of becoming infected with HBV 276 87.6 
Complications of HBV can lead to death 264 83.8 
The microorganism that causes HB is virus 259 82.2 
The infected person with HBV might contract liver cirrhosis 258 81.9 
You know a person is really a HBV case by medical examination 246 78.1 
HBV is a communicable infectious disease 241 76.5 
Pregnant women should be medically screened for HBV 235 74.6 
Medical treatment is available for HBV 199 63.1 
The infected person with HBV might contract liver cancer after a period of 
time 
171 54.2 
Most primary liver tumours are caused by the HBV 97 30.7 
Table 4.17: Percentage of the respondents who gave correct answers about key facts of 
HBV-HCWs(N= 315) 
*N indicates the number of respondents who provided correct answers.  
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Knowledge about likely and unlikely ways of transmission of HBV 
Most knew that blood, injections by syringe used by other people, needle stick injury and 
surgery tools that were used before, are potential ways of transmission. Lower percentages of 
the participants knew the other common likely ways of transmission (Table 4.18). 
Knowledge about likely ways of HBV transmission N* % 
Syringes used by other persons 291 92.4 
Blood 290 92.0 
Through needle stick injury 280 88.9 
Surgery tools that was used before 280 88.9 
Acupuncture needles used by another person 273 86.7 
Dentist tools 267 84.8 
Tattooing 259 82.2 
Circumcision tools that were used before 258 81.9 
Using another person's razor 256 81.3 
Cupping tools used by another person 249 79.1 
Piercing, for example of the nose or ear 233 73.9 
Using another person's toothbrush 226 71.8 
Sexual intercourse 220 69.8 
From an infected mother to the foetus during delivery 208 66.1 
Nail clippers used by other person 199 63.2 
From an infected person who is asymptomatic 195 61.9 
Knowledge about unlikely ways of HBV transmission N* % 
Hugging an infected person 264 83.8 
A sneeze of an infected person 228 72.4 
Being coughed on by an infected person 223 70.8 
Eating food prepared by an infected person 214 67.9 
Eating food on a shared plate with an infected person 196 62.2 
Drinking water in cups used by others: such as in public places 175 55.6 
Through breast-feeding from the infected mother to her infant 89 28.3 
Table 4.18: Percentage of the respondents who gave correct answers about likely and 
unlikely ways of transmitting HBV-HCWs(N=315) 
*N indicates the number of respondents who provided correct answers. 
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Knowledge about HBV vaccine and immunity 
Almost four fifths of the respondents knew that HCWs without a reliable history of HBV should 
receive the HB vaccine. Conversely, a minority of respondents knew that HB vaccine is made 
from killed HB pathogens (Table 4.19). 
HBV knowledge about vaccine and immunity N* % 
HCWs without a reliable history of HBV should receive the HB vaccine 254 80.6 
To obtain optimum protection for HCWs, three doses of HB vaccine are 
needed 
241 76.5 
Acquired immunity after natural HBV is lifelong. 113 35.8 
The immunity following HB vaccination is not life-long 102 32.3 
The HB vaccine is safe for pregnant woman 99 31.4 
The HB vaccine is killed HB pathogens (protein subunit). 46 14.6 
Table 4.19: Percentage of the respondents who gave correct answers about HBV vaccine 
and immunity-HCWs(N=315) 
*N indicates the number of respondents who provided correct answers. 
Perspectives of the respondents about behaviour towards HCWs infected with HBV 
Over two thirds knew that an infected worker could safely eat food with colleagues but less 
than half knew that it is necessary to isolate an infected worker (in the infectious stage) from 
direct contact with patients in hospital (Table 4.20) 
Items reflecting attitude  N* % 
The infected worker can shake hands with colleagues 269 85.4 
All family members of an infected worker require medical examination 224 71.1 
The infected worker can eat food with colleagues 218 69.2 
It is necessary to isolate the infected worker from direct contact with patients in 
a hospital 
130 41.3 
Table 4.20: Percentage of the respondents who gave correct answers about behaviours 
towards the HCWs infected with HBV-HCWs(N= 315) 
*N indicates the number of respondents who provided correct answers. 
Knowledge in different aspects of HBV 
The median and inter-quartile range with percentage of the respondents who gave correct 
answers in previous aspects of HBV is shown in Table 4.21. The median total knowledge score 
on the 43 items was 32 (inter-quartile range 26-35), corresponding to a percentage of 74.4% in 
knowledge variation (inter-quartile range 60.4- 81.4%). Concerning the subscales, the best 
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score was seen on the likely ways of transmission (median 14) while it was the lowest (median 
3) for the HBV vaccine and immunity. 
Knowledge aspects Median IQR 
As % of all questions 
median IQR 
Total knowledge score (43Questions) 32 (26-35) 74.4 (60.4-81.4) 
Key facts of HBV (10Questions) 8 (6-9) 80.0 (60.0-90.0) 
Likely ways of transmission  
(16 Questions) 
14 (12-15) 87.5 (75.0-93.7) 
Unlikely ways of transmission  
(7Questions) 
5 (3-6) 71.4 (42.8-85.7) 
HBV vaccine and immunity  
(6Questions) 
3 (2-4) 50.0 (33.3-66.6) 
Attitude towards infected worker  
(4Questions) 
3 (2-3) 75.0 (50.0-75.0) 
Table 4.21: Percentage of the respondents who gave correct answers in different HBV 
knowledge aspects-HCWs(N=315) 
HBV knowledge score and sociodemographic characteristics 
There was a small, statistically significant positive correlation between the HBV knowledge 
score and age in years with HBV knowledge increasing with age (Table 4.22). Also, there was 
a medium, statistically significant positive correlation between HBV knowledge and years of 
experience in health care institutions, with HBV knowledge increasing with years of 
experience. 
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HBV knowledge score among HCWs N 
Pearson 
Correlation 
P value 
Age 314 0.25 <0.001 
Time spent in formal education 308 0.08 0.12 
Years of experience in health care institutions 309 0.45 <0.001 
Dental visits 281 0.08 0.17 
Table 4.22: Correlation between HBV knowledge score and sociodemographic 
characteristics-HCWs 
The non-Saudi HBV median knowledge score was significantly higher than the Saudis. It was 
also considerably higher in non-Muslims (vs. Muslims), ever-married (vs. singles), and 
postgraduate (vs. undergraduates) (Table 4.23). 
Characteristics N(%) 
HBV knowledge score  
P value*  (43 questions) 
Median(IQR) 
Sex  
 
0.97 
Male 124(39.4%) 32.0(24.2-35.7) 
Female 191(60.6%) 31.0(27.0-35.0) 
Nationality  
 
<0.001 
Saudi 165(52.4%) 27.0(22.0-32.0) 
Non-Saudi 150(47.6%) 35.0(32.0-37.0) 
Religion  
 
<0.001 
Muslim 223(70.8%) 30.0(24.0-34.0) 
Non-Muslim 92(29.2%) 34.0(31.2–3.0) 
Marital status  
 
0.003 
Single  198(62.9%) 31.0(25.7–34.0) 
Ever married 117(37.1%) 33.0(28.0–37.0) 
Education level  
 
<0.001 
Under graduate 268(85.1%) 31.0(25.2–34.0) 
Post graduate 47(14.9%) 35.0(29.0-38.0) 
Table 4.23: HBV knowledge score and sociodemographic characteristics-HCWs(N=315) 
*Based on Mann-Whitney U test  
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HBV knowledge score and occupational characteristics 
There was a significant association between HBV knowledge score and location of practise, 
(Table 4.24). Those who were working in PHCs had the highest score, while those working in 
the KSAU-HS reported the lowest knowledge. A statistically significant association between 
HBV knowledge score and occupation was reported. The highest such score was recorded by 
physicians, while the lowest by administrators. The HBV knowledge score was also 
significantly associated with speciality. It was considerably higher among those who work in 
clinical services compared to those who work in administrative and technical support services. 
HCWs also scored differently in HBV knowledge according to their positions, staff physicians 
had greater scores of HBV knowledge followed by specialist physicians and then nurses. 
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Characteristics N(%) 
HBV knowledge score 
P 
value * 
(43 questions) 
Median(IQR) 
Practise location  
 
<0.001 
KKH 191(60.6%) 32.0(27.0-35.0) 
KSAU-HS 66(21.0%) 28.0(21.0-32.0) 
PHCs 58(18.4%) 34.0(26.7-36.0) 
Occupation 
 
<0.001 
Physician 70(22.2%) 35.0(33.7-38.0) 
Nurse 99(31.4%) 33.0(30.0-35.0) 
Medical Specialist /technician 75(23.8%) 30.0(26.0-34.0) 
Admin 71(22.5%) 23.0(15.0-27.0) 
Speciality 
 
<0.001 
Clinical services 116(36.8%) 34.0(30.0-37.0) 
Administrative/technical support 69(21.9%) 23.0(15.0-27.0) 
Nursing services 63(20.0%) 34.0(31.0-36.0) 
Pathology/laboratory 42(13.3%) 31.0(27.0-36.0) 
Ancillary medical services 25(7.9%) 31.0(26.0-33.0) 
Position 
 
<0.001 
Staff nurse 86(27.3%) 33.0(30.0-35.0) 
Admin/technician assistant 97(30.8%) 26.0(20.0-31.0) 
Specialist 39(12.4%) 28.0(25.0-33.0) 
Staff physician 35(11.1%) 36.0(34.0-38.0) 
Academic staff 33(10.5%) 31.0(25.0-35.0) 
Specialist physician 25(7.9%) 35.0(33.0-37.0) 
Table 4.24: HBV knowledge score and occupational characteristics-HCWs(N=315) 
*Based on Kruskal Wallis test 
HBV knowledge score and sources of information 
Those who had enough information about HBV scored higher in HBV knowledge than those 
who did not have sufficient information (Table 4.25). Those whose source of information about 
HBV was TV/Radio scored a lower knowledge score than those whose information was formal 
education-based. Moreover, better knowledge score was observed among those who reported 
education as the main source of information about HBV. 
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The source of HBV knowledge  N(%) 
HBV knowledge score  
P value 
* 
(43 questions) 
Median(IQR) 
Have information about HBV?  
 
<0.001 
Yes, enough (as perceived by the 
participant) 
129(42.2%) 
35.0(32.0-37.0) 
Yes, but it is not enough 177(57.8%) 29.0(23.0-33.0) 
TV/Radio  
 
0.01 
Yes 54(17.6%) 29.0(22.0-34.2) 
No 252(82.4%) 32.0(27.0-35.0) 
Newspapers/Magazines  
 
0.25 
Yes 59(19.3%) 31.0(23.0-35.0) 
No 247(80.7%) 32.0(27.0-35.0) 
Education  
 
<0.001 
Yes 240(78.4%) 33.0(30.0-36.0) 
No 66(21.6%) 23.0(17.7-27.0) 
Colleagues  
 
0.95 
Yes 91(29.7%) 33.0(26.0-35.0) 
No 215(70.3%) 32.0(27.0-35.0) 
Families  
 
0.01 
Yes 30(9.8%) 27.5(23.7-33 5) 
No 276(90.2%) 32.0(27.0-35.0) 
Internet  
 
0.76 
Yes 161(52.6%) 32.0(27.0-35.0)  
No 154(47.4%) 31.0(26.0-35.0) 
Table 4.25: HBV knowledge score and the source of knowledge-HCWs(N=306) 
*Based on Mann-Whitney U test  
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HBV knowledge score among HCWs tested for HBV, exposure or have immunity against 
HBV 
Those tested for HBV, tested immune against HBV or received regular doses of HB vaccines, 
demonstrated significantly higher scores in their median HBV knowledge than their 
counterparts (Table 4.26). The laboratory serology results suggest that those who have 
immunity against HBV scored significantly higher on HBV knowledge. 
 
Characteristics  N(%) 
HBV knowledge 
score  P 
value* (43 questions) 
Median (IQR) 
Tested for HBV?(N=315) 
 
<0.001 
Yes 237(75.2%) 33.0(29.0-36.0) 
No or not sure 78(24.8%) 25.5(18.7-30.0) 
Tested for immune status against 
HB?(N=315) 
 
<0.001 
Yes 171(54.3%) 34.0(31.0-37.0) 
No or not sure 144(45.7%) 27(22.0- 32.7) 
Regular HB vaccine doses were received 
(N=246) 
 
<0.001 
Regular on time 166(67.5%) 34.0(30.0-36.2) 
Not regular 80(32.5%) 31.0(27.0-34.0) 
Family member has been infected with 
HBV?(N=315) 
 
0.12 
Yes 15(4.8%) 28.0(22.0-33.0) 
No 300(95.2%) 32.0(27.0-35.0) 
Exposure to HBV(HBcAb) (N=315) 
 
0.47 
Positive 16(5.1%) 33.0(26.0-35.0) 
Negative 299(94.9%) 32.0(6.0-35.0) 
Immunity against HBV(N=315) 
 
<0.001 
Positive 227(72.1%) 32.0(27.0-35.0) 
Negative 88(27.9%) 28.0(22.2-34.0) 
Table 4.26: HBV knowledge score tested for HBV, exposure or have immunity against 
HBV-HCWs 
*Based on Mann-Whitney U test  
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Potential predictors of hepatitis B knowledge  
Table 4.27 shows the results of a multiple linear regression investigating the potential 
predicators of HBV knowledge. Variables included in the initial model are: age, years of 
experience (Table 4.22); nationality, religion, marital status, education level (Table 4.23); 
location, occupation, specialty, position (Table 4.24) and the source of knowledge (Table 4.25), 
tested for HBV, tested for immune status, Regular HB vaccine doses were received and 
immunity against HBV (Table 4.26). The model, with all included variables, explained 54.7% 
of the variance in HBV knowledge. 
As shown in Table 4.27, non-Saudi HCWs were more likely to have a better HBV knowledge 
score than Saudi HCWs and scored 3.01 points higher in knowledge. Furthermore, those HCWs 
who specialised in administrative technical support services had an average lower knowledge 
score compared to those working in clinical services and scored (-3.76) points lower in 
knowledge. Moreover, those who reported that source of knowledge about HBV was formal 
education had significantly higher HBV knowledge and scored 4.4 points higher in knowledge. 
Those HCWs working as physicians were significantly more likely to have higher knowledge 
scores compared to those working as nurses scoring 2.05 points higher in knowledge. Also, 
those who reported that they had enough information about HBV were more likely to have a 
better HBV knowledge score compared to not-enough information and scored 1.78 points 
higher in knowledge. Additionally, HCWs who were tested for immune status against HBV 
were statistically more likely to have a higher knowledge score compared to those who were 
not tested and scored 1.96 points higher in knowledge. Conversely, having post graduate 
education was marginally significant. There was more likelihood of having a higher knowledge 
score among post-graduate group compared with under graduate education levels. 
Variables determining HBV knowledge after adjustment for confounders were investigated, 
Non-Saudi as a variable was considered a confounder to all other variables. However, 
administrative technical support services variable was not affected. 
The interaction between independent determinant variables in the final model of HBV 
knowledge score were investigated (Table 4.28). The interaction between occupation and 
education as source of information indicated that physicians had much higher scores of HBV 
knowledge -1.62 points when education was reported as source of information. In contrast, the 
interaction between education as source and those who said to have enough HBV information 
indicated that those who said education as source had much higher scores of HBV knowledge 
-2.49 points when having enough HBV information. 
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Furthermore, the interaction between nationality and education as source of information 
indicated that Non Saudis had much higher scores of HBV knowledge -3.47 points when 
education was reported as source of information. No other statistical significance of interactions 
was found. 
Variable* 
Coefficients 
B 
95% C.I for B P value 
Constant 23.36 21.36 25.35 <0.001 
Nationality- 
Non-Saudi(ref Saudi) 
3.01 1.65 4.35 <0.001 
Education level-  
Post graduate(ref other) 
1.71 -0.03 3.46 0.055 
Occupation – 
Physician(ref Nurse) 
2.05 0.45 3.65 0.01 
Speciality –  
Administrative technical support 
Services(ref:Clinical services) 
-3.76 -5.78 -1.74 <0.001 
Do you think that you have 
information about HBV?-  
Yes, enough 
1.78 0.44 3.11 0.009 
The source of HBV knowledge is 
Education. 
Yes 
4.40 2.46 6.34 <0.001 
Were you ever tested for 
immune status against HBV? 
Yes 
1.96 0.68 3.24 0.003 
Table 4.27: Independent determinants of HBV knowledge score-HCWs(N=306) 
*Multiple linear regression 
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Variable* B 95%C.I P value 
Interaction(Occupation*Education source of information) 
Nationality-Non Saudi  3.31 1.87 4.75 <0.001 
Occupation-Physician 5.94 3.91 7.97 <0.001 
Speciality-administrative technical support 
-4.89 
-
6.75 
-3.03 <0.001 
Speciality-Nursing services 2.09 0.37 3.80 0.01 
Do you think that you have information about HBV?Yes, 
enough 
1.97 0.60 3.34 0.005 
Were you ever tested for HBV?Yes 
1.56 
-
0.05 
3.18 0.058 
Occupation and education source of information interaction 1.62 0.81 2.43 <0.001 
Interaction(Education source of information*Have enough information about HBV) 
Nationality-Non Saudi  3.51 2.11 4.91 0.001 
Occupation-Physician 2.89 1.35 4.43 0.001 
Speciality-administrative technical support  
-6.21 
-
7.98 
-4.45 0.001 
Were you ever tested for HBV?Yes 1.85 0.21 3.49 0.02 
Education source of information*have enough information 
interaction 
2.49 1.08 3.89 0.001 
Interaction(Nationality*Education source of information) 
Occupation-Physician 2.98 1.45 4.51 <0.001 
Speciality-administrative technical support 
-6.18 
-
7.95 
-4.40 <0.001 
Do you think that you have information about HBV?Yes, 
enough 
2.18 0.80 3.56 0.002 
Were you ever tested for HBV?Yes 1.92 0.29 3.54 0.02 
Nationality and education source of information interaction 3.74 2.36 5.12 <0.001 
Table 4.28: Interaction between independent determinants variables in the final model of 
HBV knowledge-HCWs 
*Multiple linear regression  
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4.3.3 Concern and attitude about HBV  
With few exceptions, HCWs agreed that HBV is a serious disease and its vaccination should be 
compulsory for them (Table 4.29). Furthermore, most respondents agreed that an employee not 
infected with it before should be vaccinated to avoid the infection, as should family members 
and colleagues if not already immune. Almost a quarter of participants expressed willingness 
to deal with HBV-infected colleagues in health care as normal, and more than half indicated 
that they would deal with them carefully. A minority reported that they would not deal with 
infected persons. When respondents were asked about their perception of an infected person 
marrying one of their relatives, more than a third stated they would disagree, and almost half 
expressed the need to clarify the risks to the family member before agreeing. 
Statement Degree of agreement N % 
HBV is a serious disease 
Agree 305 96.8 
Neutral 9 2.9 
Disagree 1 0.3 
HB vaccination should be made 
compulsory for HCWs 
Agree 308 97.8 
Neutral 7 2.2 
Disagree 0 0.0 
It is important for an employee who was 
not infected by HBV before, to be 
vaccinated 
Agree 305 96.8 
Neutral 9 2.9 
Disagree 1 0.3 
It is recommended for family members 
and colleagues to be vaccinated if they are 
not immune 
Agree 283 89.8 
Neutral 28 8.9 
Disagree 4 1.3 
If a HBV infected person (inactive) works 
with you in a health care centre, you will 
deal with him 
Normally 75 23.8 
Carefully 207 65.7 
I won’t deal with him 15 4.8 
I don't know 18 5.7 
A person infected with HBV wishes to 
marry a relative in your family (not 
infected with HBV), what is your opinion 
I agree without precaution 16 5.1 
I agree after reminding risks 126 40.0 
I do not agree 121 38.4 
I do not know 52 16.5 
Table 4.29: Participants’ concern and attitude towards the HBV and HBV-infected 
colleagues-HCWs(N=315) 
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Concern and attitude about HBV and sociodemographic characteristics  
There was a small and negative correlation between length of experience in health-care 
institutions and the recommendation for vaccinating HBV free employees; as years of 
experience increases, there was reduced agreement. The correlation was also small and negative 
between the length of experience in health-care institutions and the recommendation that non-
immune family members and colleagues should be vaccinated; as years of experience increases, 
there was less agreement (Table 4.30). The correlation was also small and negative between 
HBV knowledge and those who said HBV is a serious disease: as HBV knowledge increases, 
there was less agreement. Furthermore, there was small and negative correlation between HBV 
knowledge and the recommendation that infection-free employees should be vaccinated; the 
more the knowledge increase, agreement reduces. 
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Participants’ concern and attitude 
HBV is a 
serious 
disease 
HBV vaccination 
should be made 
compulsory for 
HCWs 
Important for an 
employee who was not 
infected by HBV before, 
to be vaccinated 
Family members and 
colleagues should be 
vaccinated if they were not 
immune 
Age 
Correlation* -0.01 -0.05 -0.01 -0.02 
P value 0.83 0.30 0.73 0.71 
Time spent in 
formal education 
Correlation* -0.10 0.04 0.04 0.10 
P value 0.06 0.38 0.44 0.06 
Experience in 
health institutions 
Correlation* -0.05 -0.08 -0.14 -0.12 
P value 0.36 0.11 0.01 0.03 
HBV knowledge 
score  
Correlation* -0.10 -0.10 -0.11 -0.01 
P value 0.05 0.06 0.03 0.06 
Table 4.30: Correlation between participants’ concern and attitude towards the HBV and HBV-infected colleagues and sociodemographic 
characteristics-HCWs(N=315) 
*Based on Spearman's rho correlation 
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A majority of non-Saudi employees recommended HBV-free employees be vaccinated, the 
association between this and nationality was statistically significant. Similarly, the majority of 
non-Muslims recommended HBV-free employees be vaccinated, the association between this 
recommendation and religious beliefs was also statistically significant (Table 4.31 and 
Table 4.32). Furthermore, a majority of non-Saudis and non-Muslims agreed that family 
members and colleagues should be vaccinated if they were not immune and this association 
between recommendation and nationality/religion was statistically significant. 
Over of 30 year olds or above said they would carefully deal with HBV-infected colleagues. 
Furthermore, about with a year or more experience would do the same. The association for 
both groups was statistically significant. Two thirds of those whose HBV knowledge score was 
above median expressed willingness to deal with HBV-infected colleagues carefully. About 
11.2% of those with knowledge scores below median stated “I don't know”, and this association 
was statistically significant. 
Further, more than half of those who spent 16 years or less in formal education would not 
object to an infected person marrying a relative after reminding him/her of the risks. However, 
nearly half of those with more than 19 years in formal education disagreed, and this association 
was statistically significant. 
More than half of those whose HBV knowledge score was above median would agree to a 
relative marrying an infected person after reminding him/her of possible risks. However, of 
those with a knowledge score below median expressed disagreement and this association was 
statistically significant (Table 4.33 and Table 4.34). 
In contrast, over two thirds of non-Saudis and non-Muslims expressed contentedness in dealing 
with HBV-infected colleagues carefully. Furthermore, over two-fifths of females, of non-
Saudis and two thirds of non-Muslims agreed to an infected person marrying a relative after a 
reminder of the risks. This association was statistically significant for females, non-Saudis, and 
non-Muslims. However, nearly half of those who have a postgraduate degree expressed non-
agreement - this association being statistically significant (Table 4.35 and Table 4.36).
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Characteristics  N 
HBV is a serious disease 
P-Value  
HB vaccination should be made 
compulsory for HCWs 
P-Value* 
Disagree or 
Neutral 
Agree 
Disagree or 
Neutral 
Agree 
Sex    0.75*   0.44* 
Male 124 3(2.4%) 121(97%) 4(3.2%) 120(96.8%) 
Female  191 7(3.7%) 184(96.3%) 3(1.6%) 188(98.4%) 
Nationality    1.00*   0.01* 
Saudi 165 5(3.0%) 160(97%) 7(4.2%) 158(95.8%) 
Non-Saudi 150 5(3.3%) 145(96.7%) 0(0%) 150(100) 
Religion     0.48*   0.11* 
Muslim 223 6(2.7%) 217(97.3%) 7(3.1%) 216(96.9%) 
Non-Muslim 92 4(4.3%) 88(95.7%) 0(0.0%) 92(100.0%) 
Marital status    0.1*   1.00* 
Single 198 9(4.5%) 189(95.5%) 5(2.5%) 193(97.5%) 
Ever married 117 1(0.9%) 116(99.1%) 2(1.7%) 115(98.3%) 
Education level    0.37*   0.6* 
Under graduate 268 10(3.7%) 258(96.3%) 7(2.6%) 261(97.4%) 
Post graduate 47 0(0.0%) 305(96.8%) 0(0.0%) 47(100.0%) 
Table 4.31: Association between participants’ concern and attitude towards the HBV and HBV-infected colleagues and sociodemographic 
characteristics-HCWs(N=315)(a) 
*Based on Fisher’s exact test   
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Characteristics  N 
 Important for an employee who was not 
infected by HBV before, to be 
vaccinated 
P-
Value* 
 Family members and colleagues 
should be vaccinated if they were 
not immune 
P-Value* 
Disagree or Neutral Agree Disagree or Neutral Agree 
Sex    0.2*   0.1** 
Male 124 6(4.8%) 118(95.2%) 17(13.7%)  107(86.3%) 
Female 191 4(2.1%) 187(97.9%) 15(7.9%) 176(92.1%) 
Nationality    0.02*   0.001** 
Saudi 165 9(5.5%) 156(94.5%) 26(15.8%) 139(84.2%) 
Non-Saudi 150 1(0.7%) 149(99.3%) 6(4.0%) 144(96.0%) 
Religion       0.03*   0.01** 
Muslim 223 10(4.5%) 213(95.5%) 29(13 0%) 194(87.0%) 
Non-Muslim 92 0(0%) 92(100%) 3(3.3%) 89(96.7%) 
Marital status    0.09*   0.59** 
Single 198 9(4.5%) 189(95.5%) 22(11.1%) 176(88.9%) 
Ever married 117 1(0.9%) 116(99.1%) 10(8.5%) 107(91.5%) 
Education level    0.64*   0.70** 
Under graduate 268 8(3.0%) 260(97.0%) 26(9.7%) 242(90.3%) 
Post graduate 47 2(4.3%) 45(95.7%) 6(12.8%) 41(87%) 
Table 4.32: Association between participants’ concern and attitude towards the HBV and HBV-infected colleagues and sociodemographic 
characteristics-HCWs(N=315)(b) 
*Based on Fisher’s exact test **Based on Continuity Correction  
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Characteristics  N 
 If a HBV infected person works with you in a health care 
centre, you will deal with him P-
Value*  Normally  Carefully 
 I won’t deal 
with him 
 I don't know 
Age in category(Years)   
 
0.04 
<25 75 17(22.7%) 47(62.7%) 4(5.3%) 7(9.3%) 
25-30 150 33(22.0%) 97(64.7%) 11(7.3%) 9(6.0%) 
>30 90 25(27.8%) 63(70.0%) 0(0.0%) 2(2.2%) 
Time spent in formal education(Years)   0.06 
≤16 156 41(26.3%) 100(64.1%) 5(3.2%) 10(6.4%) 
17-18 91 22(24.2%) 56(61.5%) 5(5.5%) 8(8.8%) 
≥19 68 12(17.6%) 51(75.0%) 5(7.4%) 0(0.0%) 
Experience in health care institutions(Years)   0.001 
<1 75 19(25.3%) 35(46.7%) 9(12.0%) 12(16.0%) 
1-3 95 21(22.1%) 66(69.5%) 4(4.2%) 4(4.2%) 
4-6 72 14(19.4%) 54(75.0%) 2(2.8%) 2(2.8%) 
>6 73 21(28.8%) 52(71.2%) 0(0.0%) 0(0.0%) 
HBV knowledge   0.001 
Knowledge score equal to median or below 174 36(20.7%) 108(62.1%) 13(7.5%) 17(9.8%) 
Knowledge score above median 141 39(27.7%) 99(70.2%) 2(1.4%) 1(0.7%) 
Table 4.33: Attitude towards the HBV and HBV-infected colleagues and sociodemographic characteristics-HCWs(N=315)(a) 
*Based on Monte Carlo method  
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Characteristics  N 
A person infected with HBV wishes to marry a relative in your family (not 
infected with HBV), what is your opinion  P-
Value* I agree without 
precaution 
I agree after reminding 
him of the risks 
I do not agree  I do not know 
Age in category(Years)    0.15 
<25 75 5(6.7%) 24(32.0%) 35(46.7%) 11(14.7%) 
25-30 150 7(4.7%) 60(40.0%) 51(34.0%) 32(21.3%) 
>30 90 4(4.4%) 42(46.7%) 35(38.9%) 9(10.0%) 
Time spent in formal education(Years)    0.004 
≤16 156 4(2.6%) 79(50.6%) 49(31.4%) 24(15.4%) 
17-18 91 5(5.5%) 30(33.0%) 40(44.0%) 16(17.6%) 
≥19 68 7(10.3%) 17(25.0%) 32(47.1%) 12(17.6%) 
Experience in health care institutions(Years)    0.001 
<1 75 6(8.0%) 17(22.7%) 31(41.3%) 21(28.0%) 
1-3 95 4(4.2%) 33(34.7%) 42(44.2%) 16(16.8%) 
4-6 72 2(2.8%) 35(48.6%) 23(31.9%) 12(16.7%) 
>6 73 4(5.5%) 41(56.2%) 25(34.2%) 3(4.1%) 
HBV knowledge    0.001 
Knowledge score equal to median or below 174 11(6.3%) 59(33.9%) 63(36.2%) 41(23.6%) 
Knowledge score above median 141 5(3.5%) 67(47.5%) 58(41.1%) 11(7.8%) 
Table 4.34: Attitude towards the HBV and HBV-infected colleagues and sociodemographic characteristics-HCWs(N=315)(b) 
*Based on Monte Carlo method  
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Characteristics N 
 If a HBV infected person works with you in a health care centre, you will deal with him 
P-Value* 
 Normally  Carefully  I won’t deal with him  I don't know 
Sex   
 
0.56* 
Male 124  31(25.0%) 80(64.5%) 4(3.2%) 9(7.3%) 
Female  191 44(23.0%)  127(66.5%) 11(5.8%) 9(4.7%) 
Nationality   
 
0.001* 
Saudi 165  35(21.2%) 100(60.6%) 13(7.9%) 17(10.3%) 
Non-Saudi 150  40(26.7%) 107(71.3%) 2(1.3%) 1(0.7%) 
Religion    
 
0.001* 
Muslim 223  48(21.5%) 143(64.1%) 14(6.3%) 18(8.1%) 
Non-Muslim 92 27(29.3%)  64(69.6%) 1(1.1%) 0(0.0%) 
Marital status   
 
0.85* 
Single 198  50(25.3%) 127(64.1%) 9(4.5%) 12(6.1%) 
Ever married 117  25(21.4%) 80(68.4%) 6(5.1%) 6(5.1%) 
Education level   
 
0.07 * 
Under graduate 268  69(25.7%) 1 71(63.8)  11(4.1%)  17(6.3%) 
Post graduate 47 6(12.8%) 36(76.6%) 4(8.5%) 1(2.1%) 
Table 4.35: Attitude towards the HBV and HBV-infected colleagues and sociodemographic characteristics-HCWs(N=315)(c) 
*Based on Monte Carlo method 
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Characteristics N 
A person infected with HBV wishes to marry a relative in your family (not 
infected with HBV) ,what is your opinion  
P-Value* 
 I agree without 
precaution 
I agree after reminding 
him of the risks 
I do not agree  I do not know 
Sex     0.005* 
Male 124 3(2.4%) 47(37.9%) 43(34.7%) 31(25.0%) 
Female  191 13(6.8%) 79(41.4%) 78(40.8%) 21(11.0%) 
Nationality    0.001* 
Saudi 165  10(6.1%) 38(23.0%) 80(48.5%) 37(22.4%) 
Non-Saudi 150  6(4.0%) 88(58.7%) 41(27.3%) 15(10.0%) 
Religion     0.001* 
Muslim 223 13(5.8%)  64(28.7%) 100(44.8%) 46(20.6%) 
Non-Muslim 92  3(3.3%) 62(67.4%) 21(22.8%) 6(6.5%) 
Marital status    0.36* 
Single 198  11(5.6%) 85(42.9%) 69(34.8%) 33(16.7%) 
Ever married 117 5(4.3%)  41(35.0%) 52(44.4%) 19(16.2%) 
Education level    0.04 
Under graduate 268  11(4.1%) 111(41.4%) 98(36.6%) 48(17.9%)  
Post graduate 47  5 (10.6%) 15(13.9%) 23(48.9%)  4(8.5%) 
Table 4.36: Attitude towards the HBV and HBV-infected colleagues and sociodemographic characteristics-HCWs(N=315)(d) 
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Concern and attitude about HBV and occupational characteristics  
There was no significant association between participants’ concern and attitude towards HBV 
and HBV-infected colleagues among HCWs and occupational characteristics (Table 4.37, 
Table 4.38, Table 4.39 and Table 4.40). 
About half of those working in PHC expressed willingness to deal with HBV-infected 
colleagues carefully, however, nearly half of those working at the KSAU-HS would not and 
this association was statistically significant. In terms of occupation, nearly two thirds of nurses 
would deal with HBV-infected colleagues carefully, however, more than half of physicians and 
two fifths of administrators would not deal with them and this association was statistically 
significant (Table 4.41). 
Further, nearly two fifths of those working in the KKH expressed agreement if an infected 
person wants to marry one of their relatives after a reminder of the risks, but two fifths of those 
working in the KSAU-HS would disagree and this association was statistically significant. In 
terms of occupation, nearly two thirds of nurses would agree if an infected person wants to 
marry one of their relatives after a reminder of the risks but about half the physicians, specialists 
and two fifths of administrators expressed non-agreement and this association was statistically 
significantly (Table 4.43). 
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Characteristics  N 
HBV is a serious disease 
P-Value* 
HB vaccination should be made 
compulsory for HCWs 
P-Value* 
Disagree or 
Neutral 
Agree Disagree or Neutral Agree 
Practise location    0.4   0.61 
KKH 191 7(3.7%) 184(96.3%) 4(2.1%) 187(97.9%) 
KSAU-HS 66 2(3.0%) 64(97.0%) 3(4.5%) 63(95.5%) 
PHCs 58 1(1.7%) 57(98.3%) 0(0%) 58(100.0%) 
Occupation    0.1   0.18 
Physician 70 0(0%) 70(100%) 1(1.4%) 69(98.6%) 
Nurse 99 3(3.0%) 96(97.0%) 1(1.0%) 98(99.0%) 
Specialist/Technician 75 4(5.3%) 71(94.7%) 2(2.7%) 73(97.3%) 
Admin 71 3(4.2%) 68(95.8%) 3(4.2%) 68(95.8%) 
Table 4.37: Association between participants’ concern and attitude towards the HBV and HBV-infected colleagues and occupational 
characteristics-HCWs(N=315)(a) 
*Based on (Monte Carlo method) 
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Characteristics N 
HBV is a serious disease 
P-Value* 
HB vaccination should be made 
compulsory for HCWs 
P-Value* 
Disagree or 
Neutral 
Agree 
Disagree or 
Neutral 
Agree 
Speciality    0.37   0.63 
Clinical services 116 2(1.7%) 114(98.3%) 2(1.7%) 114(98.3%) 
Administrative/Technical  69 3(4.3%) 66(95.7%) 3(4.3%) 66(95.7%) 
Nursing services 63 2(3.2%) 61(96.8%) 0(0.0%) 63(100%) 
Pathology/laboratory 42 2(4.8%) 40(95.2%0 0(0.0%) 42(100.0%) 
Ancillary medical services 25 1(4.0%) 24(96.8%0 2(8.0%) 23(92.0%) 
Position    0.32   0.58 
Staff nurse 86 3(3.5%) 83(96.5%) 1(1.2%) 85(98.8%) 
Admin & technician  97 4(4.1%) 93(95.9%) 3(3.1%) 94(96.9%) 
Specialist 39 2(5.1%) 37(94.9%) 1(2.6%) 38(97.4%) 
Staff physician 35 0(0.0%) 35(100%) 0(0.0%) 35(100%) 
Academic staff 33 1(3.0%) 32(97.0%) 1(3.0%) 32(97.0%) 
Specialist physician 25 0(0.0%) 25(100.0%) 1(4.0%) 24(96.0%) 
Table 4.38: Association between participants’ concern and attitude towards the HBV and HBV-infected colleagues and occupational 
characteristics-HCWs(N=315)(b) 
*Based on (Monte Carlo method)  
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Characteristics  N 
 Important for an employee who 
was not infected by HB before, to 
be vaccinated 
P-Value* 
 Family members and colleagues should 
be vaccinated if they were not immune 
P-
Value* 
Disagree or 
Neutral 
Agree 
Disagree or 
Neutral 
Agree 
Practise location    0.2   0.19 
KKH 191 7(3.7%) 184(96.3%) 16(8.4%) 175(91.6%) 
KSAU-HS 66 3(4.5%) 63(95.5%) 8(12.1%) 58(87.9%) 
PHCs 58 0(0.0%) 58(100%) 8(13.8%) 50(86.2%) 
Occupation    0.4   0.85 
Physician 70 2(2.9%) 68(97.1%) 10(14.3%) 60(85.7%) 
Nurse 99 3(3.0%) 96(97.0%) 5(5.1%) 94(94.9%) 
Specialist/Technician 75 1(1.3%) 74(98.7%) 8(10.7%) 67(89.3%) 
Admin 71 4(5.6%) 67(94.4%) 9(12.7%) 62(87.3%) 
Table 4.39: Association between participants’ concern and attitude towards the HBV and HBV-infected colleagues and occupational 
characteristics-HCWs(N=315)(c) 
*Based on (Monte Carlo method) 
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Characteristics N 
 Important for an employee who 
was not infected by HBV before, 
to be vaccinated 
P-
Value* 
 Family members and colleagues 
should be vaccinated if they were 
not immune 
P-
Value* 
Disagree or 
Neutral 
Agree 
Disagree or 
Neutral 
Agree 
Speciality    0.28   0.33 
Clinical services 116 4(3.4%) 112(96.6%) 15(12.9%) 101(87.1%) 
Administrative / Technical  69 4(5.8%) 65(94.2%) 9(13.0%) 60(87.0%) 
Nursing Services 63 1(1.6%) 62(89.4%) 1(1.6%) 62(98.4%) 
Pathology/laboratory 42 1(2.4%) 41(97.6%) 3(7.1%) 39(92.9%) 
Ancillary medical Services 25 0(0.0%) 25(100%) 4(16.0%) 21 (84.0%) 
Position    0.41   0.059 
Staff Nurse 86 3(3.5%) 83(96.5%) 3(3.5%) 83(96.5%) 
Admin & Technician  97 4(4.1%) 93(95.9%) 10(10.3%) 87(89.7%) 
Specialist 39 1(2.6%) 38(97.4%) 7(17.9%) 32(82.1%) 
Staff Physician 35 1(2.9%) 34(97.1%) 4(11.4%) 31(88.6%) 
Academic staff 33 1(3.0%) 32(97.0%) 4(12.1%) 29(87.0% 
Specialist Physician 25 0(0.0%) 25(100.0%) 4(16.0%) 21(84.0%) 
Table 4.40: Association between participants’ concern and attitude towards the HBV and HBV-infected colleagues and occupational 
characteristics-HCWs(N=315)(d) 
*Based on (Monte Carlo method) 
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Characteristics  N 
 If a HBV infected person works with you in a health care centre, you will 
deal with him 
P-Value* 
 Normally  Carefully  I won’t deal with him  I don't know 
Practise location   0.01 
KKH 191 10(5.2%) 81(42.4%) 72(37.7%) 28(14.7%) 
KSAU-HS 66 3(4.5%) 15(22.7%) 29(43.9%) 19(28.8%) 
PHCs 58 3(5.2%) 30(51.7%) 20(34.5%) 5(8.6%) 
Occupation   0.001 
Physician 70 4(5.7%) 22(31.4%) 36(51.4%) 8(11.4%) 
Nurse 99 4(4.0%) 62(62.6%) 23(23.2%) 10(10.1%) 
Specialist/Technician 75 0(0.0%) 29(38.7%) 23(23.2%) 13(17.3%) 
Admin 71 8(11.3%) 13(18.3%) 29(40.8%) 21(29.6%) 
Table 4.41: Attitude towards the HBV and HBV-infected colleagues and occupational characteristics-HCWs(N=315)(a) 
*Based on (Monte Carlo method) 
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Characteristics N 
If a HBV infected person works with you in a health care centre, you will 
deal with him 
P-Value* 
 Normally  Carefully 
 I won’t deal 
with him 
 I don't know 
Speciality    0.001 
Clinical services 116 6(5.2%0 46(39.7%) 47(40.5%) 17(14.7%) 
Administrative/Technical  69 8(11.6%) 13(18.8%) 27(39.1%) 21(30.4%) 
Nursing services 63 2(3.2%) 42(66.7%) 17(27.0%) 2(3.2%) 
Pathology/laboratory 42 0(0.0%) 19(45.2%) 15(35.7%) 8(19.0%) 
Ancillary medical services 25 0(0.0%) 6(24.0%) 15(60.0%) 4(16.0%) 
Position   0.001 
Staff nurse 86 4(4.7%) 51(59.3%) 22(25.6%) 9(10.5%) 
Admin/Technician  97 8(8.2%) 37(38.1%) 31(32.0%0 21(21.6%) 
Specialist 39 0(0.0%) 9(23.1%) 24(61.5%) 6(15.4%) 
Staff physician 35 0(0.0%) 15(42.9%) 15(42.9%0 5(14.3%) 
Academic staff 33 2(6.1%) 8(24.2%) 14(42.4%0 9(27.3%) 
Specialist physician 25 2(8.0%) 6(24.0%) 15(60.0%) 2(8.0%) 
Table 4.42: Attitude of participants towards the HBV and HBV-infected colleagues and occupational characteristics-HCWs-(N=315)(b) 
*Based on Monte Carlo method  
  
115 
Characteristics  N 
A person infected with HBV wishes to marry a relative in your family (not infected 
with HBV), what is your opinion  
P-Value*  I agree 
without 
precaution 
I agree after 
reminding him of 
the risks 
I do not agree  I do not know 
Practise location   0.01 
KKH 191 10(5.2%) 81(42.4%) 72(37.7%) 28(14.7%) 
KSAU-HS 66 3(4.5%) 15(22.7%) 29(43.9%) 19(28.8%) 
PHCs 58 3(5.2%) 30(51.7%) 20(34.5%) 5(8.6%) 
Occupation   0.001 
Physician 70 4(5.7%) 22(31.4%) 36(51.4%) 8(11.4%) 
Nurse 99 4(4.0%) 62(62.6%) 23(23.2%) 10(10.1%) 
Specialist/Technician 75 0(0.0%) 29(38.7%) 33(44.0%) 13(17.3%) 
Admin 71 8(11.3%) 13(18.3%) 29(40.8%) 21(29.6%) 
Table 4.43: Attitude of participants towards the HBV and HBV-infected colleagues and occupational characteristics(N=315)(c) 
*Based on (Monte Carlo method) 
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Characteristics N 
A person infected with HBV wishes to marry a relative in your family 
(not infected with HBV), what is your opinion 
P-Value * 
I agree without 
precaution 
I agree after 
reminding him of 
the risks 
I do not agree I do not know 
Speciality   0.001 
Clinical services 116 6(5.2%) 46(39.7%) 47(40.5%) 17(14.7%) 
Administrative/Technical  69 8(11.6%) 13(18.8%) 27(39.1%) 21(30.4%) 
Nursing services 63 2(3.2%) 42(66.7%) 17(27.0%) 2(3.2%) 
Pathology/laboratory 42 0(0.0%) 19(45.2%) 15(35.7%) 8(19.0%) 
Ancillary medical services 25 0(0.0%) 6(24.0%) 15(60.0%) 4(16.0%) 
Position   0.001 
Staff nurse 86 4(4.7%) 51(59.3%) 22(25.6%) 9(10.5%) 
Admin/Technician  97 8(8.2%) 37(38.1%) 31(32.0%) 21(21.6%) 
Specialist 39 0(0.0%) 9(23.1%) 24(61.5%) 6(15.4%) 
Staff physician 35 0(0.0%) 15(42.9%) 15(42.9%) 5(14.3%) 
Academic staff 33 2(6.1%) 14(42.4%) 14(42.4%) 9(27.3%) 
Specialist physician 25 2(8.0%) 15(60.0%) 15(60.0%) 2(8.0%) 
Table 4.44: Attitude of participants towards the HBV and HBV-infected colleagues and occupational characteristics-HCWs(N=315)(d) 
*Based on (Monte Carlo method) 
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4.3.4 Summary of HBV serology results among health care workers who completed the 
questionnaire 
Seroprevalence of HBV markers 
Only two HCWs were HBV infected with a minority exposed to HBV earlier in their life and 
about a quarter not having serological evidence of immunity against HBV (Table 4.45). 
 
Serology test Results N % 95%C.I 
HBsAg 
Negative 313 99.4  (97.7-99.8) 
Positive 2 0.6  (0.2-2.3) 
HBcAb 
Negative 299 94.9  (91.9-96.8) 
Positive 16 5.1  (3.2-8.1) 
HBsAb 
Negative 88 27.9  (23.3-33.1) 
Positive 227 72.1  (66.9-76.7) 
Table 4.45: The laboratory results for HBV markers-HCWs(N=315) 
Clinical interpretation of hepatitis B serological markers 
Two thirds of HCWs had serological evidence of immunity against HBV mostly through HB 
vaccination, and about a quarter was never exposed, never vaccinated and susceptible for 
infection. Meanwhile, a minority of participants were immune due to natural infection, and just 
two cases were HBV chronic carriers (Table 4.46). 
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Serology test Result N % Interpretation  
HBsAg Negative 
213 67.6 
1-Most probably; immune due to 
HBV vaccination. 
2-Might be repeated exposure to 
antigen without infection. 
3-Might be recovery from infection 
with loss of detectable HBcAb. 
HBcAb Negative 
HBsAb Positive 
HBsAg Negative 
86 27.3 
Never exposed, never vaccinated, 
susceptible for infection 
HBcAb Negative 
HBsAb Negative 
HBsAg Negative 
14 4.4 Immune due to natural infection HBcAb Positive 
HBsAb Positive 
HBsAg Positive 
2 0.6 Chronic carrier infection HBcAb Positive 
HBsAb Negative 
Table 4.46: Clinical interpretation of HBV serological markers-HCWs(N=315) 
Seroprevalence of HBV antibodies-HBcAb 
Sociodemographic characteristics of the respondents positive to HBcAb 
The prevalence of HBcAb increased steadily with age (Table 4.47). It ranged between 4.0% 
among those aged between 25 and 30 to 11.1% among those aged 30 or above, and this 
association was statistically significant. However, the prevalence did not vary significantly 
with sex, nationality, marital status, level of education, length of time spent in formal education 
and years of experience in health care institutions. 
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Characteristics 
Negative 
HBcAb 
(N=299) 
Positive 
HBcAb  
(N=16) 
Overall 
N 
P-Value  
Age in category (Years)   0.003* 
< 25  75(100%) 0(0%) 75  
25-30 144(96.0%) 6(4.0%) 150  
>30 80(88.9%) 10(11.1%) 90  
Sex   0.67** 
Female 180(94.2%) 11(5.8%) 191  
Male 119(96%) 5(4.0%) 124  
Nationality   0.33** 
Saudi 159(96.4%) 6(3.6%) 165  
Non-Saudi 140(93.3%) 10(6.7%) 150  
Marital status   0.40** 
Single 190(96%) 8(4%) 198  
Ever married 109(93.2%) 8(6.8%) 117  
Education level       0.71*** 
Under graduate 255(95.1%) 13(4.9%) 268  
Post graduate 44(93.6%) 3(6.4%) 47  
Time spent in formal education(Years) 
 
   0.50* 
≤16 148(94.9%) 8(5.1%) 156  
17-18 88(96.7%) 3(3.3%) 91  
≥19 63(92.6%) 5(7.4%) 68  
Experience in health care 
institutions(Years) 
 
   
0.31* 
<1 72(96%) 3(4.0%) 75  
1-3 92(96.8%) 3(3.2%) 95  
4-6 69(95.8%) 3(4.2%) 72  
>6 66(90.4%) 7(9.6%) 73  
Table 4.47: Sociodemographic characteristics of the positive respondents to HBcAb-
HCWs(N=315) 
*Based on Monte Carlo method**Based on Chi-square for continuity correction***Based on Fisher's Exact test 
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Occupational Characteristics 
The prevalence of HBcAb was significantly higher among those designated to work in the 
KKH than in those designated to work either in the KSAU-HS or PHCs (Table 4.48). However, 
the prevalence did not vary significantly with occupation, speciality or with job position. 
Characteristics  
Negative  
HBcAb(N=299) 
Positive 
HBcAb (N=16) 
Overall 
N 
P-
Value
*  
Practise location 
 
0.01 
KKH 176(92.1%) 15(7.9%) 191 
KSAU-HS 65(98.5%) 1(1.5%) 66 
PHCs 58(100%) 0(0.0%) 58 
Occupation  0.72 
Physician 65(92.9%) 5(7.1%) 70 
Nurse 94(94.9%) 5(5.1%) 99 
Medical Specialist/Technician 71(94.7%) 4(5.3%) 75 
Admin 69(97.2%) 2(2.8%) 71 
Speciality  0.80 
Clinical services 110(94.8%) 6(5.2%) 116 
Administrative/technical 
support  
67(97.1%) 2(2.9%) 69 
Nursing services 59(93.7%) 4(6.3%) 63 
Pathology/laboratory 40(95.2%) 2(4.8%) 42 
Ancillary medical services 23(92.0%) 2(8.0%) 25 
Position  0.17 
Specialist physician 21(84.0%) 4(16%) 25 
Staff physician 33(94.3%) 2(5.7%) 35 
Academic staff 33(100%) 0(0.0%) 33 
Specialist 38(97.4%) 1(2.6%) 39 
Staff nurse 81(94.2%) 5(5.8%) 86 
Admin/technician assistant 93(95.9%) 4(4.1%) 97 
Table 4.48: Occupational characteristics of the positive respondents to HBcAb-HCWs 
(N=315) 
*Based on Monte Carlo method  
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Exposure to risks of acquiring HBV 
Exposure to potential risks of acquiring HBV among respondents is demonstrated in Table 4.49 
and Table 4.50. Seroprevalence of HBcAb did not vary significantly with any of the 
investigated potential variables. 
Potential risks 
Negative 
HBcAb 
(N=299) 
Positive 
HBcAb 
(N=16)  
Overall 
N 
P-
value* 
Have you ever had a blood transfusion?   1.00 
No 289(94.8%) 16(5.2%) 305  
Yes 10(100.0%) 0(0.0%) 10  
Have you ever had surgery?   0.78 
No 214(95.1%) 11(4.9%) 225  
Yes 85(94.4%) 5(5.6%) 90  
Have you ever undergone cupping?   0.25 
No 282(95.3%) 14(4.7%) 296  
Yes 17(89.5%) 2(10.5%) 19  
Have you ever undergone endoscopy?   1.00 
No 281(94.9%) 15(5.1%) 296  
Yes 18(94.7%) 1(5.3%) 19  
Have you ever undergone acupuncture?   1.00 
No 284(94.7%) 16(5.3%) 300  
Yes 15(100.0%) 0(0.0%) 15 
Used syringes repeatedly?    1.00 
No 282(94.6%) 16(5.4%) 298  
Yes 17(100.0%) 0(0.0%) 17  
Used another person’s toothbrush?   0.13 
No 288(95.4%) 14(4.6%) 302  
Yes 11(84.6%) 2(15.4%) 13  
Have you ever had a tattoo?   1.00 
No 294(94.8%) 16(5.2%) 310  
Yes 5(100.0%) 0(0.0%) 5  
Table 4.49: History of exposure to potential risks of acquiring HBV among respondents 
found to be positive to HBcAb-HCWs(N=315)(a) 
*Based on Fisher's Exact test  
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Potential risks 
Negative 
HBcAb 
(N=299) 
Positive 
HBcAb 
(N=16)  
Overall 
N 
P-
value* 
Have you ever had renal dialysis? 
 
   0.051 
No 299(95.2%) 15(4.8%) 314  
Yes 0(0.0%) 1(100.0%) 1 
Yellow discolouration in eyes or skin?       1.00 
No 294(94.8%) 16(5.2%) 310  
Yes 5(100.0%) 0(0.0%) 5  
Family member infected with HBV?       1.00 
No 284(94.7%) 16(5.3%) 300  
Yes 15(100.0%) 0(0.0%) 15  
Average visits to the dentist (N=288)       1.00 
less than 3times/ year 180(95.2%) 9(4.8%) 189  
3 times/year and more 94(94.9%) 5(5.1%) 99  
Table 4.50: History of exposure to potential risks of acquiring HBV among respondents 
found to be positive to HBcAb-HCWs(N=315)(b) 
*Based on Fisher's Exact test 
Seroprevalence of HBV antibodies-HBsAb 
HBV seroimmunity and sociodemographic characteristics. 
There was a significant association between HBsAb among HCWs and year of work experience 
(Table 4.51). However, no significant association was seen between HBsAb among HCWs and 
age, time spent in formal education, or number of dental visits. 
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Characteristics 
Cross tabulation  Univariate analysis  
Negative 
HBsAb 
(N=88) 
Positive 
HBsAb 
(N=227) 
Overall 
N 
OR(95%CI) 
LRT-
P* 
Age in category 
(Years)(N=315)     
 
0.12 
<25 26  49  75 Reference 
25-30 34  116 150  1.81(0.98-3.33) 
>30 28  62 90  1.17(0.61-2.25) 
Years of work experience 
(Years)(N=315)     
0.001 
<1 34  41  75  Reference 
1-3 26  69  95  2.20(1.16-4.17) 
4-6 16  56  72  2.90(1.41-5.95) 
>6 12  61  73 4.21(1.95-9.08) 
Formal 
education(Years)(N=315)     
 
0.27 
≤16 48  108  156 Reference 
17-18 26  65  91  1.11(0.63-1.96) 
≥19 14  54  68  1.71(0.86-3.38) 
Dentist visits(N=288)     
 
0.97 
<than 3times/year 55  134  189  Reference 
3 times/year and more 29  70  99  0.99(0.58-1.69) 
Table 4.51: HBV seroimmunity and sociodemographic characteristics-HCWs 
*LRT:Likelihood ratio test 
 
The odds of positive HBsAb among the Non-Saudi respondents were double those in 
comparison to the Saudis (Table 4.52). Furthermore, the odds of positive HBsAb among non-
Muslims were twice higher in comparison to Muslims. However, there was no evidence of an 
association between sex, marital status or level of education and HBsAb. 
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Characteristics 
Cross tabulation  Univariate analysis  
Negative 
HBsAb 
(N=88) 
Positive 
HBsAb 
(N=227) 
Overall 
N 
OR(95%CI) LRT-P 
Sex     0.34 
Male 31  93  124  Reference 
Female 57  134  191  1.27(0.77-2.13) 
Nationality      0.001 
Saudi 59  106  165  Reference 
Non-Saudi 29  121  150  2.32(1.38-3.88) 
Religion       0.002 
Muslim 73  150  223  Reference 
Non-Muslim 15  77  92  2.49(1.34-4.64) 
Marital Status      0.93 
Ever married 33  84  117  Reference 
Single 55  143  198  1.02(0.61-1.70) 
Education level       0.68 
Under graduate 76  192  268  Reference 
Post graduate 12  35  47  1.15(0.56-2.34) 
Table 4.52: HBV seroimmunity and sociodemographic characteristics-HCWs(N=315) 
 
HBV seroimmunity and occupational characteristics. 
In comparison to those working in administrative jobs, the odds of positive HBsAb among 
physicians were six times higher and four times more among nurses (Table 4.53). Moreover, 
the odds of positive HBsAb for administrators and technicians were significantly lower than 
for clinicians. However, no association was found between those working in PHCs and those 
working in KKH or at KSAU-HS on the one hand and HBsAb on the other. 
  
  
125 
Characteristics 
Cross tabulation  Univariate analysis  
Negative 
HBsAb 
(N=88) 
Positive 
HBsAb 
(N=227) 
Overall 
N 
OR(95%CI) 
LRT-
P 
Practise location       0.69 
KKH 54  137 191 Reference  
KSAU-HS 16  50  66  1.23(0.65-2.34) 
PHCs 18  40 58  0.87(0.46-1.66) 
Occupation       <0.001 
Admin  37  34  71  Reference 
Physician 10  60  70  6.53(2.89-14.76) 
Nurse 20  79  99  4.3(2.19-8.45)  
Medical 
specialist/Technician 
21 54 75  2.80(1.41-5.56) 
Speciality       <0.001 
Clinical services 20  96  116  Reference 
Administrative/technical 
support services 
36  33  69  0.19(0.09-0.37) 
Nursing services 11  52  63  0.98(0.43-2.21) 
Pathology/laboratory 13  29  42  0.46(0.20-1.04) 
Ancillary medical services 8  17  25  0.44(0.16-1.16) 
Position       <0.001 
Staff nurse 18 68 86 Reference 
Admin/technician 41 56 97 0.36(0.18-0.69) 
Specialist 16 23 39 0.38(0.16-0.86) 
Staff physician 4 31 35 2.05(0.64-6.56) 
Academic staff 3 30 33 2.64(0.72-9.67) 
Specialist physician 6 19 25 0.83(0.29-2.4) 
Table 4.53: HBV seroimmunity and occupational characteristics-HCWs(N=315) 
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HBV seroimmunity and potential risk variables 
The odds of positive HBsAb among those who had an HBV-infected family member were 
significantly lower and thus having an infection risk when compared with those with families 
free from HBV infection (Table 4.54 and Table 4.55). However, no association was found 
between HBsAb and those who had surgery, cupping or who used syringes repeatedly, and who 
used another person’s toothbrush. 
Characteristics 
(No is reference) 
Cross tabulation Univariate analysis 
Negative 
HBsAb 
(N=88) 
Positive 
HBsAb 
(N=227) 
Overall 
N 
OR(95%CI) 
LRT-
P 
Had a blood 
transfusion?  
86 219 305  
0.55 
Yes 2 8 10 1.57(0.32-7.54) 
Had a surgery?  64 161 225  0.75 
Yes 24 66 90 1.09(0.63-1.89) 
Had a cupping 
"Hijamah"?  
83 213 296  
0.87 
Yes 5 14 19 1.09(0.38-3.12) 
Had an endoscopy 84 212 296  0.49 
Yes 4 15 19 1.48(0.47-4.6) 
Had an acupuncture 83 217 300  0.63 
Yes 5 10 15 0.76(0.25-2.3) 
Used syringes 
repeatedly? 
83 215 298  
0.89 
Yes 5 12 17 0.92(0.31-2.71) 
Table 4.54: HBV seroimmunity and risk variables-HCWs(N=315)(a) 
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Characteristics 
(No is reference) 
Cross tabulation Univariate analysis 
Negative 
HBsAb 
(N=88) 
Positive 
HBsAb 
(N=227) 
Overall 
N 
OR(95%CI) 
LRT-
P 
Used another person’s 
toothbrush? 
85 217 302  
0.68 
Yes 3 10 13 1.3(0.35-4.86) 
Had a tattoo?  88 222 310  0.06 
Yes 0 5 5 N/A* 
Had a renal dialysis?  87 227 314  0.11 
Yes 1 0 1 N/A* 
Had a yellow 
discolouration in eyes 
or skin? 
86 224 310  
0.55 
Yes 2 3 5 0.57(0.09-3.5) 
Family member 
infected with HBV? 
79 221 300  
0.008 
Yes 9 6 15 0.23(0.08-0.69) 
Table 4.55 : HBV seroimmunity and risk variables-HCWs(N=315)(b) 
*N/A Not available 
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Potential Predictors of HBV seroimmunity 
Table 4.56 shows the results of a logistic regression model identifying the potential predicators 
of HBV seroimmunity. Variables included in the initial model are: age, work experience 
(Table 4.51); nationality, religion (Table 4.52); occupation, specialty, position (Table 4.53) and 
the family member infected with HBV (Table 4.55). The model as a whole explained 21.3% of 
the variance in seroimmunity HBsAb. Hosmer and Lemeshow indicated that the model was a 
reasonable fit (P=0.51). 
Two of the studied variables (religion and position) made an independent significant 
contribution to the model. Compared to Muslims, the odds of positive HBsAb among non-
Muslims were four times higher. Furthermore, in comparison to staff nurses, the odds of 
positive HBsAb among those working as staff physicians as academic staff were significantly 
seven times higher. The highest odds of HBsAb seroimmunity was working as staff physician, 
indicating that staff physicians, when compared to nurses, were over seven times more likely 
to be immune against HBV than those who are not, controlling for all other independent 
variables in the model. 
Variables determining HBV seroimmunity of HCWs after adjustment for confounders were 
investigated, religion and position were considered not to be confounding to variables tested 
for HBV seroimmunity, and no specific variable could determine HBV seroimmunity of 
HCWs. 
The interaction between age category and religion indicated that higher odds of positive HBsAb 
1.34 among 25-30 year olds and lower 0.32 among those who were over 30 for Muslims. 
Furthermore, the odds of positive HBsAb were twice as high as for those who were 25-30 year 
and non-Muslims compared to Muslims in the same age category. Moreover, the odds of 
positive HBsAb were thirteen times higher among those above 30 and non-Muslims compared 
to Muslims in the same age category (Table 4.57). 
In conclusion, different age patterns between Muslims and non-Muslims related to HBsAb, for 
non-Muslims seroimmunity increased markedly with age, while with Muslims there was a 
notable decrease among those over 30. 
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Variable* OR(95%CI) LRT-P 
Age in category (Years)  0.04 
<25 Reference 
25-30 1.26(0.60-2.61) 
>30 0.51(0.21-1.20) 
Religion   <0.001 
Muslim Reference 
Non-Muslim 4.07(1.90-8.71) 
Position  <0.001 
Staff nurse Reference 
Admin/Technician 0.70(0.33-1.47) 
Specialist 0.89(0.34-2.33) 
Staff physician 7.22(1.89-27.53) 
Academic staff 7.08(1.78-28.23) 
Specialist physician 2.88(0.84-9.86) 
Table 4.56: Independent determinants of HBsAb seroimmunity-HCWs(N=315) 
*Multiple logistic regression 
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Variable* OR(95%CI) LRT-P** 
Interaction(Age in category*Religion)  
Age in category (Years)  0.003 
<25 Reference 
25-30 1.34(0.62-2.86) 
>30 0.32(0.12-0.83) 
Position staff   <0.001 
Nurse Reference 
Admin & Technician Assistant 0.54(0.26-1.16) 
Specialist 0.75(0.29-1.91) 
Staff physician 8.99(2.22-36.32) 
Academic staff 6.77(1.66-27.54) 
Specialist physician 2.96(0.83-10.64) 
Age in category*Religion  <0.001 
25-30 Years by non-Muslim 2.48(0.96-6.41) 
>30 Years by non-Muslim 13.38(3.48-51.38) 
Table 4.57: Interaction between independent determinants variables in the final model of 
HBV seroimmunity-HCWs(N=315) 
*Multiple logistic regression 
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4.3.5 Summary of HBV serology results among health care workers who were not given the 
questionnaire 
Seroprevalence of HBV markers 
A small minority were infected with HBV (Table 4.58). Furthermore, a minority had been 
exposed to HBV before in their life and about a quarter did not have serological evidence of 
immunity against HBV. 
Serology test Results N % 95%C.I 
HBsAg 
Negative 3996 99.6 (99.3-99.7) 
Positive 17 0.4 (0.3-0.7) 
HBcAb 
Negative 3721 92.7 (91.9-93.5) 
Positive 292 7.3 (6.5-8.1) 
HBsAb 
Negative 994 24.8 (23.5-26.1) 
Positive 3019 75.2 (73.9-76.5) 
Table 4.58 : The laboratory results for HBV markers-HCWs(N = 4013) 
 
Clinical interpretation of hepatitis B serological markers 
Almost two thirds of HCWs have serological evidence of immunity against HBV, mostly 
through vaccination. About a quarter were never exposed, never vaccinated and are susceptible 
for infection. Meanwhile, a small minority were immune due to natural infection, and about 17 
were chronic HBV carriers (Table 4.59). 
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Serology test Result N % Interpretation  
HBsAg Negative 
2744 68.4 
1-Most probably, immune due to 
HBV vaccination. 
2-Might be repeated exposure to 
antigen without infection. 
3-Might be recovery from infection 
with loss of detectable anti-HBc. 
HBcAb Negative 
HBsAb Positive 
HBsAg Negative 
977 24.3 
Never exposed, Never vaccinated, 
susceptible for infection,  
HBcAb Negative 
HBsAb Negative 
HBsAg Negative 
275 6.9 Immune due to natural infection HBcAb Positive 
HBsAb Positive 
HBsAg Positive 
17 0.4 Chronic carrier infection HBcAb Positive 
HBsAb Negative 
Table 4.59: Clinical interpretation of HBV serological markers-HCWs(N=4013) 
 
Seroprevalence of HBsAg 
Sociodemographic and occupational characteristics of the respondents’ positive to HBsAg 
The prevalence of HBsAg was associated with nationality of HCWs (Table 4.60). Saudis HCWs 
were more infected with HBV than non-Saudis (just 2 cases were non-Saudi; one Malaysian, 
one Yemeni), this association being statistically significant. Additionally, there was a 
statistically significant association between HBsAg and occupation. However, the prevalence 
did not depend significantly on sex or practise location. 
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Characteristics  
Negative 
HBsAg 
(N=3996) 
Positive 
HBsAg  
(N=17) 
Overall 
N 
P-
Value  
Sex  0.32* 
Female 2208(99.7%) 7(0.3%) 2215 
Male 1788(99.4%) 10(0.6%) 1798 
Nationality  0.003* 
Saudi 2065(99.3%) 15(0.7%) 2080 
Non-Saudi 1931(99.9%) 2(0.1%) 1933 
Practise location  0.11 
KKH 3102(99.7%) 10(0.3%) 3112 
KSAU-HS 792(99.1%) 7(0.9%) 799 
PHCs 102(100.0%) 0(0.0%) 102 
Occupation   0.01** 
Physician 688(99.6%) 3(0.4%) 691 
Nurse 1438(100.0%) 0(0.0%) 1438 
Medical specialist 554(99.5%) 3(0.5%) 557 
Medical technician 554(99.1%) 5(0.9%) 559 
Admin 762(99.2%) 6(0.8%) 768 
Table 4.60: Sociodemographic characteristics of the positive respondents to HbsAg-
HCWs(N=4013) 
*Based on Fisher's Exact test **Based on Monte Carlo method 
 
Potential Predictors of HBsAg seroprevalence 
Table 4.61 shows the results of a logistic regression model determining the potential predicators 
of HBsAg seroprevalence. Variables included in the initial model being nationality and 
occupation (Table 4.60). The model as a whole explained 9.0% of the variance in 
seroprevalence HBsAg. Hosmer and Lemeshow indicated support for the model being a 
reasonable fit (P=0.9). None of the studied variables made a statistically significant contribution 
to the model. 
Variable* OR(95% CI) LRT-P 
Nationality  0.09 
Saudi Reference 
Non-Saudi 0.32(0.07-1.45) 
Table 4.61: Independent determinants of HBsAg seroprevalence-HCWs(N=4013) 
*Multiple logistic regression  
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Seroprevalence of HBV antibodies- HBcAb 
Sociodemographic characteristics of the respondents positive to HBcAb 
The prevalence of HBcAb was significantly associated with nationality and world region of 
origin. This higher rate of exposure to HBV was among non-Saudis especially those originally 
from the Americas or the WPR. However, the prevalence of HBcAb did not significantly differ 
between males and females (Table 4.62). 
Characteristics  
Negative 
HBcAb 
(N=3721) 
Positive 
HBcAb  
(N=292) 
Overall 
N 
P-Value  
Sex  0.77* 
Female 2051(92.6%) 164(7.4%) 2215 
Male 1670(92.9%) 128(7.1%) 1798 
Nationality  <0.001* 
Saudi 2011(96.7%) 69(3.3%) 2080 
Non-Saudi 1710(88.5%) 223(11.5%) 1933 
World region  <0.001** 
MER 2277(96.0%) 96(4.0%) 2373 
WPR 1042(86.5%) 163(13.5%) 1205 
Europe 162(94.7%) 9(5.3%) 171 
Africa 129(90.2%) 14(9.8%) 143 
SEAR 82(94.3%) 5(5.7%) 87 
Americas 29(85.3%) 5(14.7%) 34 
Table 4.62: Sociodemographic characteristics of the positive respondents to HBcAb-
HCWs(N=4013) 
*Based on Chi-square for continuity correction,**Based on Monte Carlo method. 
 
 
Occupational Characteristics 
A significance association was found between exposure to HBV and occupation, specialities 
and positions (Table 4.63). However, the prevalence of exposure to HBV did not vary 
significantly with the practise location. 
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Characteristics  
Negative  
HBcAb  
(N=3721) 
Positive 
HBcAb  
(N=292) 
Overall 
N 
P-
Value*
  
Practise location  0.53 
KKH 2878(92.5%) 234(7.5%) 3112 
KAMC not working in clinical section 748(93.6%) 51(6.4%) 799 
PHCs 95(93.1%) 7(6.9%) 102 
Occupation   <0.001 
Physician 654(94.6%) 37(5.4%) 691 
Nurse 1298(90.3%) 140(9.7%) 1438 
Medical specialist 533(95.7%) 24(4.3%) 557 
Medical technician 515(92.1%) 44(7.9%) 559 
Admin 721(93.9%) 47(6.1%) 768 
Speciality   <0.001 
Clinical services 1159(93.2%) 84(6.8%) 1243 
Nursing services 977(90.1%) 107(9.9%) 1084 
Ancillary medical services 700(94.0%) 45(6.0%) 745 
Administrative services 654(94.5%) 38(5.5%) 692 
Pathology/laboratory 142(96.6%) 5(3.4%) 147 
Technical support Services 89(87.3%) 13(12.7%) 102 
Position   <0.001 
Staff nurse 1155(90.5%) 121(9.5%) 1276 
Technician 558(92.5%) 45(7.5%) 603 
Intern 404(96.9%) 13(3.1%) 417 
Specialist physician 361(94.3%) 22(5.7%) 383 
Admin assistant 296(94.0%) 19(6.0%) 315 
Specialist 292(95.1%) 15(4.9%) 307 
Assistant 268(96.1%) 11(3.9%) 279 
Staff physician 199(93.0%) 15(7.0%) 214 
Information technology technician 82(87.2%) 12(12.8%) 94 
Supervisory and leadership 67(84.8%) 12(15.2%) 79 
Patient care technician 39(84.8%) 7(15.2%) 46 
Table 4.63: Occupational characteristics of the positive respondents to HBcAb-HCWs(N 
=4013) 
*Based on Monte Carlo method  
  
136 
Potential Predictors of HBcAb seroimmunity  
Table 4.64 shows the results of a logistic regression model investigating the potential 
predicators of HBcAb seroimmunity. Variables included in the initial model are; nationality, 
world region of origin (Table 4.62); occupation, speciality, position (Table 4.63). The model as 
a whole explained 9.3% of the variance in seroimmunity HBcAb. Hosmer and Lemeshow 
indicated that the model was a reasonable fit (P=0.66). 
Three of the studied variables (nationality, world region and occupational position) made a 
significant independent contribution to the model. The odds of positive HBcAb among non-
Saudis were thrice those Saudis, furthermore, the odds of positive HBcAb among those 
recruited from the WPR were higher than those from the MER. In comparison to staff nurses, 
the odds of positive HBcAb among those working as technicians were higher, among those 
working as specialist physicians were twice, among those working as information technology 
technicians were four times, and those working in a supervisory and leadership position were 
four times. 
The highest odds of HBcAb seroimmunity was for those working in supervisory and leadership 
roles, indicating that those, in comparison to staff nurses, were over four times more likely to 
be exposed to HBV, controlling for all other independent variables in the model. Variables 
determining HBV seroimmunity of HCWs after adjustment for confounders were investigated, 
only supervisory and leadership variable was variable determining HBcAb seroimmunity of 
HCWs. 
The interaction between world region of origin and occupational position indicated the odds of 
positive HBcAb were lower among those who were working as admin assistant and recruited 
from the MER, and were three times higher among those working in supervisory and leadership 
positions and recruited from the MER. Furthermore, the odds of positive HBcAb were five 
times higher among those who were specialist physicians and recruited from the WPR 
compared to those specialist physicians in different world regions of origin. Moreover, the odds 
of positive HBcAb were about seven times higher among those who were admin assistant and 
recruited from the WPR compared to those admin assistant in different world regions of origin. 
In conclusion, different immune status patterns between those recruited from MER and WPR 
related to HBcAb, for those recruited from WPR seroimmunity increased markedly among 
admin assistants while with those recruited from MER there was a notable decrease among 
admin assistants.   
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Variable* OR(95% CI) LRT-P 
Nationality  <0.001 
Saudi Reference 
Non-Saudi 3.80(2.16-6.67) 
World region  0.001 
MER Reference 
WPR 1.74(1.01-2.99) 
Europe 0.53(0.23-1.24) 
Africa 1.20(0.57-2.57) 
SEAR 0.56(0.20-1.57) 
Americas 1.58(0.54-4.67) 
Position   <0.001 
Staff Nurse Reference 
Technician 1.45(1.00-2.12) 
Intern 1.53(0.77-3.04) 
Specialist physician 2.43(1.38-4.28) 
Admin assistant 1.35(0.80-2.30) 
Specialist 1.02(0.57-1.82) 
Assistant 1.18(0.60-2.31) 
Staff physician 1.32(0.66-2.64) 
Information technician 4.04(2.02-8.11) 
Supervisory/leadership 4.59(2.28-9.25) 
Patient care Technician 1.66(0.72-3.84) 
Table 4.64: Independent determinants of HBcAb seroimmunity-HCWs(N=4013) 
*Multiple logistic regression 
Furthermore, the interaction between nationality and occupational position indicated that the 
odds of positive HBcAb were lower among Saudis who were working as admin assistants and 
about four times higher among Saudis who were working in a supervisory and leadership 
position. However, the odds of positive HBcAb were five times higher than specialist 
physicians and non-Saudis and about seven times higher among those who were admin assistant 
and non-Saudis. In conclusion, there was a different immune status pattern among admin 
assistants and nationality related to HBcAb, for those non-Saudis seroimmunity increased 
markedly while notable decreasing among Saudis. 
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Seroprevalence of HBV antibodies-HBsAb 
HBV seroimmunity and sociodemographic characteristics. 
The odds of positive HBsAb among females were double that of males (Table 4.65). 
Furthermore, the odds of positive HBsAb among Non-Saudis were double those for Saudis. 
Also, the odds of positive HBsAb among those recruited from Africa were nine times higher 
than those from the MER. 
Characteristics 
Cross tabulation Univariate analysis 
Negative 
HBsAb 
(N=994) 
Positive 
HBsAb 
(N=3019) 
Over
all 
N 
OR LRT-P 
(95% CI) 
Sex     <0.001 
Male 624 1174 1798 Reference 
Female  370 1845 2215 2.65(2.28-3.07) 
Nationality     <0.001 
Saudi 698 1382 2080 Reference 
Non-Saudi 296 1637 1933 2.79(2.39-3.25) 
World region     <0.001 
MER 775 1598 2373 Reference 
WPR 168 1037 1205 2.99(2.49-3.59) 
Europe 19 152 171 3.88(2.39-6.29) 
Africa 7 136 143 9.42(4.38-20.23) 
SEAR 18 69 87 1.85(1.09-3.14) 
Americas 7 27 34 1.87(0.81-4.31) 
Table 4.65: HBV seroimmunity and sociodemographic characteristics-HCWs(N=4013) 
 
HBV seroimmunity and occupational characteristics. 
The odds of positive HBsAb among those working in the KAMC, but not in clinical or nursing 
duties, were less than those working in the KKH (Table 4.66). Also, in comparison to those 
working in nursing jobs, the odds of positive HBsAb among those working as medical 
technicians and admin were lesser. Additionally, the odds of positive HBsAb among those 
specialised in nursing services were higher than those who were specialised in clinical services. 
Conversely, the odds of positive HBsAb among those working in administrative services were 
less than specialist clinical services. Meanwhile, the odds of positive HBsAb among those 
appointed in assistant positions (administrative occupation) were less than those who were 
appointed in staff nurse position.  
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Characteristics 
Cross tabulation analysis Univariate analysis 
Negative 
HBsAb 
(N=994) 
Positive 
HBsAb 
(N=3019) 
Total 
N 
OR(95%CI) 
LRT-
P* 
Current location of practise     <0.001 
KKH 574 2538 3112 Reference 
KAMC not working in clinical  398 401 799 0.22(0.19-0.26) 
PHCs 22 80 102 0.82(0.50-1.33) 
Occupation     <0.001 
Nurse  180 1258 1438 Reference 
Physician 112 579 691 0.74(0.57-0.95) 
Medical specialist 153 404 557 0.37(0.29-0.48) 
Medical technician 164 395 559 0.34(0.27-0.43) 
Admin 385 383 768 0.14(0.11-0.17) 
Speciality     <0.001 
Clinical services 196 1047 1243 Reference 
Nursing services 152 932 1084 1.14(0.91-1.44) 
Ancillary medical services 223 522 745 0.43(0.35-0.54) 
Administrative services 354 338 692 0.17(0.14-0.22) 
Pathology/laboratory 24 123 147 0.95(0.60-1.52) 
Technical support services 45 57 102 0.23(0.15-0.36) 
Position     <0.001 
Staff nurse 131 1145 1276 Reference 
Technician 188 415 603 0.25(0.19-0.32) 
Intern 133 284 417 0.24(0.18-0.32) 
Specialist physician 43 340 383 0.90(0.62-1.30) 
Admin assistant 139 176 315 0.14(0.10-0.19) 
Specialist 75 232 307 0.35(0.25-0.48) 
Assistant 159 120 279 0.08(0.06-0.11) 
Staff physician 47 167 214 0.40(0.28-0.58) 
Information technician 41 53 94 0.14(0.09-0.23) 
Supervisory/leadership 30 49 79 0.18(0.11-0.30) 
Patient care technician 8 38 46 0.54(0.24-0.19) 
Table 4.66: HBV seroimmunity and occupational characteristics-HCWs(N=4013)   
  
140 
Potential predictors of HBsAb seroimmunity  
Table 4.67 and Table 4.68 show the results of a logistic regression model identifying the 
potential predicators of HBsAb seroimmunity. Variables included in the initial model are: sex, 
nationality, world region of origin (Table 4.65); practise location, occupation, speciality, 
position (Table 4.66). The model as a whole explained 21.5% of the variance in seroimmunity 
HBsAb. Hosmer and Lemeshow indicated that the model was a reasonable fit (P=0.12). 
Five of the studied variables (sex, world region of origin, speciality, occupational position and 
practise location) made a significant independent contribution to the model. The odds of 
positive HBsAb among females were higher than for males. Also, the odds of positive HBsAb 
among those who originated from Africa were double MER origin. Additionally, the odds of 
positive HBsAb among those working in pathology and laboratory medicine were twice those 
working in clinical services. Meanwhile, the odds of HBsAb seroimmunity among those 
working as assistants were lower than staff nurses. The odds of HBsAb seroimmunity among 
those working in the PHCs were lower than those in KKH. The highest odds of HBsAb 
seroimmunity was for those from Africa, indicating they were over four times more likely to be 
immune against HBV than those from MER, controlling for all other independent variables in 
the model. 
The interaction between sex and speciality indicated the odds of positive HBsAb were lower 
among females, who were working in ancillary medical services. 
Variable* OR(95%CI) LRT-P 
Sex   <0.001 
Male Reference 
Female 1.80(1.52-2.14) 
Nationality  0.10 
Saudi Reference 
Non-Saudi 0.74(0.52-1.05) 
Table 4.67: Independent determinants of HBsAb seroimmunity-HCWs(N=4013)(a) 
*Multiple logistic regression 
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Variable* OR(95%CI) LRT-P 
WHO Region  <0.001 
MER Reference 
WPR 2.18(1.51-3.81) 
Europe 2.07(1.51-3.18) 
Africa 4.73(2.05-10.94) 
SEAR 2.02(1.06-3.86) 
Americas 1.53(0.62-3.80) 
Speciality  <0.001 
Clinical services Reference 
Nursing services 0.71(0.51-1.00) 
Ancillary medical services 0.74(0.54-1.01) 
Administrative services 0.57(0.30-1.12) 
Pathology/laboratory 1.99(1.91-3.34) 
Technical support services 0.38(0.09-1.72) 
Position   <0.001 
Staff nurse Reference 
Technician 0.41(0.28-0.61) 
Intern 0.31(0.21-0.48) 
Specialist physician 1.23(0.76-2.01) 
Admin assistant 0.48(0.28-0.85) 
Specialist 0.58(0.36-0.95) 
Assistant 0.24(0.14-0.43) 
Staff physician 0.70(0.42-1.17) 
Information technician 0.85(0.18-4.08) 
Supervisory/leadership 0.48(0.26-0.94) 
Patient care technician 0.63(0.29-1.43) 
Practise location  0.02 
KKH Reference 
KAMC not working in clinical sections 0.60(0.36-1.01) 
PHCs 0.57(0.34-0.98) 
Table 4.68: Independent determinants of HBsAb seroimmunity-HCWs-(N=4013)(b) 
*Multiple logistic regression 
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4.4 Measles among Health Care Workers 
4.4.1 Previous measles related health history 
Previous investigation for measles 
Under a fifth of HCWs reported having been infected with measles (Table 4.69). For those 
infected more than a year before, the median age is 20 (inter-quartile range 15-25) of a range 
3–40, of whom almost two thirds indicated that they had been infected less than 20 years 
previously. Almost a quarter were sure they had been previously investigated for measles, 
others responding having never been screened or being unsure. Of those sure of being measles 
investigated, almost three quarters indicated being informed they were immune, only eight 
persons were not immune. 
Investigation against measles N %  
Previous infection to measles(N=315)   
Yes 53 16.8 
No 224 71.1 
Not sure 38 12.1 
Time of infection with measles in years(N=53)   
<=20 years 32 60.4 
21 years and more 21 39.6 
Previous investigation against measles immune status(N=315)     
Yes 89 28.3 
No 121 38.4 
Not sure 105 33.3 
Results of investigations against measles immune status(N=89)     
Immune 66 74.2 
Not immune 8 9.0 
Not sure 15 16.8 
Place at which investigations were done(N=89)     
KSA 55 61.8 
Philippines 16 18.0 
India 8 9.0 
Others* 10 11.2 
Non-Saudis for whom investigations were done in KSA (N=47) 13 27.7 
Table 4.69: Investigation against measles infection-HCWs 
*Others (N): Malaysia(4), Pakistan(2), South Africa(2), Sudan(1), UK(1)  
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Measles immunisation 
About a fifth of HCWs had received the two doses required for protection against measles. 
Furthermore, almost a fifth stated that they had received one dose. Alternatively, two fifths did 
not know if they had received the vaccine, and only 23 HCWs had not been offered it 
(Table 4.70 and Table 4.71). 
Of those vaccinated against measles, about two thirds were vaccinated before primary school, 
and 42 participants recently (within a year), the median being 4 months (inter-quartile range 3-
6 months) and range 1–10. Meanwhile, 7 participants were vaccinated more than a year before, 
median - 2 years (inter-quartile range 1-2 years), range 1–3 years. 
Of those measles vaccinated before, about half had been vaccinated in KSA and a quarter in 
Philippines. Mostly reasons to be vaccinated were either for work requirements or on doctor’s 
recommendation; only 5.3% for personal motivation. Over received regular vaccine doses and 
the same proportion expressing that they did not know if they were vaccinated in a regular 
pattern. 
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Characteristics N %  
Measles vaccination status(N=315)   
More than two doses  35 11.1 
Two doses  61 19.4 
One dose  63 20.0 
Measles vaccine not offered 23 7.3 
Measles vaccine offered, but not taken 2 0.6 
I do not know 131 41.6 
Time of administration of measles vaccine(N=158)     
Before primary school 91 57.6 
During primary school 20 12.7 
During secondary school 5 3.2 
During undergraduate study 13 8.2 
I do not know 29 18.4 
Place of administration measles vaccine(N=207)     
KSA 101 48.8 
Philippines 52 25.2 
Malaysia 13 6.3 
Pakistan 10 4.8 
India 8 3.9 
Egypt 6 2.9 
Sudan 5 2.4 
Others* 12 5.7 
Table 4.70: History of immunisation with measles vaccine-HCWs(a) 
*Others (N): Jordan(2), Algeria(1), Canada(1), Czech(1), Eritrea(1), Germany(1) Libya(1), UAE(1) 
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Characteristics N %  
The reason for being vaccinated(N=207)     
Immunisation campaigns 90 43.5 
Doctor’s recommendation 68 32.9 
Work requirement 63 30.4 
Self-motivation 11 5.3 
Governmental vaccination policy 9 4.3 
Others* 5 2.4 
Were the doses of measles vaccine regular**?(N=207)    
Regular 80 38.6 
Irregular 28 13.5 
I did not receive all two doses 17 8.2 
I do not know 82 39.6 
Table 4.71: History of immunisation with measles vaccine-HCWs(b) 
*Others(N): School requirements(4), Parent's recommendation(1). 
**(The second dose from one to 2 months of 1st dose). Any other regimen is considered irregular 
 
The reasons why some HCWs were not vaccinated against measles are summarised in 
Table 4.72. 
The reason why not vaccinated against measles  N % 
I do not believe myself at risk. 36 33.3 
Difficulty access obtaining the measles vaccine. 9 8.3 
Natural measles infection is preferable to vaccine. 7 6.5 
I am concerned about the safety of the measles vaccine. 7 6.5 
No awareness. 5 4.6 
I do not know 42 38.8 
Others* 10 9.2 
Table 4.72: The reason why not vaccinated against measles-HCWs(N=108) 
Others*: I had been infected with measles(3), measles is not a serious enough disease to warrant immunisation 
(2), Born before vaccine invention(1), Not cleared that adults should have vaccine. What is evidence?(1), I am 
concerned about the cost(1) 
 
Self-reporting of the respondents who had positive or negative IgG Measles about the history 
of immunisation 
Of those sero-positive IgG measles, one third of them received two doses or more, and a small 
minority were never vaccinated before. Meanwhile, about a third received the vaccine mainly 
in immunisation campaigns. Furthermore, about two fifths of positive IgG measles-alone cases 
did not receive regular doses (Table 4.73 and Table 4.74). 
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IgG measles is positive  N % 
Were you ever infected with measles?   
Yes 47 18.0 
No 180 69.0 
Not sure 34 13.0 
I was infected with measles in   
<=20 years ago 29 11.1 
21 years ago and more 18 6.9 
I was not infected or not sure 214 82.0 
Tested for immune status against measles and result was  
Immune 57 21.8 
Not Immune 5 1.9 
Not sure 12 4.6 
I was not tested for immune status  187 71.6 
Measles vaccination status  
I have had more than two doses  30 11.5 
I have had two doses  50 19.2 
I have had one dose  54 20.7 
I was not offered  19 7.3 
I do not know 108 41.4 
Measles vaccination time   
Before primary school 82 31.4 
During primary school 16 6.1 
During secondary school 3 1.1 
During undergraduate study 7 2.7 
I was vaccinated during 11 months ago 36 13.8 
I was vaccinated during last 1 -3 years ago 6 2.3 
I do not know 24 9.2 
I was not vaccinated 87 33.3 
Table 4.73: Self-reporting of the respondents who had positive IgG measles alone about 
the history of immunisation-HCWs(N=261)(a) 
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IgG measles is positive  N % 
The reason to be vaccinated against measles  
Doctor’s recommendation 57 21.8 
Self-motivation 9 3.4 
Immunisation campaigns 76 29.1 
Work requirement 51 19.5 
Other 11 4.2 
I was not vaccinated  87 33.3 
Were the doses regular? 
 
Regular on time  65 24.9 
Not regular 109 41.7 
I was not vaccinated 87 33.3 
Table 4.74: Self-reporting of the respondents who had positive IgG measles alone about 
the history of immunisation-HCWs(N=261)(b) 
 
Of those who had negative IgG measles alone, six HCWs had been infected by measles, almost 
a fifth reported being immune, about a third reported that vaccine had been received in two 
doses or more and about a quarter received in regular pattern. Nonetheless, more than a third 
were never vaccinated (Table 4.75 and Table 4.76). 
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IgG measles is negative  N % 
Were you ever infected with measles?   
Yes 6 11.1 
No 44 81.5 
Not sure 4 7.4 
I was infected with measles in   
<=20 years ago 3 5.6 
21 years ago and more 3 5.6 
I was not infected 48 88.9 
Tested for immune status against measles and result was   
Immune 9 16.7 
Not Immune 3 5.6 
Not sure 3 5.6 
I was not tested for immune status 39 72.2 
Table 4.75: Self-reporting of the respondents who had negative IgG measles alone about 
the history of immunisation-HCWs(N=54)(a) 
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IgG measles is negative  N % 
Statements describes about receiving the measles vaccination   
I have had more than two doses 5 9.3 
I have had two doses 11 20.4 
I have had one dose 9 16.7 
I was offered the measles vaccine, but I have not had it 2 3.7 
I was not offered the measles vaccine. 4 7.4 
I do not know 23 42.6 
I was vaccinated against measles    
Before primary school 9 16.7 
During primary school 4 7.4 
During secondary school 2 3.7 
During undergraduate study 6 11.1 
I was vaccinated during 11 months ago 6 11.1 
I was vaccinated during last 1 -20 years ago 1 1.9 
I do not know 5 9.3 
I was not vaccinated 21 38.8 
Were the doses regular?   
Regular on time 15 27.8 
Not regular 18 33.2 
I was not vaccinated 21 38.9 
Table 4.76: Self-reporting of the respondents who had negative IgG measles alone about 
the history of immunisation-HCWs-(N=54)(b) 
 
Exposure to potential risks of acquiring measles 
About a quarter of HCWs indicated that they have seen at least one patient within the previous 
five years with a measles infection and about a third heard of one or more patients being 
hospitalised for measles-related conditions. 
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4.4.2 Measles knowledge 
Self-reporting of the respondents about their level of knowledge and sources of their 
information 
Almost all HCWs expressed having measles knowledge, over two thirds describing their 
knowledge as inadequate, and more than a quarter thought it was adequate. Of those whose 
knowledge was enough or inadequate, over three-quarters pointed to formal education, and 
about half quoted the internet as the main source of information (Table 4.77). 
Measles-Level of knowledge and source of information N % 
Do you have information?(N=315)     
Yes, enough 90 28.6 
Yes, but it is not enough 203 64.4 
No 22 7 
The main source of knowledge(N=293)     
Education 224 76.5 
Internet 127 43.3 
Colleagues 73 24.9 
Family/relatives 57 19.5 
Newspapers/Magazines 53 18.1 
TV/Radio 49 16.7 
Others* 2 0.7 
Table 4.77: Respondents’ self-reported level of measles knowledge and source of 
information-HCWs. 
*Others(N): Books(1), Brochures(1) 
  
  
151 
Knowledge about key facts of measles 
The highest percentage of correct answers was recorded for those who knew that HCWs may 
have an increased risk of becoming infected with measles, and the lowest percentage was 
recorded for knowledge about the incubation period (Table 4.78). 
Key facts of measles N* % 
HCWs may have an increased risk of becoming infected with measles 242 76.8 
Measles is a highly communicable infectious disease 239 75.9 
The microorganism that causes measles is virus 220 69.8 
You know a person is really a measles case by medical examination 135 42.9 
Complications of measles are relatively common 42 13.3 
The incubation period of measles is approximately 7 to 21 days 21 6.7 
Table 4.78: Percentage of the respondents who gave correct answers about key facts of 
measles-HCWs(N=315) 
*N indicates the number of respondents who provided correct answers. 
Knowledge about measles transmission  
Two thirds of HCWs knew that infectious secretions from the nose and throat are a possible 
way of transmitting the disease, and lower percentages of the participants knew that a measles 
patient is considered contagious before the appearance of the rash (Table 4.79). 
Knowledge about measles transmission N* % 
Measles can spread through infectious secretions from the nose and 
throat 
205 65.1 
Measles can spread through inhalation of infectious droplets which 
can occur during (speaking, coughing, and sneezing) 
203 64.4 
Short duration of exposure is enough for measles transmission 185 58.7 
Measles can be transmitted from asymptomatic patients 149 47.3 
A measles patient is considered to be contagious before the 
appearance of the rash 
121 38.4 
Table 4.79: Percentage of the respondents who gave correct answers about measles 
transmission-HCWs(N=315) 
*N indicates the number of respondents who provided correct answers.  
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Knowledge about measles vaccine and immunity 
More than two thirds of respondents knew that HCWs without a reliable history of measles 
should receive the vaccine but a small minority knew the vaccine can be given to people with 
an egg allergy (Table 4.80).  
Measles knowledge about vaccine and immunity N* % 
HCWs without a reliable history of measles disease should receive measles 
vaccine 
218 69.2 
Acquired immunity after natural measles infection is permanent (lifelong) 180 57.1 
The measles vaccine is a live attenuated vaccine (made from attenuated 
measles pathogen) 
174 55.2 
The measles vaccine cannot be given for someone with severe acute illness, 
with or without fever 
160 50.8 
To obtain optimum protection for HCWs, two doses of measles vaccine are 
required 
139 44.1 
The measles vaccine is not safe for pregnant woman 121 38.4 
Measles vaccine can be given to people with an egg allergy 33 10.5 
Table 4.80: Percentage of the respondents who gave correct answers about measles 
vaccine and immunity-HCWs(N=315) 
*N indicates the number of respondents who provided correct answers. 
Perspectives of the respondents about behaviour towards HCWs infected with measles 
About three quarters knew that an infected HCW should be isolated from work or daily activity 
and about two thirds of the respondents knew that an infected worker cannot shake hands or eat 
food with colleagues (Table 4.81).  
Items reflecting attitude against the HCWs infected with measles N* % 
It is necessary to isolate the infected worker from work or daily activity 239 75.9 
The infected worker cannot shake hands with colleagues 198 62.9 
The infected worker’s contacts should be traced and investigated of measles 197 62.5 
Infected worker’s contacts should be immunised promptly if they do not have 
documentation of proved immunity against measles 
194 61.6 
The infected worker cannot eat food with colleagues 193 61.3 
Table 4.81: Percentage of the respondents who gave correct answers about behaviours 
towards the HCWs infected with measles-HCWs(N=315) 
*N indicates the number of respondents who provided correct answers.  
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Perspectives of the respondents about measles outbreak in a health care centre 
About three quarters knew that all contacts should receive the vaccine if they do not have 
evidence of immunity. Conversely, only a third of respondents knew that the recommended 
duration for isolation of measles patients is four days before and after a related skin rash 
(Table 4.82). 
Measles outbreak response  N* % 
All contacts should receive the measles vaccine if they do not have evidence of 
immunity 
239 75.9 
If there is evidence of immunity among contacts, they can immediately return to 
work 
180 57.1 
In case of a contact with a patient who cannot take or refuses to receive the 
measles vaccine, they should be restricted from work for a period of 21 days 
from the last case 
103 32.7 
The recommended duration for isolation measles patients is four days before and 
after skin rash 
100 31.7 
Table 4.82: Percentage of the respondents who gave correct answers about measles 
outbreak-HCWs(N=315) 
*N indicates the number of respondents who provided correct answers. 
Knowledge in different aspects of measles 
The median and inter-quartile range with percentage of the respondents who gave correct 
answers is demonstrated in Table 4.83. The median total knowledge score on the 27 items was 
15 (inter-quartile range 10.0-19.0), this corresponds with a percentage of 55.5% in knowledge 
variation (inter-quartile range 37.1-70.4%). Concerning the subscales, the best score was seen 
on the attitude towards infected worker (median 4). Alternatively, in the median score on the 
key facts of measles, the knowledge score was the lowest (median 3). 
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Knowledge aspects Median IQR 
As % of all questions 
median IQR 
Total knowledge score(27 Questions) 15 (10-19) 55.5 (37.1-70.4) 
Key facts of measles(6 Questions) 3 (2-4) 50.0 (33.3–66.6) 
Measles transmission(5 Questions) 3 (1-4) 60.0 (20.0–80.0) 
Measles vaccine and immunity 
(7 Questions) 
4 (2-5) 57.1 (28.5-71.4) 
Attitude towards infected worker 
(5 Questions) 
4 (2-5) 80.0 (40.0–100.0) 
Measles outbreak response(4 Questions) 2 (1-3) 50.5 (25.5–75.5) 
Table 4.83: Percentage of the respondents who gave correct answers in different measles 
knowledge aspects-HCWs(N=315) 
Measles knowledge score and sociodemographic characteristics 
There was a small, statistically significant positive correlation between the measles knowledge 
score and age in years with measles knowledge increasing with age (Table 4.84). Also, there 
was a medium, statistically significant positive correlation between measles knowledge and 
years of experience in health care institutions, with measles knowledge increasing with years 
of experience. 
Measles knowledge score among HCWs N 
Spearman's 
rho correlation 
P value 
Age 315 0 .30 <0.001 
Time spent in formal education 315 -0.04 0.43 
Years of experience in health care institutions 315 0.55 <0.001 
Table 4.84: Correlation between measles knowledge score and sociodemographic 
characteristics 
The non-Saudis, non-Muslims and those who have a postgraduate level of education were more 
significantly knowledgeable about measles. However, there was no significant association in 
the measles knowledge score between sex and by marital status (Table 4.85). 
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Characteristics N(%) 
Measles knowledge score  
P value*  (26 questions) 
Median(IQR) 
Sex    0.44 
Male 124(39.4%) 15.0(8.0–19.0) 
Female 191(60.6%) 16.0(11.0-19.0) 
Nationality    <0.001 
Saudi 165(52.4%) 12.0(7.0-16.0) 
Non-Saudi 150(47.6%) 18.0(15.8-20.0) 
Religion    <0.001 
Muslim 223(70.8%) 14.0(8.0-17.0) 
Non-Muslim 92(29.2%) 19.0(16.0–20.0) 
Marital status    0.11 
Single  198(62.9%) 15.0(10.0–18.0) 
Ever married 117(37.1%) 16.0(11.0–20.0) 
Level of education    0.007 
Under graduate 268(85.1%) 15.0(9.25–19.0) 
Post graduate 47(14.9%) 18.0(14.0-20.0) 
Table 4.85: Measles knowledge score and sociodemographic characteristics-HCWs(N= 
315) 
*Based on Mann-Whitney U test 
Measles knowledge score and occupational characteristics 
There was a significant association between measles knowledge score and practise locations 
(Table 4.86). Those who were working in PHCs had the highest score, while those working in 
the KSAU-HS reported the lowest knowledge. A significant association between measles 
knowledge score and occupation was reported. The highest such score was recorded by 
physicians and nurses, while the lowest was administrators. 
The measles knowledge score was significantly associated with speciality, being considerably 
higher among those in nursing services compared to administrative and technical support 
services. HCWs also scored differently in measles knowledge according to their positions, 
specialist physicians scoring higher in measles knowledge followed by staff nurses and then 
staff physicians. 
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Characteristics N(%) 
Measles knowledge score 
P 
value * 
(26 questions) 
Median(IQR) 
Practise location   <0.001 
KKH 191(60.6%) 16.0(12.0-19.0) 
KSAU-HS 66(21.0%) 12.0(6.0-16.0) 
PHCs 58(18.4%) 17.0(11.0-20.0) 
Occupation   <0.001 
Physician 70(22.2%) 18.0(14.0-20.0) 
Nurse 99(31.4%) 18.0(15.0-20.0) 
Medical specialist/technician 75(23.8%) 12.0(7.0-17.0) 
Admin 71(22.5%) 9.0(3.0-15.0) 
Speciality   <0.001 
Clinical services 116(36.8%) 17.0(13.0-19.75) 
Administrative/Technical Support 69(21.9%) 9.0(3.0-14.50) 
Nursing services 63(20.0%) 19.0(16.0-20.0) 
Pathology/laboratory 42(13.3%) 14.0(7.75-19.0) 
Ancillary medical services 25(7.9%) 13.0(6.0-16.0) 
Position   <0.001 
Staff nurse 86(27.3%) 18.0(15.0-20.0) 
Admin/technician assistant 97(30.8%) 13.0(6.5-17.0) 
Specialist 39(12.4%) 11.0(7.0-14.0) 
Staff physician 35(11.1%) 17.0(13.0-20.0) 
Academic staff 33(10.5%) 12.0(6.0-17.5) 
Specialist physician 25(7.9%) 19.0(14.0-20.5) 
Table 4.86: Measles knowledge score and occupational characteristics-HCWs(N=315) 
*Based on Kruskal Wallis test 
Measles knowledge score and sources of information 
Those who had enough information about measles scored higher in measles knowledge than 
those who did not have sufficient information (Table 4.87). Those whose source of information 
about measles was families scored a lower median knowledge score than those whose 
information was education-based. Better knowledge scores were observed among those who 
observed that education was the main source of information about measles. 
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The source of measles 
knowledge  
N(%) 
Measles knowledge score  
P value  (26 questions) 
Median(IQR) 
Have information about 
measles?(N=315) 
  
<0.001* 
Yes, enough(as perceived by the 
participant) 
90(28.6%) 18.5(15.7-21.0) 
Yes, but it is not enough 203(64.4%) 14.0(9.0-18.0) 
No 22(7.0%) 4.0(1.0–8.0) 
TV/Radio(N=293)   0.76** 
Yes 49(16.7%) 16.0(12.0-20.0) 
No 244(83.3%) 16.0(11.0-19.0) 
Newspapers/Magazines(N=293)   0.45** 
Yes 53(18.3%) 16.0(12.0-19.5) 
No 240(80.7%) 16.0(11.2-19.0) 
Education(N=293)   <0.001** 
Yes 224(76.5%) 17.0(14.0-20.0) 
No 69(23.5%) 10.0(5.0-15.0) 
Colleagues(N=293)   0.54** 
Yes 73(24.9%) 16.0(11.0-19.5) 
No 220(75.1%) 16.0(12.0-19.0) 
Families(N=293)   0.01** 
Yes 57(19.5%) 14.0(9.5-17.5) 
No 236(80.5%) 16.0(12.0-19.0) 
Internet(N=293)   0.45** 
Yes 127(43.3%) 16.0(10.0-19.0) 
No 166(56.7%) 16.0(12.0-19.0) 
Table 4.87: Measles knowledge score and the source of knowledge-HCWs 
*Based on Kruskal Wallis test**Based on Mann-Whitney U test 
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Measles knowledge score among health care workers tested for measles, exposure or have 
immunity against measles 
Significantly, higher scores in median measles knowledge were recorded among those 
respondents who were tested for immunity against measles or who received regular doses of 
measles vaccines (Table 4.88). The laboratory serology results suggest that those who scored 
significantly higher on measles knowledge have immunity against measles. 
Characteristics  N(%) 
Measles 
knowledge score  P 
value* (26 questions) 
Median(IQR) 
Tested for immune status against measles? 
(N=315) 
  
<0.001 
Yes 89(28.3%) 17.0(13.0-20.0) 
No or not sure 226(71.7%) 14.0(9.0-18.0) 
Regular measles vaccine doses were 
received(N=207) 
  
0.001 
Regular on time 80(38.6%) 18.0(15.0-20.0) 
Not regular 127(61.4%) 16.0(12.0-19.0) 
Immunity against measles (IgG Measles) 
(N=315) 
  
0.01 
Negative 54(17.1%) 13.5(7.7-17.0) 
Positive 261(82.9%) 16.0(11.0-19.0) 
Table 4.88: Measles knowledge score tested for measles, exposure or have immunity 
against measles-HCWs 
*Based on Mann-Whitney U test 
 
Potential predictors of measles knowledge  
Table 4.89 shows the results of a multiple linear regression model looking into potential 
predicators of measles knowledge. Variables included in the initial model are; age, years of 
experience (Table 4.84); nationality, religion, level of education (Table 4.85); location, 
occupation, specialty, position (Table 4.86); have information about measles , the source of 
knowledge as education or family (Table 4.87), tested for immune status against measles, and 
immunity against measles (Table 4.88). The model with all included variables explained 46.4% 
of the variance in measles knowledge. 
As shown in Table 4.89, an increase of one year in age among HCWs was associated with an 
increase of measles knowledge score 0.17 points. Additionally, those HCWs working in PHCs 
were marginally significant on average with higher measles knowledge scores compared to 
those working in KKH scoring 1.70 points higher in knowledge. Nurses had significantly lower 
knowledge score compared to physicians and scored 3.22 points lower with medical specialist 
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& technicians significantly more likely to have lower knowledge scores compared to 
physicians, scoring 4.23 points lower. Also, admin were significantly more likely to have lower 
knowledge scores compared to physicians at -8.23 points. 
Those HCWs working as specialists were significantly more likely to have a lower knowledge 
score compared to those working as staff nurses at -2.77 points. Also, those HCWs working as 
staff physicians were significantly more likely to score lower than those working as staff nurses 
(-4.77). Moreover, those HCWs working in academic positions were significantly more likely 
to have lower knowledge scores compared to those working as staff nurses (-3.13). HCWs 
working as specialist physicians were significantly more likely to score lower than those 
working as staff nurse (-4.72). 
Those who reported they have insufficient information about measles had significantly lower 
knowledge and scored 2.80 points lower than those who reported they have enough information. 
Those who reported that source of measles knowledge was formal education had significantly 
lower knowledge and scored 2.67 points lower than those who reported other sources of 
information. 
The interaction between occupation and education as source of information indicated that in 
comparison to physicians, other occupation categories had much lower scores of measles 
knowledge (-1.52) when education was reported as the source of information (Table 4.90). 
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Variable* Coefficients B 95%C.I for B* P value 
Constant 17.02 12.53 21.50 <0.001 
Age 0.17 0.08 0.26 0.01 
Practise location-PHC(ref KKH) 1.70 0.39 3.02 0.055 
Occupation–(ref Physician) 
Nurse 
-3.22 -6.46 0.02 0.051 
Medical specialist/Technician -4.23 -7.19 -1.27 0.005 
Admin -8.23 -11.74 -4.72 <0.001 
Position–(ref Staff nurse) 
Specialist 
-2.77 -5.13 -0.42 0.02 
Staff physician -4.77 -8.26 -1.27 0.008 
Academic staff -3.13 -5.48 -0.78 0.009 
Specialist physician -4.72 -8.13 -1.32 0.007 
Do you think that you have 
information about measles? 
Not enough 
-2.80 -3.94 -1.66 <0.001 
The source of knowledge about 
measles is education. 
Yes 
-2.67 -4.19 -1.16 0.001 
Were you ever tested for immune 
status against measles?  
Yes 
0.97 -0.13 2.08 0.09 
Table 4.89: Independent determinants of measles knowledge score-HCWs(N=293). 
*Multiple linear regression 
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Variable* B 95%C.I for B* P value 
Interaction (Occupation*Education) 
Age 0.18 0.09 0.27 <0.001 
Practise location-PHCs 1.63 0.33 2.93 0.01 
Occupation-Nurse -2.97 -6.17 0.24 0.07 
Occupation-Medical Specialist/technician -3.93 -6.86 -1.00 0.009 
Occupation-Admin -6.54 -10.22 -2.86 0.001 
Position-Specialist -2.62 -4.95 -0.30 0.02 
Position-Staff physician -4.68 -8.14 -1.22 0.008 
Position-Academic staff -3.02 -5.35 -0.69 0.01 
Position-Specialist physician -4.57 -7.94 -1.20 0.008 
Do you think that you are knowledgeable about 
measles?Not Enough 
-2.75 -3.87 -1.62 <0.001 
Were you ever tested for immune status against 
measles?Yes 
0.97 -0.13 2.06 0.08 
Occupation by source of measles information is 
education 
-1.52 -2.20 -0.83 <0.001 
Table 4.90: Interaction between independent determinants variables in the final model of 
measles knowledge score among HCWs(N=293) 
*Multiple linear regression  
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4.4.3 Concern and attitude about measles 
Almost four fifths agreed that measles is a serious disease (Table 4.91). Moreover, the majority 
agreed that measles vaccination should be compulsory and the need to be vaccinated to avoid 
infecting an employee not infected before. Furthermore, most HCWs agreed that family 
members and colleagues should be vaccinated if they were not already immune. 
Few HCWs expressed willingness to deal with measles-infected colleagues as normal persons, 
while almost two thirds indicated that they would deal with them carefully. In contrast, almost 
a fifth reported that they would not deal with measles-infected persons. 
Statement Degree of agreement N % 
Measles is a serious disease 
Agree 249 79.1 
Neutral 59 18.7 
Disagree 7 2.2 
Measles vaccination should be made 
compulsory for HCWs 
Agree 273 86.7 
Neutral 38 12.1 
Disagree 4 1.2 
It is important for an employee who was 
not infected by measles before, to be 
vaccinated 
Agree 280 88.9 
Neutral 30 9.5 
Disagree 5 1.6 
It is recommended for family members 
and colleagues to be vaccinated if they 
were not immune 
Agree 265 84.1 
Neutral 43 13.7 
Disagree 7 2.2 
If a measles infected person works with 
you in a health care centre, you will deal 
with him 
Normally 35 11.1 
Carefully 206 65.4 
I won’t deal with him 59 18.7 
I don't know 15 4.8 
Table 4.91: Participants’ concern and attitude towards the measles and measles-infected 
colleagues-HCWs(N=315) 
Concern and attitude about measles and sociodemographic characteristics  
There was a small, negative significant correlation between age and those who said measles 
vaccination should be compulsory for HCWs; the older the respondent, the less the agreement 
(Table 4.92). The correlation was also small and negative between the age and those who said 
it is important for an employee who was not infected by measles before to be vaccinated; the 
older the respondent, the less the agreement was. 
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The correlation was also small, negative between time spent in formal education and those who 
said measles vaccination should be compulsory for HCWs; the greater the years, the less 
agreement. Also, there was a small, negative correlation between period of formal education 
and those stating it was important for an employee not previously infected to be vaccinated; as 
years of education increase, there was less agreement. Furthermore, there was a small negative 
correlation between time spent in formal education and the recommendation that non-immune 
family members and colleagues should be vaccinated; as years of education increases, there 
was less agreement. 
The correlation was also small and positive between measles knowledge and those stating 
measles is a serious disease; as measles knowledge increases, there was more agreement. 
Moreover, there was small and positive correlation between measles knowledge and those who 
said its vaccination should be compulsory for HCWs; as measles knowledge increases, there 
was more agreement. Also, the correlation was small and positive between measles knowledge 
and those who said it is important for an employee not infected before to be vaccinated; as 
measles knowledge increases, there was more agreement. Additionally, there was a small, 
positive correlation between measles knowledge and the recommendation that non-immune 
family members and colleagues should be vaccinated; as measles knowledge increases, there 
was more agreement. 
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Participants’ concern and attitude  
Measles is a 
serious disease 
Measles vaccination 
should be made 
compulsory for HCWs 
Important for an employee who 
was not infected by measles 
before, to be vaccinated 
Family members and 
colleagues should be 
vaccinated if they were not 
immune 
Age 
Correlation* -0.03 -0.15 -0.16 -0.04 
P value 0.54 0.01 <0.001 0.45 
Time spent in 
formal education 
Correlation* -0.02 -0.18 -0.15 -0.15 
P value 0.79 <0.001 0.01 0.01 
Experience in 
health institutions 
Correlation* 0.08 -0.03 -0.07 0.07 
P value 0.17 0.58 0.24 0.22 
Measles 
knowledge score  
Correlation* 0.23 0.14 0.12 0.21 
P value <0.001 0.01 0.03 <0.001 
Table 4.92: Correlation between participants’ concern and attitude towards the measles and measles -infected colleagues and sociodemographic 
characteristics-HCWs(N=315) 
*Based on Spearman's rho correlation  
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The majority of females and non-Muslims agreed that measles vaccination should be 
compulsory for HCWs and the associations between sex and agreement and sex and religion 
were both statistically significant. Similarly, a majority of singles and undergraduates agreed 
that measles vaccination should be compulsory for HCWs. Statistically significant associations 
are shown between agreement and marital status and education level (Table 4.93). 
Furthermore, the majority of females and undergraduates recommended measles infection-free 
employees be vaccinated, this association between sex and recommendation and sex and 
education level being statistically significant (Table 4.94). 
The majority of females wanted family members and colleagues to be vaccinated if they were 
not immune, being statistically significant. Furthermore, a majority of non-Muslims and 
undergraduates recommended that family members and colleagues should be vaccinated if they 
were not immune, this association between religion and recommendation and education level 
being statistically significant. 
Concern and attitude about measles and occupational characteristics  
Nearly two thirds of administrators agreed that measles is a serious disease; this was less 
compared to other jobs and this association was statistically significant. Also, about three 
quarters of physicians agreed the measles vaccination should be compulsory for HCWs in 
comparison to other jobs; this association was statistically significant (Table 4.95). 
Furthermore, about three quarters of physicians agreed to the recommendation that measles 
infection-free employees should be vaccinated; this association was statistically significant. The 
majority of nurses, those specialised in nursing services and those who work as staff nurses, 
recommended that family members and colleagues should be vaccinated if they were not 
immune; this association between occupation and recommendation was statistically significant, 
and speciality/position was statistically significant (Table 4.96). 
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Characteristics  N 
Measles is a serious disease 
P-Value* 
Measles vaccination should be made 
compulsory for HCWs P-Value* 
Disagree or Neutral Agree Disagree or Neutral Agree 
Sex    0.31*   0.007* 
Male 124 30(24.2%) 94(75.8%) 25(20.2%) 99(79.8%) 
Female  191 36(18.8%) 155(81.2%) 17(8.9%) 174(91.1%) 
Nationality    0.10*   0.86* 
Saudi 165 41(24.8%) 124(75.2%) 23(13.9%) 142(86.1%) 
Non-Saudi 150 25(16.7%) 125(83.3%) 19(12.7%) 131(87.3%) 
Religion     0.39*   0.005* 
Muslim 223 50(22.4%) 173(77.6%) 38(17.0%) 185(83.0%) 
Non-Muslim 92 16(17.4%) 76(82.6%) 4(4.3%) 88(95.7%) 
Marital status    0.77*   0.04* 
Single 198 43(21.7%) 155(78.3%) 20(10.1%) 178(89.9%) 
Ever married 117 23 (19.7%) 94(80.3%) 22(18.8%) 95(81.2%) 
Education level    0.52*   0.001* 
Under graduate 268 54(20.1%) 214(79.9%) 28(10.4%) 240(89.6%) 
Post graduate 47 12(25.5%) 35(74.5%) 14(29.8%) 33(70.2%) 
Table 4.93: Association between participants’ concern and attitude towards the measles and measles -infected colleagues and sociodemographic 
characteristics-HCWs(N=315)(a) 
*Based on Continuity Correction   
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Characteristics  N 
 Important for an employee who was not 
infected by measles before, to be vaccinated P-Value* 
 Family members and colleagues should 
be vaccinated if they were not immune 
P-
Value* 
Disagree or Neutral Agree Disagree or Neutral Agree 
Sex    0.03*   0.03* 
Male 124 20(16.1%) 104(83.9%) 27(21.8%) 97(78.2%) 
Female  191 15(7.9%) 176(92.1%) 23(12.0%) 168(88.0%) 
Nationality    0.7   0.051* 
Saudi 165 17(10.3%) 148(89.7%) 33(20.0%) 132(80.0%) 
Non-Saudi 150 18(12.0%) 132(88.0%) 17(11.3%) 133(88.7%) 
Religion     0.28*   0.03* 
Muslim 223 28(12.6%) 195(87.4%) 42(18.8%) 181(81.2%) 
Non-Muslim 92 7(7.6%) 85(92.4%) 8(8.7%) 84(91.3%) 
Marital status    0.09*   0.21* 
Single 198 17(8.6%) 181(91.4%) 27(13.6%) 171(86.4%) 
Ever married 117 18(15.4%) 99(84.6%) 23(19.7%) 94(80.3%) 
Education level    0.03*   0.02* 
Under graduate 268 25(9.3%) 243(90.7%) 37(13.8%) 231(86.2%) 
Post graduate 47 10(21.3%) 37(78.7%) 13(27.7%) 34(72.3%) 
Table 4.94: Association between participants’ concern and attitude towards the measles and measles -infected colleagues and sociodemographic 
characteristics-HCWs(N=315)(b) 
*Based on Continuity Correction   
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*Based on Chi-Square Monte Carlo method  
Characteristics  N 
Measles is a serious disease 
P-Value*  
Measles vaccination should be made 
compulsory for HCWs 
P-Value* 
Disagree 
 or Neutral 
Agree Disagree or Neutral Agree 
Practise location    0.51   0.9 
KKH 191 38(19.9%) 153(80.1%) 27(14.1%) 164(85.9%) 
KSAU-HS 66 17(25.8%) 49(74.2%) 8(12.1%) 58(87.9%) 
PHCs 58 11(19.0%) 47(81.0%) 7(12.1%) 51(87.9%) 
Occupation    0.02   0.007 
Physician 70 11(15.7%) 59(84.3%) 15(21.4%) 55(78.6%) 
Nurse 99 17(17.2%) 82(82.8%) 6(6.1%) 93(93.9%) 
Specialist/Technician 75 14(18.7%) 61(81.3%) 7(9.3%) 68(90.7%) 
Admin 71 24(33.8%) 47(66.2%) 14(19.7%) 57(80.3%) 
Speciality    0.06   0.23 
Clinical services 116 17(14.7%) 99(85.3%) 17(14.7%) 99(85.3%) 
Administrative/Technical  69 22(31.9%) 47(68.1%) 13(18.8%) 56(81.2%) 
Nursing services 63 12(19.0%) 51(81.0%) 4(6.3%) 59(93.7%) 
Pathology/laboratory 42 8(19.0%) 34(81.0%) 4(9.5%) 38(90.5%) 
Ancillary medical services 25 7(28.0%) 18(72.0%) 4(16.0%) 21(84.0%) 
Position    0.2   0.09 
Staff nurse 86 15(17.4%) 71(82.6%) 6(7.0%) 80(93.0%) 
Admin/Technician  97 26(26.8%) 71(73.2%) 14(14.4%) 83(85.6%) 
Specialist 39 8(20.5%) 31(79.5%) 5(12.8%) 34(87.2%) 
Staff physician 35 5(14.3%) 30(85.7%) 9(25.7%) 26(74.3%) 
Academic staff 33 4(12.1%) 29(87.9%) 3(9.1%) 30(90.9%) 
Specialist physician 25 8(32.0%) 17(68.0%) 5(20.0%) 20(80.0%) 
Table 4.95: Association between participants’ concern and attitude towards the measles and measles -infected colleagues and occupational 
characteristics-HCWs(N=315)(a) 
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Characteristics  N 
 Important for an employee who was not 
infected by measles before, to be vaccinated 
P-
Value
* 
 Family members and colleagues should 
be vaccinated if they were not immune 
P-
Value
* Disagree or Neutral Agree Disagree or Neutral Agree 
Practise location    0.9   0.95 
KKH 191 22(11.5%) 169(88.5%) 30(15.7%) 161(84.3%) 
KSAU-HS 66 7(10.6%) 59(89.4%) 10(15.2%) 56(84.8%) 
PHCs 58 6(10.3%) 52(89.7%) 10(17.2%) 48(82.8%) 
Occupation    0.003   0.01* 
Physician 70 15(21.4%) 55(78.6%) 16(22.9%) 54(77.1%) 
Nurse 99 7(7.1%) 92(92.9%) 6(6.1%) 93(93.9%) 
Specialist/Technician 75 3(4.0%) 72(96.0%) 13(17.3%) 62(82.7%) 
Admin 71 10(14.1%) 61(85.9%) 15(21.1%) 56(78.9%) 
Speciality    0.11**   0.02** 
Clinical services 116 19(16.4%) 97(83.6%) 21(18.1%) 95(81.9%) 
Administrative/Technical  69 9(13.0%) 60(87.0%) 14(20.3%) 55(79.7%) 
Nursing services 63 4(6.3%) 59(93.7%) 3(4.8%) 60(95.2%) 
Pathology/laboratory 42 2(4.8%) 40(95.2%) 5 (11.9%) 37(88.1%) 
Ancillary medical services 25 1(4.0%) 24(96.0%) 7(28.0%) 18(72.0%) 
Position    0.03**   0.005*
* Staff Nurse 86 7(8.1%) 79(91.9%) 5(5.8%) 81(94.2%) 
Admin/Technician  97 9(9.3%) 88(90.7%) 15(15.5%) 82(84.5%) 
Specialist 39 2(5.1%) 37(94.9%) 10(25.6%) 29(74.4%) 
Staff physician 35 10(28.6%) 25(71.4%) 8(22.9%) 27(77.1%) 
Academic staff 33 3(9.1%) 30(90.9%) 4(12.1%) 29(87.9%) 
Specialist physician 25 4(16.0%) 21(84.0%) 8(32.0%) 17(68.0%) 
Table 4.96: Association between participants’ concern and attitude towards the measles and measles -infected colleagues and occupational 
characteristics-HCWs(N=315)(b) 
*Based on Chi-Square Monte Carlo method,**Based on Fisher’s Exact test in Monte Carlo method
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4.4.4 Summary of measles serology results among health care workers who completed the 
questionnaire 
Seroprevalence and clinical interpretations of measles  
About a fifth did not have serological evidence of immunity against measles, possibly due to 
lack of a specific immune response to measles immunisation or no prior exposure to the measles 
virus (Table 4.97). 
Serology test Result N  (95%C.I) Interpretation  
IgG measles Negative 54(17.1%) (13.4-21.7) 
1-Might be lack of a specific 
immune response to 
immunisation. 
2-Might be no prior exposure to 
the measles virus. 
IgG measles Positive 261(82.9%) (78.3–86.6) 
Prior exposure to the measles 
virus through infection or 
immunisation 
Table 4.97: Clinical interpretation of measles serological markers-HCWs(N=315) 
Seroprevalence of measles antibodies and associated variables 
Measles seroimmunity and sociodemographic characteristics 
The odds of positive IgG measles among those who have 6 or more years’ experience were four 
times higher and about two times higher among those with 4-6 years (Table 4.98). Furthermore, 
the odds of positive IgG measles among those formally educated between 17-18 years were 
lower in comparison to those who with less than 16 years. The odds of positive IgG measles 
among the Non-Saudis respondents were four times higher in comparison to the Saudis. 
Additionally, the odds of positive IgG measles among non-Muslims were six times higher in 
comparison to Muslims. 
 
Measles seroimmunity and occupational characteristics 
The odds of positive IgG measles among nurses were four times higher and among physicians 
twice as high(Table 4.99). Additionally, the odds of positive IgG measles for administrators 
and technicians were significantly lower than for clinicians. 
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Characteristics 
Cross tabulation  Univariate analysis  
Negative 
IgG 
measles 
(N=54) 
Positive 
IgG 
measles 
(N=261) 
Overall 
N 
OR(95%CI) 
LRT-
P 
Age in category(Years)    
 
0.17 
<25 14 61 75 Reference 
25-30 30 120 150 0.92(0.45-1.86) 
>30 10  80 90 1.84(0.76-4.41) 
Work of experience(Years)    
 
0.01 
<1 20 55 75 Reference 
1-3 19 76 95 1.45(0.71-2.98) 
4-6 9 63 72 2.54(1.07-6.05) 
>6 6 67  73 4.06(1.52-10.81) 
Formal education(Years)    
 
0.002 
≤16 17 139 156 Reference 
17-18 26 65 91 0.30(0.15-0.60) 
≥19 11 57 68 0.63(0.27-1.43) 
Sex     0.31 
Male 18 106 124 Reference 
Female 36 155 191 0.73(0.39-1.35) 
Nationality      <0.001 
Saudi 43 122 165 Reference 
Non-Saudi 11 139 150 4.45(2.20-9.01) 
Religion       <0.001 
Muslim 50 173 223 Reference 
Non-Muslim 4 88 92 6.35(2.22-18.17) 
Marital status      0.52 
Ever married 18 99 117 Reference  
Single 36 162 198 0.81(0.44-1.51) 
Education level       0.65 
Undergraduate 47 221 268 Reference 
Post graduate 7 40 47 1.21(0.51-2.87) 
Table 4.98: Measles seroimmunity and sociodemographic characteristics-HCWs(N=315) 
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Characteristics 
Cross tabulation  Univariate analysis  
Negative 
IgG 
Measles 
(N=54) 
Positive 
IgG 
Measles 
(N=261) 
Overall 
N 
OR(95%CI) 
LRT-
P 
Practise location      0.66 
KKH 30 161 191 Reference 
KSAU-HS 12 54 66 0.83(0.40-1.75) 
PHCs 12 46 58 0.71(0.46-1.66) 
Occupation      0.007 
Admin 21 50 71 Reference 
Physician 12 58 70 2.03(0.90-4.53) 
Nurse 9 90 99 4.20(1.78-9.86) 
Medical 
specialist/Technician 
12 63 75 2.20(0.99-4.91) 
Speciality      0.01 
Clinical services 16 100 116 Reference 
Administrative & 
Technical Support 
Services 
21 48 69 0.36(0.18-0.76) 
Nursing Services 5 58 63 1.85(0.64-5.33) 
Pathology/laboratory 7 35 42 0.80(0.30-2.10) 
Ancillary medical 
services 
5 20 25 0.64(0.21-1.94) 
Position      0.20 
Staff nurse 9 77 86 Reference 
Admin/Technician 
assistant 
22 75 97 0.39(0.17-0.92) 
Specialist 8 31 39 0.45(0.16-1.28) 
Staff physician 7 28 35 0.46(0.15–1.37) 
Academic staff 6 27 33 0.52(0.17-1.61) 
Specialist physician 2 23 25 1.34(0.27-6.66) 
Table 4.99: Measles sero-immunity and occupational characteristics-HCWs(N=315) 
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Potential predictors of measles seroimmunity  
Table 4.100 shows the results of a logistic regression model looking into the potential 
predicators of measles seroimmunity. Variables included in the initial model are; years of work 
experience, formal education, nationality and religion (Table 4.98), and occupation and 
specialty (Table 4.99). The model as a whole explained 13.53% of the variance in seroimmunity 
IgG measles. Hosmer and Lemeshow indicated that the model was a reasonable fit, (P=0.42) 
Two of the studied variables (time spent in formal education and nationality) made significant 
independent contribution to the model. Compared to those spending 16 years or less in formal 
education, the odds of positive IgG measles among those who spent 17/18, was lower. 
Additionally, in comparison to the Saudis, the odds of positive IgG among non-Saudis were 
almost four times higher. The highest odds of IgG measles seroimmunity was for non-Saudis, 
indicating they, when compared to Saudis, they were almost four times more likely to be 
immune against measles, controlling for all other independent variables in the model. Variables 
determining measles seroimmunity of HCWs were investigated, and none of them was 
considered as a confounder. 
Variable* OR(95%CI) LRT-P 
Time spent in formal education(Years)  0.04 
≤16 Reference 
17-18 0.42(0.21-0.84) 
≥19 0.67(0.29-1.56) 
Nationality   <0.001 
Saudi Reference 
Non-Saudi 3.73(1.81-7.68) 
Table 4.100: Independent determinants of measles seroimmunity-HCWs(N=315) 
*Multiple logistic regression 
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4.4.5 Summary of measles serology results among health care workers who were not given 
the questionnaire 
Seroprevalence and clinical interpretations of measles serological markers 
Seroprevalence and clinical interpretation of serological markers about measles are summarised 
in (Table 4.101).  
Serology test Result N (95%C.I) Interpretation  
IgG measles Negative 1434(35.7%) (34.3-37.2) 
1-Might be lack of a specific 
immune response to 
immunisation. 
2-Might be no prior exposure to 
the measles virus. 
IgG measles Positive 2579(64.3%) (62.8–65.7) 
Prior exposure to the measles 
virus through infection or 
immunisation 
Table 4.101: The laboratory results for measles markers-HCWs(N=4013) 
Seroprevalence of measles antibodies and associated variables 
Measles seroimmunity and sociodemographic characteristics 
The odds of positive IgG measles among females were 28% higher than males (Table 4.102). 
Moreover, the odds of positive IgG measles among Non-Saudis were double those for Saudis. 
Also, the odds of positive IgG measles among those recruited from the WPR were double, 
among those recruited from the Europe were 54% higher, among those recruited from Africa 
were double and among those recruited from the SEAR were five times higher, in comparison 
to those from the MER. 
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Characteristics 
Cross tabulation Univariate analysis 
Negative 
IgG measles 
(N=1434) 
Positive IgG 
measles 
(N=2579) 
Overall 
N 
OR (95% CI) LRT-P 
Sex     <0.001 
Male 699 1099 1798 Reference 
Female  735 1480 2215 1.28(1.12-1.45) 
Nationality     <0.001 
Saudi 947 1133 2080 Reference 
Non-Saudi 487 1446 1933 2.48(2.17-2.83) 
World region     <0.001 
MER 1017 1356 2373 Reference 
WPR 304 901 1205 2.22(1.90-2.59) 
Europe 56 115 171 1.54(1.10-2.14) 
Africa 33 110 143 2.50(1.68-3.72) 
SEAR 11 76 87 5.18(2.73-9.80) 
Americas 13 21 34 1.21(0.60-2.43) 
Table 4.102: Measles seroimmunity and sociodemographic characteristics-
HCWs(N=4013) 
 
Measles seroimmunity and occupational characteristics 
The odds of positive IgG measles among those working in the KAMC, but not in clinical or 
nursing duties, were less than those working in KKH (Table 4.103). Also, the odds of positive 
IgG Measles among those working as medical technicians and admin were less. Furthermore, 
the odds of positive IgG measles among those specialised in ancillary medical services were 
lower than those who were specialised in clinical services. 
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Characteristics 
Cross tabulation analysis Univariate analysis 
Negative 
IgG 
measles 
(N=1434) 
Positive 
IgG 
measles 
(N=2579) 
Total 
N 
OR(95%CI) 
LRT-
P 
Practise location     <0.003 
KKH 1083 2029 3112 Reference 
KAMC not working in 
clinical  
323 476 799 0.78(0.67-0.92) 
PHCs 28 74 102 1.41(0.90-2.19) 
Occupation     <0.001 
Nurse 427 1011 1438 Reference 
Physician 220 471 691 0.90(0.74-1.10) 
Medical specialist 264 293 557 0.46(0.38-0.57) 
Medical technician 208 351 559 0.71(0.58-0.87) 
Admin 315 453 768 0.61(0.50-0.72) 
Speciality     <0.001 
Clinical services 397 846 1243 Reference 
Nursing services 329 755 1084 1.07(0.90-1.28) 
Ancillary medical services 297 448 745 0.70(0.58-0.85) 
Administrative services 282 410 692 0.68(0.56-0.82) 
Pathology/laboratory 86 61 147 0.33(0.23-0.47) 
Technical support services 43 59 102 0.64(0.42-0.97) 
Position     <0.001 
Staff nurse 354 922 1276 Reference 
Technician 230 373 603 0.62(0.50-0.76) 
Intern 265 152 417 0.22(0.17-0.27) 
Specialist physician 104 279 383 1.03(0.79-1.33) 
Admin assistant 128 187 315 0.56(0.43-0.72) 
Specialist 119 188 307 0.60(0.46-0.78) 
Assistant 114 165 279 0.55(0.42-0.72) 
Staff physician 40 174 214 1.67(1.16-2.40) 
Information technology 
technician 
41 53 94 0.49(0.32-0.76) 
Supervisory/Leadership 22 57 79 0.99(0.59-1.65) 
Patient care technician 17 29 46 0.65(0.35-1.20) 
Table 4.103: Measles sero-immunity and occupational characteristics-HCWs(N=4013) 
  
  
177 
Potential predictors of measles seroimmunity  
Table 4.104 shows results of a logistic regression model looking into the potential predicators 
of measles seroimmunity. Variables included in the initial model: sex, nationality, world 
regional (Table 4.102); practise location, occupation, speciality, occupational position 
(Table 4.103). The model as a whole explained 11.7% of the variance in seroimmunity IgG 
measles. Hosmer and Lemeshow indicated that the model was a reasonable fit (P=0.61). 
Four of the studied variables (sex, WHO region, occupation and position) made an independent 
significant independent contribution to the model. The odds of positive IgG measles among 
females were higher than males. Additionally, the odds of positive IgG measles among those 
from the SEAR were three times higher than those from the MER. Also, the odds of positive 
IgG measles among those who originated from WPR were higher than those from MER. The 
odds of positive IgG measles among physicians were lower than for nurses. Furthermore, the 
odds of positive IgG measles among interns were lower than for staff nurses. Conversely, the 
odds of positive IgG measles among those who are working as specialist physician were five 
times higher and among staff physicians were six times higher than staff nurses. 
The highest odds of IgG measles seroimmunity was for staff physician, indicated they were 
over six times more likely to be immune against measles than staff nurses, controlling for all 
other independent variables in the model. 
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Variable* OR(95%CI) LRT-P 
Sex  <0.001 
Male Reference 
Female 1.83(1.32-2.53) 
WHO Region  0.001 
MER Reference 
WPR 1.42(1.01-1.98) 
Europe 0.89(0.57-1.39) 
Africa 1.53(0.93-2.51) 
SEAR 2.96(1.47-5.97) 
Americas 0.66(0.31-1.41) 
Occupation   0.004 
Nurse Reference 
Physician 0.41(0.19-0 87) 
Medical specialist 1.41(0.69-2.89) 
Medical technician 1.07(0.57-1.98) 
Admin 0.69(0.23-2.09) 
Speciality 
 
0.06 
Clinical services Reference 
Nursing services 1.05(0.79-1.39) 
Ancillary medical services 1.16(0.80-1.68) 
Administrative services 1.60(0.57-4.52) 
Pathology/laboratory 0.62(0.38-1.03) 
Technical support Services 2.00(0.38-12.10) 
Position  <0.001 
Staff nurse Reference 
Technician 0.93(0.55-1.59) 
Intern 0.50(0.30-0.86) 
Specialist physician 5.53(2.56-11.94) 
Admin assistant 0.93(0.49-1.74) 
Specialist 0.66(0.36-1.21) 
Assistant 1.01(0.54-1.90) 
Staff physician 6.29(2.77-14.25) 
Information technology technician 0.61(0.10-3.59) 
Supervisory/leadership 1.64(0.82-3.26) 
Patient care technician 0.69(0.37-1.29) 
Table 4.104: Independent determinants of IgG measles seroimmunity-HCWs(N=4013) 
*Multiple logistic regression 
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The interaction between sex and occupation indicated the odds of positive IgG measles were 
lower among physicians and females. The interaction between sex and position indicated the 
odds of positive IgG measles were higher among technician and females, and the odds of 
positive IgG measles were lower among specialist physician and females. In conclusion, 
different sex patterns between specialist physicians related to IgG measles, for males 
seroimmunity increased markedly while with females there was a notable decrease.  
The interaction between WHO Region of origin and occupation indicated the odds of positive 
IgG measles were double among medical technicians and among those from WPR. Similarly, 
the odds of positive IgG measles were lower among medical technicians and among those who 
originated from Africa. Furthermore, the odds of positive IgG measles were lower among 
medical specialist and among those who originated from Africa. 
In conclusion, there were different occupational patterns between medical technicians and 
specialist physicians among those who originated from Africa related to IgG measles, for nurses 
seroimmunity increased markedly while with medical technicians and specialist physicians 
there was a notable decrease. 
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4.5 Varicella among Health Care Workers 
 
4.5.1 Previous varicella related health history 
Previous investigation for varicella 
About half the study participants reported having been infected with varicella (Table 4.105). 
For those infected more than a year before, at a median of 18 (inter-quartile range 12 -20 years) 
and a range of 1–41, almost two thirds indicated it occurred 21-30 years before. Almost a 
quarter were sure they had been previously investigated for varicella, and the rest responded 
that they had never been screened or were unsure. Of those sure they had had varicella 
investigations, almost four fifths indicated being informed they were immune, only four HCWs 
not being. The screening tests mainly took place in KSA and Philippines, more than a third of 
non-Saudis being screened in KSA. 
 
Varicella immunisation 
Only a few had received the two doses required for protection against varicella. Furthermore, 
more than half the respondents did not know if they had received the varicella vaccine, and 
about a fifth had not been offered (Table 4.106). 
Of those vaccinated before, about half of HCWs were vaccinated before primary school, 11 
participants were vaccinated recently (within a year ago), a range of 2–11 months. Three 
participants were vaccinated more than a year before, and range of 1–3 years. 
Of those vaccinated, more than half were in KSA and a quarter in Philippines. Most reasons to 
be vaccinate were either immunisation campaigns or a doctor’s recommendation or work 
requirement, only ten HCWs reported that personal motivation was the reason .Over a third 
received regular vaccine doses and almost half expressed that they did not know if they were 
vaccinated in a regular pattern. 
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Investigation against varicella N % 
Previous infection to varicella(N=315)   
Yes 163 51.7 
No 118 37.5 
Not sure 34 10.8 
Time of infection with varicella in years(N=162)   
<=10years ago 28 17.3 
11-20 years ago 97 59.9 
21years ago and more 37 22.8 
Previous investigation against varicella immune status(N=315)    
Yes 71 22.5 
No 130 41.3 
Not sure 114 36.2 
Results of investigations against varicella immune status(N=71)    
Immune 57 80.3 
Not immune 4 5.6 
Not sure 10 14.1 
Place at which investigations were done(N=71)    
KSA 46 64.7 
Philippines 8 11.2 
India 6 8.3 
Others* 11 15.8 
Non-Saudis for whom investigations were done in KSA(N=38) 13 34.2 
Table 4.105: Investigation against varicella-HCWs 
*Others(N): Malaysia(4), Pakistan(2), South Africa(2), Czech(1), UK(1), USA(1)  
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Characteristics N % 
Varicella vaccination status(N=315)   
More than two doses 13 4.1 
Two doses 23 7.3 
One dose 35 11.1 
Varicella vaccine not offered 57 18.1 
Varicella vaccine offered, but not taken 6 1.9 
I do not know 181 57.5 
Time of administration of varicella vaccine(N=97)     
Before primary school 53 54.6 
During primary school 18 18.6 
During secondary school 2 2.1 
During undergraduate study 7 7.2 
I do not know 17 17.5 
Place of administration varicella vaccine(N=111)     
KSA 61 55.0 
Philippines 27 24.3 
Malaysia 7 6.3 
Others* 16 14.4 
The reason for being vaccinated(N=111)     
Immunisation campaigns 55 49.5 
Doctor’s recommendation 41 36.9 
Work requirement 21 18.9 
Self-motivation 10 9.0 
Governmental vaccination policy 5 4.5 
Parent's recommendation 1 0.9 
Were the doses of varicella vaccine regular**?(N=111)    
Regular 42 37.8 
Irregular 9 8.1 
I did not receive all two doses 11 9.9 
I do not know 49 44.1 
Table 4.106: History of immunisation with varicella vaccine-HCWs 
*Others(N): India(4), Pakistan(4), South Africa(2), Algeria(1), Egypt (1), Jordan(1), Sudan(1), Syria(1), UAE(1) 
**(The second dose from one to 2 months of 1st dose). Any other regimen is considered irregular 
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The reasons why some of HCWs were not vaccinated against varicella are shown in 
Table 4.107. 
The reason why not vaccinated against varicella  N % 
I do not believe myself at risk. 48 23.5 
Natural varicella infection is preferable to vaccine. 34 16.7 
I had been infected with varicella 22 10.8 
Varicella is not a serious enough disease to warrant 
immunisation 
20 9.8 
Difficulty access obtaining the varicella vaccine. 18 8.8 
I am concerned about the safety of the varicella vaccine. 12 5.8 
No awareness. 9 4.4 
I do not know 56 27.5 
Others* 12 5.9 
Table 4.107: The reason why not vaccinated against varicella(N=204) 
Others*: I am concerned about the cost. (4); Born before vaccine invention (3), I suffer from a medical condition. 
(2) 
 
Self-reporting of the respondents who had positive or negative IgG varicella about the history 
of immunisation 
Self-reporting histories of immunisation among those who had sero-positive IgG varicella alone 
are described in Table 4.108 and Table 4.109. Of those seropositive IgG varicella, more than 
half reported being infected by varicella and a third had been infected between 11- 20 years 
before. Furthermore, almost a fifth reported being immune while a minority reported that they 
were not sure, however, the majority’s immune statuses were not tested. 
Of those seropositive IgG varicella, one tenth indicated they had received two doses or more 
and about two thirds were never vaccinated. Meanwhile, about a fifth of those quoted 
immunisation campaigns as the main reason of vaccination. Moreover, about a fifth of positive 
IgG varicella-alone cases did not receive regular doses and two thirds were never vaccinated.  
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IgG varicella is positive  N % 
Were you ever infected with varicella?   
Yes 143 56.7 
No 86 34.1 
Not sure 23 9.1 
I was infected with varicella in   
<=10years ago 22 8.7 
11-20 years ago 88 34.9 
21-30 years ago 29 11.5 
31 years ago and more 4 1.6 
I was not infected or not sure 109 43.3 
Tested for immune status against varicella and result was   
Immune 45 17.9 
Not sure 7 2.8 
I was not tested for immune status 200 79.3 
Varicella vaccination status   
I have had more than two doses 11 4.4 
I have had two doses 14 5.6 
I have had one dose  29 11.5 
I was offered the vaccine, but I have not had it 5 2.0 
I was not offered the vaccine 47 18.6 
I do not know 146 57.9 
Varicella vaccination time    
Before primary school 44 17.5 
During primary school 14 5.6 
During secondary school 1 0.4 
During undergraduate study 4 1.6 
I was vaccinated during 11 months ago 6 2.4 
I was vaccinated more than 1year ago 1 0.4 
I do not know 15 6.0 
I was not vaccinated 167 66.3 
Table 4.108: Self-reporting of the respondents who had positive IgG varicella alone about 
the history of immunisation-HCWs(N=252)(a) 
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IgG varicella is positive  N % 
The reason to be vaccinated against varicella   
Doctor’s recommendation 30 11.9 
Self-motivation 6 2.4 
Immunisation campaigns 45 17.9 
Work requirement 12 4.8 
Other 6 2.4 
I was not vaccinated against varicella 167 66.3  
Were the doses regular? 
 
Regular on time  32 12.7 
Not regular 53 21.0 
I was not vaccinated 167 66.3  
Table 4.109: Self-reporting of the respondents who had positive IgG varicella alone about 
the history of immunisation-HCWs(N=252)(b) 
 
Responses of HCWs self-reporting history of immunisation among those who do not have any 
evidence of seroimmunity against IgG varicella alone are described in Table 4.110 and 
Table 4.111. Of those seronegative IgG varicella, a third had been infected before, a fifth 
reported being immune against varicella, about a fifth reported that vaccine had been received 
in two doses or more and about a quarter received varicella vaccine in an irregular pattern. 
Nonetheless, more than half were never vaccinated. 
IgG varicella is negative  N % 
Were you ever infected with varicella?   
Yes 20 31.7 
No 32 50.8 
Not sure 11 17.5 
I was infected with varicella in   
Less than year  1 1.6 
<=10 years ago 6 9.5 
11-20 years ago 9 14.3 
21-30 years ago 4 6.3 
I was not infected 43 68.3 
Table 4.110: Self-reporting of the respondents who had negative IgG varicella alone about 
the history of immunisation-HCWs(N=63)(a) 
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IgG varicella is negative  N % 
Tested for immune status against varicella and result was   
Immune 12 19.1 
Not Immune 4 6.3 
Not sure 3 4.8 
I was not tested for immune status 44 69.8 
Statements describes about receiving the varicella vaccination   
I have had more than two doses 2 3.2 
I have had two doses 9 14.3 
I have had one dose 6 9.5 
I was offered the varicella vaccine, but I have not had it 1 1.6 
I was not offered the vaccine. 10 15.8 
I do not know 35 55.6 
I was vaccinated against varicella    
Before primary school 9 14.3 
During primary school 4 6.3 
During secondary school 1 1.6 
During undergraduate study 3 4.8 
I was vaccinated during 11 months ago 5 7.9 
I was vaccinated during last 1 -20 years ago 2 3.2 
I do not know 2 3.2 
I was not vaccinated 37 58.7 
Were the doses regular?   
Regular on time 10 15.9 
Not regular 16 25.4 
I was not vaccinated 37 58.7 
Table 4.111: Self-reporting of the respondents who had negative IgG varicella alone about 
the history of immunisation-HCWs(N=63)(b) 
Exposure to potential risks of acquiring varicella 
Two fifths indicated that they had seen at least one patient within the previous five years with 
a varicella infection and a third heard of one or more patients being hospitalised for varicella- 
related conditions. 
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4.5.2 Varicella knowledge 
Self-reporting of the respondents about their level of knowledge and sources of their 
information 
The majority of HCWs expressed that they had varicella knowledge, more than half described 
their knowledge as inadequate, and more than a third thought it adequate (Table 4.112). Of 
those whose knowledge was enough or inadequate, about three-quarters pointed to education, 
and about two fifths quoted the internet as the main source of information. 
Varicella-Level of knowledge and source of information N % 
Do you have information?(N=315)     
Yes, enough 117 37.1 
Yes, but it is not enough 165 52.4 
No 33 10.5 
The main source of knowledge(N=282)     
Education 231 73.3 
Internet 126 40.0 
Colleagues 78 24.8 
Family/relatives 81 25.7 
Newspapers/magazines 50 15.9 
TV/Radio 45 14.3 
Others* 3 1.0 
Table 4.112: Respondents’ self-reported level of varicella knowledge and source of 
information-HCWs 
*Others(N): Self-experience(2), I was infected by varicella(1) 
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Knowledge about key facts of varicella 
The highest percentage was recorded for those who knew that varicella is a highly 
communicable infectious disease while the lowest knowledge percentage was recorded for 
incubation period (Table 4.113). 
Key facts of varicella N* % 
Varicella is a highly communicable infectious disease 262 83.2 
HCWs may have an increased risk of becoming infected with varicella 238 75.6 
The microorganism that causes varicella is virus 226 71.7 
Reactivation of the varicella microorganism can cause herpes zoster disease 
later in life after primary infection 
166 52.7 
The risk of complications and mortality due to varicella is 10 times higher 
among adults than children 
133 42.2 
You know a person is really a varicella case by medical examination 117 37.1 
The incubation period with a range of ten to 21 days 17 5.4 
Table 4.113: Percentage of the respondents who gave correct answers about key facts of 
varicella-HCWs(N=315) 
*N indicates the number of respondents who provided correct answers. 
Knowledge about varicella transmission  
Most respondents knew that varicella can spread through direct contact with fluids from the 
blister of an infected person, and lower percentages knew a varicella patient is considered 
contagious before the appearance of the rash (Table 4.114). 
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Knowledge about varicella transmission N* % 
Varicella can spread through direct contact with fluids from the blister of a 
person infected with varicella. 
265 84.1 
Varicella can be spread through direct contact with a sore from a person with 
shingles. 
240 76.2 
The source of the varicella infection could be a case of varicella or herpes 
zoster 
209 66.3 
Varicella can spread through infectious secretions from the nose and throat. 190 60.3 
Varicella can spread through inhalation of infectious droplets which can 
occur during (speaking, coughing, and sneezing) 
189 60.0 
Varicella can be transmitted from asymptomatic patients 165 52.4 
A varicella patient is considered to be contagious before the appearance of 
the rash 
115 36.5 
Table 4.114: Percentage of the respondents who gave correct answers about varicella 
transmission-HCWs(N=315) 
*N indicates the number of respondents who provided correct answers. 
Knowledge about varicella vaccine and immunity 
Almost two thirds knew that HCWs without a reliable history of varicella should receive the 
vaccine. Alternatively, a minority knew that immunity following varicella vaccination is not 
life-long (Table 4.115). 
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Varicella knowledge about vaccine and immunity N* % 
HCWs without a reliable history of varicella disease should receive varicella 
vaccine 
198 62.9 
The varicella vaccine is a live attenuated vaccine. 175 55.6 
Acquired immunity after natural varicella infection is permanent (lifelong) 173 54.9 
The varicella vaccine cannot be given for someone with severe acute illness, 
with or without fever 
156 49.5 
The varicella vaccine is not safe for pregnant woman 117 37.1 
To obtain optimum protection for HCWs, two doses of varicella vaccine are 
required 
106 33.7 
Immunisation of a person who has natural varicella immunity is not harmful 102 32.4 
The varicella vaccine can only be taken by those aged 12 months and above 92 29.2 
The varicella vaccine can protect if given within 72 hours of exposure 64 20.3 
Immunity following varicella vaccination is not life-long 41 13.0 
Table 4.115: Percentage of the respondents who gave correct answers about varicella 
vaccine and immunity-HCWs(N=315) 
*N indicates the number of respondents who provided correct answers. 
Perspectives of the respondents about behaviour towards workers infected with varicella 
About four fifths knew that an infected worker should be isolated from work or daily activity 
and over two thirds knew that an infected worker cannot shake hands nor eat food with 
colleagues (Table 4.116). 
Items reflecting attitude against the HCWs infected with varicella N* % 
It is necessary to isolate the infected worker from work or daily activity 250 79.4 
The infected worker cannot shake hands with colleagues 216 68.6 
The infected worker’s contacts should be traced and investigated of varicella 211 67.0 
The infected worker cannot eat food with colleagues 209 66.3 
Infected worker’s contacts should be immunised promptly if they do not have 
documentation of proved immunity against varicella 
198 62.9 
Table 4.116: Percentage of the respondents who gave correct answers about behaviours 
towards the HCWs infected with varicella-HCWs(N=315) 
*N indicates the number of respondents who provided correct answers. 
Perspectives of the respondents about varicella outbreak in a health care centre 
About three quarters knew that all contacts should receive the varicella vaccine if they do not 
have evidence of immunity while only a third knew that the recommended duration for isolation 
of patients is two days before and five days after skin rash (Table 4.117).  
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Varicella outbreak response  N* % 
All contacts should receive the varicella vaccine if they do not have evidence of 
immunity 
229 72.7 
If there is evidence of immunity among contacts, they can immediately return to 
work 
206 65.4 
The recommended duration for isolation varicella patients is two days before and 
five days after skin rash. 
118 37.5 
In case of a contact with a patient who cannot take or refuses to receive the 
varicella vaccine, they should be restricted from work for a period of 21 days 
from the last case 
100 31.7 
Table 4.117: Percentage of the respondents who gave correct answers about varicella 
outbreak in health care centre-HCWs(N= 315) 
*N indicates the number of respondents who provided correct answers. 
Knowledge in different aspects of varicella  
The median total knowledge score on the 33 items was 19 (inter-quartile range 13-23), 
corresponding with a percentage of 57.6% in knowledge variation (inter-quartile range 39.4-
69.8%)(Table 4.118). Concerning the subscales, the best score was seen on the attitude towards 
an infected worker (median 4) while the median score on the varicella vaccine and immunity 
scores was the lowest (4). 
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Knowledge aspects Median IQR 
As % of all questions 
median IQR 
Total knowledge score (33Questions) 19 (13-23) 57.6 (39.4-69.8) 
Key facts of varicella (7Questions) 4 (2-5) 57.1 (28.6–71.5) 
Varicella transmission (7Questions) 5 (3-6) 71.3 (42.9–85.7) 
Varicella vaccine/immunity(10Questions) 4 (2-6) 40.0 (20.0-60.0) 
Attitude towards infected HCW(5Questions) 4 (3-5) 80.0 (60.0–100.0) 
Varicella outbreak response(4Questions) 2 (1-3) 50.0 (25.0–75.0) 
Table 4.118: Median and inter-quartile range with percentage of the respondents who 
gave correct answers in different knowledge aspects about varicella-HCWs(N=315) 
Varicella knowledge score and sociodemographic characteristics 
There was a small statistically significant positive correlation between varicella knowledge 
scores and age with knowledge increasing with age (Table 4.119). Also, there was a medium 
statistically significant positive correlation between varicella knowledge and years of 
experience in health care institutions, with varicella knowledge increasing with years of 
experience. 
Varicella knowledge score among HCWs N Spearman's 
rho correlation 
P value 
Age 315 0.17 0.002 
Time spent in formal education 315 -0.08 0.14 
Years of experience in health care institutions 315 0.43 <0.001 
Table 4.119: Correlation between varicella knowledge score and sociodemographic 
characteristics-HCWs 
  
  
193 
The non-Saudis and non-Muslims were more significantly knowledgeable about varicella. 
However, there was no significant association in the varicella knowledge score by sex, marital 
status and level of education (Table 4.120). 
Characteristics N(%) 
Varicella knowledge score  
P value*  (33 questions) 
Median(IQR) 
Sex    0.43 
Male 124(39.4%) 18.0(13.0–22.7) 
Female 191(60.6%) 19.0(13.0-23.0) 
Nationality    <0.001 
Saudi 165(52.4%) 16.0(10.5-19.0) 
Non-Saudi 150(47.6%) 22.0(15.8-20.0) 
Religion    <0.001 
Muslim 223(70.8%) 17.0(12.0-21.0) 
Non-Muslim 92(29.2%) 22.0(20.0–25.0) 
Marital status    0.19 
Single  198(62.9%) 18.0(13.0–22.0) 
Ever married 117(37.1%) 19.0(14.0–24.0) 
Education level   0.10 
Under graduate 268(85.1%) 18.5(13–22.0) 
Post graduate 47(14.9%) 19.0(15.0-24.0) 
Table 4.120: Varicella knowledge score and sociodemographic characteristics-
HCWs(N=315) 
*Based on Mann-Whitney U test 
Varicella knowledge score and occupational characteristics 
There was a significant association between varicella knowledge score and locations of service 
practise (Table 4.121). Those who were working in PHCs had the highest score, while those in 
KSAU-HS reported the lowest. A significant association between varicella knowledge score 
and occupation was reported. The highest such score was recorded by nurses then physicians, 
while the lowest by administrators. The varicella knowledge score was significantly associated 
with speciality, it was considerably higher among those who work in nursing services compared 
with administrative and technical support services. HCWs also scored differently in varicella 
knowledge according to their position; staff nurses had a higher score of varicella knowledge 
followed by specialist physicians and then staff physicians. 
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Characteristics N(%) 
Varicella knowledge 
score P 
value * (33 questions) 
Median(IQR) 
Practise location   <0.001 
KKH 191(60.6%) 19.0(15.0-23.0) 
KSAU-HS 66(21.0%) 15.0(8.0-20.0) 
PHCs 58(18.4%) 19.5(15.75-24.25) 
Occupation   <0.001 
Physician 70(22.2%) 20.0(16.0-24.0) 
Nurse 99(31.4%) 22.0(17.0-25.0) 
Medical specialist/Technician 75(23.8%) 17.0(13.0-21.0) 
Admin 71(22.5%) 13.0(5.0-18.0) 
Speciality   <0.001 
Clinical services 116(36.8%) 20.0(16.2-23.7) 
Administrative/Technical support 69(21.9%) 13.0(5.0-18.00) 
Nursing services 63(20.0%) 22.0(18.0-25.0) 
Pathology/laboratory 42(13.3%) 17.5(13.0-21.5) 
Ancillary medical services 25(7.9%) 16.0(10.5-22.0) 
Position   <0.001 
Staff nurse 86(27.3%) 22.0(17.0-25.0) 
Admin/Technician assistant 97(30.8%) 16.0(7.0-20.0) 
Specialist 39(12.4%) 16.0(12.0-19.0) 
Staff physician 35(11.1%) 19.0(17.0-24.0) 
Academic staff 33(10.5%) 16.0(8.5-22.5) 
Specialist physician 25(7.9%) 21.0(15.0-25.0) 
Table 4.121: Varicella knowledge score and occupational characteristics-HCWs(N=315) 
*Based on Kruskal Wallis test 
Varicella knowledge score and sources of information 
Those who had enough information about varicella had higher varicella knowledge scores than 
those who did not have sufficient information (Table 4.122). Those whose source of 
information was families scored a lower median knowledge score than those whose information 
was education-based. Additionally, better knowledge scores were observed among those who 
reported education as the main source of information about varicella. However, no significant 
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association was reported between median varicella knowledge score and obtaining information 
about varicella through TV/Radio, newspapers/magazines, colleagues or the internet. 
The source of varicella 
knowledge 
N(%) 
Varicella knowledge score  
P value  (33 questions) 
Median(IQR) 
Have information about 
varicella?(N=315) 
  
<0.001* 
Yes, enough(as perceived by the 
participant) 
117(37.1%) 21.0(17.0-25.0) 
Yes, but it is not enough 165(52.4%) 18.0(13.0-22.0) 
No 33(10.5%) 5.0(0.0–12.0) 
TV/Radio(N=282)   0.35** 
Yes 45(16.0%) 21.0(16.5-23.0) 
No 237(84.0%) 19.0(15.0-23.0) 
Newspapers/Magazines(N=282)   0.07** 
Yes 50(17.7%) 22.0(15.7-25.0) 
No 232(82.3%) 19.0(15.0-23.0) 
Education(N=282)    <0.001** 
Yes 231(81.9%) 20.0(16.0-24.0) 
No 51(18.1%) 15.0(9.0-20.0) 
Colleagues(N=282)   0.24** 
Yes 78(27.7%) 20.0(17.0-24.0) 
No 204(72.3%) 19.0(15.0-23.0) 
Families(N=282)   0.004** 
Yes 81(28.7%) 18.0(13.0-21.0) 
No 201(71.3%) 20.0(16.0-24.0) 
Internet(N=282)   0.42** 
Yes 126(44.7%) 20.0(15.7-24.0) 
No 156(55.3%) 19.0(15.0-23.0) 
Table 4.122: Varicella knowledge score and the source of knowledge-HCWs 
*Based on Kruskal Wallis test ** Based on Mann-Whitney U test 
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Varicella knowledge score among health care workers tested for varicella, exposure or 
have immunity against varicella 
Significantly higher scores in median varicella knowledge score were recorded among those 
who tested for immunity or received regular doses (Table 4.123). 
Characteristics  N(%) 
Varicella 
knowledge score  P 
value* (33 questions) 
Median(IQR) 
Tested for immune status against 
varicella?(N=315) 
  
<0.001 
Yes 71(22.5%) 22.0(17.0-24.0) 
No or not sure 244(77.5%) 18.0(13.0-22.0) 
Regular varicella vaccine doses were 
received(N=111) 
  
<0.001 
Regular on time 42(37.8%) 23.0(21.0-25.0) 
Not regular 69(62.2%) 19.0(14.5-23.0) 
Immunity against varicella(N=315)   0.18 
Negative 63(80.0%) 13.5(7.7-17.0) 
Positive 252(20.0%) 16.0(11.0-19.0) 
Table 4.123: Varicella knowledge score among HCWs tested for varicella, exposure or 
have immunity against varicella 
* Based on Mann-Whitney U test 
Potential predictors of varicella knowledge  
Table 4.124 displays the results of a multiple linear regression model investigating the potential 
predicators of varicella knowledge. Variables included in the initial model are; age, years of 
experience (Table 4.119); nationality and religion(Table 4.120) practise location, occupation, 
specialty, position (Table 4.121); having information about varicella , source of knowledge as 
education or family (Table 4.122), and testing for immune status against varicella (Table 4.123). 
The model with all included variables explained 29.1% of the variance in varicella knowledge. 
As shown in Table 4.124, non-Muslims were more likely to have a better knowledge score 
about varicella than Muslim HCWs and scored 3.66 points higher in knowledge. Additionally, 
those HCWs working as medical specialists & technicians had an average lower knowledge 
score compared to those working as physicians at -2.40 points lower. Those HCWs who 
specialised in administrative technical support services were significantly more likely to have 
lower knowledge scores compared to those working in clinical services at -3.55 points. Also, 
those who reported having information about varicella but not enough were significantly higher 
in varicella knowledge and scored 2.4 points higher in knowledge. 
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Variables determining varicella seroimmunity of HCWs after adjustment for confounders were 
investigated, with the religion variable considered a confounder to occupation and speciality 
variables. However, occupation, speciality and having information about varicella variables 
were not affected, therefore being able to determine varicella knowledge of HCWs. 
The interaction between religion and occupation indicated that non-Muslims had much higher 
scores of varicella knowledge at 6.40 points among medical specialist & technician. 
Conversely, the interaction between religion and speciality indicated that non-Muslims had 
much lower scores (-6.93) among administrative technical support services. 
Furthermore, the interaction between speciality and having information about varicella 
indicated that those working in administrative technical support services had much lower scores 
(-6.00) when not having enough information. 
Variable* 
Coefficients 
B 
95%C.I for B P value 
Constant 17.97 16.84 19.10 <0.001 
Religion- 
Non-Muslim(ref Muslim) 
3.66 2.35 4.98 <0.001 
Occupation– 
Medical Specialist/Technician (ref 
Physician) 
-2.40 -3.84 -0.95 0.001 
Speciality– 
Administrative technical support 
(ref Clinical Services) 
-3.55 -5.47 -1.63 <0.001 
Do you think that you have 
information about varicella?-  
Not enough (enough is ref) 
2.45 1.23 3.67 <0.001 
Table 4.124: Independent determinants of varicella knowledge score-HCWs(N=282). 
* Multiple linear regression 
4.5.3 Concern and attitude about varicella 
Over three quarters agreed that varicella is a serious disease (Table 4.125). Additionally, about 
four fifths agreed that the varicella vaccination should be compulsory for HCWs and also to 
avoid infecting employees not previously infected. Furthermore, about four fifths of HCWs 
agreed that family members and colleagues should be vaccinated if not already immune. Few 
participants endorsed dealing with varicella-infected colleagues in a health care centre as 
normal, while almost two thirds indicated that they would deal with them carefully. Almost a 
fifth reported that they would not deal with varicella -infected people. 
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Statement Degree of agreement N % 
Varicella is a serious disease 
Agree 221 70.2 
Neutral 78 24.8 
Disagree 16 5.1 
Varicella vaccination should be made 
compulsory for HCWs 
Agree 256 81.3 
Neutral 51 16.2 
Disagree 8 2.5 
It is important for an employee who was 
not infected by varicella before, to be 
vaccinated 
Agree 261 82.9 
Neutral 47 14.9 
Disagree 7 2.2 
It is recommended for family members 
and colleagues to be vaccinated if they 
were not immune 
Agree 254 80.6 
Neutral 49 15.6 
Disagree 12 3.8 
If a varicella infected person works with 
you in a health care centre, you will deal 
with him 
Normally 47 14.9 
Carefully 199 63.2 
I won’t deal with him 63 20.0 
I don't know 6 1.9 
Table 4.125: Participants’ concern and attitude towards the varicella and varicella -
infected colleagues-HCWs(N=315) 
Concerns and attitudes about varicella and sociodemographic characteristics  
There was a small, positive correlation between age and those who said varicella is a serious 
disease; the older the respondent, the more the agreement (Table 4.126). Moreover, there was 
a small, negative correlation between time spent in formal education and those who said 
varicella vaccination should be compulsory for HCWs; the more years, the less agreement. The 
correlation was also small negative between period spent in formal education and the 
recommendation that varicella infection-free HCWs should be vaccinated; the longer, the less 
the agreement. Also, there was a small negative correlation between period spent in formal 
education and the recommendation that non-immune family members and colleagues should be 
vaccinated; the longer, the less the agreement. Furthermore, there was a small, positive 
correlation between experience in health institutions and those who stated varicella was a 
serious disease, as years of experience increases, the more the agreement. 
There was a small, positive correlation between varicella knowledge and those believing it a 
serious disease; agreement increasing with the varicella knowledge score. Moreover, there was 
a small, positive correlation between varicella knowledge and those suggesting vaccination 
should be compulsory for HCWs; agreement increasing with the knowledge score. Also, there 
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was a small, positive correlation between varicella knowledge and those stating it to be 
important for an employee not previously infected to be vaccinated; the agreement increasing 
with the varicella knowledge score. Furthermore, there was a small, positive correlation 
between varicella knowledge and the recommendation that non-immune family members and 
colleagues should be vaccinated; the agreement increasing with the varicella knowledge score. 
A majority of non-Saudis and non-Muslims agreed varicella is a serious disease and this 
association between nationality, agreement and religion was statistically significant 
(Table 4.127). Similarly, a majority of non-Saudis, non-Muslims and undergraduates agreed 
that the vaccination be made compulsory for HCWs, and this association between nationality 
and agreement, between religion and agreement, and between education level and agreement 
are each statistically significant. A majority of non-Muslims and undergraduates recommended 
varicella infection-free employees be vaccinated; this association between religion and 
recommendation being statistically significant (Table 4.128). The majority of non-Saudis 
believed family members and colleagues should be vaccinated if they were not immune; this 
association was statistically significant. Additionally, a majority of non-Muslims and 
undergraduates recommended that family members and colleagues should be vaccinated if they 
were not immune and this association between religion and recommendation, and education 
level was statistically significant. 
Concerns and attitudes about varicella and occupational characteristics  
 
Most nurses, those specialised in nursing services and those who work as staff nurses agreed 
that varicella is a serious disease; this association between occupation and agreement, and 
speciality, and position was statistically significant (Table 4.129). Additionally, the same 
grouping agreed that the vaccination should be compulsory for HCWs and this association 
between occupation and agreement, and speciality, and position were each statistically 
significant. 
Furthermore, a majority of nurses, those specialised in nursing services and those who work as 
staff nurses recommended varicella infection-free employees be vaccinated; this association 
between occupation and recommendation, and speciality, and position were each statistically 
significant. The same grouping recommended that family members and colleagues should be 
vaccinated if not immune; this association between occupation and recommendation, and 
speciality, and position were each statistically significant Table 4.130.
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Participants’ concern and attitude  
Varicella is a 
serious disease 
Varicella vaccination 
should be made 
compulsory for 
HCWs 
Important for an 
employee who was not 
infected by varicella 
before, to be vaccinated 
Family members and 
colleagues should be 
vaccinated if they were not 
immune 
Age 
Correlation* 0.13 0.008 -0.07 -0.01 
P value 0.01 0.88 0.21 0.74 
Time spent in 
formal education 
Correlation* -0.08 -0.22 -0.24 -0.25 
P value 0.12 <0.001 <0.001 <0.001 
Experience in 
health institutions 
Correlation* 0.22 0.09 0.04 0.04 
P value <0.001 0.08 0.46 0.44 
Varicella 
knowledge score  
Correlation* 0.21 0.16 0.18 0.20 
P value <0.001 0.003 <0.001 <0.001 
Table 4.126: Correlation between participants’ concern and attitude towards the varicella and varicella -infected colleagues and 
sociodemographic characteristics-HCWs(N=315) 
*Based on Spearman's rho correlation 
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Characteristics N 
Varicella is a serious disease 
P-Value*  
Varicella vaccination should be made 
compulsory for HCWs 
P-Value * 
Disagree or Neutral Agree Disagree or Neutral Agree 
Sex    0.70*   0.11* 
Male 124 39(31.5%) 85(68.5%) 29(23.4%) 95(76.6%) 
Female  191 55(28.8%) 136(71.2%) 30(15.7%) 161(84.3%) 
Nationality    <0.001*   0.01* 
Saudi 165 68(41.2%) 97(58.8%) 40(24.2%) 125(75.8%) 
Non-Saudi 150 26(17.3%) 124(82.7%) 19(12.7%) 131(87.3%) 
Religion     <0.001*   0.002* 
Muslim 223 83(37.2%) 140(62.8%) 52(23.3%) 171(76.7%) 
Non-Muslim 92 11(12.0%) 81(88.0%) 7(7.6%) 85(92.4%) 
Marital status    0.38*   0.98* 
Single 198 63(31.8%) 135(68.2%) 37(18.7%) 161(81.3%) 
Ever married 117 31(26.5%) 86(73.5%) 22(18.8%) 95(81.2%) 
Education level     0.99*   0.04* 
Under graduate 268 80(29.9%) 188(70.1%) 45(16.8%) 223(83.2%) 
Post graduate 47 14(29.8%) 33(70.2%) 14(29.8%) 33(70.2%) 
Table 4.127: Association between participants’ concern and attitude towards the varicella and varicella -infected colleagues and 
sociodemographic characteristics-HCWs(N=315)(a) 
*Based on Continuity Correction   
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Characteristics  N 
 Important for an employee who was not 
infected by varicella before, to be vaccinated 
P-Value * 
 Family members and colleagues should 
be vaccinated if they were not immune P-Value 
* 
Disagree or Neutral Agree Disagree or Neutral Agree 
Sex    0.19*   0.058* 
Male 124 26(21.0%) 98(79.0%) 31(25.0%) 93(75.0%) 
Female  191 28(14.7%) 163(85.3%) 30(15.7%) 161(84.3%) 
Nationality    0.06*   0.01* 
Saudi 165 35(21.2%) 130(78.8%) 41(24.8%) 124(75.2%) 
Non-Saudi 150 19(12.7%) 131(88.0%) 20(13.3%) 130(86.7%) 
Religion     0.01*   0.003* 
Muslim 223 46(20.6%) 177(79.4%) 53(23.8%) 170(76.2%) 
Non-Muslim 92 8(8.7%) 84(91.3%) 8(8.7%) 84(91.3%) 
Marital status    0.65*   0.58* 
Single 198 32(16.2%) 166(83.8%) 36(18.2%) 162(81.8%) 
Ever married 117 22(18.8%) 95(81.2%) 25(21.4%) 92(78.6%) 
Education level    <0.001*   0.01* 
Under graduate 268 36(13.4%) 232(86.6%) 45(16.8%) 223(83.2%) 
Post graduate 47 18(38.3%) 29(61.7%) 16(34.0%) 31(66.0%) 
Table 4.128: Association between participants’ concern and attitude towards the varicella and varicella -infected colleagues and 
sociodemographic characteristics-HCWs(N=315)(b) 
*Based on Continuity Correction   
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Characteristics  N 
Varicella is a serious disease 
P-Value*  
Varicella vaccination should be 
made compulsory for HCWs P-Value * 
Disagree or neutral Agree Disagree or neutral Agree 
Practise location    0.19   0.9 
KKH 191 58(30.4%) 133(69.6%) 40(20.9%) 151(79.1%) 
KSAU-HS 66 22(33.3%) 44(66.7%) 13(19.7%) 53(80.3%) 
PHCs 58 14(24.1%) 44(75.9%) 6(10.3%) 52(89.7%) 
Occupation    <0.001   0.003 
Physician 70 16(22.9%) 54(77.1%) 17(24.3%) 53(75.7%) 
Nurse 99 16(16.2%) 83(83.8%) 7(7.1%) 92(92.9%) 
Specialist/Technician 75 33(44.0%) 42(56.0%) 16(21.3%) 59(78.7%) 
Admin 71 29(40.8%) 42(59.2%) 19(26.8%) 52(73.2%) 
Speciality    <0.001   0.01** 
Clinical services 116 26(22.4%) 90(77.6%) 22(19.0%) 94(81.0%) 
Administrative/Technical  69 28(40.6%) 41(59.4%) 18(26.1%) 51(73.9%) 
Nursing services 63 10(15.9%) 53(84.1%) 4(6.3%) 59(93.7%) 
Pathology/laboratory 42 16(38.1%) 26(61.9%) 8 (19.0%) 34(81.0%) 
Ancillary medical services 25 14(56.0%) 11(44.0%) 7(28.0%) 18(72.0%) 
Position    <0.001   0.002** 
Staff nurse 86 14(16.3%) 72(83.7%) 7(8.1%) 79(91.9%) 
Admin/Technician  97 32(33.0%) 65(67.0%) 18(18.6%) 79(81.4%) 
Specialist 39 27(69.2%) 12(30.8%) 15(38.5%) 24(61.5%) 
Staff physician 35 8(22.9%) 27(77.1% 7(20.0%) 28(80.0%) 
Academic staff 33 6(18.2%) 27(81.8%) 5(15.2%) 28(84.8%) 
Specialist physician 25 7(28.0%) 18(72.0%) 7(28.0%) 18(72.0%) 
Table 4.129: Association between participants’ concern and attitude towards the varicella and varicella -infected colleagues and occupational 
characteristics-HCWs(N=315)(a) 
*Based on Chi-Square Monte Carlo method,** Based on Fisher’s Exact test in Monte Carlo method  
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Characteristics  N 
 Important for an employee who was not 
infected before, to be vaccinated 
P-
Value
 * 
 Family members and colleagues should 
be vaccinated if they were not immune 
P-
Value
 * Disagree or neutral Agree Disagree or neutral Agree 
Practise location    0.1   0.52 
KKH 191 37(19.4%) 154(80.6%) 41(21.5%) 150(78.5%) 
KSAU-HS 66 12(18.2%) 54(81.8%) 11(16.7%) 55(83.3%) 
PHCs 58 5(8.6%) 53(91.4%) 9(15.5%) 49(84.5%) 
Occupation    0.01   0.002* 
Physician 70 18(25.7%) 52(74.3%) 21(30.0%) 49(70.0%) 
Nurse 99 8(8.1%) 91(91.9%) 8(8.1%) 91(91.9%) 
Specialist/Technician 75 13(17.3%) 62(82.7%) 16(21.3%) 59(78.7%) 
Admin 71 15(21.1%) 56(78.9%) 16(22.5%) 55(77.5%) 
Speciality    0.08**   0.003*
* Clinical services 116 23(19.8%) 93(80.2%) 29(25.0%) 87(75.0%) 
Administrative/Technical  69 14(20.3%) 55(79.7%) 15(21.7%) 54(78.3%) 
Nursing services 63 4(6.3%) 59(93.7%) 3(4.8%) 60(95.2%) 
Pathology/laboratory 42 7(16.7%) 35(83.3%) 6(14.3%) 36(85.7%) 
Ancillary medical services 25 6(24.0%) 19(76.0%) 8(32.0%) 17(68.0%) 
Position    0.004*
* 
  <0.001
** Staff nurse 86 7(8.1%) 79(91.9%) 6(7.0%) 80(93.0%) 
Admin/technician  97 15(15.5%) 82(84.5%) 16(16.5%) 81(83.5%) 
Specialist 39 12(30.8%) 27(69.2%) 15(38.5%) 24(61.5%) 
Staff physician 35 7(20.0%) 28(80.0%) 10(28.6%) 25(71.4%) 
Academic staff 33 4(12.1%) 29(87.9%) 5(15.2%) 28(84.8%) 
Specialist physician 25 9(36.0%) 16(64.0%) 9(36.0%) 16(64.0%) 
Table 4.130: Association between participants’ concern and attitude towards the varicella and varicella -infected colleagues and occupational 
characteristics-HCWs(N=315)(b) 
*Based on Chi-Square Monte Carlo method,**Based on Fisher’s Exact test in Monte Carlo method 
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4.5.4 Summary of varicella serology results among health care workers who completed the 
questionnaire 
Seroprevalence and clinical interpretations of varicella  
About a fifth did not have serological evidence of immunity against varicella, possibly due to 
a lack of a specific immune response to immunisation or no prior exposure to the varicella 
zoster virus (Table 4.131). 
Serology test Result N  (95%C.I) Interpretation  
IgG Varicella Negative 63(20.0%) (16.0-24.8) 
1-Might be lack of a specific 
immune response to 
immunisation. 
2-Might be no prior exposure to 
the varicella zoster virus. 
IgG Varicella Positive 252(80.0%) (75.2-84.0) 
Prior exposure to the varicella 
zoster virus through infection or 
possible immunisation. 
Table 4.131: Clinical interpretation of varicella (N=315) 
Seroprevalence of varicella antibodies and associated variables 
Varicella seroimmunity and sociodemographic characteristics 
No statistically significant association was found between varicella seroimmunity among 
HCWs and age, years of work experience, formal education, nationality, religion, sex, marital 
status or level of education (Table 4.132). 
Varicella seroimmunity and occupational characteristics 
The odds of IgG varicella seropositivity among those working in the KSAU-HS was three times 
higher than those working in the KKH, however, no association was found between IgG 
varicella and occupation, speciality and position (Table 4.133). 
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Characteristics 
Cross tabulation 
Univariate analysis Negative 
IgG 
Varicella 
(N=63) 
Positive 
IgG 
Varicella 
(N=252) 
Overall 
N 
OR(95%CI) LRT-P 
Age in category(Years)     0.17 
<25 14 61 75 Reference 
25-30 32 118 150 1.01(0.46-2.22) 
>30 17 73 90 0.85(0.44-1.65) 
Work 
experience(Years) 
    
0.07 
<1 12 63 75 Reference 
1-3 26 69 95 0.50(0.23-1.08) 
4-6 16 56 72 0.66(0.29-1.53) 
>6 9 64 73 1.35(0.53-3.43) 
Formal education 
(Years) 
    
0.48 
≤16 27 129 156 Reference 
17-18 20 71 91 0.74(0.38-1.41) 
≥19 16 52 68 0.68(0.33-1.36) 
Sex     0.95 
Male 25 99 124 Reference 
Female 38 153 191 1.01(0.57-1.78) 
Nationality      0.25 
Saudi 37 128 165 Reference 
Non-Saudi 26 124 150 1.37(0.78-2.41) 
Religion      0.28 
Muslim 48 175 223 Reference 
Non-Muslim 15 77 92 1.40(0.74-2.66) 
Marital Status      0.68 
Ever married 22 95 117 Reference 
Single 41 157 198 0.88(0.49-1.57) 
Education level      0.87 
Under graduate 54 214 268 Reference 
Post graduate 9 38 47 1.06(0.48-2.33) 
Table 4.132: Varicella seroimmunity and sociodemographic characteristics-
HCWs(N=315) 
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Characteristics 
Cross tabulation  Univariate analysis  
Negative 
IgG 
Varicella 
(N=63) 
Positive 
IgG 
Varicella 
(N=252) 
Overall 
N 
OR(95%CI) 
LRT-
P* 
Practise location     0.02 
KKH 46 145 191 Reference 
KSAU-HS 6 60 66 3.17(1.28-7.82) 
PHCs 11 47 58 1.35(0.65-2.82) 
Occupation      0.3 
Admin  18 53 71 Reference 
Physician 15 55 70 1.24(0.57-2.72) 
Nurse 20 79 99 1.34(0.64-2.77) 
Medical 
Specialist/Technician 
10 65 75 2.20(0.94-5.18) 
Speciality      0.13 
Clinical services 24 92 116 Reference 
Administrative/Technical 
Support services 
18 51 69 0.73(0.36-1.48) 
Nursing services 13 50 63 1.00(0.47-2.14) 
Pathology/laboratory 3 39 42 3.39(0.96-11.92) 
Ancillary medical 
Services 
5 20 25 1.04(0.35-3.06) 
Position      0.15 
Staff nurse 20 66 86 Reference 
Admin/technician 
Assistant 
22 75 97 1.03(0.51-2.06) 
specialist 5 34 39 2.06(0.71-5.97) 
Staff physician 8 27 35 1.02(0.40-2.60) 
Academic staff 2 31 33 4.69(1.03-21.36) 
Specialist physician 6 19 25 0.96(0.33-2.72) 
Table 4.133: Varicella seroimmunity among HCWs and occupational characteristics (N = 
315) 
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Potential predictors of varicella seroimmunity  
Table 4.134 shows the results of a logistic regression model investigating the potential 
predicators of varicella seroimmunity. Variables included in the initial model are; age in 
category and years of work experience (Table 4.132); practise location, and speciality and 
position (Table 4.133). The model as a whole explained 7.9% of the variance in seroimmunity 
IgG varicella. Hosmer and Lemeshow indicated that the model was a reasonable fit (P=0.98). 
Two of the studied variables (years of work experience and current location of practise) made 
a significant independent contribution to the model. Compared to those working in KKH, the 
odds of positive IgG varicella among those working in the KSAU-HS were higher - over three 
times. Variables determining varicella seroimmunity of HCWs were adjusted to confounders, 
those working in the KSAU-HS were considered as a unique variable that determine varicella 
seroimmunity. 
Variable* OR(95%CI) LRT-P 
Years of work experience(Years)  0.04 
<1 Reference 
1-3 0.58(0.26-1.26) 
4-6 0.78(0.33-1.82) 
>6 1.83(0.71-4.76) 
Practise location  0.01 
KKH Reference 
KSAU-HS 3.59(1.43-9.02) 
PHCs 1.41(0.67-2.98) 
Table 4.134: Independent determinants of varicella seroimmunity-HCWs(N=315) 
*Multiple logistic regression 
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4.5.5 Summary of varicella serology results among health care workers who were not given 
the questionnaire 
Seroprevalence and clinical interpretations of varicella 
The majority of the HCWs have positive sero-evidence of prior exposure to the varicella zoster 
virus through infection or possible immunisation (Table 4.135). 
Serology test Result N  (95%C.I) Interpretation  
IgG varicella Negative 576(14.4%) (13.3–15.5) 
1-Might be lack of a specific 
immune response to 
immunisation. 
2-Might be no prior exposure to 
the varicella zoster virus. 
IgG varicella Positive 3437(85.6%) (84.5–86.7) 
Prior exposure to the varicella 
zoster virus through infection or 
possible immunisation. 
Table 4.135: The laboratory results for varicella markers-HCWs(N=4013) 
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Seroprevalence of varicella antibodies and associated variables. 
Varicella seroimmunity and sociodemographic characteristics 
In comparison to those recruited from MER, the odds of positive IgG varicella among those 
from WPR were 70% lower, and among those from SEAR 54% lower. However, the odds of 
positive IgG varicella among those recruited from Europe were double in comparison to those 
from MER (Table 4.136). 
Characteristics Cross tabulation  Univariate analysis 
Negative 
IgG 
varicella 
(N=576) 
Positive 
IgG 
varicella 
(N=3437) 
Overall 
N 
OR(95%CI) LRT-P 
Sex     0.47 
Male  266 1532 1798 Reference 
Female  310 1905 2215 1.06(0.89-1.27) 
Nationality     0.34 
Saudi 288 1792 2080 Reference 
Non-Saudi 288 1645 1933 0.91(0.76-1.09) 
World region     <0.001 
MER  314 2059 2373 Reference 
WPR 210 995 1205 0.72(0.59-0.87) 
Europe 12 159 171 2.02(1.11-3.67) 
Africa 19 124 143 0.99(0.60-1.63) 
SEAR 19 68 87 0.54(0.32-0.92) 
Americas 2 32 34 2.44(0.58- 0.23) 
Table 4.136: Varicella seroimmunity and sociodemographic characteristics-
HCWs(N=4013) 
 
Varicella seroimmunity and occupational characteristics 
In comparison to those working in nursing jobs, the odds of positive IgG varicella among those 
working as physicians were 48% higher (Table 4.137 and Table 4.138). The odds of positive 
IgG varicella among those specialised in ancillary medical services and administrative services 
were 70% lower than those specialised in clinical services, however, the odds of positive IgG 
varicella among those specialised in pathology and laboratory medicine were three times higher 
than those specialised in clinical services. The odds of positive IgG varicella among those 
appointed in specialist physician positon were 73% higher than those who were appointed to 
staff nurse position.  
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Characteristics 
Cross tabulation analysis Univariate analysis 
Negative 
IgG 
varicella 
(N=1434) 
Positive 
IgG 
Varicella 
(N=2579) 
Total 
N 
OR(95%CI) LRT-P 
Practise location     0.18 
KKH 430 2682 3112 Reference 
KAMC not working in 
clinical  
128 671 799 0.84(0.67-1.04) 
PHCs 18 84 102 0.74(0.44-1.25) 
Occupation     0.02 
Nurse 214 1224 1438 Reference 
Physician 73 618 691 1.48(1.11-1.96) 
Medical specialist 85 472 557 0.97(0.73-1.27) 
Medical technician 82 477 559 1.01(0.77-1.34) 
Admin 122 646 768 0.92(0.72-1.17) 
Speciality     <0.001 
Clinical services 158 1085 1243 Reference 
Nursing services 161 923 1084 0.83(0.65-1.05) 
Ancillary medical 
services 
127 618 745 0.70(0.55-0.91) 
Administrative services 111 581 692 0.76(0.58-0.99) 
Pathology/laboratory 7 140 147 2.91(1.33-6.33) 
Technical services 12 90 102 1.09(0.58-2.04) 
Table 4.137: Varicella seroimmunity and occupational characteristics-HCWs(N=4013)(a) 
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Characteristics 
Cross tabulation analysis Univariate analysis 
Negative 
IgG 
varicella 
(N=1434) 
Positive 
IgG 
Varicella 
(N=2579) 
Total 
N 
OR(95%CI) LRT-P 
Position     0.001 
Staff Nurse 184 1092 1276 Reference 
Technician 88 515 603 0.98(0.74-0.29) 
Intern 75 342 417 0.76(0.57-1.03) 
Specialist Physician 34 349 383 1.73(1.17-2.54) 
Admin Assistant 58 257 315 0.74(0.53-1.03) 
Specialist 42 265 307 1.06(0.74-1.52) 
Assistant 43 236 279 0.92(0.64-1.32) 
Staff Physician 19 195 214 1.72(1.05-2.84) 
Information technician 9 85 94 1.59(0.78-3.21) 
Supervisory/leadership 14 65 79 0.78(0.43-1.42) 
Patient care technician 10 36 46 0.60(0.29-1.24) 
Table 4.138: Varicella seroimmunity and occupational characteristics-HCWs(N=4013)(b) 
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Potential predictors of varicella seroimmunity 
Table 4.139 shows results of a logistic regression model looking into the potential predicators 
of varicella seroimmunity. Variables included in the initial model are; world regional 
(Table 4.136); occupation, speciality, and position (Table 4.137 and Table 4.138). The model 
as a whole explained 3.8% of the variance in seroimmunity IgG varicella. Hosmer and 
Lemeshow indicated that the model was a reasonable fit (P=0.97). 
Three of the studied variables (WHO region, occupation and position) made a significant 
independent contribution to the model. The odds of positive IgG varicella among those from 
Europe were almost twice those from MER. Also, the odds of positive IgG varicella among 
those from WPR were 67% lower than from MER, additionally, the odds of positive IgG 
varicella among those from SEAR were 50% lower those from MER. 
The odds of positive IgG varicella among those specialised in pathology and laboratory 
medicine were five times higher than clinical services specialists. Meanwhile, the odds of 
positive IgG varicella among those appointed in technician position were 91% lower than staff 
nurses, however, the odds of positive IgG varicella among those appointed in specialist 
physician position were 45% higher than those who were appointed in staff nurse position. 
The highest odds of IgG varicella seroimmunity was among those who are specialised in 
pathology and laboratory medicine, indicated those who are specialised in pathology and 
laboratory medicine were over five times more likely to be immune against varicella than those 
who are specialised in clinical services, controlling for all other independent variables in the 
model. The interaction between world region of origin and speciality and between world region 
of origin and position were investigated, there being no significant interaction. 
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Variable* OR(95%CI) LRT-P 
WHO Region  <0.001 
MER Reference 
WPR 0.67(0.52-0.87) 
Europe 1.93(1.02-3.65) 
Africa 0.92(0.54-1.57) 
SEAR 0.50(0.29-0.86) 
Americas 2.38(0.56-10.11) 
Speciality  <0.001 
Clinical services Reference 
Nursing Services 1.12(0.83-1.52) 
Ancillary medical services 0.92(0.64 -1.32) 
Administrative services 1.44(0.81-2.57) 
Pathology/laboratory 5.11(2.26-11.52) 
Technical Support Services 0.30 (0.07-1.32) 
Position  <0.001 
Staff Nurse Reference 
Technician 0.91(0.61-1.36) 
Intern 0.52(0.33-0.81) 
Specialist Physician 1.45(0.89-2.38) 
Admin Assistant 0.50(0.26-0.96) 
Specialist 1.03(0.60-1.75) 
Assistant 0.61(0.33-1.16) 
Staff physician 1.50(0.84-2.68) 
Information technician 5.04(0.95-26.72) 
Supervisory/leadership 0.51(0.24-1.05) 
Patient care technician 0.64(0.31-1.32) 
Table 4.139: Independent determinants of IgG varicella seroimmunity-HCWs(N=4013) 
*Multiple logistic regression. 
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4.6 Assessment Participation Bias in the Questionnaire Surveys 
In terms of occupation type, there was a quite small significant difference between those who 
participated in the questionnaire and those who did not. For immunity against measles, there 
was a high measles IgG positivity among those who completed the questionnaire. Additionally, 
there was a high varicella IgG negativity among those who participated in the questionnaire 
Table 4.140  
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Characteristics Participated in the questionnaire Overall 
N 
P-Value  
 No (N=4013) Yes (N=315) 
Sex   0.07* 
Female 2215(92.1%) 191(7.9%) 2406 
Male 1798(93.5%) 124(6.5%) 1922  
Nationality   0.89* 
Saudi 2080(92.7%) 165(7.3%) 2245 
Non-Saudi 1933(92.8%) 150(7.2%) 2083 
Occupation   0.03** 
Physician 691(90.8%) 70(9.2%) 761 
Nurse 1438(93.6%) 99(6.4%) 1537 
Medical Specialist / Technician 1116(93.7%) 75(6.3%) 1191 
Admin 768(91.5%) 71(8.5%) 839 
HbsAg   0.64*** 
Negative 3996(92.7%) 313(7.3%) 4309 
Positive 17(89.5%) 2(10.5%) 19 
HbcAb   0.17* 
Negative 3721(92.6%) 299(7.4%) 156  
Positive 292(94.8%) 16(5.2%) 91  
HbsAb   0.23* 
Negative 994(91.9%) 88(8.1%) 1082 
Positive 3019(93.0%) 227(7.0%) 3246 
IgG Measles  0.001* 
Negative 1434(96.4%) 54(3.6%) 1488 
Positive 2579(90.8%) 261(9.2%) 2840 
IgG Varicella  0.008* 
Negative 576(90.1%) 63(9.9%) 639 
Positive 3437(93.2%) 252(6.8%) 3689 
Table 4.140:Participation bias in the questionnaire surveys among those who completed 
questionnaire and those for whom only serology data available-HCWs (N=4328) 
* Based on Continuity Correction ** Based on Pearson Chi-Square *** Based on Fisher's Exact Test 
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4.7 Integration of Findings across the Three Diseases 
Among those participating in the questionnaire, the odds of positive IgG varicella among HCWs 
who were immunised against HBV and measles were double, as were the odds of positive 
HBsAb and IgG measles among those who were immunised against varicella. Among those 
who did not participate in the questionnaire, the odds of positive varicella among HCWs, who 
were immunised against measles, was 24% higher and the odds of positive measles was 24% 
higher among those who were immunised against varicella, (Table 4.141,Table 4.142 and 
Table 4.143). 
Variable* 
Completed the questionnaire(N=315) Not given the questionnaire(N=4013) 
OR(95%CI) LRT-P OR(95%CI) LRT-P 
IgG Measles  0.27  0.07 
Negative Reference Reference 
Positive 1.42(0.75-2.69) 1.14(0.98-1.32) 
IgG Varicella  0.003  0.62 
Negative Reference Reference 
Positive 2.42(1.35-4.34) 1.05(0.85-1.28) 
Table 4.141:Immune status against measles and varicella if an individual had been 
immunised against HBV among HCWs 
*Multiple logistic regression 
 
Variable* 
Completed the questionnaire(N=315) Not given the questionnaire(N=4013) 
OR(95%CI) LRT-P OR(95%CI) LRT-P 
HBsAb  0.27  0.07 
Negative Reference Reference 
Positive 1.42(0.75-2.69) 1.14(0.98-1.32) 
IgG Varicella  0.007  0.01 
Negative Reference Reference 
Positive 2.49(1.29-4.82) 1.24(1.03-1.48) 
Table 4.142:Immune status against HBV and varicella if an individual had been 
immunised against measles among HCWs 
*Multiple logistic regression 
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Variable* 
Completed the questionnaire(N=315) Not given the questionnaire(N=4013) 
OR(95%CI) LRT-P OR(95%CI) LRT-P 
HBsAb  0.003  0.62 
Negative Reference Reference 
Positive 2.42(1.35-4.34) 1.05(0.85-1.28) 
IgG 
Measles 
 
0.007  0.01 
Negative Reference Reference 
Positive 2.49(1.29-4.82) 1.24(1.03-1.48) 
Table 4.143:Immune status against HBV and measles if an individual had been 
immunised against varicella among HCWs 
*Multiple logistic regression 
 
 
Among those who participated in the questionnaire, those who were immunised against HBV 
had knowledge scorings almost three points higher in measles and varicella knowledge. 
Additionally, those who were immunised against HBV and measles were nine and almost six 
points higher in total knowledge. However, those who were immunised against varicella had 
scores five points lower in total knowledge, (Table 4.144, Table 4.145, Table 4.146, 
Table 4.147). 
Variable* Coefficients B 95%C.I for B* P value 
Constant 28.51 25.90 31.12 <0.001 
IgG Measles – Positive 1.65 -0.75 4.06 0.17 
IgG Varicella - Positive -0.38 -2.65 1.87 0.73 
Table 4.144:Knowledge of HBV and immune status about measles and varicella among 
those who completed the questionnaire -HCWs(N=315). 
*Multiple linear regression 
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Variable* Coefficients B 95%C.I for B* P value 
Constant 13.29 11.57 15.01 <0.001 
HBsAb – Positive 2.84 1.32 4.35 <0.001 
IgG Varicella - Positive -1.59 -3.30 0.10 0.06 
Table 4.145:Knowledge of measles and immune status about HBV and varicella among 
those who completed the questionnaire -HCWs(N=315). 
*Multiple linear regression 
 
Variable* Coefficients B 95%C.I for B* P value 
Constant 14.00 11.84 16.17 <0.001 
HBsAb – Positive 2.81 1.07 4.54 0.002 
IgG Measles - Positive 1.69 -0.36 3.75 0.10 
Table 4.146:Knowledge of varicella and immune status about HBV and measles among 
those who completed the questionnaire -HCWs(N=315). 
*Multiple linear regression 
 
Variable* Coefficients B 95%C.I for B* P value 
Constant 53.92 47.48 60.37 <0.001 
HBsAb – Positive 9.25 4.58 13.91 <0.001 
IgG Measles - Positive 5.69 0.15 11.24 0.04 
IgG Varicella - Positive -5.30 -10.59 -0.01 0.04 
Table 4.147:Total knowledge and immune status about HBV, measles and varicella 
among those who completed the questionnaire -HCWs(N=315). 
*Multiple linear regression 
 
Among those participating in the questionnaire, those who scored above the median in measles 
knowledge scored 1.59 points lower in varicella knowledge and those who scored above the 
median in varicella knowledge were 0.91 points higher in measles knowledge, ( Table 4.148, 
Table 4.149 and Table 4.150) 
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Variable* Coefficients B 95%C.I for B* P value 
Constant 16.65 14.87 18.43 <0.001 
Knowledge score about measles 0.68 0.48 0.88 <0.001 
Knowledge score about varicella 0.18 0.01 0.36 0.03 
Table 4.148:knowledge of HBV and potential association of knowledge score to measles 
and varicella among those who completed the questionnaire -HCWs(N=315). 
*Multiple linear regression 
 
Variable* Coefficients B 95%C.I for B* P value 
Constant -1.88 -3.19 -0.57 <0.001 
Knowledge score about HBV 0.18 0.12 0.23 <0.001 
Knowledge score about varicella -1.59 0.54 0.66 <0.001 
Table 4.149:knowledge of measles and potential association of knowledge score to HBV 
and varicella among those who completed the questionnaire -HCWs(N=315). 
*Multiple linear regression 
 
Variable* Coefficients B 95%C.I for B* P value 
Constant 2.41 0.81 4.02 0.003 
Knowledge score about HBV 0.07 0.005 0.14 0.03 
Knowledge score about measles 0.91 0.81 1.00 <0.001 
Table 4.150:knowledge of varicella and potential association of knowledge score to HBV 
and measles among those who completed the questionnaire-HCWs(N=315). 
*Multiple linear regression 
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Chapter 5. Results-Quantitative Research-Military Soldiers 
Findings about HBV, measles, and varicella among soldiers are presented in this chapter. 
Characteristics of the study group (military soldiers), their previous health histories in relation 
to the aforementioned diseases, the respondents' knowledge about each disease, as well as their 
concerns and perspectives towards such diseases and people infected by them are also reported. 
It also includes each of the above diseases' seroprevalence among participants who completed 
the questionnaire and those who did not. Each sub section first describes the participants' 
characteristics and their response rate before moving to detail results for each of this study's 
phases. 
 
5.1 Characteristics of the Studied Military Soldiers 
 
5.1.1 Sociodemographic characteristics 
A total of 409 soldiers were enrolled into the study (Table 5.1). The median age of the 
respondents was 23 (inter-quartile range 22-25) at age range 18-32. The median time that 
participants spent in formal education was 12 years (inter-quartile range 12-13) with a range of 
12-16. About two fifths of the respondents were aged 22-24, almost a quarter of them aged 21 
or less and the remainder aged up to 32. Additionally, about half spent 12 years in formal 
education and the majority have no previous experience in the military field. 
The majority were single, two thirds of them were secondary school degree holders, and this 
fraction represented participants holding the highest level of qualification in this group. 
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Characteristics N % 
 Age(Years)   
≤21 102 24.9 
22-24 165 40.3 
≥25 142 34.7 
Time spent in formal education(Years)    
≤12 232 56.7 
≥13 177 43.3 
Experience in military field(Years)   
<1 or No experience 381 93.2 
One 28 6.8 
Marital Status    
Single 337 82.4 
Married 65 15.9 
Divorced 7 1.7 
Highest level of Education      
Secondary school 273 66.7 
Diploma* 136 33.3 
Table 5.1: Sociodemographic characteristics-Soldiers(N=409) 
*Diploma: one to two years training after the secondary school 
Nearly four fifths of the recruited soldiers were born in WR KSA (Jeddah, Madinah, Makkah 
and Taif) where SANG mainly provides health services (Table 5.2). About a quarter were 
Jeddah, then Madinah and Makkah. The largest group of those born outside WR were born in 
Riyadh. 
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Birth Region N % 
Jeddah 108 26.4 
Madinah 80 19.6 
Makkah 74 18.1 
Taif 64 15.6 
Riyadh 12 2.9 
Asir 11 2.7 
Tabuk 10 2.4 
Baha 9 2.2 
Jazan 9 2.2 
Eastern 8 2.0 
Qunfotha 8 2.0 
Najran 7 1.7 
 Others* 9 2.2 
Table 5.2: Places of birth based on health regions-Soldiers(N=409) 
*Others (N): Bisha(4), Hail(4), Qassim(1). 
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5.2 Hepatitis B among Soldiers 
 
5.2.1 Previous hepatitis B related health history 
Previous investigation for HBV 
Almost three quarters were sure they had not been previously investigated, while the rest that 
they had been screened or were unsure (Table 5.3). Out of those who were sure, nearly all 
indicated that they had been informed that they were not carrying the disease and only two 
soldiers were infected. Almost two thirds of the HBV screening tests were in SMOH, and the 
others MNG-HA. 
Investigation against HBV  N % 
Previous investigation against HBV(N=409)     
Yes 27 6.6 
No 316 77.3 
Not sure 66 16.1 
Results of investigations against HBV(N=27)     
Not infected 22 81.5 
Infected 2 7.4 
Not sure 3 11.1 
Place at which investigations were done(N=27)     
SMOH 16 59.3 
MNG-HA 9 33.3 
Private hospital 2 7.4 
Table 5.3: Investigations against HBV-Soldiers 
 
Nearly three quarters of the soldiers were sure that their immune status was not previously 
investigated, while the rest were checked or uncertain (Table 5.4). Of those who were sure, 
more than half indicated that they had been informed that they were immune against the disease. 
Almost three quarters of the investigations were done by SMOH, MNG-HA the others.  
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Investigation against immune status of HBV N % 
 Previous investigation against immune status of HBV(N=409)     
Yes 15 3.7 
No 307 75.1 
Not sure 87 21.3 
Results of investigations against HBV immune status(N=15)    
Immune 8 53.3 
Not Immune 2 13.3 
Not sure 5 33.3 
Place at which investigations were done(N=15)     
SMOH 11 73.3 
MNG-HA 4 26.7 
Table 5.4: Investigations against immune status of HBV-Soldiers 
HBV immunisation 
More than three quarters of recruited soldiers did not know if they had received the HB vaccine, 
and only two soldiers received all three doses required for protection, six soldiers receiving 
more than three doses. Additionally, about a fifth stated that they had not been offered the 
vaccine, (Table 5.5). 
Of those vaccinated, two fifths did not know when that was, while a fifth stated in primary 
school. SMOH did three quarters of the vaccinations, the rest were MNG-HA. Most 
vaccinations took place due to immunisation campaigns, personal motivation, or doctors’ 
recommendation. Only four were vaccinated because it was a job requirement, and only two 
cases received regular vaccine doses. However, two thirds did not know if they were vaccinated 
in a regular pattern. 
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Characteristics N % 
HB vaccination status(N=409)   
More than three doses 6 1.5 
Three doses 2 0.5 
Two doses 1 0.2 
One dose 6 1.5 
HB vaccine not offered 66 16.1 
HB vaccine offered, but not taken 16 3.9 
I do not know 312 76.3 
Time of administration of HB vaccine(N=40)     
Before primary school 6 15.0 
During primary school 8 20.0 
During secondary school 6 15.0 
During undergraduate study 3 7.5 
I do not know 17 42.5 
Place of administration HB vaccine(N=40)     
SMOH 29 22.5 
MNGH-HA 9 72.5 
School health 2 5.0 
The reason for being vaccinated(N=40)    
Immunisation campaigns 24 60.0 
Self-motivation 8 20.0 
Doctor’s recommendation 7 17.5 
Work requirement 4 10.0 
Others* 2 5.0 
Were the doses of HB vaccine regular**?(N=40)    
Regular 2 5.0 
Irregular 5 12.5 
I did not receive all three doses 7 17.5 
I do not know 26 65.0 
Table 5.5: Immunisation history with HB vaccine-Soldiers 
*Others(N): Outbreak happened in my school(1) To perform Hajj ritual(1) 
**The second dose from one to two months after 1st dose and the third dose four to six months after the of 1st dose. 
Any other regimen is considered irregular. 
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The reasons why some of soldiers were not vaccinated against HBV are shown in Table 5.6. 
The reason why not vaccinated against HBV  N % 
I do not believe myself at risk 214 57.9 
Difficulty to access the HB vaccine 41 11.1 
HBV is not a serious enough disease to warrant immunisation 33 8.9 
I am concerned about the safety of the HB vaccine 15 4.1 
I am concerned about the effectiveness of the HB vaccine 15 4.1 
I am concerned about the cost 14 3.8 
No awareness 13 3.5 
I do not know 49 13.2 
Others 6 1.6 
Table 5.6: The reason why not vaccinated against HBV-Soldiers(N=369) 
Others(N): Natural HBV is preferable to vaccine(4), I suffer from a medical condition(2) 
Self-reporting of the respondents who had positive or negative HBsAb about the history of 
immunisation 
Two soldiers had immunity against HBV, while the majority’s immune status was not tested. 
Only three soldiers received three or more HB vaccine doses, while the majority did not know 
if they were vaccinated or not. Furthermore, only one positive-HBsAb-alone case received 
regular doses against HB. However, a majority reported to have never been vaccinated against 
HBV (Table 5.7). 
Among those who had negative HBsAb alone, three respondents reported being immune against 
HBV, about a fifth reported that the vaccine had not been offered. Nonetheless, the majority 
were never vaccinated against HBV (Table 5.8). 
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HBsAb is positive  N % 
Tested for immune status against HBV and result was   
Immune 2 2.1 
Not Immune 1 1.0 
Not sure 2 2.1 
Not tested 91 94.8 
HB vaccination status   
More than three doses 3 3.1 
One dose 1 1.0 
I was offered the HB vaccine, but I have not had it. 2 2.1 
I have not been offered the HB vaccine. 10 10.4 
I do not know. 80 83.3 
HB vaccination time    
Before primary school 3 3.1 
During primary school 1 1.0 
During secondary school 1 1.0 
I do not know 6 6.3 
Not vaccinated 85 88.5 
The reason to be vaccinated against HBV   
Doctor’s recommendation 2 2.1 
Self-motivation 3 3.1 
Immunisation campaigns 6 6.3 
Work requirement 2 2.1 
Other 11 11.5 
Not vaccinated 85 88.5 
Were the doses regular? 
 
Not regular 10 10.4 
Regular, on time 1 1.0 
Not vaccinated 85 88.5 
Table 5.7: Self-reporting of the respondents who had positive HBsAb alone about the 
immunisation history-Soldiers(N=96) 
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HBsAb and other HBV markers are negative N % 
Tested for immune status against HB and result was   
Immune 3 1.3 
Not Immune 1 0.4 
Not sure 2 0.9 
Not tested 224 97.4 
Statements describes about receiving the HB vaccination   
More than three doses 1 0.4 
Three doses 1 0.4 
One dose 3 1.3 
I was offered the HB vaccine, but I have not had it. 10 4.3 
I have not been offered the HB vaccine. 40 17.4 
I do not know. 175 76.1 
I was vaccinated against HBV    
Before primary school 3 1.3 
During primary school 4 1.7 
During secondary school 4 1.7 
I do not know 8 3.5 
Not vaccinated 211 91.7 
Were the doses regular?   
Regular on time 1 0.4 
Not regular 18 7.8 
Not vaccinated 211 91.7 
Table 5.8: Self-reporting of the respondents who had negative HBsAb and other HBV 
markers about the immunisation history-Soldiers(N=230) 
Exposure to potential risks of acquiring HBV 
A majority attended dental clinics. Out of those, two thirds attended regularly and fewer than 3 
times a year. Furthermore, 14.0% had once or more undergone cupping, and a further 10.0% 
underwent surgical operations once or more (Table 5.9). Additionally, 18 soldiers (4.4%) came 
across HBV-positive friends or neighbours, and 33 soldiers (8.1%) heard of one or more 
patients being hospitalised for HBV-related conditions. 
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Potential exposure risk Response N % 
Past 'Hijamah' (cupping) Yes, once 45 11.0 
Yes, more than once 13 3.2 
Previous surgery Yes, once 33 8.1 
 Yes, more than once 4 1.0 
Previous blood transfusion Yes, once 17 4.2 
 Yes, more than once 13 3.2 
Previous endoscopy Yes, once 5 1.2 
Yes, more than once 1 0.2 
Past dental treatment Yes 277 67.7 
Previous syringe use Yes 24 5.9 
Past use of others' tooth brush Yes 21 5.1 
Family member infected with HB Yes 10 2.4 
Suffered from yellow discolouration in eyes or skin Yes 10 2.4 
Previous renal analysis Yes 2 0.5 
Previous acupuncture Yes 1 0.2 
Previous tattoos Yes 1 0.2 
Table 5.9: Exposure to potential risks of acquiring HBV-Soldiers(N=409) 
  
  
231 
5.2.2 HBV Knowledge 
Self-reporting of the respondents about their level of knowledge and sources of their 
information 
Over two thirds of the soldiers did not know about HBV and a quarter described their 
knowledge as inadequate. Of those whose knowledge was enough or inadequate, about half 
attributed such sources of information to colleagues, and a third to the internet as personal 
interest (Table 5.10). 
Level of knowledge and source of information N % 
Do you have information about HB?(N=409)     
Yes, enough 15 3.7 
Yes, but it is not enough 113 27.6 
No 281 68.7 
The main source of knowledge about HB(N=128)     
Colleagues 64 50.0 
Internet 48 37.5 
TV/Radio 45 35.2 
Family/relatives 21 16.4 
Newspapers/magazines 17 13.3 
Education 15 11.7 
Others* 3 2.3 
Table 5.10: Respondents’ self-reported level of knowledge and source of information-
Soldiers. 
*Others (N): Health education campaigns(2), self-experience(1). 
Knowledge about key facts of HBV 
One quarter answered correctly in relation to infectivity pathogenesis and virulence of the virus. 
The lowest percentage knew the fact that soldiers are at a high risk of HBV infection 
(Table 5.11). 
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Key facts of HBV N* % 
You know a person is really a HB case by medical examination 197 48.2 
The infected person with HB might contract liver cirrhosis 145 35.5 
Pregnant women should be medically screened for HBV 145 35.5 
Complications of HB can lead to death 135 33.0 
Medical treatment is available for HBV 128 31.3 
HBV is a communicable infectious disease 122 29.8 
The microorganism that causes HB is virus 104 25.4 
The infected person with HBV might contract liver cancer after a period of 
time 
101 24.7 
Most primary liver tumours are caused by the HB 83 20.3 
Soldiers may have an increased risk of becoming infected with HBV 61 14.9 
Table 5.11: Percentage of the respondents who gave correct answers about key facts of 
HBV-Soldiers(N=409) 
*N indicates the number of respondents who provided correct answers. 
Knowledge about likely and unlikely ways of HBV transmission 
Over one third knew that injections by syringes used by other people and using another person's 
razor are potential ways of transmission. Lower than a third knew the other common likely 
ways of transmission (Table 5.12). Only a few knew that HBV is unlikely to be transmitted 
from eating food on a shared plate with an infected person. The lowest percentage knew breast-
feeding an unlikely way to transmit HBV. 
Knowledge about HBV vaccine and immunity 
About a quarter of them knew that HB vaccine is safe for pregnant women and a few knew that 
the immunity following HB vaccination is not life-long (Table 5.13). 
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Knowledge about likely ways of HBV transmission N* % 
Syringes used by other persons 162 39.6 
Surgery tools that were used before 157 38.4 
Using another person's razor 150 36.7 
Cupping tools used by another person 141 34.5 
Using another person's toothbrush 137 33.5 
Blood 131 32.0 
Dentist tools 127 31.1 
Acupuncture needles used by another person 124 30.3 
Circumcision tools that were used before 104 25.4 
Piercing, for example of the nose or ear 83 20.3 
Through needle stick injury 76 18.6 
Nail clippers used by other person 77 18.8 
Tattooing 75 18.3 
Sexual intercourse 71 17.4 
From an infected person who is asymptomatic 65 15.9 
From an infected mother to the foetus during delivery 62 15.2 
Knowledge about unlikely ways of HBV transmission N* % 
Hugging an infected person 75 18.3 
Eating food on a shared plate with an infected person 55 13.4 
Eating food prepared by an infected person 52 12.7 
Being coughed on by an infected person 43 10.5 
A sneeze of an infected person 42 10.3 
Drinking water in cups used by others: such as in public places 35 8.6 
Breast-feeding from the infected mother to her infant 25 6.1 
Table 5.12: Percentage of the respondents who gave correct answers about likely and 
unlikely ways of transmitting HBV-Soldiers-(N=409) 
*N indicates the number of respondents who provided correct answers. 
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HBV Knowledge about vaccine and immunity N* % 
Soldiers without a reliable history of HBV should receive the HB vaccine 151 36.9 
The HB vaccine is safe for pregnant woman 101 24.7 
To obtain optimum protection for soldiers, three doses of HB vaccine are 
needed 
89 21.8 
Acquired immunity after natural HBV is lifelong 33 8.1 
The immunity following HB vaccination is not life-long 32 7.8 
The HB vaccine is killed HB pathogens. 18 4.4 
Table 5.13: Percentage of the respondents who gave correct answers about HBV vaccine 
and immunity-Soldiers(N=409) 
*N indicates the number of respondents who provided correct answers. 
Perspectives of the respondents about behaviour towards soldiers infected with HBV 
 
Almost half knew that all family members of an infected soldier require medical examination. 
Additionally, about a quarter knew the necessity of isolating an infected soldier (in the 
infectious stage) from direct contact with other soldiers in a battalion and a similar percentage 
knew that an infected soldier can safely shake hands with colleagues (Table 5.14).  
Items reflecting attitude  N* % 
All family members of an infected soldier require medical examination 190 46.5 
It is necessary to isolate the infected soldier from direct contact to other soldiers 
in a battalion 
111 27.1 
The infected soldier can shake hands with colleagues 106 25.9 
The infected soldier can eat food with colleagues 70 17.1 
Table 5.14: Percentage of the respondents who gave correct answers about behaviours 
towards the soldiers infected with HBV(N=409) 
*N indicates the number of respondents who provided correct answers. 
Knowledge in different aspects of HBV among soldiers 
The median total knowledge score on the 43 items was eight (inter-quartile range 1-17), this 
corresponds with a percentage of 18.6% in knowledge variation (inter-quartile range 2.3-
39.5%) (Table 5.15). Concerning the subscales, the best score was seen on the key facts of HBV 
and the likely ways of transmission (median 2). Conversely, for HBV vaccine and immunity, 
the median knowledge score was slightly lower (1), while it was the lowest (0) for unlikely 
ways of transmission. 
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Knowledge aspects Median IQR 
As% of all questions 
median IQR 
Total knowledge score(43 Questions) 8 (1-17) 18.6 (2.3–9.5) 
Key facts of HBV(10 Questions) 2 (0-5) 20.0 (0.0-50.0) 
Likely ways of transmission(16 Questions) 2 (0-8) 12.5 (0.0-50.0) 
Unlikely ways of transmission (7 Questions) 0 (0-1) 0.0 (0.0-14.2) 
HBV vaccine and immunity(6 Questions) 0 (0-2) 0.0 (0.0-33.3) 
Attitude towards infected worker(4 Questions) 1 (0-2) 25.0 (0.0-50.0) 
Table 5.15: Median and inter-quartile range with percentage of the respondents who gave 
correct answers in different knowledge aspects about HBV-Soldiers(N=409) 
HBV knowledge score and sociodemographic characteristics 
There was a small, statistically significant positive correlation between the HBV knowledge 
score among soldiers and time spent in formal education, with HBV knowledge increasing with 
time spent in formal education (Table 5.16). Also, there was a small, statistically significant 
positive correlation between HBV knowledge and experience in military field, with HBV 
knowledge increasing with years of experience. 
HBV knowledge score  N 
Spearman's rho 
Correlation 
P-value 
Age 409 0.02 0.64 
Time spent in formal education 409 0.14 0.006 
Years of experience in military field 409 0.13 0.008 
Dental visits 277 0.10 0.09 
Table 5.16: Correlation between HBV knowledge score and sociodemographic 
characteristics-Soldiers 
  
  
236 
There was a significant association between HBV knowledge score and highest level of 
education, those having a diploma had greater HBV knowledge. A significant association 
between HBV knowledge score and region of birth was reported, the highest such score was 
recorded by those who were born in Madinah, with the lowest Taif (Table 5.17). 
Characteristics N(%) 
HBV knowledge score  
P-
value 
(43 questions) 
Median(IQR) 
Marital status    0.18* 
Single  337(82.4%) 8.0(1.0–17.0) 
Ever married 72(17.6%) 10.5(3.0–19.0) 
Education level   <0.001
* Secondary school 273(66.7%) 7.0(1.0–15.5) 
Diploma 136(33.3%) 13.0(3.0-20.0) 
Birth Region  0.01** 
Jeddah 108(26.4%) 8.0(1.0–17.7) 
Madinah 80(19.6%) 10.0(2.0–17.7) 
Makkah 74(18.1%) 9.0(1.75–18.2) 
Taif 64(15.6%) 3.0(0.0–13.5) 
Others 83(20.3%) 10.0(3.0–17.0) 
Table 5.17: HBV knowledge score and sociodemographic characteristics-Soldiers(N=409) 
*Based on Mann-Whitney U test,**Based on Kruskal Wallis test 
HBV knowledge score and sources of information 
Those who had enough information about HBV scored higher in HBV knowledge than those 
who did not have sufficient information (Table 5.18). Better knowledge scores were observed 
among those who reported families as the main source of information about HBV. 
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The source of HBV knowledge  N(%) 
HBV knowledge score  
P-
value* 
(43 questions) 
Median(IQR) 
Have information about HBV?    0.77 
Yes, enough (as perceived by the 
participant) 
15(11.7%) 20.0(3.0-27.0) 
Yes, but it is not enough 113(88.3%) 17.0(9.0-24.0) 
TV/Radio    0.16 
Yes 45(35.2%) 15.0(7.5-21.5) 
No 83(64.8%) 17.0(9.0-25.0) 
Newspapers/Magazines    0.44 
Yes 17(13.3%) 19.0(10.0-26.0) 
No 111(86.7%) 17.0(8.0-24.0) 
Education   0.73 
Yes 15(11.7%) 17.0(6.0-23.0) 
No 113(88.3%) 17.0(9.5-24.0) 
Colleagues    0.97 
Yes 64(50.0%) 16.5(9.2-24.0) 
No 64(50.0%) 17.0(8.2-24.0) 
Families    0.001 
Yes 21(16.4%) 24.0(16.5-30.0) 
No 107(83.6%) 16.0(7.0-21.0) 
Internet    0.63 
Yes 48(37.5%) 17.0(9.0-23.0)  
No 80(62.5%) 17.0(9.0-24.0) 
Table 5.18: HBV knowledge score and the source of knowledge-Soldiers(N=128) 
*Based on Mann-Whitney U test  
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HBV knowledge score among soldiers tested for HBV, exposure or have immunity against 
hepatitis B 
Significantly higher scores in median HBV knowledge were recorded among those respondents 
who were tested for HB, respondents who tested for immunity against HB, respondents who 
had an HB-infected family member and respondents who had immunity against the disease 
(Table 5.19). 
Characteristics  N(%) 
HBV knowledge 
score  P-
value* (43 questions) 
Median(IQR) 
Tested for HB?(N=409)   0.003 
Yes 27(6.6%) 20.0(3.0-28.0) 
No or not sure 382(93.4%) 8.0(1.0-17.0) 
Tested for immune status against 
HBV?(N=409) 
  
0.002 
Yes 15(3.7%) 24.0(10.0-28.0) 
No or not sure 394(96.3%) 8.0(1.0-17.0) 
Regular HB vaccine doses were received 
(N=40) 
  
0.4 
Regular on time 2(0.5%) 19.0(17.0-19.0) 
Not regular 38(9.3%) 13.0(3.0-20.5) 
Family member was infected with 
HB?(N=409) 
  
0.008 
Yes 10(2.4%) 16.0(13.7-28.7) 
No 399(97.6%) 8.0(1.0-17.0) 
Exposure to HBV(HBcAb)(N=326)   0.13 
Positive 2(0.6%) 1.0(1.0-2.0) 
Negative 324(99.4%) 8.0(1.0-17.0) 
Immunity against HBV 
(N=326) 
  
0.01 
Positive 96(29.4%) 11.0(3.0-20.0) 
Negative 230(70.6%) 7.0(1.0-16.0) 
Table 5.19: HBV knowledge score tested for HBV, exposure or have immunity against 
HBV-Soldiers 
*Based on Mann-Whitney U test 
Potential predictors of hepatitis B knowledge  
Table 5.20 shows the results of a logistic regression model investigating the potential 
predicators of HB knowledge. Variables included in the initial model are: time spent in formal 
education, years of experience in the military field (Table 5.16); education level, birth region 
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(Table 5.17); whether tested for HB, or for immune status against HB, family member being 
infected with HB, immunity against HBV, (Table 5.19). The model explained 7.8% of the 
variance in HB knowledge. Hosmer and Lemeshow indicated that the model was a reasonable 
fit (P=0.78). 
As shown in Table 5.20, diploma-holding soldiers scored double in HBV knowledge compared 
to those holders of secondary school certificates. Also, those soldiers having one HBV-infected 
family member scored seven times higher in HBV knowledge than those without. 
Variables determining HBV knowledge of soldiers after adjustment for confounders were 
investigated, both significant variables (level of education and having a HB-infected family 
member) were not considered a confounder to variables tested for HBV knowledge. Therefore, 
these two significant variables determine HBV knowledge of soldiers. 
Variable* OR(95%C.I) LRT-P 
Education level  0.002 
Secondary school Reference 
Diploma 2.15(1.31-3.54) 
Tested for immune status against HB?  0.06 
No Reference 
Yes 3.85(0.79-18.69) 
Family member was infected with HB?  0.02 
No Reference 
Yes 7.54(0.90-63.28) 
Table 5.20: Independent determinants of HB knowledge score-Soldiers(N=326) 
*Multiple logistic regression 
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5.2.3 Concern and attitude about HBV 
About three quarters of soldiers agreed that HBV is a serious disease and more than two thirds 
agreed HB vaccination should be made compulsory for soldiers (Table 5.21). Additionally, 
more than two thirds agreed that a soldier who was not infected by HB before should be 
vaccinated to avoid the infection and almost three quarters agreed that family members and 
colleagues should take the HB vaccine if they were not already immune. Almost two fifths 
expressed that they would deal with HBV-infected colleagues in a military barrack carefully, 
and more than a third indicated that they don't know. When the respondents were asked about 
their perception if an infected person wants to marry one of their relatives, more than a third of 
the participants stated that they would disagree, and almost half expressed that they did not 
know. 
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Statement Degree of agreement N % 
HBV is a serious disease 
Agree 310 75.8 
Neutral 61 14.9 
Disagree 38 9.3 
HB vaccination should be made 
compulsory for soldiers 
Agree 285 69.7 
Neutral 73 17.8 
Disagree 51 12.5 
It is important for a soldier who was not 
infected by HB before, to be vaccinated 
Agree 276 67.5 
Neutral 85 20.8 
Disagree 48 11.7 
It is recommended for family members 
and colleagues to be vaccinated the HB 
vaccine if they are not immune 
Agree 301 73.6 
Neutral 68 16.6 
Disagree 40 9.8 
If a HBV infected person (inactive) works 
with you in a military barrack, you will 
deal with him 
Normally 36 8.8 
Carefully 163 39.9 
I won’t deal with him 59 14.4 
I don't know 151 36.9 
A person infected with HBV wishes to 
marry a relative in your family (not 
infected with HBV), what is your opinion 
I agree without precaution 16 3.9 
I agree after reminding risks 69 16.9 
I do not agree 148 36.2 
I do not know 176 43.0 
Table 5.21: Participants’ concern and attitude towards the HBV and HBV-infected 
colleagues-Soldiers(N=409) 
Concern and attitude about HBV and sociodemographic characteristics  
There was a small positive correlation between those who suggested that vaccination against 
HBV should be compulsory for soldiers and age (Table 5.22). The older the respondent, the 
more the agreement was. A similar correlation between respondent age and the 
recommendation for vaccinating HBV free soldiers was seen. The older the respondents, the 
more the agreement. 
Additionally, there was a small positive correlation between period spent in formal education 
and the recommendation that HBV-free soldiers should be vaccinated, the longer, the more the 
agreement. There was also small positive correlation between period spent in formal education 
and those who said family members and colleagues should take the HB vaccine if they were 
not immune, the longer the years of experience, the more the agreement. 
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The correlation was small and positive between HBV knowledge and those who said HBV is a 
serious disease, the agreement increases with the HBV knowledge score. There was also small 
and positive correlation between HBV knowledge and the recommendation that HBV-free 
soldiers should be vaccinated, the more the knowledge, the more the agreement. There was also 
small and positive correlation between HBV knowledge and those who said family members 
and colleagues should take the HB vaccine if they were not immune, the more the knowledge, 
and the more the agreement. 
There was a significant numerical similarity among higher scoring HBV knowledge 
respondents in terms of stated willingness to work with HBV infected colleagues and “don’t 
know” replies. (Table 5.25). Similar ratios were found in response to “would you agree to a 
relative marrying an infected person” (Table 5.26). Further, half of married respondents firmly 
rejected the notion of a relative marrying an infected person with almost half of single personnel 
responding “don’t know.” (Table 5.28). 
More statistically significant associations were discovered in responses based on level of 
education – 46.3% of diploma-holding soldiers (and a quarter would accept a relative’s 
marriage after education) would carefully deal with the target group and two thirds at secondary 
school education level expressing that they “don’t know” (Table 5.27 and Table 5.28). 
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Participants’ concern and attitude 
HB is a serious 
disease 
HB vaccination 
should be made 
compulsory for 
soldiers 
Important for the a soldier 
who was not infected by HB 
before, to be vaccinated  
Family members and 
colleagues should be 
vaccinated if they were not 
immune 
Age Correlation* 0.09 0.14 0.10 0.054 
P-value 0.07 0.005 0.04 0.28 
Time spent in formal 
education 
Correlation* 0.04 0.07 0.15 0.11 
P-value 0.44 0.15 0.002 0.02 
Experience in 
military field 
Correlation* 0.07 0.055 0.053 0.04 
P-value 0.15 0.27 0.29 0.39 
HBV knowledge 
score  
Correlation* 0.30 0.31 0.28 0.29 
P-value <0.001 <0.001 <0.001 <0.001 
Table 5.22: Correlation between participants’ concern and attitude towards the HBV and HBV-infected colleagues and sociodemographic 
characteristics-Soldiers(N=409) 
*Based on Spearman's rho correlation  
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Characteristics  N 
HB is a serious disease 
P-
Value* 
HB vaccination should be made 
compulsory for soldiers 
P-
Value
* Disagree or neutral Agree Disagree or neutral Agree 
Marital status    0.3*   0.1* 
Single 337 85(25.2%) 252(74.8%) 108(32.0%) 229(68.0%) 
Ever married 72 14(19.4%) 58(80.6%) 16(22.2%) 56(77.8%) 
Education level    0.1*   0.01* 
Secondary school 273 73(26.7%) 200(73.3%) 94(34.4%) 179(65.6%) 
Diploma  136 26(19.1%) 110(80.9%) 30(22.1%) 106(77.9%) 
Birth region    0.5**   0.1** 
Jeddah 108 31(28.7%) 77(71.3%) 36(33.3%) 72(66.7%) 
Madinah 80 19(23.8%) 61(76.3%) 26(32.5%) 54(67.5%) 
Makkah 74 13(17.6%) 61(82.4%) 20(27.0%) 54(73.0%) 
Taif 64 17(26.6%) 47(73.4%) 25(39.1%) 39(60.9%) 
Others  83 19(22.9%) 64(77.1%) 17(20.5%) 66(79.5%) 
Table 5.23: Association between participants’ concern and attitude towards the HBV and HBV-infected colleagues and sociodemographic 
characteristics-Soldiers(N=409)(a) 
*Based on Continuity Correction**Based on Monte Carlo method   
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Characteristics  N 
 Important for a soldier who was not 
infected by HB before, to be vaccinated P-
Value* 
 Family members and colleagues should 
be vaccinated if they were not immune P-
Value* 
Disagree or neutral Agree Disagree or neutral Agree 
Marital status    0.5*   0.8* 
Single 337 112(33.2%) 225(66.8%) 90(26.7%) 247(73.3%) 
Ever married 72 21(29.2%) 51(70.8%) 18(25.0%) 54(75.0%) 
Education level    0.009*   0.04* 
Secondary school 273 101(37.0%) 172(63.0%) 81(29.7%) 192(70.3%) 
Diploma  136 32(23.5%) 104(76.5%) 27(19.9%) 109(80.1%) 
Birth region    0.6**   0.1** 
Jeddah 108 34(31.5%) 74(68.5%) 28(25.9%) 80(74.1%) 
Madinah 80 30(37.5%) 50(62.5%) 25(31.3%) 55(68.8%) 
Makkah 74 20(27.0%) 54(73.0%) 18(24.3%) 56(75.7%) 
Taif 64 23(35.9%) 41(64.1%) 22(34.4%) 42(65.6%) 
Others 83 26(31.3%) 57(68.7%) 15(18.1%) 68(81.9%) 
Table 5.24: Association between participants’ concern and attitude towards the HBV and HBV-infected colleagues and sociodemographic 
characteristics-Soldiers(N=409)(b) 
*Based on Continuity Correction**Based on Monte Carlo method   
  
246 
Characteristics  N 
 If a HB infected person works with you in a military barrack, you will 
deal with him P-
Value * 
 Normally  Carefully 
 I won’t deal with 
him 
 I don't know 
Age by category 
  
0.7 
≤21 102 7(6.9%) 42(41.2%) 16(15.7%) 37(36.3%) 
22-24 165 18(10.9%) 69(41.8%) 21(12.7%) 57(34.5%) 
≥25 142 11(7.7%) 52(36.6%) 22(15.5%) 57(40.1%) 
Time spent in formal education(Years)   0.1 
≤12 232 20(8.6%) 84(36.2%) 32(13.8%) 96(41.4%) 
≥13 177 16(9.0%) 79(44.6%) 27(15.3%) 55(31.1%) 
Experience in military field(Years)   0.4 
<1 or no experience 381 32(8.4%) 150(39.4%) 57(15.0%) 142(37.3%) 
1 Year 28 4(14.3%) 13(46.4%) 2(7.1%) 9(32.1%) 
HBV knowledge 
 
 <0.001 
Knowledge score equal to median or 
below 
207 11(5.3%) 60(29.0%) 21(10.1%) 115(55.6%) 
Knowledge score above median 202 25(12.4%) 103(51.0%) 38(18.8%) 36(17.8%) 
Table 5.25: Attitude of participants towards the HBV and HBV-infected colleagues and sociodemographic characteristics-Soldiers(N=409)(a) 
*Based on Monte Carlo method  
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Characteristics N 
A person infected with HB wishes to marry a relative in your family (not 
infected with HB), what is your opinion  P-
Value*  I agree without 
precaution 
I agree after reminding 
him of the risks 
I do not agree  I do not know 
Age by category(Years) 
 
 0.9 
≤21 102 4(3.9%) 14(13.7%) 38(37.3%) 46(45.1%) 
22-24 165 6(3.6%) 30(18.2%) 57(34.5%) 72(43.6%) 
≥25 142 6(4.2%) 25(17.6%) 53(37.3%) 58(40.8%) 
Time spent in formal education(Years)   0.09 
≤12 232 8(3.4%) 29(12.5%) 81(34.9%) 114(49.1%) 
≥13 177 8(4.5%) 40(22.6%) 67(37.9%) 62(35.0%) 
Experience in military field(Years)   0.1 
<1 Years or no experience 381 13(3.4%) 66(17.3%) 135(35.4%) 167(43.8%) 
1 Year 28 3(10.7%) 3(10.7%) 13946.4%) 9(32.1%) 
HBV knowledge 
 
 <0.001 
Knowledge score equal to median or 
below 
207 5(2.4%) 25(12.1%) 53(25.6%) 124(59.9%) 
Knowledge score above median 202 11(5.4%) 44(21.8%) 95(47.0%) 52(25.7%) 
Table 5.26: Attitude of participants towards the HBV and HBV-infected colleagues and sociodemographic characteristics-Soldiers(N=409)(b) 
*Based on Monte Carlo method  
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Characteristics  N 
 If a HB infected person works with you in a military barrack, you will deal with him 
P-
Value*  Normally  Carefully  I won’t deal with him  I don't know 
Marital status    0.9 
Single 337 30(8.9%) 133(39.5%) 50(14.8%) 124(36.8%) 
Ever married 72 6(8.3%) 30(41.7%) 9(12.5%) 27(37.5%) 
Education level   0.01 
Secondary school 273 21(7.7%) 100(36.6%) 36(13.2%) 116(42.5%) 
Diploma  136 15(11.0%) 63(46.3%) 23(16.9%) 35(25.7%) 
Birth Region   0.1 
Jeddah 108 10(9.3%) 50(46.3%) 15(13.9%) 33(30.6%) 
Madinah 80 7(8.8%) 29(36.3%) 11(13.8%) 33(41.3%) 
Makkah 74 9(12.2%) 23(31.1%) 16(21.6%) 26(35.1%) 
Taif 64 2(3.1%) 22(34.4%) 8(12.5%) 32(50.0%) 
Others 83 8(9.6%) 39(47.0%) 9(10.8%) 27(32.5%) 
Table 5.27: Attitude of participants towards the HBV and HBV-infected colleagues and sociodemographic characteristics-Soldiers(N=409)(c) 
*Based on Monte Carlo method 
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Characteristics  N 
A person infected with HB wishes to marry a relative in your family (not infected with HB), 
what is your opinion P-
Value*  I agree without 
precaution 
I agree after reminding 
him of the risks 
I do not agree  I do not know 
Marital status   0.02 
Single 337 14(4.2%) 56(16.6%) 112(33.2%) 155(46.0%) 
Ever married 72 2(2.8%) 13(18.1%) 36(50.0%) 21(29.2%) 
Education level   0.001 
Secondary school 273 6(2.2%) 36(13.2%) 105(38.5%) 126(46.2%) 
Diploma  136 10(7.4%) 33(24.3%) 43(31.6%) 50(36.8%) 
Birth region   0.06 
Jeddah 108 3(2.8%) 20(18.5%) 46(42.6%) 39(36.1%) 
Madinah 80 1(1.3%) 13(16.3%) 30(37.5%) 36(45.0%) 
Makkah 74 8(10.8%) 12(16.2%) 20(27.0%) 34(45.9%) 
Taif 64 3(4.7%) 7(10.9%) 22(34.4%) 32(50.0%) 
Others 83 1(1.2%) 17(20.5%) 30(36.1%) 35(42.2%) 
Table 5.28: Attitude of participants towards the HBV and HBV-infected colleagues and sociodemographic characteristics-Soldiers(N=409)(d) 
*Based on Monte Carlo method 
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5.2.4 Summary of serology results among soldiers who completed the questionnaire 
Seroprevalence of HBV markers 
Just one soldier was infected with HBV, additionally, only two were exposed to HBV earlier in 
their life and about three quarters did not have serological evidence of immunity against HBV 
(Table 5.29). 
Serology test Results N % 95%C.I 
HBsAg 
Negative 325 99.7 (98.3-99.9) 
Positive 1 0.3 (0.1-1.7) 
HBcAb 
Negative 324 99.4 (97.8-99.8) 
Positive 2 0.6 (0.2-2.2) 
HBsAb 
Negative 230 70.6 (65.4-75.2) 
Positive 96 29.4 (24.8-34.6) 
Table 5.29: The laboratory results for HBV markers-Soldiers(N=326) 
Clinical interpretation of hepatitis B serological markers 
One third of soldiers had serological evidence of immunity against HBV mostly through HB 
vaccination, and over two thirds were never exposed, never vaccinated and susceptible for 
infection. Meanwhile, just one soldier was immune due to natural infection, and one soldier 
was a chronic carrier (Table 5.30). 
  
  
251 
Serology test Result N % Interpretation  
HBsAg Negative 
95 29.1 
1-Most probably; immune due to 
HBV vaccination. 
2-Might be repeated exposure to 
antigen without infection. 
3-Might be recovery from infection 
with loss of detectable HBcAb. 
HBcAb Negative 
HBsAb Positive 
HBsAg Negative 
229 70.3 
Never exposed, never vaccinated, 
susceptible for infection. 
HBcAb Negative 
HBsAb Negative 
HBsAg Negative 
1 0.3 Immune due to natural infection HBcAb Positive 
HBsAb Positive 
HBsAg Positive 
1 0.3 
Chronic carrier infection 
 
HBcAb Positive 
HBsAb Negative 
Table 5.30: Clinical interpretation of HBV serological markers-Soldiers(N=326) 
 
Seroprevalence of HBV antibodies-HBsAb 
 
HBV seroimmunity and sociodemographic characteristics 
There was a significant association between HBsAb among soldiers and age, formal education, 
marital status (Table 5.31). However, no significant association was seen between HBsAb 
among soldiers and work experience, education level, or birth region. 
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Characteristics 
Cross tabulation  Univariate analysis  
Negative 
HBsAb 
(N=230) 
Positive 
HBsAb 
(N=96) 
Overall 
N 
OR(95%CI) LRT-P 
Age(Years)     <0.001 
≤21 64 24 88 Reference 
22-24 103 25 128 0.64(0.34-1.22) 
≥25 63 47 110 1.98(1.08-3.63) 
Work experience(Year)     0.13 
<1 Year or no 210 92 302 Reference 
1 Year 20 4 24 0.45(0.15-1.37) 
Formal education(Years)    
 
0.03 
≤12 142 47 189 Reference 
≥13 88 49 137 1.68(1.04-2.72) 
Marital Status      0.02 
Single 195 71 266 Reference 
Ever married 35 25 60 1.96(1.09-3.50) 
Education level      0.13 
Secondary school 168 62 230 Reference 
Diploma 62 34 96 1.48(0.89-2.47) 
Birth Region      0.13 
Jeddah  57 24 81 Reference 
Madinah 38 27 65 1.68(0.85-3.35) 
Makkah 45 18 63 0.95(0.46-1.96) 
Taif 41 14 55 0.81(0.37-1.75) 
Others 49 13 62 0.63(0.29-1.36) 
Table 5.31: HBV seroimmunity and sociodemographic characteristics-Soldiers(N=326) 
 
HBV seroimmunity and potential risk variables 
The odds of positive HBsAb among those who had an endoscopy were marginally significantly 
seven times higher compared with those who did not have an endoscopy (Table 5.32). 
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Characteristics 
(No is reference) 
Cross tabulation Univariate analysis 
Negative 
HBsAb 
(N=230) 
Positive 
HBsAb 
(N=96) 
Overall 
N 
OR(95%CI) 
LRT-
P 
Had a blood transfusion?  215 87 302 
 
0.37 
Yes 15 9 24 1.48(0.62-3.51) 
Had a surgery?  207 91 298 
 
0.14 
Yes 23 5 28 0.49(0.18-1.34) 
Had a cupping?  200 82 282 
 
0.71 
Yes 30 14 44 1.13(0.57-2.25) 
Had an endoscopy 229 93 322 
 
0.058 
Yes 1 3 4 7.38(0.75-71.93) 
Used syringes repeatedly? 216 90 306 
 
0.95 
Yes 14 6 20 1.02(0.38-2.76) 
Used another person’s 
toothbrush? 
221 89 310 
 
0.21 
Yes 9 7 16 1.93(0.69-5.34) 
Had a tattoo?  230 95 325 
 
0.11 
Yes 0 1 1 N/A* 
Had a renal dialysis?  229 96 325 
 
0.40 
Yes 1 0 1 N/A* 
Had a yellow discolouration 
in eyes or skin? 
225 92 317 
 
0.33 
Yes 5 4 9 1.95(0.51-7.44) 
Family member infected 
with HB? 
224 94 318 
 
0.77 
Yes 6 2 8 0.79(0.15-4.00) 
Table 5.32: HBV seroimmunity and risk variables-Soldiers(N=326) 
*N/A Not available 
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Potential predictors of HBV seroimmunity 
Table 5.33 shows the results of a logistic regression model determining potential predicators of 
HBV seroimmunity. Variables included in the initial model were: age by category, formal 
education and marital status (Table 5.31), and those who had endoscope (Table 5.32). The 
model explained 9.2% of the variance in seroimmunity HBsAb. Hosmer and Lemeshow 
indicated that the model was a reasonable fit (P=0.39). 
One of the studied variables (age by category) made a significant independent contribution to 
the model. The odds of positive HBsAb among those 22-24 years were lower and among those 
25 or more were double those 21 or less. Variables determining HBV seroimmunity of soldiers 
after adjustment for confounding were investigated, those who had an endoscopy were 
considered not confounder to variables tested for HBV seroimmunity. 
 
Variable* OR(95%C.I) LRT-P 
Age(Years)  0.001 
≤21 Reference 
22-24 0.59(0.31-1.13) 
≥25 1.79(0.97-3.30) 
Formal education(Years)  0.09 
≤12 Reference 
≥13 1.54(0.93-2.53) 
Had an endoscopy   0.07 
No Reference 
Yes 7.31(0.67-79.14) 
Table 5.33: Independent determinants of HBsAb seroimmunity-Soldiers(N=326) 
*Multiple logistic regression  
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5.2.5 Summary of serology results among soldiers who were not given the questionnaire 
Seroprevalence of HBV markers 
Only one soldier was infected with HBV (Table 5.34). Additionally, a minority was exposed to 
HBV earlier in their life and about two thirds did not have serological evidence of immunity. 
Serology test Results N % (95%C.I) 
HBsAg 
Negative 705 99.9 (99.2-100.0) 
Positive 1 0.1 (0.0-0.8) 
HBcAb 
Negative 698 98.9 (97.8-99.4) 
Positive 8 1.1 (0.6–2.2) 
HBsAb 
Negative 489 69.3 (65.8-72.6) 
Positive 217 30.7 (27.4-34.2) 
Table 5.34: The laboratory results for HBV markers-Soldiers(N=706) 
 
Clinical interpretation of hepatitis B serological markers 
Almost a third of soldiers have serological evidence of immunity against HBV mostly through 
HB vaccination. About three quarters were never exposed, never vaccinated and susceptible for 
infection. Meanwhile, a small minority were immune due to natural infection, and only one was 
a chronic carrier (Table 5.35). 
Serology test Result N % Interpretation  
HBsAg Negative 
210 29.8 
1-Most probably, immune due to 
HBV vaccination. 
2-Might be repeated exposure to 
antigen without infection. 
3-Might be recovery from infection 
with loss of detectable HBcAb. 
HBcAb Negative 
HBsAb Positive 
HBsAg Negative 
488 69.1 
Never exposed, never vaccinated, 
susceptible for infection. 
HBcAb Negative 
HBsAb Negative 
HBsAg Negative 
7 0.9 Immune due to natural infection HBcAb Positive 
HBsAb Positive 
HBsAg Positive 
1 0.1 Chronic carrier infection HBcAb Positive 
HBsAb Negative 
Table 5.35: Clinical interpretation of HB B serological markers-Soldiers(N=706) 
  
256 
5.3 Measles among Soldiers 
 
5.3.1 Previous measles related health history 
Previous investigation for measles 
Only nine soldiers reported having been infected with measles, half being infected 15 years 
before (Table 5.36). Ten soldiers were sure they had been previously investigated for measles, 
and the majority responded that they had never been screened or were not sure. Out of those 
who sure of being measles investigated, almost three quarters indicated not being informed that 
they were immune. 
Investigation against measles N % 
Previous infection to measles(N=409)   
Yes 9 2.2 
No 360 88.0 
Not sure 40 9.8 
Time of infection with measles in years(N=9)   
14 and less 4 44.4 
15 and more 5 55.6 
Previous investigation against measles immune status(N=409)   
Yes 10 2.4 
No 325 79.5 
Not sure 74 18.1 
Results of investigations against measles immune status(N=10)   
Immune 7 70.0 
Not immune 1 10.0 
Not sure 2 20.0 
Place at which investigations were done(N=10)   
SMOH  5 50.0 
MNG-HA 3 30.0 
Private hospital 2 20.0 
Table 5.36: Investigation against measles-Soldiers 
Measles immunisation 
Only six soldiers had received the two doses required for protection against measles and 15 
stated that they had received one dose. In contrast, more than three quarters did not know if 
they had received the measles vaccine, and only 20 had not been offered the vaccine 
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(Table 5.37). Of those vaccinated, about a third were at primary school and just two soldiers 
received regular vaccine doses, a quarter of soldiers did not know if they were vaccinated in a 
regular pattern. 
Characteristics N % 
Measles vaccination status(N=409)   
More than two doses 7 1.7 
Two doses 6 1.5 
One dose 15 3.7 
Measles vaccine not offered 41 10.0 
Measles vaccine offered, but not taken 20 4.9 
I do not know 320 78.2 
Time of administration of measles vaccine(N=48)     
Before primary school 6 12.5 
During primary school 17 35.4 
During secondary school 12 25.0 
During undergraduate study 1 2.1 
I do not know 12 25.0 
Place of administration measles vaccine(N=48)     
SMOH 32 66.7 
MNG-HA 7 14.6 
School health 9 18.8 
The reason for being vaccinated(N=48)    
Immunisation campaigns 35 72.9 
Doctor’s recommendation 12 25.0 
Self-motivation 9 18.8 
Others* 4 8.3 
Were the doses of measles vaccine regular*?(N=48)    
Regular 2 4.2 
Irregular 10 20.8 
I did not receive all two doses 9 18.8 
I do not know 27 56.3 
Table 5.37: Immunisation history with measles vaccine-Soldiers 
*Others(N): Work requirement(3), For Hajj performance(1)**(The second dose from one to two months of 1st 
dose). Any other regimen is considered irregular   
  
258 
The reasons why some of the soldiers were not vaccinated against measles are summarised in 
Table 5.38. 
The reason why not vaccinated against measles N % 
I do not believe myself at risk. 205 56.7 
Measles is not a serious enough disease to warrant immunisation 42 11.6 
Difficulty access obtaining the vaccine 36 10.0 
I am concerned about the safety of the vaccine 18 5.0 
I am concerned about the efficacy of the vaccine 14 3.9 
I am concerned about the cost 11 3.0 
No awareness 8 2.2 
Natural measles infection is preferable to vaccine. 6 1.7 
I suffer from a medical condition 3 0.8 
I do not know 50 13.8 
Table 5.38: The reason why not vaccinated against measles-Soldiers(N=361) 
 
 
Self-reporting of the respondents who had positive or negative IgG Measles about the history 
of immunisation 
Of those seropositive IgG measles, majority reported not being infected while the majority’s 
immune status was not tested. Among soldiers who had sero-positive IgG measles, two received 
two doses or more, 13 received the vaccine mainly in immunisation campaigns and one received 
regular doses. However, four fifths were not previously vaccinated (Table 5.39). 
Among those who had negative IgG measles alone, few had been infected, five reported being 
immune, and four that vaccine had been received in two doses or more, minority receiving 
measles vaccine in irregular pattern. Nonetheless, fourth fifths were never vaccinated 
(Table 5.40). 
Exposure to potential risks of acquiring measles 
About a tenth of soldiers indicated that they had seen at least one patient within the previous 
five years with a measles and about a tenth heard of one or more patients being hospitalised for 
measles-related conditions. 
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IgG measles is positive  N % 
Were you ever infected with measles?   
Yes 1 1.3 
No 69 87.3 
Not sure 9 11.4 
I was infected with measles in   
13years ago 1 1.3 
Not infected or not sure 78 98.7 
Tested for immune status against measles and result was   
Not tested  79 100.0 
Measles vaccination status  
More than two doses 1 1.3 
Two doses 1 1.3 
One dose 7 8.9 
I was offered the measles vaccine, but I have not had it 2 2.5 
I have not been offered the measles vaccine 3 3.8 
I do not know 65 82.3 
Measles vaccination time   
Before primary school 2 2.5 
During primary school 4 5.1 
During secondary school 4 5.1 
I do not know 5 6.3 
Not vaccinated 64 81.0 
The reason to be vaccinated against measles   
Immunisation campaigns 13 16.5 
Doctor’s recommendation 4 5.1 
Self-motivation 1 1.3 
Not vaccinated 64 81.0 
Were the doses regular?  
Regular on time  1 1.3 
Not regular 14 17.7 
Not vaccinated 64 81.0 
Table 5.39: Self-reporting of the respondents who had positive IgG measles alone about 
the history of immunisation-Soldiers(N=79) 
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IgG measles is negative  N % 
Were you ever infected with measles?   
Yes 6 2.4 
No 218 88.3 
Not sure 23 9.3 
I was infected with measles in   
<=14 years ago 3 1.2 
15 years and more 3 1.2 
Not infected or not sure 241 97.6 
Tested for immune status against measles and result was   
Immune 5 2.0 
Not sure 2 0.8 
Not tested  240 97.2 
Statements describes about receiving the measles vaccination   
More than two doses 2 0.8 
Two doses 2 0.8 
One dose 5 2.0 
I was offered the measles vaccine, but I have not had it 16 6.5 
I have not been offered the measles vaccine 30 12.1 
I do not know 192 77.7 
I was vaccinated against measles    
Before primary school 2 0.8 
During primary school 6 2.4 
During secondary school 5 2.0 
I do not know 6 2.4 
Not vaccinated 228 92.3 
Were the doses regular?   
Not regular 19 7.7 
Not vaccinated 228 92.3 
Table 5.40: Self-reporting of the respondents who had negative IgG measles alone about 
the history of immunisation-Soldiers(N=247) 
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5.3.2 Measles knowledge 
Self-reporting of the respondents about their level of knowledge and sources of their 
information 
Over a third expressed that they had measles knowledge and mainly described their knowledge 
as inadequate. Of those whose knowledge was enough or inadequate, almost two thirds 
attributed such source of information to colleagues, and about a third pointed to the 
family/relatives as the main sources (Table 5.41). 
Level of knowledge and source of information N % 
Do you have information about measles?(N=409)     
Yes, enough 19 4.6 
Yes, but it is not enough 133 32.5 
No 257 62.8 
The main source of knowledge about measles(N=152)     
Colleagues 94 61.8 
Family/relatives 52 34.2 
Internet 33 21.7 
TV/Radio 31 20.4 
Education 27 17.8 
Newspapers/Magazines 16 10.5 
Health education 3 2.0 
Table 5.41: Respondents’ self-reported level of knowledge and source of information-
Soldiers. 
Knowledge about key facts of measles 
More than a third knew that measles is a highly communicable infectious disease and the lowest 
percentages were recorded for knowledge about the incubation period and occurrences of 
complication (Table 5.42). 
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Key facts of measles N* % 
Measles is a highly communicable infectious disease 155 37.9 
You know a person is really a measles case by medical examination 149 36.4 
Soldiers may have an increased risk of becoming infected with measles 83 20.3 
The microorganism that causes measles is virus 70 17.1 
The incubation period of measles is approximately seven to 21 days 13 3.2 
Complications of measles are relatively common 8 2.0 
Table 5.42: Percentage of the respondents who gave correct answers about key facts of 
measles-Soldiers(N=409) 
*N indicates the number of respondents who provided correct answers. 
Knowledge about measles transmission  
One quarter of soldiers knew of the risk of inhalation of infectious droplets which can occur 
during speaking, coughing, and sneezing, lower percentages knowing that a measles patient is 
considered  contagious before the appearance of the rash (Table 5.43). 
Knowledge about measles transmission N* % 
Measles can spread through inhalation of infectious droplets which can occur 
during (speaking, coughing, and sneezing). 
113 27.6 
Measles can spread through infectious secretions from the nose and throat. 106 25.9 
Short duration of exposure is enough for measles transmission. 86 21.0 
Measles can be transmitted from asymptomatic patients. 85 20.8 
A measles patient is considered to be contagious before the appearance of 
the rash. 
26 6.4 
Table 5.43: Percentage of the respondents who gave correct answers about measles 
transmission-Soldiers(N=409) 
*N indicates the number of respondents who provided correct answers. 
Knowledge about measles vaccine and immunity 
One third of the soldiers knew that soldiers without a reliable history of measles should receive 
the vaccine. A small minority knew that it cannot be given to someone with severe acute illness, 
with or without fever and a few knew that it is not safe for pregnant women (Table 5.44).  
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Measles knowledge about vaccine and immunity N* % 
Soldiers without a reliable history of measles disease should receive measles 
vaccine 
139 34.0 
To obtain optimum protection for soldiers, two doses of measles vaccine are 
required 
72 17.6 
The measles vaccine is a live attenuated vaccine. 69 16.9 
Acquired immunity after natural measles infection is permanent. 66 16.1 
Measles vaccine can be given to people with an egg allergy. 40 9.8 
The measles vaccine cannot be given for someone with severe acute illness, 
with or without fever. 
17 4.2 
The measles vaccine is not safe for pregnant woman. 9 2.2 
Table 5.44: Percentage of the respondents who gave correct answers about measles 
vaccine and immunity-Soldiers(N=409) 
*N indicates the number of respondents who provided correct answers. 
Perspectives about behaviour towards soldiers infected with measles 
About two fifths knew that an infected soldier’s contacts should be traced and investigated and 
about a third knew that an infected soldier should be isolated from work or daily activity 
(Table 5.45). 
Items reflecting attitude against the soldiers infected with measles N* % 
The infected soldier’s contacts should be traced and investigated of measles 162 39.6 
It is necessary to isolate the infected soldier from work or daily activity 150 36.7 
Infected soldier’s contacts should be immunised promptly if they do not have 
documentation of proved immunity against measles 
150 36.7 
The infected soldier cannot eat food with colleagues 131 32.0 
The infected soldier cannot shake hands with colleagues 121 29.6 
Table 5.45: Percentage of the respondents who gave correct answers about behaviours 
towards the soldiers infected with measles in a military cohort(N=409) 
*N indicates the number of respondents who provided correct answers. 
Perspectives of the respondents about measles outbreak in a military cohort 
About half knew that all contacts should receive the vaccine if they do not have evidence of 
immunity. Conversely, few knew that the recommended duration for isolation is 4 days before 
and after a related skin rash (Table 5.46). 
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Measles outbreak response  N* % 
All contacts should receive the measles vaccine if they do not have evidence of 
immunity 
203 49.6 
If there is evidence of immunity among contacts, they can immediately return to 
work 
128 31.3 
The recommended duration for isolation measles patients is four days before and 
after skin rash 
35 8.6 
In case of a contact with a patient who cannot take or refuses to receive the 
measles vaccine, they should be restricted from work for a period of 21 days 
from the last case 
24 5.9 
Table 5.46: Percentage of the respondents who gave correct answers about measles 
outbreak in a military cohort.(N=409) 
*N indicates the number of respondents who provided correct answers. 
Knowledge in different aspects of measles 
The median total knowledge score on the 27 items was four (inter-quartile range 0-10), 
corresponding to 14.8% in knowledge variation (inter-quartile range 0.0-37.1%) (Table 5.47). 
In subscales, the best score was on the key facts of measles knowledge (median 1). Conversely, 
the median score on the measles vaccine and immunity knowledge was the lowest (0). 
Knowledge aspects Median IQR 
As% of all questions 
median IQR 
Total knowledge score(27 Questions) 4 (0-10) 14.8 (0.0-37.1) 
Key facts of measles(6 Questions) 1 (0-2) 16.6 (0.0–33.3) 
Measles transmission(5 Questions) 0 (0-2) 0.0 (0.0–40.0) 
Measles vaccine and immunity(7 Questions) 0 (0-2) 0.0 (0.0-28.5) 
Attitude towards infected soldier(5 Questions) 1 (0-3) 0.0 (0.0–60.0) 
Measles outbreak response(4 Questions) 1 (0-2) 0.0 (0.0–50.0) 
Table 5.47: Median and inter-quartile range with percentage of the respondents who gave 
correct answers in different knowledge aspects about measles-Soldiers(N=409) 
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Measles knowledge score and sociodemographic characteristics 
The correlation was not statistically significant between measles knowledge score and studied 
sociodemographic characteristics in Table 5.48. 
Measles knowledge score N 
Spearman's 
rho correlation 
P-value 
Age 409 -0.03 0.51 
Time spent in formal education 409 0.06 0.20 
Years of experience in military fields 409 0.03 0.50 
Table 5.48: Correlation between measles knowledge score and sociodemographic 
characteristics-Soldiers. 
 
Those with a diploma had greater measles knowledge (Table 5.49). Additionally, the score was 
significantly associated with birth region, being higher among those born in Madinah compared 
to Taif. 
Characteristics N(%) 
Measles knowledge score  
P-
value 
(26 questions) 
Median(IQR) 
Marital status    0.21* 
Single  337(82.4%) 4.0(0.0–10.0) 
Ever married 72(17.6%) 6.0(1.0–12.0) 
Education level   0.02* 
Secondary school 273(66.7%) 4.0(0.0–10.0) 
Diploma 136(33.3%) 6.0(2.0-11.0) 
Birth region  0.03** 
Jeddah 108(26.4%) 4.0(0.0–9.0) 
Madinah 80(19.6%) 6.0(1.0–11.0) 
Makkah 74(18.1%) 5.0(1.0–11.2) 
Taif 64(15.6%) 2.0(0.0–7.7) 
Others 83(20.3%) 6.0(1.0–1.0) 
Table 5.49: Measles knowledge score and sociodemographic characteristics-
Soldiers(N=409) 
*Based on Mann-Whitney U test,**Based on Kruskal Wallis test 
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Measles knowledge score and sources of information 
Those who had enough information about measles scored higher in measles knowledge than 
those who did not have sufficient information, (Table 5.50). Better knowledge score were 
observed among those stating colleagues as the main source of information. 
The source of measles 
knowledge  
N(%) 
Measles knowledge 
score  
P-value 
(26 questions) 
Median(IQR) 
Have information about 
measles?(N=409) 
  
<0.001* 
Yes, enough(as perceived by the 
participant) 
19(4.6%) 14.0(6.0-16.0) 
Yes, but it is not enough 133(32.5%) 7.0(3.0-12.5) 
No 257(62.8%) 3.0(0.0–8.0) 
TV/Radio(N=152)   0.59** 
Yes 31(20.4%) 7.0(4.0-12.0) 
No 121(79.6%) 8.0(3.0-13.5) 
Newspapers/Magazines(N=152)   0.34** 
Yes 16(10.5%) 10.0(4.2-17.2) 
No 136(89.5%) 8.0(3.0-13.0) 
Education(N=152)    0.76** 
Yes 27(17.8%) 8.0(4.0-14.0) 
No 125(82.2%) 8.0(3.0-13.0) 
Colleagues(N=152)   0.06** 
Yes 94(61.8%) 6.5(3.0-13.0) 
No 58(38.2%) 9.0(4.7-14.0) 
Families(N=152)   0.75** 
Yes 52(34.2%) 8.0(2.2-12.0) 
No 100(65.8%) 8.0(3.0-14.0) 
Internet(N=152)   0.33** 
Yes 33(21.7%) 6.0(1.5-13.0)  
No 119(78.3%) 9.0(3.0-14.0) 
Table 5.50: Measles knowledge score and the source of knowledge-Soldiers 
*Based on Kruskal Wallis test ** Based on Mann-Whitney U test  
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Measles knowledge score among soldiers tested for measles, exposure or have immunity 
against measles 
There was no significance association between measles knowledge and among those 
respondents who were tested for immunity against measles or respondents who received regular 
doses of measles vaccines or those who have immunity against measles (Table 5.51). 
Characteristics  N(%) 
Measles 
knowledge score  P-
value* (26 questions) 
Median(IQR) 
Tested for measles immune status(N=409)   0.12 
Yes 10(2.4%) 8.5(0.0-10.0) 
No or not sure 399(97.6%) 4.0(2.7-14.0) 
Regular measles vaccine doses(N=48)   0.19 
Regular on time 2(4.2%) 14.0(12.0-16.0) 
Not regular 46(95.8%) 7.5(2.0-13.0) 
Immunity against measles(N=326)   0.38 
Positive 79(24.2%) 6.0(0.0-11.0) 
Negative 247(75.8%) 4.0(0.0-10.0) 
Table 5.51: Measles knowledge score among soldiers tested for measles, exposure or have 
immunity against measles 
*Based on Mann-Whitney U test 
 
Potential predictors of measles knowledge  
Table 5.52 shows the results of a logistic regression model identifying the potential predicators 
of measles knowledge. Variables included in the initial model are: level of education, birth 
region (Table 5.49); having information about measles (Table 5.50); testing for immune status 
against measles (Table 5.51). 
The model explained 15.3% of the variance in measles knowledge. Hosmer and Lemeshow 
indicated that the model was a reasonable fit (P=0.88). 
Birth region and having information made a significant independent contribution to the model. 
Measles knowledge score were significantly associated with birth region, compared to being 
Jeddah born, the odds of measles knowledge among those born outside the western region were 
double. Additionally, in comparison to those who had no information about measles, the odds 
of measles knowledge among those who had enough information about measles were three 
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times higher, and the odds of measles knowledge among those who did not have sufficient 
information were eight times higher. 
Variable* OR(95%CI) LRT-P 
Birth region   0.01 
Jeddah Reference 
Madinah 1.56(0.84-2.86) 
Makkah 1.29(0.69-2.41) 
Taif 0.65(0.33-1.29) 
Others 2.09(1.14-3.84) 
Have information about measles?   <0.001 
No Reference 
Yes, enough(as perceived by the participant) 2.96(1.90-4.63) 
Yes, but it is not enough 7.93(2.22-28.32) 
Table 5.52: Independent determinants of measles knowledge score-Soldiers(N=409). 
*Multiple logistic regression 
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5.3.3 Concern and attitude about measles 
 
Almost two thirds of the soldiers agreed measles is a serious disease (Table 5.53) and that the 
vaccination should be compulsory for soldiers. Furthermore, 73.0% agreed that family 
members and colleagues should take it if not already immune. 
Few soldiers expressed contentedness to treat measles-infected colleagues normally, and almost 
40.0% indicated that they would do so carefully. Almost a third reported being unsure. 
Statement Degree of agreement N % 
Measles is a serious disease 
Agree 275 67.2 
Neutral 82 20.0 
Disagree 52 12.7 
Measles vaccination should be made 
compulsory for soldiers 
Agree 291 71.1 
Neutral 67 16.4 
Disagree 51 12.5 
It is important for a soldier who was not 
infected by measles before, to be 
vaccinated 
Agree 274 67.0 
Neutral 93 22.7 
Disagree 42 10.3 
It is recommended for family members 
and colleagues should be vaccinated if 
they were not immune 
Agree 297 72.6 
Neutral 77 18.8 
Disagree 35 8.6 
If a measles infected person works with 
you in a military barrack, you will deal 
with him 
Normally 42 10.3 
Carefully 178 43.5 
I won’t deal with him 55 13.4 
I don't know 134 32.8 
Table 5.53: Participants’ concern and attitude towards the measles and measles-infected 
colleagues-Soldiers(N=409) 
Concern and attitude about measles and sociodemographic characteristics 
 
There was a small, positive significant correlation between period spent in formal education 
and those who suggested that vaccination against measles should be compulsory for soldiers, 
the more years equating to more in agreement (Table 5.54). Also, there was a small, positive 
correlation between years spent in formal education and those who said it was important for a 
soldier not infected by measles before, to be vaccinated. As years of education increase, there 
was higher agreement. 
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The correlation was also small, positive between measles knowledge and those who said it is a 
serious disease, the agreement increasing with the measles knowledge score. Additionally, there 
was a small and positive correlation between measles knowledge and those who said its 
vaccination should be compulsory for soldiers, the agreement increasing with the measles 
knowledge score. Further, the correlation was small and positive between measles knowledge 
and those who said it is important for a soldier who had not been infected by measles to be 
vaccinated, again increasing with the measles knowledge score. Additionally, there was a small, 
positive correlation between measles knowledge and the recommendation that non-immune 
family members and colleagues should be vaccinated against measles, again increasing with 
the measles knowledge score. 
Almost three quarters of diploma-holding soldiers agreed that measles is a serious disease and 
the association between education level and agreement was statistically significant, 
(Table 5.55). Similarly, four fifths of diploma-holding soldiers agreed that measles vaccination 
should be made compulsory for soldiers and this association between education level and 
agreement was statistically significant. Furthermore, more than three quarters of those who ever 
married, recommended measles infection-free soldiers be vaccinated and this association 
between marital status and agreement was statistically significant (Table 5.56). 
Over half of those with experience of a year or more in the military field expressed 
contentedness to deal with measles-infected colleagues carefully and about one third of those 
whose experience was less or none, expressed that they “don't know”, and this association was 
statistically significant (Table 5.57). Additionally, more than half of those whose measles 
knowledge score was above median would deal with measles-infected colleagues carefully and 
about half of those whose knowledge score was below median expressed that they “don't 
know”. This association was statistically significant. 
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Participants’ concern and 
attitude  
Measles is a 
serious disease 
Measles vaccination 
should be made 
compulsory for soldiers 
Important for a soldier 
who was not infected by 
measles before, to be 
vaccinated  
Family members and 
colleagues should be 
vaccinated if they were not 
immune 
Age Correlation* 0.07 0.06 0.09 0.04 
P-value 0.15 0.17 0.059 0.45 
Time spent in 
formal education 
Correlation* 0.08 0.14 0.12 0.04 
P-value 0.07 0.004 0.01 0.36 
Experience in 
military field 
Correlation* 0.02 0.09 0.01 0.008 
P-value 0.62 0.06 0.73 0.87 
Measles 
knowledge score  
Correlation* 0.28 0.31 0.27 0.36 
P-value <0.001 <0.001 <0.001 <0.001 
Table 5.54: Correlation between participants’ concern and attitude towards the measles and measles-infected colleagues and sociodemographic 
characteristics-Soldiers(N=409) 
*Based on Spearman's rho correlation 
  
  
272 
Characteristics N 
Measles is a serious disease 
P-Value 
Measles vaccination should be made 
compulsory for soldiers 
P-Value 
Disagree or neutral Agree Disagree or neutral Agree 
Marital status    0.98*   0.83* 
Single 337 111(32.9%) 226(67.1%) 96(28.5%) 241(71.5%) 
Ever married 72 23(31.9%) 49(68.1%) 22(30.6%) 50(69.4%) 
Education level    0.04*   0.001* 
Secondary school 273 99(36.3%) 174(63.7%) 94(34.4%) 179(65.6%) 
Diploma 136 35(25.7%) 101(74.3%) 24(17.6%) 112(82.4%) 
Birth region    0.23**   0.12** 
Jeddah 108 34(31.5%) 74(68.5%) 34(31.5%) 74(68.5%) 
Madinah 80 29(36.3%) 51(63.8%) 21(26.3%) 59(73.8%) 
Makkah 74 17(23.0%) 57(77.0%) 17(23.0%) 57(77.0%) 
Taif 64 26(40.6%) 38(59.4%) 26(40.6%) 38(59.4%) 
Others 83 28(33.7%) 55(66.3%) 20(24.1%) 63(75.9%) 
Table 5.55: Association between participants’ concern and attitude towards the measles and measles-infected colleagues and sociodemographic 
characteristics-Soldiers(N=409)(a) 
*Based on Continuity Correction.**Based on Monte Carlo method  
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Characteristics  N 
 Important for a soldier who was not 
infected by measles before, to be 
vaccinated P-Value 
 Family members and colleagues should be 
vaccinated if they were not immune 
P-Value 
Disagree or neutral Agree Disagree or neutral Agree 
Marital status 
 
  0.04*   0.95* 
Single 337 119(35.3%) 218(64.7%) 93(27.6%) 244(72.4%) 
Ever married 72 16(22.2%) 56(77.8%) 19(26.4%) 53(73.6%) 
Education level 
 
  0.09*   0.26* 
Secondary school 273 98(35.9%) 175(64.1%) 80(29.3%) 193(70.7%) 
Diploma 136 37(27.2%) 99(72.8%) 32(23.5%) 104(76.5%) 
Birth region    0.68**   0.45** 
Jeddah 108 34(31.5%) 74(68.5%) 30(27.8%) 78(72.2%) 
Madinah 80 29(36.3%) 51(63.8%) 25(31.3%) 55(68.8%) 
Makkah 74 23(31.1%) 51(68.9%) 19(25.7%) 55(74.3%) 
Taif 64 25(39.1%) 39(60.9%) 21(32.8%) 43(67.2%) 
Others 83 24(28.9%) 59(71.1%) 17(20.5%) 66(79.5%) 
Table 5.56: Association between participants’ concern and attitude towards the measles and measles-infected colleagues and sociodemographic 
characteristics-Soldiers(N=409)(b) 
*Based on Continuity Correction.**Based on Monte Carlo method 
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Characteristics N 
If a measles infected person works with you in a 
military barrack, you will deal with him 
P-
Value  
Normally Carefully 
I won’t 
deal with 
him 
I don't 
know 
Age by category(Years)      0.43* 
≤21 102 12(11.8%) 40(39.2%) 17(16.7%) 33(32.4%) 
22-24 165 12(7.3%) 81(49.1%) 21(12.7%) 51(30.9%) 
≥25 142 18(12.7%) 57(40.1%) 17(12.0%) 50(35.2%) 
Time spent in formal 
education(Years) 
     0.13* 
12 and less 232 21(9.1%) 94(40.5%) 30(12.9%) 87(37.5%) 
13 and more 177 21(11.9%) 84(47.5%) 25(14.1%) 47(26.6%) 
Experience in military 
field(Years) 
     0.04** 
<1 Year or no experience 381 37(9.7%) 163(42.8%) 55(14.4%) 126(33.1%) 
1 Year 28 5(17.9%) 15(53.6%) 0(0%) 8(28.6%) 
Marital status      0.09* 
Single 337 30(8.9%) 143(42.4%) 48(14.2%) 116(34.4%) 
Ever married 72 12(16.7%) 35(48.6%) 7(9.7%) 18(25.0%) 
Education level      0.10* 
Secondary school 273 23(8.4%) 115(42.1%) 36(13.2%) 99(36.3%) 
Diploma 136 19(14.0%) 63(46.3%) 19(14.0%) 35(25.7%) 
Birth region      0.06* 
Jeddah 108 17(15.7%) 45(41.7%) 16(14.8%) 30(27.8%) 
Madinah 80 12(15.0%) 33(41.3%) 8(10.0%) 27(33.8%) 
Makkah 74 4(5.4%) 31(41.9%) 10(13.5%) 29(39.2%) 
Taif 64 0(0.0%) 29(45.3%) 8(12.5%) 27(42.2%) 
Others 83 9(10.8%) 40(48.2%) 13(15.7%) 21(25.3%) 
Measles knowledge      <0.001
* 
Knowledge score equal to 
median or below 
208 15(7.2%) 70(33.7%) 22(10.6%) 101(48.6%) 
Knowledge score above 
median 
201 27(13.4%) 108(53.7%) 33(16.4%) 33(16.4%) 
Table 5.57: Attitude of participants towards the measles and measles-infected colleagues 
among and sociodemographic characteristics-Soldiers(N=409) 
*Based on Monte Carlo method**Based on Fisher's Exact test 
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5.3.4 Summary of serology results among soldiers who completed the questionnaire 
Seroprevalence and clinical interpretations of measles  
About three quarters did not have serological evidence of immunity against measles, and this 
might be either due to lack of a specific immune response to measles immunisation or no prior 
exposure to the measles virus (Table 5.58). 
Serology test Result N (95%C.I) Interpretation  
IgG measles Negative 247(75.8%) (70.8-80.1) 
1-Might be lack of a specific 
immune response to 
immunisation. 
2-Might be no prior exposure to 
the measles virus. 
IgG measles Positive 79(24.2%) (19.9–29.2) 
Prior exposure to the measles 
virus through infection or 
immunisation 
Table 5.58: Clinical interpretation of measles serological markers-Soldiers(N=326) 
 
Seroprevalence of measles antibodies and associated variables 
Measles seroimmunity and sociodemographic characteristics 
When compared with those 21 years old or less, the odds of positive IgG measles among those 
between 22 and 24 years old were two times higher and also almost two times higher among 
those 25 years old or more (Table 5.59). 
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Characteristics 
Cross tabulation  Univariate analysis  
Negative 
IgG 
Measles 
(N=247) 
Positive 
IgG 
Measles 
(N=79) 
Overall 
N 
OR(95%CI) 
LRT-
P 
Age by category(Years)    
 
0.03 
≤ 21 75 13 88 Reference 
22 24 94 34 128 2.08(1.02-4.23) 
≥25 78 32 110 1.84(0.76-4.41) 
Years of work 
experience(Years) 
228 74 302 
 
0.68 
<1 Year or no experience     Reference 
1 Year 19 5 24 0.81(0.29-2.24) 
Formal education(Years)     
 
0.13 
12 and less 149 40 189 Reference 
13 and more 98 39 137 1.48(0.89-2.46) 
Marital Status      0.87 
Single 202 64 266 Reference 
Ever married 45 15 60 1.05(0.55-2.01) 
Education level     0.72 
Secondary school 173 57 230 Reference 
Diploma 74 22 96 0.90(0.51-1.58) 
Birth region      0.18 
Jeddah  58 23 81 Reference 
Madinah 45 20 65 1.12(0.54-2.29) 
Makkah 47 16 63 0.85(0.40-1.80) 
Taif 47 8 55 0.42(0.17-1.04) 
Others 50 12 62 0.60(0.27-1.33) 
Table 5.59: Measles seroimmunity and sociodemographic characteristics-Soldiers(N=326) 
 
Potential predictors of measles seroimmunity  
Table 5.60 shows the results of a logistic regression model investigating the potential 
predicators of measles seroimmunity. Variables included in the initial model were: Age by 
category, formal education and region of birth (Table 5.59). The model explained 3.0% of the 
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variance in seroimmunity IgG measles. Hosmer and Lemeshow indicated that the model was a 
reasonable fit (P=1.00). Only the age variable made an independent significant contribution to 
the model. Compared to those 21 years old or less, the odds of positive IgG measles among 
those 22 and 24 years old were twice and also almost two times higher among those 25 years 
old or more. 
Variable* OR(95%CI) LRT-P 
Age by category (Years)  0.04 
≤ 21 Reference 
22 24 2.08(1.02-4.23) 
≥25 2.36(1.15-4.85) 
Table 5.60: Independent determinants of measles seroimmunity-Soldiers(N=326) 
*Multiple logistic regression 
 
5.3.5 Summary of measles serology results among soldiers who were not given the 
questionnaire 
Seroprevalence and clinical interpretations of measles serological markers 
Seroprevalence and clinical interpretation of serological markers about measles is summarised 
in Table 5.61.  
Serology test Result N (95%C.I) Interpretation  
IgG measles Negative 463(65.6%) (62.0-69.0) 
1-Might be lack of a specific 
immune response to 
immunisation. 
2-Might be no prior exposure to 
the measles virus. 
IgG measles Positive 243(34.4%) (31.0–38.0) 
Prior exposure to the measles virus 
through infection or immunisation 
Table 5.61: The laboratory results for measles markers-Soldiers(N=706) 
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5.4 Varicella among Soldiers 
 
5.4.1 Previous varicella related health history 
Previous investigation for varicella 
About a third reported having been infected with varicella (Table 5.62). For those varicella 
infected more than a year before, the median was 10 years (inter-quartile range 8-15 years) and 
a range of (1–26 years), of whom, almost half indicated that they had been infected during the 
previous 10 years ago. A minority were sure they had been previously investigated for varicella, 
and the rest responded that they had never been screened or were not sure. Of the latter 
grouping, almost half indicated that they had been informed that they were immune, only two 
soldiers being not immune. 
Investigation against varicella N % 
Previous infection to varicella(N=409)   
Yes 148 36.2 
No 218 53.3 
Not sure 43 10.5 
Time of infection with varicella(N=148)   
<= 10 years ago 83 56.1 
11 years ago and more  65 43.9 
Previous investigation against varicella immune status(N=409)     
Yes 24 5.9 
No 292 71.4 
Not sure 93 22.7 
Results of investigations against varicella immune status(N=24)     
Immune 13 54.2 
Not immune 2 8.3 
Not sure 9 37.5 
Place at which investigations were done(N=24)     
SMOH  22 91.7 
MNG-HA  1 4.2 
Private hospital 1 4.2 
Table 5.62: Investigation against varicella-Soldiers 
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Varicella immunisation 
Only a few had received the two doses required for protection against varicella. Additionally, 
about three quarters did not know if they had received it, and about a tenth had not been offered 
(Table 5.63 and Table 5.64). 
Of those vaccinated before, about half were during primary school stage and three quarters in 
SMOH. Most reasons to be vaccinated were either immunisation campaigns or on a doctor’s 
recommendation, a quarter were vaccinated because of personal motivation. Only 12 soldiers 
received regular vaccine doses and almost half did not know if they were vaccinated in a regular 
pattern. 
Characteristics N % 
Varicella vaccination status(N=409)   
More than two doses 13 3.2 
Two doses  6 1.5 
One dose 22 5.4 
Varicella vaccine not offered 45 11.0 
Varicella vaccine offered, but not taken 16 3.9 
I do not know 307 75.1 
Time of administration of varicella vaccine(N=72)     
Before primary school 4 5.6 
During primary school 41 56.8 
During secondary school 13 18.1 
During undergraduate study 3 4.2 
I do not know 11 15.3 
Place of administration varicella vaccine(N=72)     
SMOH 54 75.0 
MNG-HA 13 18.1 
Others* 5 6.9 
Table 5.63: Immunisation history with varicella vaccine-Soldiers(a) 
*Others(N): School health(3), Private hospital(2) 
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Characteristics N %  
The reason for being vaccinated(N=72)     
Immunisation campaigns 38 52.8 
Doctor’s recommendation 23 31.9 
Self-motivation 18 25.0 
Work requirement 7 9.7 
Parent's recommendation 2 2.8 
Were the doses of varicella vaccine regular*?(N=72)    
Regular 12 16.7 
Irregular 11 15.3 
I did not receive all two doses 9 12.5 
I do not know 40 55.6 
Table 5.64: Immunisation history of varicella vaccine-Soldiers(b) 
*(The second dose from one to 2 months of 1st dose). Any other regimen is considered irregular. 
 
The reasons why some of the soldiers were not vaccinated against varicella are shown in 
Table 5.65. 
The reason why not vaccinated against varicella  N % 
I do not believe myself at risk. 197 58.5 
Varicella is not a serious enough disease to warrant immunisation 58 17.2 
Difficulty access obtaining the varicella vaccine. 24 7.1 
I am concerned about the efficacy of the varicella vaccine 17 5.0 
I am concerned about the safety of the varicella vaccine. 14 4.2 
Natural varicella infection is preferable to vaccine. 12 3.6 
I suffer from a medical condition 6 1.8 
I had been infected with varicella 5 1.5 
I do not know 41 12.2 
Others* 8 2.4 
Table 5.65: The reason why not vaccinated against varicella-Soldiers(N=337) 
*Others: No awareness(4), I am concerned about the cost(4) 
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Self-reporting of the respondents who had positive or negative IgG varicella about the history 
of immunisation 
Of those seropositive IgG varicella, about two fifths of those reported being infected by 
varicella and a quarter during the last ten years (Table 5.66). Additionally, few reported being 
immune against varicella and the majority’s immune status was not tested. Among soldiers who 
had seropositive IgG varicella, 15 soldiers (5%) received two doses or more and about three 
quarters did not know if they had received it. Meanwhile, about a tenth received it in 
immunisation campaigns and seven soldiers received regular doses. However, four fifths were 
never vaccinated before (Table 5.67). 
Of those seronegative IgG varicella, few had been infected before, two reporting being immune 
against varicella, three soldiers reported receipt in two doses or more and four soldiers in a 
regular pattern. Nonetheless, the majority were never vaccinated (Table 5.68). 
 
Exposure to potential risks of acquiring varicella 
One third of the soldiers indicated that they have seen at least one patient within the previous 
five years with a varicella infection and a tenth heard of one or more patients being hospitalised 
for varicella-related conditions. 
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IgG varicella is positive  N % 
Were you ever infected with varicella?   
Yes 138 45.5 
No 131 43.2 
Not sure 34 11.2 
I was infected with varicella in   
<= 10 years ago 79 26.1 
11 years ago and more 59 19.5 
Not infected or not sure 165 54.5 
Tested for immune status against varicella and result was  
Immune 11 3.6 
Not Immune 1 0.3 
Not sure 8 2.6 
Not tested  283 93.4 
Varicella vaccination status   
More than two doses 11 3.6 
Two doses 5 1.7 
One dose 19 6.3 
I was offered the varicella vaccine, but I have not had it 14 4.6 
I have not been offered the varicella vaccine. 33 10.9 
I do not know 221 72.9 
Varicella vaccination time    
Before primary school 3 11.0 
During primary school 30 9.9 
During secondary school 12 3.9 
During undergraduate study 2 0.7 
I do not know 11 3.6 
Not vaccinated  245 80.8 
Table 5.66: Self-reporting of the respondents who had positive IgG varicella alone about 
the immunisation history-Soldiers(N=303)(a) 
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IgG varicella is positive  N % 
The reason to be vaccinated against varicella   
Immunisation campaigns 31 10.2 
Doctor’s recommendation 21 6.9 
Self-motivation 14 4.6 
Other* 5 1.6 
Not vaccinated 245 80.9 
Were the doses regular? 
 
Regular on time  7 2.3 
Not regular 51 16.8 
Not vaccinated 245 80.9 
Table 5.67: Self reporting of the respondents who had positive IgG varicella alone about 
the immunisation history-Soldiers(N=303)(b) 
*Other (N): Work requirement(4), School health(1) 
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IgG varicella is negative  N % 
Were you ever infected with varicella?   
Yes 6 6.1 
No 83 84.7 
Not sure 9 9.2 
I was infected with varicella in   
<= 10 years ago 2 2.0 
11 years ago and more 4 4.1 
Not infected or not sure  92 93.9 
Tested for immune status against varicella and result was   
Immune 2 2.0 
Not immune 1 1.0 
Not sure 1 1.0 
Not tested  94 95.9 
Statements describes about receiving the varicella vaccination   
More than two doses 2 2.0 
Two doses 1 1.0 
One dose 3 3.1 
I was offered the varicella vaccine, but I have not had it 1 1.0 
I have not been offered the varicella vaccine. 11 11.2 
I do not know. 80 81.6 
I was vaccinated against varicella    
Before primary school 1 1.0 
During primary school 10 10.2 
During secondary school 1 1.0 
During undergraduate study 1 1.0 
Not vaccinated 85 86.7 
Were the doses regular?   
Regular on time 4 4.1 
Not regular 9 9.2 
Not vaccinated 85 86.7 
Table 5.68: Self-reporting of the respondents who had negative IgG varicella alone about 
the immunisation history-Soldiers(N=98) 
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5.4.2 Varicella knowledge 
Self-reporting of the respondents about their level of knowledge and sources of their 
information 
Over half the soldiers expressed having varicella knowledge and more than two fifths described 
their knowledge as inadequate (Table 5.69). Of those whose knowledge was enough or 
inadequate, over half pointed to colleagues, and half quoted the family/relatives as the main 
sources of information. 
Knowledge level and source of information N % 
Do you have information about varicella?(N=409)     
Yes, enough 56 13.7 
Yes, but it is not enough 175 42.8 
No 178 43.5 
The main source of knowledge about varicella(N=231)     
Colleagues 135 58.4 
Family/relatives 122 52.8 
Internet 61 26.4 
Education 45 19.5 
TV/Radio 41 17.7 
Newspapers/Magazines 17 7.4 
Others* 2 0.9 
Table 5.69: Respondents’ self-reported level of knowledge and source of information-
Soldiers. 
*Others(N): Health education materials(1), I was infected by varicella(1) 
Knowledge about key facts of varicella 
Half the soldiers knew that varicella is a highly communicable infectious disease and the lowest 
percentage was recorded for knowledge about the incubation period of varicella (Table 5.70). 
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Key facts of varicella N* % 
Varicella is a highly communicable infectious disease 208 50.9 
Soldiers may have an increased risk of becoming infected with varicella 114 27.9 
The microorganism that causes varicella is virus 78 19.1 
You know a person is really a varicella case by medical examination 59 14.4 
The risk of complications and mortality due to varicella is 10 times higher 
among adults than children 
57 13.9 
Reactivation of the varicella microorganism can cause herpes zoster disease 
later in life after primary infection 
31 7.6 
The incubation period with a range of ten to 21 days 9 2.2 
Table 5.70: Percentage of the respondents who gave correct answers about key facts of 
varicella-Soldiers(N=409) 
*N indicates the number of respondents who provided correct answers. 
Knowledge about varicella transmission  
 
Nearly a fifth knew that varicella can be spread through infectious secretions from the nose and 
throat. Lower percentages of the soldiers knew that a varicella patient is considered contagious 
before the appearance of the rash (Table 5.71).  
Knowledge about varicella transmission N* % 
Varicella can spread through direct contact with fluids from the blister of a 
person infected with varicella 
184 45.0
, 
Varicella can spread through inhalation of infectious droplets which can 
occur during (speaking, coughing, and sneezing) 
173 42.3 
Varicella can spread through infectious secretions from the nose and throat 145 35.5 
Varicella can be spread through direct contact with a sore from a person with 
shingles (shingles is a painful localised skin rash often with blisters) 
106 25.9 
Varicella can be transmitted from asymptomatic patients 90 22.0 
The source of the varicella infection could be a case of varicella or herpes 
zoster 
81 19.8 
A varicella patient is considered to be contagious before the appearance of 
the rash 
35 8.6 
Table 5.71: Percentage of the respondents who gave correct answers about varicella 
transmission-Soldiers(N=409) 
*N indicates the number of respondents who provided correct answers 
  
  
287 
Knowledge about varicella vaccine and immunity 
Almost a third knew that soldiers without a reliable history of varicella should receive the 
varicella vaccine. Also, a minority of soldiers knew that the varicella vaccine is not safe for 
pregnant women (Table 5.72).  
Varicella knowledge about vaccine and immunity N* % 
Soldiers without a reliable history of varicella disease should receive varicella 
vaccine 
130 31.8 
Acquired immunity after natural varicella infection is permanent 84 20.5 
The varicella vaccine is a live attenuated vaccine 63 15.4 
To obtain optimum protection for soldiers, two doses of varicella vaccine are 
required 
59 14.4 
The varicella vaccine can protect if given within 72 hours of exposure 52 12.7 
The varicella vaccine can only be taken by those aged 12 months and above 48 11.7 
Immunity following varicella vaccination is not life-long 36 8.8 
The varicella vaccine cannot be given for someone with severe acute illness, 
with or without fever 
17 4.2 
Immunisation of a person who has natural varicella immunity is not harmful 16 3.9 
The varicella vaccine is not safe for pregnant woman 14 3.4 
Table 5.72: Percentage of the respondents who gave correct answers about varicella 
vaccine and immunity-Soldiers(N=409) 
*N indicates the number of respondents who provided correct answers. 
Perspectives of the soldiers about behaviour towards soldiers infected with varicella 
The knowledge of the respondents towards the hypothetical situation where positive cases of 
varicella are present close to them, is described in Table 5.73.  
Items reflecting attitude against the soldiers infected with varicella N* % 
The infected soldier’s contacts should be traced and investigated of varicella 195 47.7 
It is necessary to isolate the infected soldier from work or daily activity 182 44.5 
Infected soldier’s contacts should be immunised promptly if they do not have 
documentation of proved immunity against varicella 
176 43.0 
The infected soldier cannot shake hands with colleagues 176 43.0 
The infected soldier cannot eat food with colleagues 165 40.3 
Table 5.73: Percentage of the respondents who gave correct answers about behaviours 
towards the soldiers infected with varicella(N=409) 
*N indicates the number of respondents who provided correct answers. 
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Perspectives of the respondents about varicella outbreak in a military cohort 
The knowledge of the soldiers towards the hypothetical situation about a sudden varicella 
outbreak in a military cohort is summarised in Table 5.74.  
Varicella outbreak response  N* % 
All contacts should receive the varicella vaccine if they do not have evidence of 
immunity 
202 49.4 
If there is evidence of immunity among contacts, they can immediately return to 
work 
143 35.0 
The recommended duration for isolation varicella patients is 2 days before and 
5 days after skin rash. 
32 7.8 
In case of a contact with a patient who cannot take or refuses to receive the 
varicella vaccine, they should be restricted from work for a period of 21 days 
from the last case 
28 6.8 
Table 5.74: Percentage of the respondents who gave correct answers about varicella 
outbreak in a military cohort. (N= 409) 
*N indicates the number of respondents who provided correct answers. 
Knowledge in different aspects of varicella 
The median total knowledge score on the 33 items was seven (inter-quartile range 1-13), 
corresponding to a percentage of 21.2% in knowledge variation (inter-quartile range 3.0-39.4%) 
(Table 5.75). Concerning the subscales, the best score was seen on the attitude towards infected 
soldier (median 2). Conversely, the median score on the varicella vaccine and immunity scores 
was the lowest (0). 
Knowledge aspects Median IQR 
As% of all questions 
median IQR 
Total knowledge score(33 Questions) 7 (1-13) 21.2 (3.0-39.4) 
Key facts of varicella(7 Questions) 1 (0-2) 14.3 (0.0–28.6) 
Varicella transmission(7 Questions) 1 (0-4) 14.3 (0.0–57.1) 
Varicella vaccine and immunity(10 Questions) 0 (0-2) 0.0 (0.0-20.0) 
Attitude towards infected soldier(5 Questions) 2 (0-2) 40.0 (0.0–40.0) 
Varicella outbreak response(4 Questions) 1 (0-2) 25.0 (0.0–50.0) 
Table 5.75: Median and inter-quartile range with percentage of the respondents who gave 
correct answers in different knowledge aspects about varicella-Soldiers(N=409) 
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Varicella knowledge score and sociodemographic characteristics 
The correlation was not statistically significant between varicella knowledge score and 
sociodemographic characteristics (Table 5.76). 
Varicella knowledge score N Spearman's 
rho correlation 
P-value 
Age 409 -0.007 0.88 
Time spent in formal education 409 0.09 0.06 
Years of experience in military field 409 0.06 0.18 
Table 5.76: Correlation between varicella knowledge score and sociodemographic 
characteristics 
 
There was a significant association between varicella knowledge score and highest level of 
education, those who have a diploma had greater varicella knowledge (Table 5.77). 
Characteristics N(%) 
Varicella knowledge score  
P-value (33 questions) 
Median(IQR) 
Marital status    0.59* 
Single  337(82.4%) 7.0(0.5–13.0) 
Ever married 72(17.6%) 8.0(1.0–13.5) 
Education level  0.002* 
Secondary school 273(66.7%) 6.0(0.0–12.0) 
Diploma 136(33.3%) 10.0(4.0-14.7) 
Birth region  0.07** 
Jeddah 108(26.4%) 5.0(0.0–13.0) 
Madinah 80(19.6%) 8.0(1.2–13.0) 
Makkah 74(18.1%) 7.0(2.0–15.0) 
Taif 64(15.6%) 4.0(0.0–12.0) 
Others 83(20.3%) 8.0(1.0–14.0) 
Table 5.77: Varicella knowledge score and sociodemographic characteristics-
Soldiers(N=409) 
*Based on Mann-Whitney U test**Based on Kruskal Wallis Test 
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Varicella knowledge score and sources of information 
Those who had enough information about varicella scored higher in varicella knowledge than 
those who did not have sufficient information (Table 5.78). Those whose source of information 
was education scored a higher median knowledge score. 
The source of varicella 
knowledge 
N(%) 
Varicella knowledge score  
P-value (33 questions) 
Median(IQR) 
Have information about 
varicella?(N=409) 
  
<0.001* 
Yes, enough(as perceived by the 
participant) 
56(13.7%) 14.0(5.2-16.7) 
Yes, but it is not enough 175(42.8%) 10.0(4.0-14.0) 
No 178(43.5%) 2.0(0.0–9.0) 
TV/Radio(N=231)   0.058** 
Yes 41(17.7%) 13.0(6.5-16.0) 
No 190(82.3%) 10.0(4.0-14.2) 
Newspapers/Magazines(N=231)   0.55** 
Yes 17(7.4%) 11.0(5.0-16.5) 
No 214(92.6%) 11.0(4.0-15.0) 
Education(N=231)    0.04** 
Yes 45(19.5%) 13.0(5.0-16.0) 
No 186(80.5%) 10.0(4.0-14.0) 
Colleagues(N=231)   0.16** 
Yes 135(58.4%) 11.0(5.0-15.0) 
No 96(41.6%) 11.0(3.2-14.0) 
Families(N=231)   0.96** 
Yes 122(52.8%) 11.0(4.0-15.0) 
No 109(47.2%) 11.0(5.0-15.0) 
Internet(N=231)   0.09** 
Yes 61(26.4%) 12.0(7.0-15.0)  
No 170(73.6%) 10.0(4.0-15.0) 
Table 5.78: Varicella knowledge score and the source of knowledge-Soldiers 
*Based on Kruskal Wallis test**Based on Mann-Whitney U test  
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Varicella knowledge score among soldiers tested for varicella, exposure or have immunity 
against varicella 
Significantly higher scores in median varicella knowledge were recorded among those who 
tested for immunity against varicella (Table 5.79). 
Characteristics  N(%) 
Varicella 
knowledge score  P-
value* (33 questions) 
Median(IQR) 
Tested for immune status against 
varicella?(N=409) 
  
<0.001 
Yes 24(5.9%) 14.0(10.2-17.0) 
No or not sure 385(94.1%) 6.0(0.0-13.0) 
Regular varicella vaccine doses were 
received(N=72) 
  
0.07 
Regular on time 12(16.7%) 13.5(7.0-21.2) 
Not regular 60(83.3%) 11.00(4.0-15.0) 
Immunity against varicella(N=401)   0.23 
Negative 98(24.4%) 5.0(0.0-12.2) 
Positive 303(75.6%) 8.0(1.0-13.0) 
Table 5.79: Varicella knowledge score among soldiers tested for varicella, exposure or 
have immunity against varicella 
*Based on Mann-Whitney U test 
Potential predictors of varicella knowledge  
Table 5.80 shows the results of a logistic regression model investigating the potential 
predicators of varicella knowledge. Variables included in the initial model are: level of 
education (Table 5.77); having information about varicella (Table 5.78); testing for immune 
status against varicella (Table 5.79). 
The model explained 16.3% of the variance in varicella knowledge. Hosmer and Lemeshow 
indicated that it was a reasonable fit. (P=0.98) 
“Have information about varicella and tested for immune status against varicella variables” 
made a significant independent contribution to the model. In comparison to those who had no 
information about varicella, the odds of varicella knowledge among those who had enough 
information about varicella were four times higher, and the odds of varicella knowledge among 
those who did not have sufficient information were three times higher. Furthermore, in 
  
292 
comparison to those who had not tested or were unsure, the odds of varicella knowledge among 
those who had tested against varicella immune status were almost eight times higher. 
Variable* OR(95%CI) LRT-P** 
Have information about varicella?   <0.001 
No Reference 
Yes, but it is not enough 3.07(1.97-4.76) 
Yes, enough 4.44(2.25-8.79) 
Were you tested for immune status against varicella?   0.001 
No or not sure  Reference 
Yes 7.87(1.78-34.80) 
Table 5.80: Independent determinants of varicella knowledge score-Soldiers(N=409). 
*Multiple logistic regression 
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5.4.3 Concern and attitude about varicella  
 
Over two thirds of soldiers agreed that varicella is a serious disease (Table 5.81). Additionally, 
about three quarters-stated that the vaccination should be compulsory and for those not infected 
before. Furthermore, about three quarters agreed that family members and colleagues should 
take the vaccine if not already immune. 
Few participants accepted the duty to deal with varicella-infected colleagues in a military 
barracks as normal persons, though almost half indicated that they would deal with them 
carefully. However, a third of soldiers reported that they would not deal with varicella-infected 
persons. 
Statement Degree of agreement N % 
Varicella is a serious disease 
Agree 271 66.3 
Neutral 78 19.1 
Disagree 60 14.7 
Varicella vaccination should be made 
compulsory for soldiers 
Agree 295 72.1 
Neutral 70 17.1 
Disagree 44 10.8 
It is important for soldiers who was not 
infected by varicella before, to be 
vaccinated 
Agree 296 72.4 
Neutral 67 16.4 
Disagree 46 11.2 
It is recommended for family members 
and colleagues should be vaccinated if 
they were not immune 
Agree 306 74.8 
Neutral 65 15.9 
Disagree 38 9.3 
If a varicella infected person works with 
you in a military barrack, you will deal 
with him 
Normally 27 6.6 
Carefully 180 44.0 
I won’t deal with him 132 32.3 
I don't know 70 17.1 
Table 5.81: Participants’ concern and attitude towards the varicella and varicella-infected 
colleagues-Soldiers(N=409) 
  
  
294 
Concern and attitude about varicella and sociodemographic characteristics  
 
There was a small, positive correlation between age and those viewing varicella as a serious 
disease; the older the respondent, the more the agreement There was also, a small, positive 
correlation between age and those who suggested the vaccination should be compulsory for 
soldiers - as age increases, there was more agreement (Table 5.82). Moreover, there was a small, 
positive correlation between time spent in formal education and those who suggested that 
vaccination should be compulsory for soldiers; the longer the more the agreement. There was 
also a small, positive correlation between time spent in formal education and the 
recommendation that non-immune family members and colleagues should be vaccinated-again 
as years of education increase, there was more agreement. The correlation was also small, 
positive between period spent in formal education and the recommendation that infection-free 
soldiers should be vaccinated, as years of education increases, there was more agreement.  
There was a small, positive correlation between varicella knowledge and those who said it is a 
serious disease, the agreement increasing with the varicella knowledge score. Additionally, 
there was a small, positive correlation between varicella knowledge and those who suggested 
that vaccination should be compulsory for soldiers, the agreement increasing with the varicella 
knowledge score. Also, there was a small, positive correlation between varicella knowledge 
and those who said it is important for a soldier who was not previously infected to be vaccinated, 
as varicella knowledge increases there was more agreement. Finally, there was a small, positive 
correlation between varicella knowledge and the recommendation that non-immune family 
members and colleagues should be vaccinated-the agreement increasing with the varicella 
knowledge score. 
Almost four fifths of diploma-holding soldiers agreed that the varicella vaccination should be 
compulsory for soldiers and the association between the education level of respondents and 
agreement was statistically significant (Table 5.83). Furthermore, most diploma-holding 
soldiers recommended varicella infection-free soldiers be vaccinated and the association 
between the education level of respondents and agreement was statistically significant 
(Table 5.84). 
About half of those who spent 13 years and more in formal education expressed contentedness 
to deal with varicella-infected colleagues carefully and about two fifths of those with less 
experience responding “don't know”, this association being statistically significant (Table 5.85). 
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Almost half the diploma holders would deal with varicella-infected colleagues carefully and 
about a third of secondary school holders were “don't knows”; the association being statistically 
significant. Similarly, almost two thirds of those born outside the western sector would deal 
with varicella-infected colleagues carefully and about half of those born in Taif were “don't 
knows”; the association being statistically significant. Additionally, more than half of those 
whose varicella knowledge score was above median would deal with varicella-infected 
colleagues carefully and about half of those whose knowledge score was below median 
expressed a “don't know”, and the association was statistically significant. 
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Participants’ concern and 
attitude 
Varicella is a 
serious disease 
Varicella vaccination 
should be made 
compulsory for 
soldiers 
Important for a soldier 
who was not infected by 
varicella before, to be 
vaccinated 
Family members and 
colleagues should be 
vaccinated if they were not 
immune 
Age Correlation* 0.11 0.13 0.06 0.06 
P-value 0.02 0.008 0.16 0.17 
Time spent in 
formal education 
Correlation* 0.06 0.14 0.11 0.10 
P-value 0.20 0.004 0.01 0.03 
Experience in 
military field 
Correlation* 0.09 0.07 0.03 0.01 
P-value 0.06 0.15 0.49 0.84 
Varicella 
knowledge score  
Correlation* 0.29 0.36 0.35 0.36 
P-value <0.001 <0.001 <0.001 <0.001 
Table 5.82: Correlation between participants’ concern and attitude towards the varicella and varicella-infected colleagues and 
sociodemographic characteristics-Soldiers(N=409) 
*Based on Spearman's rho correlation   
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Characteristics  N 
Varicella is a serious disease 
P-
Value* 
Varicella vaccination should be made 
compulsory for soldiers P-
Value* 
Disagree or neutral Agree Disagree or neutral Agree 
Marital status    0.44*   0.86* 
Single 337 117(34.7%) 220(65.3%) 95(28.2%) 242(71.8%) 
Ever married 72 21(29.2%) 51(70.8%) 19(26.4%) 53(73.6%) 
Education level    0.10*   0.02* 
Secondary school 273 100(36.6%) 173(63.4%) 86(31.5%) 187(68.5%) 
Diploma 136 38(27.9%) 98(72.1%) 28(20.6%) 108(79.4%) 
Birth region    0.21**   0.32** 
Jeddah 108 38(35.2%) 70(64.8%) 29(26.9%) 79(73.1%) 
Madinah 80 30(37.5%) 50(62.5%) 27(33.8%) 53(66.3%) 
Makkah 74 17(23.0%) 57(77.0%) 17(23.0%) 57(77.0%) 
Taif 64 26(40.6%) 38(59.4%) 22(34.4%) 42(65.6%) 
Others 83 27(32.5%) 56(67.5%) 19(22.9%) 64(77.1%) 
Table 5.83: Association between participants’ concern and attitude towards the varicella and varicella-infected colleagues and sociodemographic 
characteristics-Soldiers(N=409)(a) 
*Based on Continuity Correction**Based on Monte Carlo method 
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Characteristics  N 
 Important for a soldier who was not 
infected by varicella before, to be 
vaccinated 
P-
Value* 
 Family members and colleagues 
should be vaccinated if they were 
not immune 
P-
Value* 
Disagree or neutral Agree Disagree or neutral Agree 
Marital status    0.98*   0.85* 
Single 337 93(27.6%) 244(72.4%) 86(25.5%) 251(74.5%) 
Ever married 72 20(27.8%) 52(72.2%) 17(23.6%) 55(76.4%) 
Education level    0.01*   0.06* 
Secondary school 273 86(31.5%) 187(68.5%) 77(28.2%) 196(71.8%) 
Diploma 136 27(19.9%) 109(80.1%) 26(19.1%) 110(80.9%) 
Birth region    0.13**   0.45** 
Jeddah 108 32(29.6%) 76(70.4%) 27(25.0%) 81(75.0%) 
Madinah 80 28(35.0%) 52(65.0%) 22(27.5%) 58(72.5%) 
Makkah 74 18(24.3%) 56(75.7%) 19(25.7%) 55(74.3%) 
Taif 64 20(31.3%) 44(68.8%) 20(31.3%) 44(68.8%) 
Others 83 15(18.1%) 68(81.9%) 15(18.1%) 68(81.9%) 
Table 5.84: Association between participants’ concern and attitude towards the varicella and varicella-infected colleagues and sociodemographic 
characteristics-Soldiers(N=409)(b) 
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Characteristics N 
If a varicella infected person works with you in a 
military barrack, you will deal with him P-
Value 
Normally Carefully 
I won’t 
deal with 
him 
I don't 
know 
Age by 
category(Years) 
     0.52* 
≤ 21 102 6(5.9%) 43(42.2%) 21(20.6%) 32(31.4%) 
22-24 165 11(6.7%) 78(47.3%) 30(18.2%) 46(27.9%) 
≥25 142 10(7.0%) 59(41.5%) 19(13.4%) 54(38.0%) 
Time spent in formal 
education(Years) 
     
0.01* 
12 and less 232 10(4.3%) 102(44.0%) 34(14.7%) 86(37.1%) 
13 and more 177 17(9.6%) 78(44.1%) 36(20.3%) 46(26.0%) 
Experience in 
military field 
     
0.44*
* 
<1 Year or No 
experience 
381 24(6.3%) 165(43.3%) 67(17.6%) 125(32.8%) 
1 Year 28 3(10.7%) 15(53.6%) 3(10.7%) 7(25.0%) 
Marital status      0.36*
* Single 337 21(6.2%) 149(44.2%) 62(18.4%) 105(31.2%) 
Ever married 72 6(8.3%) 31(43.1%) 8(11.1%) 27(37.5%) 
Education level      0.02* 
Secondary school 273 16(5.9%) 118(43.2%) 39(14.3%) 100(36.6%) 
Diploma  136 11(8.1%) 62(45.6% ) 31(22.8%) 32(23.5%) 
Birth region      0.006
* Jeddah 108 6(5.6%) 55(50.9%) 18(16.7%) 29(26.9%) 
Madinah 80 8(10.0%) 33(41.3%) 14(17.5%) 25(31.3%) 
Makkah 74 6(8.1%) 22(29.7%) 19(25.7%) 27(36.5%) 
Taif 64 2(3.1%) 22(34.4%) 7(10.9%) 33(51.6%) 
Others 83 5(6.0%) 48(57.8%) 12(14.5%) 18(21.7%) 
Varicella 
knowledge 
     
<0.001
* 
Knowledge score equal 
to median or below 
197 9(4.6%) 66(33.5%) 23(11.7%) 99(50.3%) 
Knowledge score 
above median 
212 18(8.5%) 114(53.8%) 47(22.2%) 33(15.6%) 
Table 5.85: Attitude of participants towards the varicella and varicella-infected colleagues 
and sociodemographic characteristics-Soldiers(N=409) 
*Based on Monte Carlo method**Based on Fisher's Exact test  
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5.4.4 Summary of serology results among soldiers who completed the questionnaire 
Seroprevalence and clinical interpretations of varicella  
About a quarter of the soldiers did not have serological evidence of immunity against varicella 
(Table 5.86). 
Serology test Result N (95%C.I) Interpretation  
IgG varicella Negative 98(24.4%) (20.5–28.9) 
1-Might be lack of a specific 
immune response to 
immunisation. 
2-Might be no prior exposure to 
the varicella zoster virus. 
IgG varicella Positive 303(75.6%) (71.1-79.5) 
Prior exposure to the varicella 
zoster virus through infection 
or possible immunisation. 
Table 5.86: Clinical interpretation of varicella-Soldiers(N=401) 
Seroprevalence of varicella antibodies and associated variables 
 
Varicella seroimmunity and sociodemographic characteristics 
 
When compared, soldiers with those 21 years old or less, the odds of positive IgG varicella 
among those whose 25 years old or more were higher (Table 5.87). 
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Characteristics 
Cross tabulation  Univariate analysis  
Negative 
IgG 
Varicella 
(N=98) 
Positive 
IgG 
Varicella 
(N=303) 
Overall 
N 
OR(95%CI) 
LRT-
P 
Age by category(Years)    
 
0.01 
21 31 68 99 Reference 
22-24 44 119 163 1.23(0.71-2.13) 
≥25 23 116 139 2.29(1.24-4.26) 
Work experience    
 
0.94 
<1 Year or no experience  91 282 373 Reference 
1 Year 7 21 28 0.96(0.39-2.35) 
Formal education(Years)    
 
0.68 
12 and less  53 171 224 Reference 
13 and more 45 132 177 0.90(0.57-1.43) 
Marital Status      0.34 
Single 84 247 331 Reference 
Ever married 14 56 70 1.36(0.72-2.56) 
Education level     0.80 
Secondary school  66 200 266 Reference 
Diploma 32 103 135 1.06(0.65-1.72) 
Birth region      0.10 
Jeddah 23 83 106 Reference 
Madinah 15 62 77 1.14(0.55-2.37) 
Makkah 14 59 73 1.16(0.55-2.45) 
Taif 23 40 63 0.48(0.24-0.96) 
Others 23 59 82 0.71(0.36-1.38) 
Table 5.87: Varicella seroimmunity and sociodemographic characteristics-
Soldiers(N=401) 
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Potential predictors of varicella seroimmunity  
Table 5.88 shows the results of a logistic regression model identifying the potential predicators 
of varicella seroimmunity. Variables included in the initial model are: age by category and 
region of birth (Table 5.87). The model explained 5.9% of the variance in seroimmunity IgG 
varicella. Hosmer and Lemeshow indicated that it was a reasonable fit (P=0.71). 
The age variable made a significant independent contribution to the model. Compared with 
those 21 years old or less, the odds of positive IgG varicella among those 25 years old or more 
were two times higher. 
Variable* OR(95%CI) LRT-P 
Age(Years)  0.01 
≤ 21 Reference 
22-24 1.32(0.75-2.32) 
≥25 2.42(1.29-4.56) 
Birth region   0.08 
Jeddah Reference 
Madinah 1.01(0.48-2.13) 
Makkah 1.16(0.55-2.47) 
Taif 0.46(0.23-0.92) 
Others 0.65(0.33-1.28) 
Table 5.88: Independent determinants of varicella seroimmunity-Soldiers(N=401) 
*Multiple logistic regression 
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5.4.5 Summary of varicella serology results among soldiers who were not given the 
questionnaire 
Seroprevalence and clinical interpretations of varicella serological markers 
Seroprevalence and clinical interpretation of serological markers about varicella summarised in 
(Table 5.89). About a third of the soldiers did not have serological evidence of immunity against 
varicella. 
 
Serology test Result N (95%C.I) Interpretation  
IgG varicella Negative 224(31.7%) (28.4–35.3) 
1-Might be lack of a specific 
immune response to 
immunisation. 
2-Might be no prior exposure to 
the varicella zoster virus. 
IgG varicella Positive 482(68.3%) (64.7–71.6) 
Prior exposure to the varicella 
zoster virus through infection or 
possible immunisation. 
Table 5.89: The laboratory results for varicella markers-Soldiers(N=706) 
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5.5 Assessment Participation Bias in the Questionnaire Surveys 
High IgG measles positivity among those for whom only serology data were available and high 
IgG varicella positivity was observed among those participating in the questionnaire Table 5.90. 
 
Characteristics Participated in the questionnaire Overall 
N 
P-Value  
 No(N=706) Yes 
HbsAg   (N=403)  1.000* 
Negative 705(63.7%) 402(36.3%) 1107 
Positive 1(50.0%) 1(50.0%) 2 
HbcAb   (N=326)  0.73* 
Negative 698(68.3%) 324(31.7%) 1022  
Positive 8(80.0%) 2(20.0%) 10 
HbsAb  (N=326)   0.72** 
Negative 489(68.0%) 230(32.0%) 719 
Positive 217(69.3%) 96(30.7%) 313 
IgG Measles   (N=326)   0.001** 
Negative 463(65.2%) 247(34.8%) 710  
Positive 243(75.5%) 79(24.5%) 322 
IgG Varicella 
 
(N=401)   0.01** 
Negative 224(69.6%) 98(30.4%) 322 
Positive 482(61.4%) 303(38.6%) 785 
Table 5.90: Participation bias in the questionnaire surveys among those who completed 
questionnaire and those for whom only serology data available-Soldiers. 
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5.6 Integration of Findings across the Three Diseases 
Among those soldiers participating and those who did not participate in the questionnaire, there 
was no statistical significant association between positive immune status against any disease 
and other diseases,(Table 5.91, Table 5.92 and Table 5.93) 
Variable* 
Completed the questionnaire(N=326) Not given the questionnaire(N=706) 
OR(95%CI) LRT-P OR(95%CI) LRT-P 
IgG Measles  0.34  0.60 
Negative Reference Reference 
Positive 0.76(0.42-1.35) 0.91(0.65-1.28) 
IgG Varicella  0.50  0.38 
Negative Reference Reference 
Positive 1.21(0.68-2.13) 1.16(0.85-1.65) 
Table 5.91:Immune status against measles and varicella if an individual had been 
immunised against HBV among soldiers 
*Multiple logistic regression 
Variable* 
Completed the questionnaire(N=326) Not given the questionnaire(N=706) 
OR(95%CI) LRT-P OR(95%CI) LRT-P 
HBsAb  0.34  0.60 
Negative Reference Reference 
Positive 0.76(0.42-1.35) 0.91(0.65-1.28) 
IgG Varicella  0.70  0.11 
Negative Reference Reference 
Positive 1.12(0.61-2.04) 1.31(0.93-1.84) 
Table 5.92:Immune status against HBV and varicella if an individual had been immunised 
against measles among soldiers 
*Multiple logistic regression 
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Variable* 
Completed the questionnaire(N=326) Not given the questionnaire(N=706) 
OR(95%CI) LRT-P OR(95%CI) LRT-P 
HBsAb  0.50  0.38 
Negative Reference Reference 
Positive 1.21(0.68-2.13) 1.16(0.82-1.65) 
IgG Measles  0.70  0.11 
Negative Reference Reference 
Positive 1.12(0.61-2.04) 1.31(0.93-1.84) 
Table 5.93:Immune status against HBV and measles if an individual had been immunised 
against varicella among soldiers 
*Multiple logistic regression 
 
Among those participating in the questionnaire, those who were immunised against HBV were 
67% higher in varicella knowledge and 76% higher in total knowledge of the three diseases. 
(Table 5.94, Table 5.95, Table 5.96 and Table 5.97). 
Variable* OR(95%CI) LRT-P 
IgG Measles  0.36 
Negative Reference 
Positive 1.26(0.76-2.10) 
IgG Varicella  0.69 
Negative Reference 
Positive 0.90(0.54-1.49) 
Table 5.94:Knowledge of HBV and immune status about measles and varicella among 
those who completed the questionnaire - soldiers(N=326). 
*Multiple logistic regression 
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Variable* OR(95%CI) LRT-P 
HBsAb  0.07 
Negative Reference 
Positive 1.54(0.95-2.49) 
IgG Varicella  0.99 
Negative Reference 
Positive 1.00(0.60-1.66) 
Table 5.95:Knowledge of measles and immune status about HBV and varicella among 
those who completed the questionnaire -soldiers(N=326). 
*Multiple logistic regression 
 
Variable* OR(95%CI) LRT-P 
HBsAb  0.03 
Negative Reference 
Positive 1.67(1.03-2.73) 
IgG Measles  0.60 
Negative Reference 
Positive 1.14(0.68-1.91) 
Table 5.96:Knowledge of varicella and immune status about HBV and measles among 
those who completed the questionnaire-soldiers(N=326). 
*Multiple logistic regression 
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Variable* OR(95%CI) LRT-P 
HBsAb  0.02 
Negative Reference 
Positive 1.76(1.08-2.87) 
IgG Measles  0.18 
Negative Reference 
Positive 1.42(0.85-2.38) 
IgG Varicella  0.63 
Negative Reference  
Positive 1.13(0.67-1.89)  
Table 5.97:Total knowledge and immune status about HBV, measles and varicella among 
those who completed the questionnaire-soldiers(N=326). 
*Multiple logistic regression 
 
Among those participating in the questionnaire, those soldiers who were scored above median 
in HBV knowledge had a six times higher measles knowledge and four times higher varicella 
knowledge. Additionally, those who scored above median in measles knowledge had a nine 
times higher varicella knowledge,(Table 5.98, Table 5.99 and Table 5.100) 
 
Variable* OR(95%CI) LRT-P 
Knowledge score about measles  <0.001 
Median and below Reference 
Above median 6.45(3.80-10.94) 
Knowledge score about varicella  <0.001 
Median and below Reference 
Above median 4.18(2.46-7.10) 
Table 5.98:Knowledge of HBV and potential association of knowledge score to measles 
and varicella among those who completed the questionnaire-soldiers(N=326). 
*Multiple logistic regression 
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Variable* OR(95%CI) LRT-P 
Knowledge score about HBV  <0.001 
Median and below Reference 
Above median 6.45(3.80-10.94) 
Knowledge score about varicella  <0.001 
Median and below Reference 
Above median 9.15(5.38-15.56) 
Table 5.99:Knowledge of measles and potential association of knowledge score to HBV 
and varicella among those who completed the questionnaire-soldiers(N=326). 
*Multiple logistic regression 
 
Variable* OR(95%CI) LRT-P 
Knowledge score about HBV  <0.001 
Median and below Reference 
Above median 4.18(2.46-7.10) 
Knowledge score about measles  <0.001 
Median and below Reference 
Above median 9.15(5.38-15.56) 
Table 5.100:Knowledge of varicella and immune status about HBV and measles among 
those who completed the questionnaire-soldiers(N=326). 
*Multiple logistic regression 
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5.7 Independent Variables Predictive of Immunity Status and or Knowledge across the 
Three Diseases or across the Two Professional Groups 
There was no similarity between independent variables predictive of immunity status and or 
knowledge across the three diseases or across the two professional groups as shown in 
Table 5.101 
Disease Comparison 
Independent predictive determinants 
HCWs Soldiers 
HBV 
Low 
knowledge* 
1- Non-physicians 
2- Saudis 
3- Not tested for immune 
status 
1- Secondary 
educational holding. 
2- Having no 
infected family member 
Low HBsAb** 
1- Male 
2- Originating from the 
MER 
3- Working in admin. 
4- Working at the PHCs. 
Those who are less than 
25 years. 
Measles 
Low 
knowledge* 
1- Younger 
2- Non-physicians 
Born in WR of KSA 
Low IgG 
measles** 
1- Saudis 
2- Males 
3- Spent 17-18 years in 
formal education 
4- Originated from the 
MER 
Those 22 years or less. 
Varicella 
Low 
knowledge* 
1- Medical specialists 
2- Technicians 
3- Admin 
Not testing for immune 
status 
Low IgG 
varicella** 
1- Originating from the 
MER, the WPR, the SEAR 
2- Technician 
3- Staff nurses 
Those 21 years or less. 
Table 5.101:Independent variables predictive of immunity status and or knowledge across 
the three diseases or across the two professional groups. 
* Multivariable linear regression **Multivariable logistic regression  
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Chapter 6. Qualitative Research Results  
The qualitative research findings are presented in this chapter, comprising characteristics of this 
study group, an overview of the interviews and key themes emerging, as well as participants’ 
views about the vaccination barriers reported. 
6.1 Characteristics of the Recruited Sample 
The main individual characteristics of the 26 interview participants are shown in Table 6.1. 
Vaccine providers’ views were obtained from: one physician and four civilian nurses on HCWs 
vaccination programme (HCWs-VP) and one physician and four military nurses represented 
views about military vaccination programme (Military-VP). Additionally, eight newly recruited 
nurses on HCWs-VP and a similar number of newly recruited soldiers on military-VP 
participated in the FGDs. 
6.2 Key Themes Emerged from Interviews 
Analyses suggested the existence of comprehensive and closely inter-related themes that helped 
explore and understand vaccine barriers in the SANG and what limitations need addressing. 
The identified main topics along with related themes and sub-themes describe the divergent, 
service user versus vaccine providers’ views towards the barriers to vaccination programme. 
A more detailed account of the results is presented under the headings of the content areas with 
the themes as sub-headings, categories, and sub-categories indicated within the text. Direct 
quotes (in italics) were presented as representations of the most salient and prevalent themes 
and sub-themes identified from all interviews and FGDs. Quotations which express the views 
of HCWs or soldiers were shown under service users’ views, while quotations which express 
the views of staff providing the vaccine were shown under providers’ views. 
  
312 
Type Quotation Code 
Interview 
Code 
Age Sex Nationality Occupation Education level 
HCWs-VP 
In depth 
interviews 
among 
providers 
 
Civilian-Nurse-1 Y-HCW 36 Female British Public health nurse(PHN) Bachelor 
Civilian-Nurse-2 O.H-HCW 42 Female Egyptian PHN Bachelor 
Civilian-Nurse-3 O-HCW 37 Female Egyptian PHN Bachelor 
Civilian-Nurse-4 S-HCW 42 Female Saudi PHN Bachelor 
Physician-1 M-HCW 45 Male USA Public health physician(PHP) Master 
FGDs among 
service users 
Eight nurses-FGD HCWs 
between 
(22-25) 
All are 
females 
Saudis Newly recruited nurses Bachelor 
Military-VP 
In depth 
Interviews 
among 
providers 
Physician-2 M-Soldier 38 Male Sudanese PHP Master 
Military-Nurse-5 Ab-Soldier 42 Male Saudi Military Nurse(MN) Diploma 
Military-Nurse-6 Al-Soldier 32 Male Saudi MN Diploma 
Military-Nurse-7 F-Soldier 37 Male Saudi MN Diploma 
Military-Nurse-8 O-Soldier 44 Male Saudi MN-Coordinator Diploma 
FGD among 
service users 
Eight soldiers-FGD Soldiers 
between 
(20-25) 
All are 
males 
Saudis Newly recruited soldiers 
Secondary 
school 
Table 6.1: Key characteristics of participants of the recruited sample(N=26)
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6.3 Vaccine Barriers among Health Care Workers and Soldiers Related to Vaccination 
Programme 
The following section covered themes, sub-themes, and factors that accounted for the vaccine 
barriers amongst newly recruited HCWs and soldiers. These include five main barriers: 
individual-related, vaccine-related, staff-providers’ vaccine, organisational-related and social 
and cultural related barriers. These barriers could directly or indirectly affect HCWs/soldiers 
adherence and compliance to vaccination. 
6.3.1 Individual related barriers 
Several individual and personal factors influenced the participants’ compliance with 
vaccination including their belief about vaccines, knowledge level, willingness to be 
vaccinated, and negative experiences with vaccinations. These subthemes could explain low 
adherence among HCWs/soldiers. 
 
Vaccine belief 
Some participants stated that some new recruits do not believe in vaccine benefits for many 
reasons such as, reading incorrect literature or anti-vaccination groups. This will affect 
acceptance of HCWs/soldiers to be vaccinated, some had the following to say: 
Providers’ views 
“Some of them do not believe in the benefit of the vaccine itself, some of them say, “I do not 
think this is necessary. I am fine. I do not feel this vaccine is important”HCWs-VP,Physician-
1 
“Sometimes there is an argument that they know so much about the vaccination. Maybe they 
read incorrect literature and incorrect information about the vaccination. For example, the 
swine flu vaccination and the flu vaccination, the MMR vaccination, they've all had a history 
of negative press in the public eye. If the employees have read this then that can affect their 
perception of the vaccination.”HCWs-VP,Nurse-1 
Some participants held a negative attitude towards vaccination; they mentioned non-
vaccination either because of negligence or their environment promoting a non-positive view 
towards vaccination, following are few quotes: 
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Service users’ views: 
“It depends, some HCWs are enthusiastic because they have the information, but others do not 
care at all.”Nurse-FGD 
“A soldier feels in a good health, so he thinks that no need for vaccination. If I have someone 
going with me, I will get encouraged, but I won’t go on my own to be vaccinated.”Soldier-FGD 
Providers’ views 
“Some of them do really need it, for example, if you want to prescribe a measles vaccine they 
will tell you, “My mother told me I got measles. I do not need it because I’ve had 
measles.”However, the lab results show that they really need the vaccine, some say, “No, I do 
not need it. I do not think this is important. I do not need it.” It’s a denial.”HCWs-
VP,Physician-1 
 
Low awareness about vaccines and vaccination 
Inadequate knowledge was widespread among participants including misconceptions and 
ignorance about how vaccines function and are administered. This could affect 
HCWs’/soldiers’ adherence and compliance to be vaccinated. Most nurses/soldiers interviewed 
demonstrated a low knowledge level about adult vaccines; some had the following to say: 
Service users’ views: 
“No, I do not know all the vaccinations that I am supposed to take or not, When? Why? And 
what are the side effects? I think that not all the HCWs know them.”Nurse-FGD 
“I bet you that more than 50% of the soldiers don’t know about the vaccination even if they 
hear its name.”Soldier–FGD 
“I am not interested to be vaccinated because I don’t know about vaccines and their 
importance.”Soldier-FGD 
 
Some nurses attributed the low level of knowledge about vaccines to an absence of education 
and promotion related to adult vaccines. While soldiers attributed this to cultural grounds, 
especially those from a Bedouin origin. 
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Service users’ views: 
“Because there is no education about the adult vaccination shown in the TV or heard on radio 
so we did not hear about vaccination.”Nurse-FGD 
“I came from an environment where no such things are known (Bedouin area). They are 
ignorant about these things.”Soldier-FGD 
 
The team providing vaccines confirmed the presence of this low level of knowledge, as well as 
HCWs/soldiers’ disinterest in asking questions about the provided vaccines. Additionally, this 
low level of awareness was reported amongst battalion commanders and leaders, possibly 
impacting decisions made about being vaccinated: 
Providers’ views: 
“Definitely. Definitely. Some people who are not educated in the healthcare field, who are not 
HCWs directly with the patients, they don't understand initially why they need the vaccination. 
Sometimes they ask me if they're having the vaccination because they have the disease. They 
really do not understand the concept of the vaccination, in which case you have to spend a lot 
of time explaining this to them.”HCWs-VP,Nurse-1 
“They are in their mind, they already completed their vaccine when they were 
children.”HCWs-VP,Nurse-2 
“Soldiers are very eager to know more about the vaccine; what is it? Why is it important? They 
want to know about its time, duration and its side effects.”Military-VP,Nurse-8 
“Many leaders know nothing about vaccination and its importance. They think of it as 
something dispensable, not essential.”Military-VP,Nurse-8 
 
Willingness to be vaccinated  
Vaccination in the SANG is mandated by regulation and encouraged by health authorities to 
safeguard HCWs and soldiers from exposure risk to infections. Some did not show a willingness 
to be vaccinated unless given reasons such as the complete recruitment process, affecting 
adherence to vaccine compliance as indicated below: 
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Service users’ views: 
“We are forced with convincing; we are forced because it is a job requirement. For example, 
no manager would allow his employees to work without it. It is one of the policies that you have 
to take Hep B and Flu vaccines.”Nurse-FGD 
“Here, we are taking these vaccines because we want to pass this military training”Military–
FGD 
Providers’ views: 
“I do not think they (HCWs) are aware and convinced. They just come and do their paperwork, 
especially the foreign HCWs, and they have to follow the rules and the policy of the hospital. 
They have to take it. Otherwise, the process of paperwork will not be approved. This is what I 
know.”HCWs-VP,Nurse-4 
“(…..)You know the problem? When you’re newly recruited soldier you feel like unless you get 
this vaccine, you will not get the job. So sometimes you feel you have no choice; you should get 
the vaccine if you agree or not. I feel like this may be a violation or against the rights of the 
vaccinated person. So we should try to convince the person and to give him the chance either 
to accept or to refuse the vaccine.”Military-VP,Physician-2 
 
Although soldiers accepted vaccines, this was because of military order, not due to belief in the 
protective potential of the vaccine: 
“I get vaccinated because I receive an order to do so.”Soldier–FGD 
“In the military environment, it is not your choice, you have to take it whether you agreed or 
not, but you know that it is for your benefit and they won’t harm you.”Soldier–FGD 
 
Some recruited nurses/soldiers exhibited disinterest in vaccination, citing a lack of motivation 
as a reason: 
Service users’ views: 
“My enthusiasm depends on the time they offer this vaccine. If I am afraid from a disease 
because I heard that it was a serious one or an outbreak happened, I would take it without 
thinking.”Nurse-FGD 
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“People around you in the society think that there is no need for such vaccination; whenever 
one gets sick; he can go to hospital.”Soldier–FGD 
Providers’ views: 
“Nobody wants to take a vaccine, especially if they are not used to taking this kind of vaccine 
in their country and just because they come here they have to take it.”HCWs-VP,Nurse-4 
 
Previous experience 
When investigating personal views about vaccination in general, most participants quoted 
previous bad experiences, including pain and/or phobia felt or witnessed on fellow 
HCWs/soldiers experiencing discomfort and restlessness. These fears seem to cause serious 
concerns and anxiety for HCWs/soldiers and could affect their adherence to vaccine 
compliance, some had the following to say: 
Service users’ views: 
“I went through a bad experience. This happened when a nurse did not vaccinate me properly 
and the area got inflamed. Such situation would be a very bad experience for anyone especially 
if he gets scared of injections.”Soldier-FGD 
Providers’ views: 
“The other reason might also be they are scared from a bad experience of a friend or colleague 
in the field. If someone gets, for example, side effect or reaction or whatever, like getting 
swelling after the needle pricking, they will come and say, “See what my friend got?. Her arm 
is very swollen and she cannot move it. I do not like it. I might end up being like her.”HCWs-
VP,Nurse-2 
“Some, hear from their colleague some stories and refuse for no reason, what does this mean, 
they think the same will happen to them.”HCWs-VP,Nurse-3 
 
Injection-induced anxiety and pain following vaccination and needle fears are a documented 
barrier to vaccination in adults(246). Such concerns were indicated: 
Service users’ views: 
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“Fearing from injection itself is the thing that may prevent me to be vaccinated, I am very afraid 
of the injection itself.”Nurse-FGD 
Providers’ views: 
“Some HCWs have a genuine needle phobia. They're frightened of the vaccine. They're 
frightened of what it will do to them. That's the main reason they refuse.”HCWs-VP,Nurse-1 
“Some of soldiers avoid vaccination because they fear the needle.”Military-VP,Nurse 5 
Role of education level 
Educational level plays a role in HCWs'/soldiers' willingness to accept or refuse vaccination; 
the higher the education level, the more willing to be vaccinated as indicated below: 
Providers’ views: 
“The response is different. For example, HCWs, doctors and nurses, they understand about 
vaccinations and they're normally quite happy to receive them. Whereas the other employees, 
for example office workers, admin workers, drivers, they do not understand, mainly, anything 
about the vaccination and they get very concerned and sometimes worried. You have to spend 
a lot of time with those type of people explaining the vaccination”HCWs-VP,Nurse-1 
“University graduate soldiers are more cooperative in vaccination. They sit with you, talk and 
ask. However, people with lower level of education are not very cooperative to get 
vaccinated.”Military-VP,Nurse-5 
Occupational position role 
There was a variation in the acceptance of vaccines among HCWs/soldiers associated with 
educational level. However, there was agreement that in higher positions among HCWs and 
low rank soldiers, vaccine compliance was reduced. 
Physicians (considered the highest position amongst HCWs’ occupations) have low 
compliance, possibly attributable to knowing more about vaccine risk or being too busy. 
However, officers are more compliant (in being vaccinated), while soldiers, and non-
commissioned officers show some reluctance and rejection, some had the following to say: 
Service users’ views: 
“Physicians are the likeliest people to hesitate to take the vaccine, I think maybe because 
physicians know the components and have more information.”Nurse-FGD 
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“In my opinion, most doctors are lazy to take the vaccine. They put in their minds that they are 
busy and there are things more important than taking vaccine or attending educational.”Nurse-
FGD 
Providers’ views: 
“Generally speaking, I would say doctors are more reluctant to get the vaccinations and they 
are the least likely to follow up with their repeat vaccinations.”HCWs-VP,Nurse-1 
“All, but mostly physicians who are the ones who refuse to take vaccines, and then nurses. 
Physicians, especially consultants, refuse taking most vaccines.”HCWs-VP,Nurse-4 
“Non-commissioned officers and soldiers were hesitant, but officers are always interactive with 
us.”Military-VP,Nurse-7 
 
Some team members tried to explain why physicians are more reluctant and how this can play 
a negative role – 
Providers’ views: 
“During the vaccination campaign, the first group to refuse to be vaccinated is doctors. We 
need to really focus on doctors. I do not know why? They would give many excuses, “I do not 
have time.” Imagine if doctor says that, what about the other HCWs?”HCWs-VP,Nurse-3 
“Usually when physicians see us in the vaccine trolley would ask, “Where is the meningitis 
vaccine? We need to take the vaccine for meningitis.” When we say, “It is flu” they would say, 
“No, this is not good, I have read articles saying that it is not beneficial and it will expose us 
to risks” and then their influence is bad on the other people around them.”HCWs-VP,Nurse-
4 
 
In addition to physicians, administrators and HCWs in academic positions show some 
reluctance and rejection: 
Providers’ views: 
“Those who are doing admin work, might not have any idea about why they would want to take 
these vaccines and they would say, “We already took them in our childhood, do we need to take 
the vaccination again?.”HCWs-VP,Physician-1 
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“The academic HCWs are sometimes reluctant to take a vaccine because they would say, 
“We’re not dealing with any patients, and we are far from direct contact with an anyone and it 
is okay for us. We’ve been already vaccinated and we are still young.” HCWs-VP,Nurse-2 
 
Although nurses are more compliant (in being vaccinated), this can be partially attributed to 
nursing department policy to urge all nurses to be vaccinated, and not because of any belief in 
the protective potential of such vaccines: 
Providers’ views: 
“I think it’s because the way we do it. With nurses what happens is all the nurse managers on 
each ward will come and take the number of doses that she will need in her ward and then the 
nurses vaccinate each other. So, for example, in this ward there are 30 nurses. They will take 
30 doses and the nurse manager will have a checklist and everybody should get the 
vaccine.”HCWs-VP,Physician-1 
“The nurses are definitely the most willing to have the vaccination because they are working 
directly with the patients. They seem to appreciate the risks that they are under and they seem 
very keen to have the vaccinations.”HCWs-VP,Nurse-1 
 
Psychological reasons 
Some neurological or immune-mediated reactions could occur after vaccination (247). These 
include seizures, episodes of hypotonic or hypo-responsiveness, allergy reactions, and 
anaphylaxis (247). Additionally some have psychological fears against vaccination. This could 
possibly reduce adherence to vaccine compliance. However, staff providing vaccines linked 
those reactions to psychological preparedness rather than vaccination or vaccines, stating: 
Service users’ views: 
“For me, I am afraid and I am concerned about the vaccination, what does is it made of? What 
are the reactions after taking it?”Nurse-FGD 
“I had dizziness at the college, but it was not a drama, maybe a fear. Because it was not one 
injection. They opened the injections then gave this and that. Finally, I dazed, and I could not 
stand.”Nurse-FGD 
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Providers’ views: 
“They ask, “Do I really have to receive this, I received it when I was young. That is enough. 
You will break the needle, it will hurt me, what will happen if I do not get the vaccine? But I 
feel okay.”HCWs-VP,Nurse-2 
“Some soldiers experience hypotension due to the fear they feel during the vaccination process, 
also some suffer convulsion or neurogenic shock. (...), it is about fear the vaccination process; 
the vaccination might have nothing to do with that.”Military-VP,Nurse 8 
 
 
6.3.2 Vaccine related barriers 
The safety of vaccines should be closely and constantly monitored, however, several factors 
determining safety could affect HCWs/soldiers adherence and compliance. The IPCP should 
identify possible vaccine side effects, acute reaction and adverse events, and the efficiency of 
reporting such events. The following are sub-themes that describe concerns and worries. 
 
Risk perception of vaccine side effects 
Of the side effects that possibly occur after comprehensive HCWs/military vaccination - fever, 
restlessness, pain, sore throat, and swelling - heightened concerns, significantly influencing 
compliance, some had the following to say: 
Service users’ views: 
“Some people do not want to suffer from side effects like the pain, fever or discomfort likely to 
be felt in the location of the injection, and some are afraid of the injection itself.”Nurse-FGD 
“One day while searching the internet I found a subject about measles vaccine. This vaccine 
was preserved by Formaldehyde that may cause children autism. Such side effect of this vaccine 
is a big problem.”Nurse-FGD 
Providers’ views: 
“The main problem that we face is their (HCWs) concern about the side effects of the 
vaccination and not understanding the reasons for the vaccination.”HCWs-VP,Nurse-1 
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“Most of them (soldiers) don’t want to get sick after the vaccination. They do not want to 
experience a fever; they say we have to get to work tomorrow and we don’t want to get 
sick.”Military-VP,Nurse-7 
 
The occurrence of side effects was mainly linked to intramuscularly administered vaccines such 
as Menactra® (meningococcal conjugate vaccine) or with live attenuated virus ones such as 
influenza, measles or varicella vaccines. The following comments clarify this: 
Providers’ views: 
“(…)for example, the measles and the varicella vaccine, they are live vaccines, so people can 
often experience a fever for 24 to 48 hours after these vaccines, particularly because they're 
live. They can also develop redness at the site of the injection. That's very common to these live 
vaccinations.”HCWs-Nurse-1 
“They (HCWs) would say, “I’ve had a very bad experience with this flu vaccine.” “A very bad 
flu that keeps coming and going, it never stops” or fever and a general ache”HCWs-Nurse-4 
“Another example is the Menactra®, meningitis. Maybe about 10% of people develop a lump 
on their arm that can be very painful.”HCWs-Nurse-3 
“Soldiers talk about this subject like the flu for example. They say that it negatively affects the 
immunity and causes pain, fever and hypertonia. Additionally, they say that meningitis causes 
you fever and keeps you in bed for days.”Military-VP,Nurse 5 
“Soldiers speak about the minor side effect, like fever. Usually after varicella vaccine for 
example. Although it’s not common.”Military-VP,Physician-2 
 
Perceived low effective vaccine and vaccine type 
Type of vaccine and its effectiveness in producing effective immunity were reported to be 
reasons for low compliance. 
The misconceptions arising from confusing symptoms of influenza and flu detracted from the 
perceived efficacy of influenza vaccination and some HCWs/soldiers do not believe in flu 
vaccine and do not want to take it, some had the following to say: 
Service users’ views: 
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“Some people think if they take the flu vaccine, they will be sick for three days. If they also have 
the flu or the infection, they will be sick for a similar period and then they will be fine. They 
will say shall we take flu vaccine and be exposed to the risk?”Nurse-FGD 
Providers’ views: 
“With the flu vaccine there is a kind of resistance for different reasons, either because of the 
health, severe side effects after taking the vaccine in the past, or maybe when they took the 
vaccine the frequency of flu was more than without the vaccine.”HCWs-VP,Physician-1 
“We found some saying,“If I take the flu vaccine I will get sick, I do not have the flu for a whole 
year and after I take the vaccine I will have flu.” It’s like that.”HCWs-VP,Nurse-3 
“Some vaccines were rejected such as influenza vaccine. When the seasonal flu was spread 
most of the military recruits rejected the vaccine although the leaders were 
concerned.”Military-VP,Nurse 6 
 
However, some HCWs mentioned that some vaccines such as HB and meningitis vaccines are 
taken by request: 
Providers’ views: 
“But some vaccines, ones they know are really important, like meningitis, they know what 
meningitis means, especially those who worked in Hajj and Makkah, they feel it is important 
and they take it easily.”HCWs-VP,Physician-1 
“Whereas they would be quite happy to have the HB vaccine, for example. They're frightened 
of particular vaccines such as flu vaccine.”HCWs-VP,Nurse-1 
 
Adverse event concerns 
The WHO defines an Adverse Event Following Immunisation (AEFI) as a medical incident that 
takes place after an immunisation, causes concern, and is believed to be caused by 
immunisation. Such events cause concerns and are thought to be immunisation related. 
A number of interviewees mentioned multiple reasons that could cause AEFI occurrence. Most 
reasons are caused by staff malpractice providing vaccines or cold chain maintenance concerns. 
This AEFI could have direct or indirect effects in reducing adherence. 
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Appropriate vaccine administration is a critical component to any successful vaccination 
programme. The “Rights of Medication Administration” should be applied to each encounter 
when vaccines are administered. These obligations are to ensure that the right patient, the right 
vaccine or diluents, the right dosage, the right route, needle length, and technique, the right site 
and, the finally the right documentation are each assured. 
Some recruited nurses/soldiers noticed the occurrence of some vaccine administration mistakes 
during vaccination, such as incorrect dosages, incorrect route, incorrect patient, and incorrect 
technique and giving a soldier two doses on the same vaccine as well as the lack of 
documentation as examples of such mistakes, some concerns being: 
Service users’ views 
“I was in a paediatric department for training. A 9-year-patient had an abscess from a school 
vaccination and was admitted to have surgery. Believe me, it was because of a vaccine 
administration technical fault!”Nurse-FGD 
“A nurse once gave me an intramuscular injection while I was standing and stressed, that 
caused me pain for couple of days.”Soldier-FGD 
“Some of my colleagues got vaccinated and got out of the vaccination room then a mix up 
happened in that they (the vaccination team) didn’t know who got vaccinated and who 
didn’t.”Soldier-FGD 
Providers’ views: 
“Some soldiers are given the same vaccine from two vaccination stations that nurses set in the 
aim of saving time. This can cause confusion which cannot be rectified after some soldiers are 
twice-vaccinated.”Military-VP,Nurse-8 
 
Staff providing vaccines reported some vaccine administration concerns and claimed that the 
incidence of this is attributed to those who provided vaccines throughout the hospital but not 
working in the IPCP: 
Providers’ views: 
“The main adverse incidents that seem to occur throughout the hospital but not in our clinic, 
are administering the wrong vaccine or using the incorrect dose.”HCWs-VP,Nurse-2 
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“I did not see it but I heard about it from the nurses in the ward not in our vaccination clinic. 
They said that there was a mistake in the method of reconstitution (mix diluent) or in the dose 
administration. Mainly this happened because of awareness and training limitations”HCWs-
VP,Nurse-4 
 
Additionally, the reliability of vaccine storage conditions, power outages, and transport 
constraints were specific concerns which arose regarding the maintenance of the cold chain. 
Such AEFI could occur: 
Providers’ views: 
“The only one problem that happened was a fault with refrigerator but not in our clinic. It was 
in PHC when a vaccine refrigerator stopped working.”HCWs-VP,Nurse-3 
“We came across to improper storage before. When a campaign was on going in a military 
field, vaccines were kept in a refrigerator and later a blackout happened. When vaccine were 
checked by the second day, all (vaccines) unfortunately had been damaged.”Military-
VP,Nurse-8 
 
Vaccine entail several visits concern 
Vaccines that need a follow-up, such as measles or varicella for the second doses and HB for 
the second and third doses, were clearly a major concern among soldiers/HCWs. Newly 
recruited attributed failure to complete; too busy schedules, clinic access difficulties, clinic 
crowdedness, low awareness about vaccine follow up: 
Service users’ views: 
“Sometimes because of the working hours and transportation, some managers refuse to give 
permission.”Nurse-FGD 
“The clinic is usually crowded and, that prevents us to go take the vaccine. Shall I stay for two 
or four hours for one injection! I will ignore it and will not go.”Nurse-FGD 
“They thought that one dosage is enough to prevent the disease.”Nurse-FGD 
Providers’ views: 
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“I think having the multi dose vaccine, like HB, the compliance. When people come for the 
vaccine you see the vaccination rate for the first dose is 100%, or 99%. We also want to keep 
this for the second and the third dose, usually we find a drop in the rate of the second dose and 
the third dose.”HCWs-VP,Physician-1 
“Some soldiers might take the first and the second dose of HB vaccine, but not the third, or they 
might take only the first dose of measles and varicella. I could say about 30% to 40% don’t 
complete the doses.”Military-VP,Nurse-8 
 
Among HCWs, staff providing vaccine link nationality and loss of position (job) as an 
underlying reason for non-compliance by Saudi Nationals: 
“The non-Saudis HCWs have to complete their dosage course even if they’re delayed. This is 
because non-Saudis are worried about having problems with their work contracts, Saudis 
HCWs do not come back to take remaining vaccine doses because Saudi do not care. They know 
there is no process of punishment or anything for them so it’s hard to follow them up to give 
them other doses.”HCWs-VP,Nurse-4 
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6.3.3 Staff providing vaccine related barriers 
The majority expressed concerns about staff providing the vaccines, including weak 
communication skills and stress caused by workload, lack of experience and understaffing. 
These sub-themes can affect interest in accepting vaccination among HCWs/soldiers. 
 
Weak communication skills 
Good communication skills are essential in building trust in health interventions particularly 
providing vaccines. However, weak communications skills exhibited by some nurses/soldiers 
can cause concerns among those intended to be vaccinated, as below: 
Service users’ views: 
“Their (team members) facial expressions were too serious, hey, you come here, give me your 
hand, and then "ta", finally, good bye.”Nurse-FGD 
“Honestly, yes it depends on the person vaccinating you, the way he talks to you and the way 
he holds the injection. He can make you relaxed or cause you to reject the vaccine.”Soldier-
FGD 
“Mood of the military nurse giving a vaccine, depends on workload; when he was giving me 
the injection, he was saying; don’t be afraid, smile it won’t hurt you.”Soldiers-FGD 
 
Little experience 
Some staff providing vaccines may have such little experience that they are seen as negligent 
in their observance of high standards in hygiene or not having enough experience in giving 
vaccine, causing HCWs/soldiers to feel anxious and reduce compliance rates: 
Service users’ views: 
“You (as staff providing vaccine) are going to give me the vaccination without wearing gloves 
and your hands are dirty! For sure, I will not allow you.”Nurse-FGD 
“Personally, I don’t want to be given the second dose by the person who gave me the first one 
the way he was holding the injection; I felt that he gave it to me the wrong way. Some of them 
can make you relaxed with the way he talks to you but others are so serious and silent which 
scares you.”Soldier-FGD 
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Providers’ views: 
“Some HCWs might give a negative picture about the vaccine. “I do not know why people take 
this vaccine”, they might say this in front of people. These negative comments might be a barrier 
when people listen to them and might affect people’s acceptance of the vaccine.”HCWs-
VP,Physician 1 
“If the staff (member) giving the vaccine panics and looks irritable, then the vaccine is highly 
likely to be rejected.”HCWs-VP,Nurse-2 
Some concerns were raised by the military vaccination programme team who inferred that 
nurses regularly joined because of military command and not on the merit of their background 
training in vaccinations: 
“We suffer from new military nurses who join the team for vaccination and preparation for a 
period of time; they don’t have enough experience and that causes lots of delay in our 
work”Military-VP,Nurse-7 
Some staff providing vaccines to soldiers claimed that the incidence of most AEFI is attributed 
to less experienced and undertrained staff recently joining: 
“Sometimes we have new vaccinating people, who are under training and supervised by the 
doctor, who might cause damage to the vaccine .”Military-VP,Nurse 6 
Lacking a good scientific background 
Some concerns about staff competence were raised primarily concerning team members lacking 
effective relevant scientific and experienced background and capability to provide vaccine 
health education: 
Service users’ views: 
“Some (a member of the vaccination team) might give a vaccine without any conviction that if 
you take it, you would get benefit. You are an expert and do not sure about a vaccine benefit!?! 
Your impression affects me, so I will not take vaccine next time.”Nurse-FGD 
Providers’ views: 
“The nurses, as you know this is a hospital with staff from different parts of the globe, most of 
them do not come with experience in vaccinations, and they do not have a vaccination 
background. It’s not easy to find a nurse that’s exclusively trained in vaccination programmes, 
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it’s not very easy. Because this is a very rare and specialised area of practise, it’s not like 
nurses who do inpatient services standing beside patient’s bed”HCWs-VP,Physician-1 
“We are not qualified for health education and there are no health education programmes, (…) 
leaders of brigades and battalions know nothing about the vaccines.”Military-VP,Nurse-5 
 
Understaffing  
The sheer number of HCWs/soldiers who should be vaccinated can lead to perceptions of 
understaffing (and actual staff shortages) which affect functionality in clinic. Most interviewees 
complained about the workload and perceived staff shortages, as the following quotes highlight: 
Providers’ views: 
“Being understaffed is one of the main barriers in the clinic not functioning very well and 
fulfilling the need of the HCWs in the hospital. I agree that being understaffed is one of the 
barriers.”HCWs-VP,Physician-1 
“There is currently one nurse to do the job, about 7,000 staff. There was a ratio of one nurse 
to 7,000 or 8,000 staff, which is quite a job for one person.”HCWs-VP,Nurse-1 
“The number of people who are giving the vaccine is insufficient. The process of forming the 
team is usually done by demand, and there is no prepared and trained team, except for a few 
people.”Military-VP,Nurse 8 
 
 
6.3.4 Organisational-related barriers 
Several SANG, MNG-HA organisational related factors on stakeholders and work environment 
influenced participants’ compliance, including concerns about vaccination clinic and cold chain 
resources, reliability and usefulness of data, weakness of inter-sectoral and department 
collaboration and insufficient health education provided. These sub-themes could partially 
explain low adherence among HCWs/soldiers. 
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Vaccination clinic concern 
The absence of an effective reminder system in vaccination clinics can cause HCWs/Soldiers 
to miss vaccination appointments, affecting vaccine adherence. Such concerns are indicated 
below: 
Service users’ views: 
“Missing an appointment when taking a vaccine that involves taking three doses is common 
because there is not an effective reminder system, like messages, to make patients keep their 
appointments.”Nurse-FGD 
Providers’ views: 
“Some will say, “We do not have time.” I mentioned that they need reminders. But this is one 
of the obstacles with compliance”HCWs-VP,Physician-1 
Additionally, clinic location and accessibility difficulties were reported as a concern leading to 
low vaccine compliance rate: 
Providers’ views: 
“The employee clinic is at one end of the hospital. The hospital is a very large service area, 
and so many employees do have to walk a very long way to get to the employee health clinic to 
receive their vaccinations, which could also be a barrier to their compliance with the 
vaccinations”HCWs-VP,Nurse-1 
 
Moreover, clinic layout and privacy were reported as concerns affecting vaccine compliance. 
Privacy concerns - caused by the unavailability of clinics - led HCWs/soldiers to avoid 
vaccination. Additionally, finding a room with satisfactorily high health standards for use is 
often problematical during vaccination campaigns either in the hospital or military battalions. 
Providers’ views: 
“We do not have a specific clinic to provide vaccines during vaccine campaigns; we used to 
vaccinate HCWs in a dressing clinic or by trolley in corridors. We just cover that by a simple 
curtain for the females, or even men to keep and maintain privacy during vaccination.”HCWs-
VP,Nurse-4 
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“There is no privacy; they take off their jacket in front of one another and no curtains or 
partitions, anyone gets in and can see people get vaccinated. Some refuse to get vaccinated for 
this reason, they get embarrassed if they expose their body.”Military-VP,Nurse-7 
“Sometimes we go and ask for a space to set up temporary clinic and they tell us to do the 
vaccination at the canteen and there is no clinic available or ready. This affects confidence and 
soldiers’ trust to accept vaccination.”Military-VP,Nurse-5 
The vaccination clinic times and long waiting were reported as factors leading to 
HCWs/soldiers avoiding vaccination: 
Service users’ views: 
“The injection clinic offers the vaccine once a week in our normal work day hours, so it will be 
difficult to go there.”Nurse-FGD 
“Maybe if it is provided to me, but I don’t think that I would go to the hospital for vaccination, 
they will give me a long waiting time before I can get vaccinated.”Soldier-FGD 
Providers’ views: 
“The employee health clinic have some specified days for vaccination. Only some of the 
employees and other departments would say this really is not enough”HCWs-VP,Nurse-2 
“Sometimes they come to the clinic and they find that they have to take an appointment and 
they have to follow the line and it’s time consuming for them” HCWs-VP,Nurse-2 
 
Vaccine and the cold chain  
The vaccination cold chain requires all materials, equipment, and procedures involved in 
maintaining vaccines to be maintained in optimal storage conditions from manufacture to final 
use. This should be available in and by MNG-HA. Any limitations in this area could affect 
vaccination functionality and thus coverage rates among target groups. Following are nursing 
teams’ concerns about vaccine transportation and storage in the military vaccination 
programme. 
 
There was not an adequate place where vaccines were provided to soldiers. Such locations did 
not have any special vaccine refrigerators during the vaccination campaigns which usually last 
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several days when vaccinating more than 1000 soldiers, or when vaccination takes place in 
cities far from hospitals that supply intended-to-use vaccines. All these factors can adversely 
affect the cold chain: 
Providers’ views: 
“The military vaccination clinics in the military training centre don’t have special places to 
store the vaccines.”Military-VP,Nurse-7 
“We have faced many challenges such as reserving the vaccines inside the vaccine box, and 
being worried for 8 hours although the reserving period for such vaccines is about 4 
hours.”Military-VP,Nurse-6 
Some suggested having a special car equipped with portable refrigerators: 
“There are many suggestions including the portable refrigerator, or the car with refrigerator, 
and we should have an alternative or a generator in case of any emergency or 
blackout.”Military-VP,Nurse 6 
 
Insufficient health education provided 
Health education should be provided and supported by the MNG-HA, any limitations in this 
support could affect vaccine awareness, acceptability and coverage rate. Participants reported 
issues in; shortages of staff, low qualifications among staff, lack of resources for effective health 
education and time limitations to provide enough education. 
The limitation of organisation resources could result from staff shortages pressurising available 
staff in providing optimum vaccination service including health education: 
Providers’ views: 
“It’s hard to have just the public health nurse covering it all, especially health 
education.”HCWs-VP,Nurse-4 
“The staff in the public health clinic are usually busy, there is not enough time to provide health 
education.”HCWs-VP,Nurse-3 
“We need more chance for education. Actually, the health education gets conducted on the 
same day. We only have a short time to conduct this health education. So, it gives us a chance 
to speak in the summary about the vaccination programmes.” Military-VP,Physician-2 
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Lack of resources could be a reason to create and design supportive education materials: 
Providers’ views: 
“We do not have a vaccine information statement. The vaccine information statement is very 
simple information that you give, but need a budget for designing and printing. It tells them 
about this vaccine, why they are taking it and what they can expect- the side effects, after the 
vaccine”HCWs-VP,Physician-1 
“The instructions are provided verbally, which are considered as obstacles affecting 
compliance. There are no education aids. It is all about individual efforts. “Military-VP,Nurse-
8 
 
Working schedule 
Work environment could be a reason for low vaccine adherence. MNG-HA is considered a 
tertiary medical centre receiving many medical referral cases from different regions. This may 
cause work pressure on staff. Additionally, the nature of military work and requirements to 
continue training could have similar effects on soldiers’ adherence to vaccination: 
Service users’ views: 
“It is the workload, I need to get permission to go to the clinic; no one will give me such 
permission.”Nurse-FGD 
“We got vaccinated four times after the training and we were very exhausted and that would 
have been harmful for us, I never will ask for vaccination once again.”Soldier-FGD 
Providers’ views: 
“So some said, I have a heavy workload, if I take this vaccine, it cause my arm to swell and 
cause pain, I need to deal with my patients. How come? No one will help me.”HCWs-
VP,Nurse-3 
“For the new recruits, it’s usually long hours of military training from the early morning 4:00 
AM to 10 p.m. with no rest. During and after the vaccination, military leaders refuse to give 
soldiers breaks or rest.”Military-VP,Nurse-7 
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Less reliable and useful data 
Reliable and useful data are essential, and additionally, their record keeping during  vaccination 
programme for evaluation, and improving and reporting to higher authorities, are important. 
This should be considered by authorities in MNG-HA in order improve management and 
planning of vaccination programmes and to find possible reasons for low vaccine adherence. 
Some staff providing vaccines reported that the HCWs’ vaccination programme incorrectly 
collects data, not including all details about vaccination history among patients and employees. 
Additionally, the situation was worse in military vaccination programme databases, being 
neither reliable nor useful. Having said such, some concerns surfaced when exploring the data 
issue as evidenced below: 
Providers’ views: 
“One of the things that is ignored in medical practice is checking the vaccination history in the 
hospital computerised system when patients come to emergency or admitted to hospitals. They 
really ignore this, this is neglected completely by physicians. Sometimes some high-risk groups 
might need some vaccinations in particular, so if you take a minute and look at the record you 
might find they are a really good candidate for these vaccines.”HCWs-VP,Physician-1 
“Most of the data we received was wrong and unreliable. We have been told the 700 people 
were not vaccinated and when we visited this military unit, some of them had been vaccinated 
before. It happened with us in Taif city.”Military-VP,Nurse 7 
“Having written data about people who got vaccinated and who didn’t, additionally 
vaccination dates and names of people who should receive second and third doses saves a lot 
of time and effort and will be very useful for years to come, but unfortunately collected data 
were not as expected.”Military-VP,Nurse 8 
One obstacle faced was receiving reliable data that includes target numbers and expected time 
to vaccinate a military unit. This is caused by a delay of reporting required data from military 
cohorts. 
“This year, we had a problem about this point which was discussed. It was really a big problem 
and barrier in vaccination coverage rate. We received data to prepare for a vaccination 
campaign too late. It was supposed to be received two months before, why? The team was not 
able to do their best and make the programme as it should be.”Military-VP,Nurse 5 
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Inter-sectoral and departments collaboration 
A number of sectors have an important role in organising and implementing vaccination 
programmes in the HCW setting and the military field. Nonetheless, there is a major defect in 
co-ordination between these sectors and stakeholders, and the IPCD. This defect could 
indirectly affect vaccination coverage rates and cause low vaccine adherence.  
Some HCW and military team members reported that working with the logistics department 
responsible for supplying vaccines created practical problems such as with suppliers or 
logistics. Other issues were reported with the target campaigns in the hospital and the routine 
adult vaccination programme. Some concerns as evidenced are below: 
 
Providers’ views: 
“We do, especially recently we have had a lot of problems with securing the supply of vaccines. 
We are completely out of some vaccines like yellow fever, and some vaccines are not available 
in a timely manner it’s a supplier problem. But it affects our practise at the end of the day.” 
HCWs-VP,Physician-1 
“Because of logistics department, we suffer from getting and bringing back the vaccines in 
military field; there are always delays”Military-VP,Nurse 7 
“The logistics department does not have a specific person who understands what the vaccine 
is. There are administrators who are not from the medical field; there are not pharmacists 
either.”HCWs-VP,Nurse-4 
Members of the vaccination team suggest assigning a professional trainee pharmacist to handle 
and supervise vaccines in the logistics department. 
“Logistics department should recruit a well-trained pharmacist who understands the process 
of vaccine distribution, and knows how to coordinate infection control and vaccine 
issues”HCWs-VP,Nurse-4 
Also, there was mention of a need for more co-ordination between the IPCP and the logistics 
department in MNG-HA, the military battalions and the SMOH regarding the supply of 
requested vaccines; 
“Obviously, if the hospital makes sure they order the vaccinations in plenty of time before they 
run out, then that would stop any supply problem.”HCWs-VP,Nurse-1 
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“Stronger coordination with SMOH regarding vaccine supply is required”HCWs-VP,Nurse-
4 
“The coordination between logistic, IPCD and the military battalions should be activated and 
in a proactive manner, e.g.: how much vaccine do I need in each campaign?”Military-
VP,Nurse 8 
A Military-VP team leader suggested having access to the logistics department's main store 
when the team finish their duties late to return or collect (extra) vaccines: 
“I suggest having open access to logistics around the clock so that whenever I need vaccines, 
I can get them. There should be staff working in shifts in this section.”Military-VP,Nurse 8 
 
Hospital administration is responsible for finances, promotions, and logistic support, for which, 
some HCW and military vaccination team members mentioned limitations, such as in financial 
and transportation aspects: 
Providers’ views: 
“Sometimes if you go and talk with the administrator, he/she would find that your subject is not 
this important and would advise you to reutilise the budget of the department if any financial 
support is needed.”HCWs-VP,Nurse-3 
“Transportation is needed. Sometimes we do not have transportation to go to primary care or 
to the SMOH or any meeting outside of MNG-HA, unfortunately, it is a hospital administration 
obstacle.”HCWs-VP,Nurse-4 
There were also comments about central administration. 
“I think decentralisation. Why should be linked to Riyadh in every single aspect? We should 
have our own programme, make decisions by ourselves and meet our needs ourselves.”HCWs-
VP,Physician-1 
Perceived changes of administration to programmes were reported as obstacles: 
“Any person or leader in charge should believe in the importance of vaccination programme. 
The leaders' or directors backgrounds and beliefs change from one person to another, and if a 
leader is not interested enough, unfortunately, this makes the mission difficult.”Military-
VP,Nurse 8  
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The military medicine department is responsible for co-ordination between the IPCD, as a 
health provider to vaccine services, and different military battalions as well as the military 
nurses' team. Those nurses are assigned to work in the vaccination programmes based on 
military orders. Despite this, there seems to be a problem in co-ordination and support: 
Providers’ views: 
“Military medicine department does not appreciate our work (…) we always face hurdles that 
weaken the team's performance, but we do not know why. We are working under pressure; we 
sometimes give vaccines to some units outside Jeddah until midnight, and no one understands 
our suffering.”Military-VP,Nurse-6 
“We suffer because we work hard and they always deny our efforts, (….) we face the infection 
hazards and yet we don’t have any bonuses.”Military-VP,Nurse-7 
Below is an example of a military nurses' opinion of the difficult work conditions caused by 
poor co-ordination between the military medicine department and other military battalions: 
“For example, Al-Mujahedeen (Bedouin soldiers in deserts) have certain working hours for 1 
or 2 months per year only, but we were shocked at their nature of work. Those Mujahedeen 
were about 100 people and we crossed about 500 or 600 km to find them. We were forced to 
work until midnight (unofficial working hours) because they were not committed to come in 
mornings although we did pre-coordinate.”Military-VP,Nurse 6 
The nurses’ team suggested that such co-ordination between IPCD and military medicine 
departments can be improved through regular meetings to explain the importance and positive 
effects of such continuous co-ordination and support. Early consultation with military battalions 
can result in better planning and implementation of the vaccination programme. This can also 
improve soldiers' compliance with such programme, as well as minimise or even help avoid 
administrative issues that could cause soldiers to refuse being vaccinated. 
“Military medicine should understand that vaccination campaigns are essential and not a 
secondary and unimportant thing. The military medicine department and the authorised leaders 
should know that the vaccination team implement an important mission here and some people 
don’t know how important this is.”Military-VP,Nurse-8 
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6.3.5 Social and cultural barriers 
Social determinants such as religion, ethnicity, nationality and social context could play an 
important role in encouraging HCWs/soldiers (who are part of this context) to accept or reject 
prevention measures such as vaccination. Additionally, cultural factors, such as, media effect 
and rumours can act either to encourage accepting or refusing prevention measures. These sub-
themes could explain low adherence among HCWs/soldiers. 
 
Social context 
Social context and environmental factors play important roles in encouraging HCWs/soldiers 
to accept or reject vaccination. The Bedouins are an Arab semi-nomadic group, descended from 
nomads who have historically inhabited the Arabian deserts. Most SANG soldiers originated 
from Bedouins, for whom cultural and/or behavioural factors are strongly determinate of 
accepting or refusing prevention measures. For example, a Bedouin Arab may not believe in 
vaccination due to the norms and loss of health infrastructure that provide such programmes or 
awareness in remote desert areas: 
Service users’ views: 
“No. Even if someone told me (a Bedouin soldier) about the vaccination, I will not ask for it. It 
is about the society you live in. because of limited access to health services and awareness 
Bedouins or villagers will not be aware or interested in being vaccinated.”Soldier–FGD 
“Talking about myself; I came from a Bedouin background where some people have never 
heard about vaccination. They think that it lasts for only 24 hours even if you explained to him, 
he might still think that it is harmful.”Soldier–FGD 
 
Additionally, the nature of thinking in Saudi society could affect the decision to be vaccinated: 
Providers’ views: 
“I think that our Saudi community has a negative role. We are a community who listen to each 
other, and unlike the foreign/European who have more reasoning, and are open to scientific 
media or information networks. We, instead, listen to our neighbours and families 
mostly.”HCWs-VP,Nurse-4 
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Religion 
Religious concerns were discussed and when queried, some participants used these to avoid 
vaccination. Some Muslims believe that the divine destiny is when God wrote down in the 
Preserved Tablet ("al-Lauḥ al-Maḥfūẓ") all that has happened and will happen, and which will 
come to pass is written. According to this belief, a person's action is not caused by what is 
written in the preserved tablet, but rather the action is written in the tablet because God already 
knows all occurrences without any restrictions of time. Such concerns indicated below: 
Service users’ views: 
“Some would say that it is their predestiny to be infected or not regardless of if they take the 
vaccine or not. No matter how hard we try to explain the scientific benefit of taking the vaccine, 
those people would still insist on refusing it.”Nurse-FGD 
Providers’ views: 
“Some soldiers say I rely on Allah to protect me from illness, (…), they have this pretext just to 
escape the vaccination.”Military-VP,Nurse-7  
“The only example I could think of is possibly in Ramadan, when some of the Muslims are not 
happy to have a vaccination during the fasting period. Most are, but some are not.” HCWs-
VP,Nurse-1 
 
Nationality and ethnicity  
Nationality or ethnicity can play a role indirectly in the decision to accept or reject vaccines. 
Filipinos HCWs are more compliant in being vaccinated, however, Arabs, South African and 
Czech staff seemed to be rather more reluctant, a reason mentioned being rarity of occurrence 
of targeted disease in country of origin. 
Providers’ views: 
“Some Arabs and South Africans, I find they are reluctant to be vaccinated, I am not sure why, 
but it could be down to traditions, or maybe because they think that vaccines should be only 
taken in childhood.”HCWs-VP,Nurse-2 
“Those who are from the Philippines are more cooperative, but Egyptians and other Arabs, are 
reluctant, I do not know why?”HCWs-VP,Nurse-3 
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“Some nationalities are more reluctant. Like the Czech Republic, nurses from the Czech 
Republic usually do not want to take these measles and varicella vaccines. They say, “No, we 
do not have these diseases in our country.” So they are very conservative in taking these 
vaccines, the Czech Republic.”HCWs-VP,Physician-1 
Some interviewees tried to explore the reasons why Saudis, in comparison to non-Saudis, tend 
not to cooperate to complete vaccine courses entailing several visits: 
“If you’re talking about two different nationalities, like the Saudi and the non-Saudi, the non-
Saudi have to complete their dose course even if they’re delayed, I think because non-Saudi are 
worried about their job contracts.”HCWs-VP,Nurse-4 
 
Media 
Some HCWs/soldiers perceive the media, such as on the internet, press, TV, radio and social 
media, could be a barrier to being vaccinated: 
Service users’ views: 
“In the corona virus infection outbreak; lots of warning messages spread through the 
WhatsApp (a messaging app) from the vaccination and we cannot understand what the 
vaccine's role is here.”Soldier-FGD 
Providers’ views: 
“There are some anti-vaccine groups who really give negative ideas in the media.”HCWs-
VP,Physician-1 
“I personally think they can have a lot of power to affect people's decision to the vaccinations. 
If they provide negative press about a vaccination then everybody will be frightened to have the 
vaccination, whether or not the claims in the media are true, as we've seen in the case of the 
MMR vaccination, for example. I think they're a very, very powerful effect on people.”HCWs-
VP,Nurse-1 
“Nurses told me, we listen to Aljazeera (Satellite television network) and they said this influenza 
vaccine is not good.” So I said, “Okay, you listen to Aljazeera and you do not want to listen to 
a doctor.”HCWs-VP,Physician-1 
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“Of course, media is very important. In the Corona outbreak, for example, they were starting 
to send false messages about the situation in the hospital through Facebook, Twitter, 
WhatsApp, about the incidence rate of Corona, how many patients died and failure of 
vaccination. All of a sudden staff started to panic and refuse to be vaccinated, we started to 
give education, our voices gone.”HCWs-VP,Nurse-3 
 
Rumours in occupational environment 
Participants' experiences and concerns can cause the spread of rumours and misinformation 
about vaccinations in the healthcare or military setting. It is widely held that because of the 
closed nature of the military environment, rumours spread rapidly. It can be difficult to correct 
misconceptions which can arise from rumours, which are made worse due to the limited 
opportunities for participants to receive in-depth information and counselling from vaccine 
providers. All of these factors can contribute to the avoidance of vaccination: 
Service users’ views: 
“You might suddenly get a rumour message from your colleagues that about 43 or so people in 
the hospital died because of a vaccine.”Nurse-FGD 
“Social media spread rumours that this vaccination would cause weakness immunity.”Soldier-
FGD 
Providers’ views: 
“Some of them, for example from my experience with Swine Flu, some of them look scared when 
you recommend such vaccines because that’s a new vaccine, there are a lot of rumours in the 
media that this vaccine is not safe.”HCWs-VP,Physician-1 
“During a polio vaccination campaign, we came across a fabricated email claiming to come 
from the SMOH and warning about the polio vaccine. A consultant said that I should not be 
vaccinated because he thought the email was genuine”HCWs-VP,Nurse-4 
“In the military environment, in general, rumours spread. For example, some might say that 
the injection is harmful, or joke with his colleague and say (lying) that the injection needle was 
broken. Hesitation might increase with false information about the vaccine.”Military-
VP,Nurse-6 
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6.3.6 Improving vaccine compliance 
This section develops some of the above-mentioned suggestions to improve compliance, as 
elaborated from the views of participants. Nurses/soldiers and staff providing vaccines 
identified some key areas for vaccine compliance improvement. The following sub-themes 
explore these areas:  
 
Design effective health education 
All of those interviewed believed increased knowledge and using attractive and effective tools 
to enhance awareness of the vaccine importance was critical to improve vaccine compliance. 
To improve this, some staff suggested designing a well-organised programme, attractively 
packaged, providing some resources in that regard, some educational material and vaccination 
leaflets to help vaccine targets understand the programme and vaccine intended to be given. 
Additionally, specific educators’ nurses, and training target managers and directors should be 
involved. The following are few quotes clarifying this: 
Service users’ views: 
“By health awareness, we will enthuse all staff. Then, we have to correct the 
misconceptions.”Nurse-FGD 
“HCWs should know all details about adult vaccines(…). Yes, with all information; what is this 
vaccine? What are its side effects? When should I take it? Why I cannot take it? This will 
definitely improve vaccine compliance.”Nurse-FGD 
Providers’ views: 
“The first key to improving compliance is education of the staff. If they understand exactly what 
the vaccine is and how it will benefit them, then they are more likely to comply.”HCWs-
VP,Nurse-1 
 
Most interviewees suggested using attractive methods in a proposed education programme such 
as using appealing statements and providing success stories in the context of HCWs/soldiers' 
environments instead of focusing solely on scientific information. 
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Service users’ views: 
“They can hang posters on a board in the hospital corridors about the importance of the Flu 
vaccine; things that might attract their attention to take the vaccine, with attractive statements. 
For example, they might be about the Flu vaccine "do you think that Flu vaccine causes specific 
diseases? Come to our campaign, and we might change your opinion.”Nurse-FGD 
Providers’ views: 
“I think developing certain health-education material leaflets dedicated for soldiers, will be 
more effective. Video, leaflets, whatsoever suits soldiers' environment. So this is one of the areas 
that we need to work on.”Military-VP,Physician 2 
“I prefer if we have a lot of sources for education. For example, when an HCW visits a clinic 
for recruitment examination, she/he can use the TV set in the clinic waiting room to show a 
Power Point presentation, or a video to explain vaccines, their benefits, and side effect, and so 
on.”HCWs-VP,Nurse-2 
“I think it would be very good if we had leaflets on the vaccine preventable diseases so the 
employees actually understand the diseases we're trying to protect them against.”HCWs-
VP,Nurse-1 
Awareness activities such as, a periodic vaccination week, were also suggested and these could 
be helpful in raising awareness and filling the knowledge gap 
“Having activities to raise awareness among the employees, like vaccination week.”HCWs-
VP,Physician-1 
 
Some suggested conducting this awareness training in the orientation period or before 
HCWs/soldiers start training. This could be achieved through a specific (hospital or military 
admission) website. 
Service users’ views: 
“They should add vaccination awareness to the orientation course to tell us what we have to 
do? And what they have to do for us?”Nurse-FGD 
Providers’ views: 
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“We need to educate the HCWs with vaccine importance and the available vaccine. It could be 
through orientation week or though the hospital website.”HCWs-VP,Nurse-4 
“A day or two should be dedicated for health education and informing the soldiers who are 
targeted for vaccination, this will prepare soldiers when vaccines are given.”Military-
VP,Nurse-5 
“We need to educate the newly recruited soldiers with vaccine importance and the available 
vaccine. It could be through orientation week or available through the admission 
website.”Military-VP,Physician-2 
 
Participants suggested how effective and important using carefully selected social media is in 
awareness raising. Social media has become a powerful and effective awareness tool at low or 
even very little cost if used correctly. Using it for this purpose can enable vaccination campaigns 
to reach further and to more service users, allowing interaction with experts and raising 
involvement and interest. The use of various media and social media platforms has become an 
everyday routine for many people. Social media applications allow individual and 
organisational users to interact dynamically and share, as well as produce, content on these 
platforms: 
Service users’ views: 
“They might advertise and promote ways about vaccination and infection prevention. This can 
be through a short and simple message rather than a long and complicated one.”Nurse-FGD 
“Using carefully social media such as, Twitter. Tweeting electronic photos, brochures, or 
posters will spread knowledge among the staff and society via Twitter followers. This can be 
useful in promoting vaccine awareness.”Nurse-FGD 
Providers’ views: 
“The media has to explain everything, including side effect reaction. They have also to make 
people feel secure, if there is side effect or anything, they can be treated without complications 
and this will assure vaccine takers.”HCWs-VP,Nurse-2 
Participants suggested the need for enhancing awareness using a specific well-trained educator 
for this job, who could provide advice, guidance, and information about the importance of 
vaccines for all. 
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“We need more health educators in this area.”HCWs-VP,Nurse-4 
“A doctor should be accompanying us because sometimes they have some information or 
questions that should be answered by a doctor. Education and providing information about the 
vaccine are the doctor’s task,”Military-VP,Nurse 7 
 
Military leaders and commanders should be involved and included in any health education 
programme. When commanders believe in and understand the importance of vaccinating, this 
will (in)directly affect vaccine compliance among soldiers. 
“Health education about vaccination should target leaders. I am sure that most of leaders did 
not know what these vaccines are, so doing narrows the distances.” Military-VP,Nurse 8 
 
Staff qualification 
Most staff providing vaccines wanted to keep their current team unchanged, but perceiving a 
need for better qualifications to reach professional levels of education about vaccine and 
vaccine provision. However, interviewees urged focusing on providing vaccination training for 
those who join the team before commencing work in that field, improving training, 
communication skills, confidence and minimising other duties. This, it is thought, would have 
an indirect effect on improving HCWs'/soldiers' compliance to accepting vaccinations as the 
following extracts go: 
Service users’ views: 
“Nurses providing vaccines should be trained well, and they should show a confidence, good 
personality and moral attitude. For sure, this will make me relaxed and happy instead of being 
hurt.”Nurse-FGD 
Providers’ views: 
“As for military nurses working with me now, they are all at the same level of great competence, 
while the rest who joined us for training were not ready. They should be qualified and do some 
courses about vaccination programmes, and sit exams supervised by the IPCD”Military-
VP,Nurse-5 
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Increase number of staff  
The team providing the vaccines claim that taking on more tasks or spending additional time 
on current ones, in addition to the growth curve for vaccines services increasing and expanding, 
without additional resources to assume these responsibilities or provide health education 
services, is reducing team effectiveness. All elaborate the need for an additional staff member 
to increase productivity, improve service users’ service and enhance current staff members’ 
performances: 
Providers’ views: 
“First of all to have enough manpower, have enough sources of education, and not to miss any 
opportunity for vaccination.”HCWs-VP,Physician-1 
“(…), the second recommendation would be to increase the number of staff at the clinic so the 
staff can actually go out of the clinic, which is a long way from the people's workplace 
sometimes, the staff can go out of the clinic directly to the employee's workplace and administer 
the vaccine where they are working. That would improve compliance.”HCWs-VP,Nurse-1 
 
Setting up an adult vaccination clinic 
In health care settings, an adult vaccination clinic should be operated daily to address issues of 
over-crowding, staff workload and guaranteed privacy and safety: 
Providers’ views: 
“So if there is a specific adult vaccination clinic open the whole day and week for HCWs, they 
(all HCWs) can book any time, any time suitable for them and will improve 
compliance.”HCWs-VP,Nurse-2 
“We hope that we have our vaccination clinic on a daily basis, and everybody can go there 
directly instead of making an appointment because if they miss the appointment, and then we 
miss the patient.”HCWs-VP,Nurse-4 
Three interviewees (Military VP) suggested a special military field unit, which should be 
designed and constructed in every military centre to guarantee privacy and safety, and provide 
all equipment necessary for administration, documentation, and disposal, stating that: 
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“My own suggestion is to have a special unit for the military vaccination programme, with a 
physician, nurses as well as using data monitoring for the vaccination process and better 
management “Military-VP,Physician-2 
“Vaccination clinic in the field should be like any other clinics in the hospital having a partition 
or curtains to maintain privacy, a fridge to preserve the vaccine and all the things that I would 
need such as gloves and swabs.”Military-VP,Nurse-8 
 
Setting up a powerful effective reminding system  
Participants suggested the need to increase participants’ compliance in taking second and third 
doses. This could be achieved by simple policy changes which target HCWs/soldiers interacting 
with the health care system to construct a reliable reminder system or use social media to that 
effect, such as through SMS (short message services through phone), telephoning the staff and 
e-mail: 
Service users’ views: 
“The SMS or emails have to be used for reminding about vaccinations.”Nurse-FGD 
Providers’ views: 
“One of the main reasons that HCWs do not come to take their vaccines is that they forget; they 
need a reminder. If you remind them with a text message or if you remind them with an email, 
or make sure that they have an appointment slip before they leave the clinic this will 
help.”HCWs-VP,Physician-1 
“To improve the system, I think it would be great to have the resources to actually telephone 
the staff that don't respond to the email, to actually telephone the staff at their place of work to 
remind them to come. Then that telephone call could identify the reason that the person hasn't 
come. Also, to send, for example, text message reminders. That would also be a useful way to 
remind people. This would require extra staffing.”HCWs-VP,Nurse-1 
 
Improving documentation and data utilisation 
To improve vaccine efficiency and compliance, correctly completed documentation should be 
considered as the cornerstone either in the IPCD at database or with or to HCWs/soldiers such 
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as via distribution vaccination cards or certificates to include details of vaccination. In this 
regard, a suggestion to improve data capture was by redesigning a specific vaccination file on 
a hospital computerised system to include all details about personal vaccine history among staff 
or patients. Following are a few quotes to clarify this: 
Service users’ views: 
“They are supposed to have an electronic system that shows who took vaccine and who did 
not.”Nurse-FGD 
“For me, the vaccination card is important for all and anyone taking the vaccine should be 
documented to be reminded of upcoming doses. Vaccines card should be in two copies; one on 
file records and the other with the staff.”Nurse-FGD 
“Soldiers should have a vaccination card with the vaccination taken.”Soldier–FGD 
Providers’ views: 
“I think that the hospital computerised system, to be blunt with you, is quite labour intensive in 
recording anything, any vaccination on that system. It takes a long time, so there is room for 
improvements in the efficiency of recording the vaccinations” HCWs-VP,Nurse-1 
“Soldiers who are vaccinated should be given signed and stamped health cards or certificate 
with information about given vaccine, date, the person who gave him the vaccination and his 
signature, in addition to keeping this in the IPCD data based”.Military-VP,Nurse-8 
The team suggested recruiting a clerk for data capture and analysis of the vaccination 
programme data to facilitate more appropriate planning geared towards an expandable 
vaccination programme and enhanced staff coverage. 
“We need more improvement in collecting data. Our main problem here is that we have a huge 
number of recruited staff in the hospital, and that is why we need staff for the data entry. We 
need deep analysis for data collected.”HCWs-VP,Nurse-3 
 “… I think we need that specialised person to manage data. We are not working only in military 
vaccination programme. We work in other programmes. So, it’s too difficult to give – to enter 
the data and make use of it.”Military-VP,Physician-2 
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Improving auditing and vaccination process evaluation 
Some interviewees suggested on-site verification activities such as, inspection or examination 
of a vaccination process or quality system, to ensure compliance to requirements, standardizing 
the process in order to monitor the process: 
Service users’ views: 
“Auditing vaccination programme and encouragement to the staff should be provided by the 
IPCD team and quality department in the hospital.”Nurse-FGD 
Providers’ views: 
“I think we should find another way to standardise this procedure. We have to look at data by 
addressing the concern of rejections and we have to look for common factors for example why 
do not they get vaccines. We have to study these finds and see where we can benefit. At this 
time, we do not have the manpower to do this, but hopefully in the future.”HCWs-
VP,Physician-1 
 
Role model participation and departmental motivation 
The leaders and directors of departments should facilitate and encourage staff to complete their 
vaccine doses and motivate their staff to meet vaccination programme objectives. This could 
also improve HCWs'/soldier’s compliance with such programmes, as well as minimising or 
even helping to avoid administrative issues that could cause HCWs/soldiers to refuse being 
vaccinated. 
Providers’ views: 
“The directors have a very important role. For example, each leader makes a session every 
time they recruit new HCWs, to explain, the importance of adult vaccination and the need to 
maintain vaccine this may prove more effective.”HCWs-VP,Nurse-2 
The participation of role models at the start of vaccine campaigns could motivate HCWs/ 
soldiers to accept and complete vaccine dose schedules and have a correspondingly positive 
impact on individuals and the community. 
“This is what we notice, if the director of a department himself opens his arms and lets us 
vaccinate him then the others staff will be take vaccine easily.”HCWs-VP,Nurse-4 
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“Some vaccines were rejected. The Swine Flu was spread, but most of the soldiers rejected the 
vaccine after the rumours, although the leaders were concerned that vaccines should be given. 
In order to motivate soldiers to take the vaccine after the spread of the swine flu, the Prince, 
other military leaders in the SANG, as well as the minister took the vaccine in public in front 
of the media. This dramatically changed responses of soldiers to be vaccinated.”Military-
VP,Nurse 6 
 
Rewards  
Most interviewees suggested that providing rewards during vaccination campaigns could 
improve adherence, for example, small gifts would attract greater attention from the staff and 
community. A strategy that actively seeks numerous small gifts was thought to have the 
potential to reap increased take-up rates. 
Service users’ views: 
“Gifts attracted the HCWs such as mugs or pens could be provided during health promotion. 
This will increase the enthusiasm among HCWs and will benefit the spread of health 
information and correct false beliefs.”Nurse-FGD 
Providers’ views: 
“We need some encouragements, such as providing a gift, to encourage them to be 
vaccinated.”HCWs-VP,Nurse-3 
 
6.4 Summary of Chapter 
The sixth chapter has presented the results derived from the analysis of qualitative data. These 
data were collected through in-depth interviews and FGDs designed to garner a profound 
understanding of vaccine compliance. The chapter covered themes, sub-themes, and factors that 
accounted for the vaccine barriers among newly recruited HCWs and soldiers. This has included 
five main barriers: individual-related, vaccine-related, staff providers’ vaccine, organisational-
related and social and cultural related barriers. These barriers could directly or indirectly affect 
HCWs/soldiers adherence and compliance to vaccination. 
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Chapter 7. Discussion –Quantitative Research  
7.1 Summary of Main Quantitative Findings 
315 multinational HCWs and 426 male Saudi soldiers completed self-administered 
questionnaires on knowledge and concerns about HBV, measles and varicella. The HCWs 
scored an intermediate median knowledge level of 43 HBV questions, 27 measles questions 
and 33 varicella questions. Of the total, 74.4% gave 32 or more correct answers, 55.5% gave 
15 or more correct answers and 57.6% gave 19 or more correct answers respectively, the 
soldiers scored a low median knowledge level 14.8% gave four or more and 21.2% gave seven 
or more correct answers respectively. 
Among HCWs, non-physicians, Saudis, those who specialised in administrative technical 
support services, not being tested for immune status against HBV, where the source of HBV 
knowledge was not education, each was a predictor of low HBV knowledge. However, those 
soldiers educationally secondary-holding and having no infected family member were 
predictors of low HBV knowledge. Among HCWs, the younger, non-physicians and those 
reporting formal education were predictors of low measles knowledge, while among soldiers 
being born in WR was a predicator of low measles knowledge. 
Among HCWs, medical specialists, technicians’ specialist, administrative technical support 
services were predictors of low varicella knowledge, while among soldiers those not testing for 
immune status against varicella was a predictor of low varicella knowledge. 
Blood samples of 4,328 multinational HCWs and 1030 male Saudi soldiers were screened for 
HBV, measles and varicella. The HBsAg seroprevalence was 19 (0.4%) among HCWs and two 
(0.2%) among soldiers, denoting a chronic HBV infection. The HBcAb positive seroimmunity 
was 289 (6.7%) among HCWs and eight (0.8%) among soldiers, denoting exposure to HBV 
and immunity due to natural infection. With HBsAb positive seroimmunity 2957 (68.3%) 
among HCWs and 305 (29.4%) among soldiers, this group mostly represent those who are 
immune due to HBV vaccination, but might also be related to repeated exposure to antigen 
without infection or recovery from infection with loss of detectable HBcAb. However, 1064 
(24.6%) among HCWs and 676 (65.6%) among soldiers were negative HBsAb and other HBV 
markers, this group being susceptible needing vaccinating. HCW supervisors and leaders are 
considered as predictors to HBV exposure while those HCWs who are Muslims (most likely 
because of the majority of them being Saudi), originating from the EMR, working in 
administration or the peripheral health centres, and male are considered as predictors to low 
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immunity status against HBV. It was found age variability is a predictor of HBsAb immunity 
among soldiers, those being less than 25 years considered as predictors to low immunity status 
against HBV. 
Among HCWs IgG measles positive seroimmunity was 2840 (64.3%) and 322 (31.2%) among 
soldiers, these groups mostly represent those who have prior exposure to the measles virus 
through infection or immunisation with a susceptibility rate 34.4% among HCWs and 68.8% 
among soldiers. Among HCWs those who spent 17 -18 years in formal education, Saudis, 
males, originating from the EMR are considered as predictors to low measles immunity status. 
However, it was found among soldiers, those 22 years or less, less considered as predictors to 
low measles immunity status. 
IgG varicella positive seroimmunity among HCWs was 3689(85.2%); among soldiers 785 
(68.3%), these groups represent those with prior exposure to the virus through infection or 
immunisation. Among HCWs, those working in hospital, originating from the EMR, the WPR, 
the SEAR, appointed in technician positions and staff nurses are considered as predictors to low 
varicella immunity status. However, it was found among soldiers those 21 years or less are 
considered as predictors to low varicella immunity status. 
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7.2 Hepatitis B 
7.2.1 Seroprevalence and seroimmunity among HCWs 
Staff are expected to be screened to HBV before hire but, a quarter responded negatively to this 
or were unsure, perhaps through unawareness. Amongst those certain of HBV immune status 
investigations indicated being informed of their immunity, being similar to the figure reported 
among dentists in north KSA and better than a tertiary care academic hospital in Riyadh 
57.5%(219,248). However, HCWs should be informed of immune status due to their high risk 
environment(121,249). 
HBsAg 
Although the HBsAg 0.4% seroprevalence is considered low prevalence, this number is 
expected to be zero as new recruits were subjected to pre-employment screening and only those 
proven to be negative for contagious diseases continue recruitment. A similar figure was 
reported in a Saudi hospital when the prevalence among HCWs was 0.3%(222). 
Prevalence among Saudi HCWs was higher than non-Saudis (two non-Saudis being infected); 
this may indicate a robust HBV screening system among non-Saudis during international 
recruitment, those positive at their home countries being excluded. Additionally, there was 
significant association between those carrying infection and occupation. These cases are usually 
referred to IPCD for clinical consultation and to apply guidelines to eliminate risks of infection 
among HCWs and patients. 
However, the prevalence of infection did not reflect a strong resemblance to that reported in 
similar seroprevalence studies because positive cases were excluded. Based on this data, 48.0% 
of new HCWs were non-Saudis; the study of seroprevalence should consider the world 
distribution of the HBV carrier rate, which shows variations depending on location. There are 
three levels describing the magnitude of the disease in different communities as determined by 
WHO; the first level includes those with high prevalence (more than 8.0%), the second- medium 
(2.0–8.0%) and third-low (less than 2.0%)(250). It was found that 81.4% were recruited 
originally from high prevalence HBsAg countries (WHO reported), namely Saudi, Philippines, 
Malaysian, and Sudan. This indicates the importance of continued screening tests being 
vigorously applied. Another study shows HBV prevalence among HCWs at 6.0% (Sudan), 
9.9% (Yemen), 1.8% (Libya) and 1.2% (India)(227,251-253). 
Memish reported, in a local study of viral HBV seropositivity incidence trends over eight years 
in KSA that in developing countries, 40.0-65.0% of HBV infections in HCWs are attributable 
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to percutaneous occupational exposure. By contrast, in developed countries, the exposure rate 
was below 10.0%, largely due to high rates of immunisation and the availability of post-
exposure prophylaxis(254). 
The prevalence (0.4%) is a valuable benchmarking to possible HBV exposure in the future 
among those screened negatively and could be used to assess the assumptions that many 
researchers approve; that HBV is a health threat to the healthcare community as reported in the 
risk of HCWs contracting the infection being four fold the adult general population(255). 
HBcAb 
The seroprevalence of HBcAb was 6.7% among new HCWs - similar to a Saudi hospital, where 
it was found that 8.0% were positive, however, in the same study, the prevalence among Saudi 
medical students was 1.7%(222). Additionally, the prevalence was similar to native Saudi blood 
donors, 5.7% of blood units were positive among the HBsAg-negative(256) and lower than 
HCWs in the five main hospitals in Libya 8.5% and Brazil 9.4%(253,257). This difference 
could be related to differences in risk to HBV exposures between MER and other regions(14), 
and the possibility of contracting HBV after a needle stick injury involving an HBV carrier’s 
blood(253). 
The prevalence of HBcAb was found to increase steadily with age, ranging between 4.0% of 
25-30 years old to 11.1% among those over 30. The significant association of HBV markers 
with age could be attributed to the longer potential exposure, lacking adult HB vaccination 
programmes, and poor awareness of HBV infection in earlier decades. Some studies showed 
that employment duration strongly correlated with HBV exposure(253). 
Furthermore, the prevalence of HBcAb was significantly higher among those designated to 
work in the hospital than in those designated to work either in the university or PHC. This could 
be attributed to the risk of exposure to HBV patients who need specialised health care usually 
provided in tertiary care. Additionally, the odds of positive HBcAb among non-Saudis were 
thrice those of Saudis and specifically with those originally from the WPR. This is probably 
because the disease is endemic in the WPR(250). 
Supervision and leadership were the independent variables determining HBcAb seroimmunity 
of HCWs. Both occupational positions are usually occupied by senior staff and mainly of aging 
factor reason, as described above, HBcAb was found to increase steadily with age, as potential 
risk of exposure increases. 
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The interaction demonstrates a different immune status pattern between those recruited from 
the EMR and WPR. For the latter, seroimmunity increased markedly among admin assistants 
while for the former there is a notable decrease among administrators. 
HBsAb 
The seroprevalence of HBsAb among new HCWs was 68.3%, better than was reported among 
newly recruited HCWs in Riyadh 57.0%, and Saudi medical students (33.3% positive) and 
51.4% of HCWs in five major hospitals in Libya, however, it was less than HCWs in a Saudi 
hospital 76.2%, the reason for this difference is most likely that the majority of the non-Saudi 
work force receives their HBV vaccine prior to their recruitment(41,222,253), and also to poor 
awareness of the importance of vaccination among Saudis. 
To understand this in more detail, HBsAb positive was verified for their previous history of 
immunisation, 77.8% being vaccinated, of whom 57.7% claimed to have received three doses 
of the vaccine or more and 67.4% described it as regular. This rate is much lower than self-
reported by other studies in Brazil 90.8%, Canada 100%, and UAE 95.8%(248,258,259). 
Additionally, among those HBsAb negative were 20.9% claiming immunity, of whom 37.2% 
received three doses of the HB vaccine, or more. 
The difference in reporting immune status and seroprevalence of immunity could be attributed 
to many reasons, first not everybody actually responds to HBV vaccine, secondly not all 
complete the three doses. Third, the level of HBsAb titres declines with the passage of time 
after vaccination(260), fourth, the possible weakness of self-reporting of vaccination status. 
Nevertheless, this suggests and illustrates the importance of serology screening. Most reasons 
to be vaccinated were either for work requirements or doctor’s recommendation and two thirds 
were vaccinated as undergraduates. It is possible that HCWs were exposed during their medical 
training to a mass campaign targeting HBV and benefits gained. 
However, about 24.6% were negative HBsAb and other HBV markers were never exposed to 
the virus. This could be explained as never vaccinated and susceptible to infection. These 
figures support continuing the mass immunisation programmes including HBV to all HCWs, 
compulsory vaccines for each HCW, and any vaccine discontinuation should be very closely 
monitored to avoid a reservoir of non-protection. 
The US, Australia and France report high levels of coverage of those completing the series 
among HCWs, at 75.0%, 77.0% and 93.0% respectively(153,261,262) and low levels of 
coverage with three doses among HCWs reported in Sweden and Japan(263,264). Furthermore, 
about a third of those not vaccinated reported that they believed they were not at risk or did not 
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have a reason to vaccinate. In similar studies among HCWs, the reasons given were either 
forgetting or a lack of time(248,263,264). In comparison to other studies, this study could 
explain how knowledge and awareness of such infections could improve vaccine compliance 
and coverage rates. Completion of multi-dose vaccinations, such as the HBV vaccine, is a 
continuous challenge for the medical community. Financial incentives in the UK and Australia 
target HCWs significantly increasing adherence, leading to full completion(265,266). This may 
be needed in KSA to improve vaccine compliance and complete multi-dose vaccinations. 
Determinants of immune status 
HBsAb 
Findings in univariate analysis revealed that immunity against HBV were increased by health 
experience, those with experience usually having more chance to access vaccines or catch up 
or an awareness campaign. Thus, experience could shape behavioural strategies that, indeed, 
might represent adaptations to a better proactive approach. 
Additionally, the prevalence of those protected among non-Saudis was double Saudis; the 
reason for this difference is most likely that the majority of the non-Saudi work force receives 
their HBV vaccine prior to their recruitment in their country. This could also be applied to non-
Muslims (double that of Muslims); 100% of Saudis in this study reported Islam as their religion, 
so non-Muslims were non –Saudis. 
Furthermore, the odds of those protected against HBV among physicians were six times higher 
than administrators and four times nurses. This indicates firstly, higher awareness of importance 
among those working in the clinical field. Secondly, clinicians benefit from catch up 
vaccinations in the field. Type of occupation, seniority in the profession and direct patient 
contact were reported as factors associated with immunity status, with a greater risk for clinical 
staff during their career as an explanation for the association found (267,268). 
However, nationality and occupation did not remain significant in the multivariable analyses, 
indicating that this association was likely confounded by other explanatory variables. Most 
likely those who were Non- Muslims originated from Philippines (79.0% of all Non-Muslims 
were from Philippines) having immunity, not because of religion, but because of immunisation 
in their country before recruitment and being committed to observing MNG-HA recruitment 
regulation. 
The interaction indicates different age patterns between Muslims and non-Muslims related to 
HBsAb. For non-Muslims seroimmunity increased markedly with age, while with Muslims it 
decreases among the under 30s. Possible explanations are; non-Muslims usually were non–
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Saudis, those usually newly recruited because of shortage among Saudis to fill position 
requirement and most likely those working in a clinical profession have experience therefore 
older and as discussed above clinical occupation, non-Saudi with experience - more likely to 
be immunised. However, as most were Saudi, usually recruited to administration and younger, 
possibly not all completing the three doses of HBV vaccine, so not achieving immunity titre 
level or the level of HBsAb titres declined with the passage of time after vaccination given in 
EPI(260). 
The odds of protection against HBV among females were higher than for males. Males were 
associated with lack of antibodies against the HBV among multinational healthcare workforce 
in KSA as reported(41). This could be that male and other certain genetic factors are proposed 
as probable reasons for a poor immune response to HBV immunisation(269), based on 
Glasxosmith Kline Biological, producer of HBV vaccine, indicating the male factor may reduce 
immunogenicity of HBV vaccines(270). Additionally, females completed the immunisation 
more frequently, which accords with previous studies, this can be attributed to their historical 
concern regarding preventive measures, especially STD(258,271). 
In comparison to the EMR, the odds of positive HBsAb among those who originated from 
Africa were four times higher with odds of positive HBsAb from WPR, European Region and 
SEAR double, a similar result to that reported in MNG-HA-Riyadh where susceptibility to HBV 
was highest among HCWs from the MER(4,41). This could be attributed to a successful 
vaccination programme for those recruited from non-MER or receiving recent vaccination catch 
up before travel. 
The interaction between sex and work speciality indicated the odds of protection against HBV 
were lower among females, if working in ancillary medical services or administrative services 
but was higher when working in nursing services or pathology and laboratory medicine. This 
could be attributed to level of awareness and clinical practice background among those working 
in nursing services or pathology and laboratory medicine, high level of awareness and direct 
patient contact encouraging better care associated with high immunity status(268). 
  
  
358 
7.2.2 Seroprevalence and seroimmunity among soldiers 
Only 6.6% of new soldiers had been screened against HBV, the remainder being either unsure 
or reporting not having been tested previously, although this occurred before hiring; being lower 
than among Saudi soldiers (12.5%), Cambodian women (38.0%) and Vietnamese men (66.0%) 
(To the best of investigator knowledge, there is no similar data for similar specific group or 
nationality)(37,186,189). However, these figures are each better than Israeli male military 
recruits (2013), 98.7% being either unsure or reporting not having been tested(223). This 
indicates either difficulty in understanding the reasons for blood screening, ineffectiveness or 
no health education at screening. This observed difference points to poor knowledge about the 
true prevalence of HBV among military personnel, and indicates that there is reduced awareness 
in community to evaluate the magnitude of HBV and its control. Also, they show the 
importance of HBV testing to confirm HBV infection and immunity since self-reported 
vaccination could not be confirmed. 
HBsAg 
Although the HbsAg 0.2% seroprevalence is considered low prevalence, it could be expected 
to be zero as all are subjected to pre-employment screening and only those negative for 
contagious diseases are recruited. 
This figure does not reflect actual prevalence to similar epidemiological characteristics, as 
positive cases were excluded before. Generally, countries in the MER are considered having 
prevalence rates <2.0%(272). Locally, the prevalence of HBsAg among Saudi soldiers on 
military duty was 4.0% in 2012(37), and according to Memish (2010) it ranged from 1.5% to 
2.6%(254). Additionally, the prevalence reported among male attendants was 3.7% in a Saudi 
general hospital in 2009(273), and as low as 1.7% among blood donors in the Saudi tertiary 
hospital in Riyadh(274).  
Although they are tested before hiring, this relatively high prevalence could be attributed to the 
increasing number of expatriates from the Far East and sub-Saharan Africa where high 
prevalence rates are determined (WHO)(250). In addition, large numbers of Hajj and Umrah 
pilgrims visit annually not all following issued health instructions and not being required to test 
for HBV before travel. In particular, head shaving or Hijama is often done without adequate 
preventive measures against blood borne diseases , thought to be a potential risk for local HBV 
spreading(60).  
Generally, prevalence of HBV infection is cited as different among armies, ranging between 
0.3%-3.9%. In NATO forces, for example, U.S. and UK armies, 0.3% and 0.3% are HBsAg 
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carriers, in Greece 0.2%, Lithuania 1.9%, Italy 0.7%, and Spain 0.4%(19,79,84,275,276). 
However, this figure 0.3% will be a useful benchmark to possible exposure to HBV in future 
carriers among those screened negatively. This could also be useful for researchers assuming 
that HBV is a health threat among the military community where extra physical activities 
characterising this group make them more prone to injuries and more liable to catching the 
disease(84,277). 
Chronic HBV carriers are expected to display a greater awareness of HBV and its sequences 
because of the possibility that an infected person could be aware of the diseases; however, 
although the infected soldier knew about his status, his basic level of HBV knowledge was 
lower than median among respondents. The lack of awareness about HBV among soldiers could 
be a risk for a potential spread and this lack of knowledge could be one of the reasons for the 
high prevalence rate in developing and underdeveloped countries in contrast to developed 
countries(187). 
HBcAb 
The seroprevalence of HBcAb 0.8% among the new soldiers was much lower than Saudi 
soldiers 13.2%(37). Additionally, it was lower than was found among blood donors in Tabuk, 
at 18.7%, the same study highlighting that the percentage was significantly higher among 
military blood donors(278), and lower than soldiers in UK 3.6%(276). All soldiers in this study 
were newly recruited, two thirds being 24 years old or less. Perhaps explaining the low risk of 
exposure to HBV could be that those already in service having a potential HBV risk more than 
those newly recruited(77,78), and the older having a greater potential risk to HBV exposure 
than younger as reported in a previous study where age strongly correlated with HBV 
prevalence(279). However, the prevalence of HBcAb was similar to military recruits in Greece 
at 1.1% positive, higher than Spain 0.0%(80,280), but this low prevalence among European 
soldiers was attributed to differences in the prevalence of the diseases in the community(80). 
The explanation for this low prevalence among Saudi soldiers could be attributed to the 
introduction of an HBV vaccination programme in 1989 for infants, improvement of socio-
economic status and education system, the rapid decrease of post-transfusion-related infection 
due to a safer blood supply and more widely practiced infection control procedures among 
medical personnel(281). 
The screening of HBcAb could be used as a potential indicator in a preventive decision, as 
shown in Pakistan where it was reported that because HBcAb screening is not done in any blood 
transfusion centre, one in 200 blood donors, who are negative for the presence of HBsAg, may 
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potentially still transmit HBV to recipients of blood components. This is especially important 
in immune-compromised patients who receive multiple transfusions of blood components, such 
as, marrow transplant recipients(282). 
HBsAb 
The seroprevalence of HBsAb among new soldiers was 29.6%, being much lower than that 
reported among Saudi soldiers on military duty (57.5%); the difference could be related to a 
mass immunisation campaign of all military personnel in SANG(37). Additionally, the new 
soldiers’ immune status is less than Brazilian soldiers at 57.0%, Greece 62.0% and Spanish 
78.3%(84,280,283). 
The SMOH incorporated the HBV vaccine within the mandatory EPI schedule for children 
from 24 years earlier than the time of data collection in 1989(281). Under this programme, all 
Saudis below the age of 24 were to have been vaccinated at birth by 2014. In this study, 60.0% 
of those vaccinated reported vaccination as part of this campaign and, additionally, 65.2% of 
the new soldiers aged below 26 years had received the vaccine under the EPI. 
To understand the nature of this immunity in greater depth, HBsAb positivity was verified for 
their previous history of immunisation. Unexpectedly, it was found that only 4.2% could 
remember that they had been vaccinated against HBV, of whom, only 3.1% expressed receiving 
three doses and the others described it as being regular, these figures being less than similar 
local studies(37). However, this could demonstrate that there are benefits gained from the EPI, 
as the prevalence of HBsAb among military personnel in Riyadh in 2001 accounted for 
17.8%(278). On the same trend, findings revealed that, out of the new soldiers who were 
negative for all HBV markers (N=230), there were four soldiers (2.1%) who indicated that they 
received the vaccine and 76.1% who indicated they did not know if they had received the HB 
vaccine. This figures were less than was reported in similar groups (37). 
The difference in reporting immune status and seroprevalence of immunity could be attributed 
to many reasons, first not everybody actually responds to HBV vaccine, secondly not all 
completed the three doses of HBV vaccine. Third, the possible weakness of self-reporting of 
vaccination status. Fourth, this could raise a concern about compliance to vaccination of 
soldiers among those who were Bedouins or from peripheral areas.  
However, about 65.6% were negative HBsAb and other HBV markers never exposed to the 
virus. This could be explained as never vaccinated and susceptible to infection. This figure was 
less than that for Saudi soldiers on military duty, 38.0% negative to HBsAb and Greece military 
  
361 
recruits 36.0%(37,84). It also empowers decision makers to support continuing the mass 
immunisation programme for all soldiers to a high degree of compulsory vaccination. 
It had been advocated that regardless of the routine childhood vaccines, including HBV 
requiring boosters to ensure full immunisation, any vaccine discontinuation in the general 
population could lead to a reservoir of unprotected adults among different cohorts including 
military populations, which could predispose to possible outbreaks(81). On the same line, and 
putting into consideration that during conflicts or peace-time disasters, mass casualties would 
require numerous blood transfusions quickly, and the only immediate source of blood donations 
is the other nearby soldiers, there may be little time or capability for preliminary screening. 
Prior immunisation of potential donors against HBV should reduce the risk of receiving an 
infectious blood transfusion and help to build confidence and morale(77). 
Furthermore, it had been asserted that HBV infection incidence is higher in armies where there 
are generally no vaccination programmes against HBV in the general population(79,80,284). 
These advocates were the impetus for the mass immunisation campaign which targeted all 
military personnel in the SANG conducted previously, and was one of the reasons for 
elaborating the HBV seroimmunity among this study group. 
When asked about reasons for not vaccinating, about two thirds of new soldiers believed they 
were not at risk, suggesting how knowledge and awareness of such infections could improve 
compliance and coverage rates possibly transferring to behaviour changes. Interestingly, 
findings concerning low vaccination rates in the previous EPI would provoke many issues, 
amongst which are, related to and jeopardizing the effectiveness of the received vaccine in 
terms of efficacy of the vaccine, number and regularity of the doses, adherence to cold chain 
instructions, and appropriate methods in administration. The level of HBsAb titres declined 
with the passage of time after vaccination(133,260,285). However, recent studies argue that 
immunologic memory persists and would be capable of preventing chronic or symptomatic 
infections for up to 22 years after vaccination; 75% of soldiers in this study being 22 or 
over(286,287). Thus, revaccination policies remain controversial, sub optimally informed by 
evidence, and practices vary from country to country(276). 
The other issue relates to lack of knowledge about immunisation status, drawing the conclusion 
that EPI might not have included health education of parents about the nature and benefits of 
the vaccine. 
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Determinants of immune status 
HBsAb 
Findings revealed that the prevalence of HBsAb among new soldiers for over 25s was double 
that of under 21s, among those with 13 or more years education compared to those with 12 or 
less, and those married twice that of singles. However, following multivariable analyses, age is 
seen to be a significant predictor of positive HBsAb among those over 25. Some studies 
suggested the opposite relationship between age at primary vaccination and HBsAb positive 
status, as older persons have a weak immunity against HBV immunisation (47,221,270). 
However, this figure among soldiers could be explained as those older are more educated, 
looking to health services for better care, or possibly to a catch-up vaccination campaigns. 
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7.2.3 HBV knowledge assessment among HCWs 
Level of HBV knowledge  
A moderate level of HBV knowledge among new HCWs was reported, as stated elsewhere(288-
290). Several studies suggested that incomplete health care provider knowledge of blood 
transmission may jeopardise the effectiveness of HBV prevention and control 
programmes(291-293). However, results show that median knowledge scores were slightly 
lower about HBV vaccine and immunity: one third knowing the HB vaccine is safe for pregnant 
women and that immunity following HB vaccination is not life-long. Similar knowledge studies 
reported similar findings(215,294) revealing a knowledge gap needing consideration during 
education and ordination programme of IPCD focusing the importance of vaccine and 
immunity. 
Among new HCWs, 71.7% wrongly reported HBV could be transmitted through breast-feeding 
from an infected mother, possibly due to issue controversy and a lack of solid evidence. 44.4% 
wrongly reported that HBV could transmit HBV through drinking water, corresponding to other 
results reported among HCWs in KSA and Ethiopia(215,219). These data suggest that high 
misconceptions of simple behaviours as risk for HBV transmission, may be confusing HBV 
transmission with other communicable diseases such as HAV.  
Although most HCWs knew of the high risk of HBV infection, 44.8% were unaware of possible 
severe consequences, including causing most primary liver tumours (HBV causes 69.3%). 
These findings suggest that HCWs are largely aware of HBV risks but not of the possible fatal 
outcomes. 
More than two thirds cited education, and half the internet, as the main sources of information, 
a better knowledge score was recorded significantly among those reporting education as source. 
These were expected as the majority were medically trained; however, the internet as a source 
without guidance and reliable related information could be risky. 
Determinants of HBV knowledge 
It was observed that physicians had greater disease and vaccine knowledge, while others might 
have insufficient information. The number of correct answers, in significant correlation with 
being a physician was reported in a similar knowledge study(295). Physicians had greater 
knowledge acquisition of the disease and the vaccine while others often displayed insufficient 
information, which would explain consistently lower scores. High levels of education are 
usually associated with enhanced exposure to knowledge and information. Those with higher 
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education probably have more and better access to educational resources such as medical 
courses and awareness. 
It was also found that non-Saudi HCWs were more likely to have better HBV knowledge than 
Saudi HCWs, possibly due to the information resources of the individual society as well as such 
other variables as cultural factors. In addition, most newly recruited non-Saudis work in clinical 
services possessing professional experience in their speciality that could increase their access 
to knowledge and education. 
Those HCWs specialising in administrative technical support services had an average lower 
knowledge score compared to those working in clinical services. Additionally, physicians were 
significantly more likely to have higher knowledge scores compared to nurses. This may reflect 
those working in clinical services have better knowledge because of medical education and 
clinical background, and specifically those working as physicians’ have greater formal training 
and clinical experience than nurses. This could evidence that it would be beneficial for all 
HCWs to receive formal training. 
Additionally, those reporting sources of HBV knowledge to be formal education had 
significantly higher HBV knowledge, indicating the effect of formal training in comparison to 
other kinds of awareness. Introducing health education programmes for such risky diseases in 
the orientation week could affect improved knowledge among those who did not receive formal 
education, such as administrators. Those who reported that they had enough HBV information 
were more likely to have a better HBV knowledge score compared to “not-enough” information 
responders, which could be a good predictor of knowledge. 
There is more likelihood of having a higher knowledge score in graduate groups compared with 
under graduate education levels. This is most likely a reflection of sociodemographic and 
acculturation factors(187). High levels of education are usually associated with greater 
exposure to knowledge and information. Those with higher education probably have more and 
better access to educational resources such as the internet and medical courses and awareness, 
similar knowledge studies reporting similar results(187,189,190,296). Additionally, HCWs 
who were tested for immune status against HBV were more likely to have a higher knowledge 
score compared to those who were not tested, possibly related to those with higher knowledge 
having the motivation for screening and testing immune status to evaluate their health status. 
The interactions indicate that physicians had much higher scores of HBV knowledge when 
education is reported as the source of information, explained by physicians usually having more 
clinical training and education than other HCWs group, their knowledge synergising when 
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source of this knowledge is formal education. Additionally, those stating education as a source 
of information had higher scores of HBV knowledge when stating enough information, possibly 
attributable to confidence in their training and education materials. 
The interaction indicated that non-Saudis had much higher scores in HBV knowledge when 
education is reported as the source of information, as most non-Saudis were recruited in clinical 
services and most likely had more clinical training and education than administrators (majority 
Saudis). 
Those in the clinical field usually have high levels of education, associated with greater 
exposure to knowledge and information. Higher education probably encompasses better 
resource access as detailed above(187,189,190,296). 
7.2.4 HBV knowledge assessment among soldiers 
Levels of HBV knowledge  
A low level of HBV knowledge among new soldiers was reported. Specifically, nearly three 
quarters of respondents were unfamiliar with “the communicable disease or virus called HBV”. 
This figure is higher than Saudi soldiers for whom two thirds were unfamiliar, Saudi dental 
patients (41.5%) and non-Saudi population at 50.0%(38,186,187). Furthermore, 15.9% knew 
that asymptomatic individuals spread HBV, similar to Saudi soldiers (17.5%) and less than the 
non-Saudi population 58.0%(38,189). 
Moreover, three quarters were unaware of the possible severe health consequences of HBV, 
including cirrhosis 68.0% and liver cancer 81.0%, being similar to Saudi soldiers(38). 
Additionally, 15.0% of soldiers were aware of a high risk of HBV infection. These findings 
suggest that military personnel are largely unaware of the serious infection risks. Likewise, they 
were unaware of the possible fatal disease outcomes; only a third knew that HBV is sometimes 
fatal. These findings accords with research in Jeddah and Riyadh(187). These figures reveal an 
HBV knowledge gap. 
The role of sexual behaviours on the prevalence of HBV is not well known among military 
personnel and needs investigation. Additionally, information about STDs in Islamic countries, 
where non-marital sex and homosexuality are prohibited, is limited. An assumed low 
prevalence of STDs and religious and cultural intolerability of non-marital sex and 
homosexuality in Islamic countries are expected reasons for the limited data(297) - only 17.4% 
knowing that sexual intercourse is a potential mode of transmission; less than findings of a 
study conducted among Saudi soldiers 39.8%, Saudi patients 31.6%, Egyptian barbers and their 
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clients 68.0% and the USA 69.0%(38,184,187,220). These differences raises two critical issues; 
first, talking openly about safe sexual behaviour is unacceptable for Saudis for religious, social 
and ethical reasons, and that communication about prevention of STD between sexual partners 
is limited(190); second, that ignorance about safe sexual behaviour puts the community in 
general and soldiers specifically at risk of acquiring STDs including HBV. 
Similarly, it was found that knowledge among new soldiers about specific HBV transmission 
routes were lower than in other similar knowledge studies. Only 36.7% knew that utilisation of 
other’s razors is a potential hazard for disease acquisition; lower than reported among Saudi 
soldiers 41.2%, and fewer, 18.8%, knew that using peers’ nail clippers posed potential risks(38). 
This gap of knowledge is usually translated into behavior where it could be noticed that sharing 
razors and nail clippers is common between soldiers, particularly when they are in hurry to 
prepare for inspections. 
Additionally, it was found 7.4% had had one or more blood transfusions, a third knowing HBV 
could be transmitted thus. This was lower than found among dental clinic’ attendants in Riyadh 
49.5%, Saudi soldiers 58.0%, and Egyptian barbers and their clients 93.0%(38,187,220). 
Furthermore, few of those surveyed knew that HBV is not spread by eating food prepared by 
an infected person 12.7%, , comparable with the results of a study conducted on Saudi soldiers 
15.0%, but lower than the percentage reported among dental clinic attendants in KSA 20.8% 
and non-Saudi population 36.0%(38,186,187). Additionally, few of those surveyed knew HBV 
is not spread by drinking water in cups used by others 8.6%, similar to study results of Saudi 
soldiers 10.8%(38). Moreover, a fifth knew that HBV is unlikely to be transmitted when being 
coughed on by an infected person, higher than Saudi soldiers at 12.8% but lower than 25.0% of 
the non-Saudi population respondents(38,189). These data suggest misconceptions of simple 
behaviours as risks for HBV transmission and low HBV knowledge may be confusing HBV 
transmission with other communicable diseases such as HAV and tuberculosis. 
Chatting with colleagues was found to be soldiers’ most prevalent source of information, which 
is common when there is no routine awareness or health education. These results, similar to 
findings among Saudi males, where friends are reported as the main source of information(298) 
suggests an environment of rumour and misinformation between similarly educated levels. 
However, better knowledge scores were significantly recorded among those reporting families 
as the main source of information, this could be attributed to parents or a family member having 
a higher knowledge and experience that could reflect in knowledge or practice of family and 
consequently improve knowledge level. 
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The low level of HBV awareness observed among new soldiers may reflect a similarly low 
level of HBV awareness in the soldiers in duty services and general public in KSA which may 
be contributing to the endemicity of HBV(38,187). This serious gap of HBV knowledge 
elaborated in this study could be attributed to many factors, namely; lack of health education 
campaign targeting military personnel and tackling important preventable disease issues such  
as HBV, similar to findings presented in a study among SANG soldiers which also 
demonstrated the effectiveness of health education awareness and campaigns in improving 
health knowledge(38). 
Additionally, ineffective interchange of health information within the soldiers’ communities 
might play a negative role in dissemination of information between them, rumours and wrong 
information were usually circulating among closed communities such as the military 
community(299). Providing solid health information to soldiers and commanders could 
overcome this minimising risks of rumours. Targeting soldiers in battalions and barracks with 
posters and education materials will improve their knowledge spreading information. 
Furthermore, it is expected that there are social barriers and cultural morals that preclude 
exchange of information particularly those related to intimate matters such as sexual behaviours 
and risks in transmitting diseases, especially through extra marital relations(297). 
Determinants of HBV knowledge 
There was a significant association between HBV knowledge score and highest level of 
education, those having a diploma had higher HBV knowledge. This finding accorded with that 
found among Saudi soldiers which is most likely a reflection of sociodemographic and 
acculturation factors(38,39). This notion is supported by Ashri who showed that greater HBV 
knowledge was associated with higher income and increasing levels of education(187). 
Additionally; the highest such score was recorded by those who were born in Madinah, while 
the lowest in Taif. This could be explained as Taif is considered a rural and semi-urban area in 
comparison to Madinah, which is urban and semi-urban and more open for people who come 
from all over the globe to visit the prophet mosque. Through socioeconomic and human 
development parameters, populations in urban areas usually have more accessibility to health 
services and more exposure to health awareness campaigns. 
A small, significant positive correlation exists between new soldiers HBV knowledge formal 
education and experience, possibly related to health awareness campaigns in formal education. 
Moreover, significantly higher scores in median HBV knowledge were recorded among 
respondents tested for HBV, for immunity against HBV, and who had immunity against the 
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disease, indicating the importance of health awareness during screening affecting knowledge 
level and awareness.  
However, following multivariable analyses, diploma-holding soldiers’ scores were observed to 
be double HBV knowledge of secondary school certificate holders. Also, those soldiers having 
one HBV-infected family member scored seven times higher in HBV knowledge than those 
without. These characteristics may be inter-correlated; for example, those with higher education 
have higher-paid jobs. HBV awareness in many populations was reported to correlate with the 
level of education. Those with higher education probably have more and better access to 
educational resources and preventive care including physicians’ advice(187,189,190,296). 
  
  
369 
7.3 Measles 
7.3.1 Seroimmunity among HCWs 
Although staff are screened to measles immunity before hire, only a quarter of HCWs were sure 
they had been previously investigated. Most likely those who reported never being screened or 
were unsure, were unaware of screening because no health education accompanied the tests, no 
documentation was provided or simply through employee ignorance.  
IgG Measles 
The seroprevalence of IgG measles among new HCWs was 65.6%. To understand this further, 
IgG measles positive was verified for their previous history of immunisation. It was found that 
65.7% could remember that they had been vaccinated. However, there was overlapping between 
those vaccinated and infected 16.8%. 
The measles vaccination coverage rate in this study was better than HCWs in Wales 42.0% and 
among Austrian HCWs 59.8%, however, a similar seroimmunity study reported a similar 
coverage rate among Greek HCWs 68.5%, HCWs in a Saudi hospital 71.8%(226,261,300,301). 
Considering this study’s results, the vaccination rates among HCWs were unsatisfactory, with 
approximately only two thirds having completed their vaccination. This inadequate vaccine 
coverage may be caused by several factors such as, lack of vaccine access, missed vaccination 
opportunities, and ignorance of its importance(302). 
The susceptibility rates in this study at 34.4% were higher than those reported among HCWs in 
Greece 20.5%, in MNG-HA in Riyadh 13.0%, in France 8.3%, an Australian hospital 8.0%, 
Italy 8.0%, newly hired HCWs in Japan 7.4%, Turkey 6.3%, in a tertiary hospital in Catalonia 
6.0%, and in a Saudi hospital 4.5%(41,224,226,300,303-307). The overall measles 
seroprevalence among HCWs was below the 93-95% recommended by the WHO for population 
immunity(99). Low seroprevalence of measles antibodies may be a result of inadequate vaccine 
coverage, vaccination failure, or waning immunity. Vaccination failures may be attributable to 
inadequate vaccine dosage, or vaccine inefficacy(302). 
Furthermore, when asking those not vaccinated about the reasons, about a third believed they 
were not at risk. In a similar study in Wales, perceived immunity, fear of side effects and in- 
sufficient knowledge about the vaccine were responses(261). This explains how gaining 
knowledge and awareness among HCWs about such risks of infection could improve practice 
and attitudes to compliance and coverage rate. 
  
370 
Determinants of immune status 
Multivariable analyses revealed 16 years or less in education made significant contribution to 
predict IgG measles positivity against those between 17 and 18 years. Low levels of immunity 
being related to missed vaccination opportunities, or ignorance of its importance. 
Additionally, in comparison to Saudis, the odds of positive IgG measles among non-Saudis 
were almost four times higher, probably related to a catch up mass vaccination given before 
issuing visa application or to effective vaccination rates in home countries. In this study, 
employees from KSA demonstrated high prevalence of susceptibility to measles, possibly 
related to failure to receive two doses of the MMR vaccine, and the decreasing prevalence of 
measles in KSA. 
The odds of positive IgG measles among females were higher. This could be because those 
females completed the immunisation more frequently than men, agreeing with previous 
studies(258,271) and attributable to historical female concern regarding preventive measures, 
especially to safe pregnancy and effectiveness of antenatal programmes. 
In addition, in comparison to those who originated from the EMR, the odds of positive IgG 
measles among those from the SEAR were three times higher, and among those from the WPR 
were higher as described before, which could be related to a catch up mass vaccination given 
to the international newly recruited before the visa process, especially those from India and 
Indonesia (the SEAR), and Malaysia and Philippines (WPR). This also could be a result of 
measles elimination strategy achieving and maintaining 95.0% population immunity against 
measles through routine and/or supplementary immunisation activities(308,309). However, 
data suggested what had been reported in a study conducted among a multinational healthcare 
workforce in KSA at MNG-HA, Riyadh about susceptibility to measles, the highest 
susceptibility was among HCWs from the MER(41). 
In comparison to staff nurses, the odds of positive IgG measles among specialist physicians 
were five times higher and among staff physicians, six times higher. This could be attributed to 
awareness and knowledge of importance of vaccination among those pursuing postgraduate 
studies(218). 
7.3.2 Seroimmunity among soldiers 
The majority responded that they had never been screened or were not sure about previous 
investigations. Currently, no screening tests for measles antibodies are provided in the military 
screening programme. A USA military study reported that screening for immunity dramatically 
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reduces vaccination rates and is cost-effective - vaccinating only those with negative 
results(310). 
IgG Measles 
The seroprevalence of IgG measles among new soldiers was 31.2%, to understand this further, 
IgG measles positive was verified for their previous history of immunisation. It was found that 
11.7% could remember being vaccinated. However, there was overlapping between those 
vaccinated and infected 2.2%. 
The measles vaccine was introduced in EPI of the KSA in 1974, initially having low coverage 
until 1982, when it was decreed compulsory before birth certification is issued(94). The oldest 
soldier in this data at time of data collection was 32 years and as it was supposed to cover all 
soldiers on this study vaccinated under EPI, the vaccine was compulsory from that age.  
The vaccine was initially given to susceptible children aged 1–9, while in 1983 it became 
routine for all infants at 9 months. In 1991, it was further advanced to 6 months with a further 
dose at 12 months. In 2001, two MMR-dose schedules were implemented, with the first dose 
at 12 months and second at pre-school age(311). The policy was amended in 2008 to be given 
within the school setting(312), in order to control a concurrent outbreak. 
Based on these dose changes, those at age 24 or less (65.2%) mainly received protocol doses in 
1991 and those over 24 mainly received 1983 protocol doses. In addition, reported 
immunisation coverage for all EPI antigens increased from <50.0% in 1980 to ≥90.0% by 1993 
and has been ≥95.0% since 2004(94,313). However, 50.0% of measles cases after 1990 in the 
1- 4 year age group occurred in vaccinated children(94). 
In a study conducted at Jeddah, KSA (2005), involving similar age groups to current targets for 
those between 7-11, seropositivity for measles was 72.6%, while for those 12-14 it was 66.4%. 
The study concluded that the prevalence of seropositivity against the above-mentioned viruses 
decreased with age(228). 
The susceptibility rate in this study is 68.8%, placing soldiers below the 93–95% level 
recommended by WHO for population immunity(99). In comparison to similar military recruit 
studies, this rate is higher than Thai 21.5%, Norwegian 9.7% and US military recruits 
15.4%(116,314,315). 
This data showed a high measles susceptibility rate and this may raise questions in the KSA. 
Inadequate vaccine coverage may be caused by several factors such as lack of vaccine access, 
missed vaccination opportunities, and ignorance of the importance of vaccination(302). In this 
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study, vaccination status was recorded from a history, so it is difficult to be confident about its 
robustness of evidence for vaccination. Additionally, a question could be asked about the 
possibility of vaccine failure, although, the measles vaccine is highly effective; most studies 
have shown that at least 90.0% of vaccine recipients are protected and many studies have 
suggested a protection level of 95% or higher(316). 
With low herd immunity, measles infection can spread easily in densely populated communities 
such as prisons, dormitories and recruit camps, such as in an epidemic outbreak that exposed 
12.0% of personnel in a Russian military unit and Israeli military units(113,115). Therefore, a 
supplementary immunisation activity for higher risk adult communities may be an effective 
preventive measure, even with the two doses of MMR vaccine taken as part of Saudi’s national 
childhood immunisation programme. Such a supplementary immunisation was applied to 
military conscripts in Norway as an outbreak prevention measure although vaccine coverage 
was higher than 95%(116). 
Neither a positive nor negative history of measles was a good predictor of immunity having no 
value as a predictor in adults, able to identify about 20.0% from positive prediction (those who 
reported having been infected and vaccinated). The negative prediction (those who reported 
having been not infected and not vaccinated) was 89.8%. This low positive immunity could be 
due to historical information being obtained by a self-administered questionnaire and not by 
face-to-face interview, during which additional information on the illness could have been 
secured. 
Furthermore, when asking those not vaccinated about the reasons, more than half the soldiers 
believed they were not at risk. This explains how gaining knowledge and awareness about the 
risks of infection could improve practice and attitude to compliance and coverage rate. 
Determinants of immune status 
Multivariable analysis indicated age variables significantly contribute to IgG measles positivity, 
the odds of positive IgG measles among those more than 22 were double those under 21. This 
high IgG measles positivity may be attributed to many reasons. First, recurrent changes in 
vaccination policy to achieve high seroimmunity(311), secondly, special measles immunisation 
campaigns introduced in addition to routine immunisation, KSA conducting two campaigns, 
(1998 and 2000), achieving a reported coverage of 96.0% and 97.0% respectively(312). In 
1998, an MMR campaign was launched in two phases, targeting school children in secondary 
schools, and in 2000 primary and intermediate schools(94). Third, exposure to the wild measles 
virus was more frequent with age, since it continued to circulate in the population several years 
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after the vaccination programme began in 1974(116). Fourth, it could simply be because of 
infection in childhood and parents not reporting or misdiagnosing as varicella infection. 
7.3.3 Measles knowledge assessment among HCWs 
Level of measles knowledge  
A moderate level of measles knowledge among new HCWs was reported, this figure was less 
than that reported among paediatricians in Brazil at 62.0% and HCWs in the US 
61.0%(143,218). However, HCWs knowledge in this study was better than both German 
medical students of whom less than a third of the students were able to answer more than 50.0% 
of the questions correctly and also Egyptian medical students who averaged 50.0%(192,196). 
The lowest percentage was recorded for knowledge about vaccine and immunity, in which only 
a small minority knew that the measles vaccine can be given to people with an egg allergy and 
only a third knew that the measles vaccine is unsafe for pregnant women. These figures show 
the presence of a knowledge gap which should be addressed during educational awareness in 
the future and an orientation programme focusing on vaccine and immunity. This will affect a 
positive attitude regarding vaccination, as a study in the Philippines showed increasing specific 
knowledge about measles vaccination resulted in higher vaccine uptake, central to the 
campaign’s success(317). 
Determinants of measles knowledge 
Multivariable analysis indicated age, occupation and educational sources significantly 
contribute to measles knowledge, an increase of one year in age among HCWs being associated 
with an increase of measles knowledge score. The number of correct answers significantly 
correlated with age of participants’ reported in a similar knowledge study(295). This could be 
explained as those older are more educated and have greater opportunity to develop their health 
education or experience a disease in comparison to the younger. This has been reported among 
Brazilian paediatricians when assessing measles knowledge(218). 
Additionally, nurses, medical specialists and technicians, and administrators were significantly 
more likely to have lower knowledge scores in comparison to physicians. Also, administrators 
were significantly more likely to have lower knowledge scores. The number of correct answers, 
in significant correlation with being a physician, was reported in a similar study(295). 
Physicians had greater knowledge acquisition of the disease and the vaccine while others often 
displayed insufficient information because of their study background experience, which would 
explain their consistently lower scores. High levels of education are usually associated with 
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enhanced exposure to knowledge and information. Those with higher education probably have 
more and better access to educational resources such as the internet, medical courses and 
awareness. Similar studies among HCWs to assess measles knowledge reveal similar findings 
between occupation types(143,218). 
Those reporting sources of measles knowledge were formal education, had significantly lower 
scores in measles knowledge compared reporters of other sources. The number of correct 
answers was significantly correlated with having had courses on vaccination or where the main 
sources of information were nursing school and secondary school, as reported in similar 
knowledge studies(295,301). This result could be attributed to two main reasons; firstly, 
weakness of the formal educational curriculum to cover preventive measures in occupational 
settings and secondly, as half the HCWs quoted the internet as their main source of information, 
this indicates how other sources of knowledge could affect increasing awareness and 
knowledge. However, using the internet as a source of information without guidance and 
reliable related information could be risky. 
 
7.3.4 Measles knowledge assessment among soldiers 
Level of measles knowledge 
A low level of measles knowledge among new HCWs was reported, and to the investigator’s 
knowledge there is no previous published work related to assessment of measles knowledge 
among soldiers. However, some soldiers’ responses average below other knowledge studies 
among different population groups, for example, 17.1% of new soldiers knew that measles was 
caused by a virus while 44.5% of non-medical students in an Egyptian University knew, and 
16.9% of soldiers knew that the measles vaccine is a live attenuated vaccine while 35.6% of 
non-medical students accorded(192). The lowest percentage was recorded for knowledge about 
complications of measles being relatively common and if the measles vaccine is safe for 
pregnant woman. Additionally, only 20.3% knew that soldiers may have an increased risk of 
becoming infected with measles. These figures reveal a knowledge gap which educational 
awareness and orientation programme focusing on vaccine and immunity should address. This 
will affect a positive attitude regarding vaccination, as a study in the Philippines showed that 
increasing specific knowledge about measles vaccination resulted in higher vaccine uptake and 
was central to the campaign’s success(317). 
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Close to two fifths of the soldiers reported that they had measles knowledge, 61.8% 
acknowledging colleagues, and 34.2% quoting family and relatives as the main sources of 
information. Similar studies reported the same results(318); showing the importance of peers 
and families in information management. Targeting soldiers in battalions and barracks with 
posters and education materials is likely to improve their knowledge and spread information to 
other soldiers as well as the general populace. A study in KSA among soldiers had reported this 
kind of education as a valid means and effective method(38). 
Determinants of measles knowledge 
Multivariable analysis and confounding adjustment indicated the region of birth variable made 
a significant contribution to measles knowledge. Compared to those born in Jeddah, the odds 
of possessing measles knowledge among those from outside the western region were double. 
Possibly explaining this; firstly, of most of those born outside the western region, 20.3%, may 
have a higher level of education with greater opportunity of exposure to knowledge and 
information. Those with higher education probably have more and better access to educational 
resources such as the internet, medical courses and awareness. Similar studies to assess 
knowledge have produced similar finding(73, 116). Secondly, the measles outbreak in the last 
ten years in KSA occurred outside the western region,(311,319-321) which might increase the 
possibility that those from there may have been exposed to educational and awareness 
programmes such as in Qassim, Tabuk, Jazan and Riyadh regions. 
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7.4 Varicella 
7.4.1 Seroimmunity among HCWs 
Although all staff are screened to varicella immunity before hire, only a quarter of the HCWs 
were sure they had been previously investigated. Most likely those never screened or unsure 
are either unaware of testing either because no health education accompanied screening, no 
documentation was provided or simply employee ignorance. 
IgG Varicella 
The seroprevalence of IgG varicella among new HCWs was 85.2% To understand this further, 
IgG varicella positive was verified for their previous history of immunisation. It was found that 
35.2% could remember being vaccinated. However, there was overlapping between those 
vaccinated and infected at 51.7%, a higher history of natural varicella was reported among 
Greek HCWs 70.4% and HCWs in a Saudi hospital 64.0%(39,300). 
The varicella vaccination coverage rate in this study outperformed that for HCWs in Greece 
19.6% but underperformed that in a Saudi hospital 68.4%(226,300). Considering these results, 
the vaccination rates among HCWs were unsatisfactory, with approximately only a third having 
completed their vaccination. Inadequate vaccine coverage may be caused by several factors 
such as lack of vaccine access, missed vaccination opportunities, and ignorance of its 
importance(302). 
The susceptibility rates at 14.8% were similar to those reported in the Greek study at 15.7%, in 
MNG-HA (Riyadh) 14.0% (2006) and 17.0% (2003), and is comparable to that of other tropical 
regions, where rates among HCWs can reach up to 24.0%(39,41,300,322,323). However, it was 
higher in comparison to other studies such as those in a Saudi hospital 11.3%, Italy 9.0%, a 
tertiary hospital in Catalonia 7.4%, new employees in a Singapore hospital 7.2%, new hires in 
Japan 4.1%, an Australian hospital 2.0%, and Turkey 1.8%(224-226,303,305-307). 
The overall varicella seroprevalence among HCWs bordered the immunity recommended by 
WHO, which recommends resources should be sufficient to support sustained vaccine coverage 
at 80.0%. Settings (such as healthcare services) where varicella vaccine coverage levels are less 
than 80.0% are at risk of an increase of severe disease and mortality in adults(324). A positive 
and negative history was not a good predictor of immunity and had no value as a predictor of 
susceptibility in adults, being able to identify about 50.0% from each group. The negative 
prediction value was reported in similar studies(325). This low negative immunity could be due 
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to historical information being obtained by a self-administered questionnaire and not by face-
to-face interviews, during which additional information on the illness could emerge. 
Furthermore, when asked, those not vaccinated about the reasons, about a quarter believed they 
were not at risk. This explains how gaining knowledge and awareness among HCWs about such 
infections could improve practice and attitude to compliance and coverage rates. 
Determinants of immune status 
In multivariable analyses, compared to those working in hospital, the odds of positive IgG 
varicella among those working in the university were threefold, a similar result being reported 
in a tertiary hospital in Singapore(225). This is in keeping with past vaccination policies which 
favoured the higher likelihood of those working in a hospital such as clinical staff being exposed 
through their line of work. Nonetheless, given that varicella is an airborne infectious disease 
which does not discriminate between vocations, more could be done to ensure that academia 
vocations are vaccinated(326). 
The odds of positive IgG varicella among those who originated from the European Region were 
almost twice those originating from the EMR. These findings support similar seroimmunity 
studies indicating those HCWs from the former usually have a higher varicella antibodies 
figure, such as , for example, in Ireland 95.7% and Belgium 98.5%(325,327). 
Additionally, the odds of positive IgG varicella among those from the WPR were 67.0% lower, 
and those who originated from the SEAR were 50.0% lower. Those originating from these 
regions represented 32.1% of manpower recruited in the previous eight years. Among the 
MNG-HA in Riyadh for multinational HCWs, varicella susceptibility was reported as more 
common among HCWs from the Far East 19.0%(41). 
The differences in immunity witnessed between these regions might be explained by past 
observations of a tropical climate affecting transmission patterns, allowing the disease to 
behave more like one of early adulthood(41,322), explaining higher immunity in employees 
from the temperate country, compared to the rates seen in Malaysia, India, and the Philippines, 
each in the tropics. Thus, susceptibility to varicella is more common among adults living in 
tropical regions than temperate(309). The disease carries greater morbidity and mortality than 
in the paediatric population(323). Therefore, it can be anticipated that it would be more 
prevalent among HCWs in this study, resulting in more serious sequelae and potential 
transmission to other HCWs and vulnerable patients. 
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Positive IgG varicella among technician positions were 91.0% lower than those appointed as 
staff nurses. In a Belgian study among HCWs, prevalence of seronegativity was significantly 
less in nursing than non-nursing staff(325), whilst in a Singapore study, administrative staff 
were 43.0% lower in odds of being immune than nurses(225). This could be attributed to 
maintaining past vaccination policies which favoured clinicians and the higher likelihood of 
clinical staff being exposed through their line of work. Nonetheless, given that varicella is an 
airborne infectious disease which does not discriminate between vocations, more could be done 
to ensure that non-clinical workforce are vaccinated(326). 
Positive IgG varicella among those appointed as specialist physicians were 45.0% higher than 
staff nurses. In an MNG-HA study (2004), physicians were more likely to be immune(135), 
possibly attributable to awareness and knowledge of the importance of vaccination in those 
pursuing postgraduate studies. 
7.4.2 Seroimmunity among soldiers 
Although all soldiers are screened to varicella immunity pre-hire, only 5.9% were sure of 
previous varicella investigation, perhaps those never screened or unsure because of no health 
education accompanying the screening, no documentation provided or employee ignorance. 
IgG Varicella 
The seroprevalence of IgG varicella among new soldiers was 70.9%, which to explain further, 
is where the IgG varicella positive was verified for their previous vaccination history. It was 
found 17.6% could remember being vaccinated. However, there was overlapping between those 
vaccinated and infected (36.2%), in a study carried out in the Singapore army, 73.7% of 
Chinese, 73.0% of Malays, and 63.6% of Indians reported having had varicella infection and/or 
vaccination(179). 
A possible explanation for immunity against varicella could relate to the infection itself and not 
the vaccine. Three reasons could be proposed; first, childhood varicella vaccine was mandatory 
in KSA as part of EPI from January 2008(122) in two doses, at 18 months and 7 years old, so, 
with the youngest soldier born in 1996, none of the new soldiers were thus covered. Secondly, 
to the best of the investigator’s knowledge, vaccination of the population prior to or during 
military service was rare, as the vaccine was marketed mainly for children. Thirdly, it was 
common for the question about varicella vaccine to be conflated by soldiers who often sought 
an explanation of the difference between measles and varicella vaccines, thus affecting their 
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answers and claims about being vaccinated before and during primary school stage although 
the vaccine was introduced when the youngest soldier was 12. 
A study in eastern KSA showed the overall number of varicella cases four years post vaccine 
decreased by 84.0% after implementation of the mandatory vaccination programme(122). This 
plays an important role in diminishing the viral reservoir, thus disrupting the chains of 
infections. However, the decreasing varicella seroprevalence indicates that the adult population 
is more susceptible now, at least until cohorts of those vaccinated in childhood reach adulthood. 
Several studies suggested that humoral immunity persists for many years after immunisation in 
healthy children, particularly when circulation of wild-type VZV continues(328). 
The susceptibility rate in this sample was 29.1%, similar to that reported among Singapore 
military recruits 24.0%(179). However, it was higher in comparison to other studies of military 
recruits such as Spanish 18.1%, South Korean 7.3%, the US in two studies 7.0% and 4.1%, and 
Israeli 5.4%(280,329-332), possibly as the vaccine was licensed earlier for children in Korea 
and the United States in 1995 and in Israel in 2000(329,333). 
The overall varicella seroprevalence among soldiers was at low borders of immunity as 
recommended by WHO. Resources should be sufficient to support sustained vaccine coverage 
≥ 80.0%. Settings (such as military barracks) where varicella vaccine coverage levels are less 
than 80.0% are at risk of an increase in severe disease and mortality in adults(324), such as a 
varicella outbreak in a US military training centre before introducing vaccine, 42.0% of recruits 
being seronegative for VZV(140). 
A positive history of varicella was not a good predictor of immunity and had no value as a 
predictor of susceptibility in adults; it was able to identify about 64.6% of positive cases. 
However, negative history of varicella was able to identify about 85.0% of negative cases. This 
low positive immunity could be due to historical information being obtained by a self-
administered questionnaire and not face-to-face, during which additional information on the 
illness could have been provided. 
Furthermore, when asked about the reasons, of those not vaccinated, half believed they were 
not at risk and about a fifth said varicella is not a serious enough disease to warrant 
immunisation. This explained how soldiers gaining knowledge and awareness about such 
infections in military barracks could improve practice and attitude to vaccine compliance and 
coverage rate. 
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Determinants of immune status 
Multivariable analyses reveal age variability as a significant contributor to IgG varicella 
positivity, for under 21s half that of over 25s, being attributed to increased exposure and greater 
use of varicella vaccination. It was reported that increasing age is a key risk factor for the 
development of VZV(332). 
7.4.3 Varicella knowledge assessment among HCWs 
Level of varicella knowledge  
A moderate level of varicella knowledge among new HCWs was reported, similar to that 
reported among medical students in Malaysia at 79.0% in the intermediate knowledge 
level(144). Some responses were less than similar knowledge studies, for example, 71.7% knew 
that varicella was caused by a virus compared to 85.0% of medical students in Malaysia(144), 
32.4% knew immunisation of a person who has natural varicella immunity is not harmful 
compared to 98.4% of HCWs in California, and 33.7% of HCWs knew two doses of varicella 
vaccine are required to obtain optimum protection against varicella while the finding in 
California was 80.7%(199). Although, most knew HCWs are at high risk of varicella, they were 
not aware about the possible complication of the disease and the varicella vaccine and immunity 
scores were the lowest recorded. These figures show a knowledge gap, improvement during 
educational awareness and orientation programmes should be targeted to affect a positive 
attitude regarding vaccination, as in the study referred to above(317). 
Three quarters of HCWs expressed varicella knowledge acknowledging education, and 40.0% 
the internet as the main sources of information. In another study, 68.5% of medical students in 
Malaysia reported education as the main source of information(144) explaining the internet as 
source information, which should be considered for future programmes. 
Determinants of varicella knowledge 
Multivariable analysis and confounding adjustment indicated HCWs working as medical 
specialists and technicians and those who specialised in administrative technical support 
services made a significant contribution to varicella knowledge. In comparison to those working 
as physicians, other HCWs not working as physicians had lower knowledge scores. 
Additionally, in comparison to those working in clinical services, HCWs who specialised in 
administrative technical support services were significantly more likely to have a lower 
knowledge score. The number of correct answers was significantly correlated with being a 
physician as reported in a similar knowledge study(295). Physicians and those working in 
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clinical services had more knowledge acquisition of the disease and vaccine while others might 
have insufficient information, which would explain their consistently lower scores. Similar 
knowledge studies among HCWs to assess knowledge reveal similar findings between 
occupational types(143,218). 
The interaction between speciality and having information about varicella indicated that those 
working in administrative technical support services had much lower scores of varicella 
knowledge when having “not enough” information about varicella, reflecting natures of 
education and experience, which seems to be below acceptable awareness levels, especially if 
reporting “not enough” information about the disease. This could suggest that it would be 
beneficial for all HCWs to receive formal training. 
7.4.4 Varicella knowledge assessment among soldiers 
Level of varicella knowledge  
A low level of varicella knowledge among new soldiers was reported. To the best of the 
investigator’s knowledge no previous published work related to assessment of varicella 
knowledge exists for soldiers. However, in comparison to other knowledge studies, 19.1% of 
new soldiers knew that varicella was virus caused while 48.9% of non-medical students in a 
Malaysian University accorded, 14.4% of new soldiers knew to obtain optimum protection, two 
doses of varicella vaccine are required compared to 18.9% of non-medical students, 8.6% of 
new soldiers knew a varicella patient is considered to be contagious before the appearance of 
the rash compared to 39.1% of non-medical students(144). Nearly a third of new soldiers knew 
that soldiers may have an increased risk of becoming infected with varicella. These figures 
show the presence of a knowledge gap and or improvement should be sought through 
educational awareness and orientation programme training to affect a positive attitude regarding 
vaccination(317). 
Over half of the soldiers expressed no varicella knowledge, 58.4% acknowledging colleagues, 
and 52.8% quoting family and relatives as the main source of information. A similar knowledge 
study reported similar results(318). This shows the importance of peers and families in 
information management. Targeting soldiers in battalions and barracks with posters and 
education materials can improve knowledge and spread information to other soldiers as well as 
the general populace. A study in KSA among soldiers had reported this kind of education as a 
valid means and effective method(38). 
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Determinants varicella knowledge 
Multivariable analysis and confounding adjustment indicated immune status tests against 
varicella significantly contributed to varicella knowledge. In comparison to those who had not 
tested or were unsure, the odds of varicella knowledge among those who had tested against 
were almost eight times higher, possibly attributable to personal motivation. Those understood 
the reasons for serology investigation - the reasons for this investigation - could affect their 
ability to understand questions and answer correctly. 
 
7.5 Participation Bias in the Questionnaire Survey 
7.5.1 HCWs 
In terms of occupation type, there was a quite small significant difference but actual number 
and percentage were similar not displaying too much difference. However, the difference 
possibly related to the sampling technique used in collected data. A quota-sampling method 
was used during recruiting people in the questionnaire which was not repeated among those for 
whom only serology data were available. Because of this sampling difference, results from the 
Chi square test may have been affected. 
Regarding immunity against measles, a high measles IgG positivity among those who 
completed the questionnaire might be related to the sampling difference and the new MNG 
regulations which came into effect in 2012 regarding the issuing of visas to work in KSA. 
According to these regulations, all recruits who need a visa are required to document 
vaccination against measles before visa issuance. These regulations were not applicable to 
HCWs for whom only serology data were available (data were collected from 2008 until a day 
before collection of the questionnaire data). 
Regarding immunity against varicella, the increased varicella IgG negativity among those who 
participated in the questionnaire is possibly related to the sampling difference and the new 
recruitment intakes of 2013 and 2014 (time of collection data) for those working in academia 
positions at KSAU-HS who usually have less contact with patients. So, they were possibly not 
exposed or not immunised. Dates are critical here as only from 2011 did the KSAU-HS became 
part of MNG-HA, with its effects on participation. 
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7.5.2 Soldiers 
Regarding measles immunity, high positivity among those for whom only serology data were 
available (recruited a year before questionnaire data) might be related to several reasons: Firstly, 
exposure to a sort of measles infection before or an immunisation campaign. Secondly, a herd 
immunity could explain more negative cases as people realised perceived negative need for 
vaccination because of a reduced number of cases being reported. Thirdly, the policy of 
obligatory vaccination had been changed in 2010 and compliance to measles vaccine could 
have decrease. Finally, the sampling difference could be a contributory factor to the non-
compliance to measles vaccinate. 
Regarding varicella immunity, high positivity among those participating in the questionnaire 
might be related to an exposure to infection or immunisation campaign especially as introduced 
in KSA on 2008. This caused an increase in opportunity to vaccinate for those recruited in 2014 
who participated in the questionnaire for whom only serology data were available (recruited a 
year before the questionnaire data – 2012-2013). So, those who are younger in age might have 
had an increased chance of vaccination compared to those who are older. 
 
 
7.6 Integration of Findings across the Three Diseases 
7.6.1 HCWs 
Varicella immunity is viewed as a potential predictor for immunity status against HBV and 
measles. Although vaccination against varicella was introduced in 2008, immunity status could 
be related to past history of exposure to the infection in addition to any recent vaccinations. The 
high positivity of measles and varicella among HCWs who did not participate in the 
questionnaire indicates an association between measles and varicella immunity but not with 
HBV immunity status. 
Moreover, the high knowledge about measles and varicella among HCWs who were immunised 
against HBV could be related to practice among HCWs who usually have a higher awareness 
and are commonly, therefore, more interested in being vaccinated against HBV because of the 
work related risks from, for example, needle stick injury and further due to the known measles 
complications. 
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Additionally, higher scoring of measles knowledge among HCWs indicates that HCWs are 
more knowledgeable about measles than varicella. This could quite probably be related to the 
usual practice among HCWs of attention to and concern about measles risks. 
7.6.2 Soldiers 
There was no significant association between positive immune status against any disease and 
other diseases. This indicates the likely possibility of no association with the vaccination policy 
regarding the three diseases among Saudi soldiers. 
Moreover, there was a high knowledge of varicella and soldiers’ total knowledge which was 
associated such that there was a high propensity of individuals being vaccinated against HBV. 
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7.7 Research Strengths and Limitations 
7.7.1 Strengths 
The study had a number of advantages. A large sample size (N =724) was obtained to determine 
knowledge, concern about HBV, measles and varicella and the analysis of a complete panel (N 
=5443) of HBV, measles and varicella serology markers, greater sample size leading to greater 
accuracy, more likely to be representative of the full diversity of the population, increased 
external validity and conclusions can be confidently drawn about subgroups of a sample. Only 
two soldiers and three HCWs refused to participate and they were substituted from the same 
target population making a response rate of 100%. Based on the research consent, every 
participant was individually invited to take part in the study with the full capacity to accept or 
refuse to participate. Furthermore, as the researcher had previously been a staff member at 
MNG-HA (prior to the carrying out of this research), steps were taken (time away and new 
recruits only surveyed) to ensure that no bias could occur as all the subjects were unknown. 
This, and the fact that Newcastle University is the research home, were intended to have added 
to the position of being an outsider. Additionally, each participant, before joining the study was 
informed that all survey data would be kept anonymously and that they had the right to change 
their mind about participating at any time with no need to give a reason, any information having 
already been given to be destroyed with no negative impact on the individual. Moreover, each 
participant was aware that they would receive a shopping voucher as a thank you for taking 
part. Taken together, each of these points was aimed at enhancing compliance and willingness 
to participate with the goal of a high response rate. This response rate was comparable to other 
similar studies(7-9), lowering cost per response and the cost necessary to achieve a sufficient 
sample, additionally reducing the extent or possibility of non-respondent bias, or the possibility 
that responders are not a representative sample(334). The evaluation of risk factors for exposure 
to address HBV, measles and varicella and thus the knowledge needed about the disease is how 
to protect themselves. History of vaccination against HBV, measles and varicella about 
immunity status was not reliable especially with low education level HCWs and soldiers. 
To the best of the investigator’s knowledge, the present study is the first to investigate the 
knowledge and concern of HBV, measles and varicella among the newly recruited in SANG 
and highlights the importance of further subject investigation vaccine programmes in KSA 
among soldiers who may represent the Saudi population, but taking into consideration origins 
from different regions of KSA and HCWs representing multinational origins from different 
world regions. Additionally, the study sends a strong message to SANG policymakers to 
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develop and adopt a clear protocol regarding HBV, measles and varicella and other infectious 
diseases to protect, prior to employment. 
7.7.2 Limitations 
There are potential limitations to this study. Because of the study design being cross-sectional; 
causality cannot be assumed or inferred. For example, while the data showed that some 
participants were aware that HBV may be curable or preventable, and knew that there were 
screening tests and vaccinations for HBV, it would be inappropriate to assume that this 
awareness or knowledge leads to the observed significant differences between those who were 
screened and vaccinated and those who were not. 
Although, both groups were informed of voluntary participation in the study, soldiers were 
more likely to comply and participate to complete the questionnaire in comparison to HCWs 
and particularly physicians, customarily well-known to be to be difficult to recruit for such 
studies due to their demanding schedules(245). However, participants were encouraged to 
complete the questionnaire as it would assist in designing future public health interventions to 
reduce incidence of vaccine preventable disease. 
Self-reported data are susceptible to bias either intentionally or unintentionally because it is 
either being ignored or because of a lack of awareness of the study. Self-reports of previous 
serologic testing and vaccination history for HBV, measles and varicella may be inaccurate due 
to faulty recall and not obtaining nor consulting recruits’ records. Also, attitude responses were 
based on the reported response of the participants and no attempt was made to directly observe 
their practices. However, the importance of accurate reporting was explained to participants to 
garner reliable data. Moreover, hepatitis caused by agents other than HBV can present with 
similar symptoms and it is possible that participants in answering the questionnaire may have 
mismatched HBV with other types of hepatitis, and may have mismatched measles and varicella 
and vice versa, possibly causing some confusion to respondents. The difference in these 
diseases were clarified to ensure each participant understood. Additionally, because of 
restrictions on inclusion of some survey questions related to the sociocultural characteristics of 
the participants, actual sexual behaviour and drug addictions were not inquired about. 
Furthermore, part of the collected blood of military soldiers’ samples were missed from the lab 
records. These samples were required for further blood analysis; however, the target matching 
of questionnaires with blood sample results was achieved. 
In data analysis, the small number of those with HBV infection (2 out of 315) among HCWs 
and (1 out of 326) among soldiers; and HBV exposure (2 out of 326) among soldiers made it 
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difficult to examine the risk factors of infection. Additionally, since HBsAb levels could decline 
over time in vaccinated individuals, it is possible that some newly recruited soldiers and HCWs 
with undetectable levels of HBsAb have already been, in fact, vaccinated. 
HCWs have more knowledge in comparison to soldiers because of their study background, 
practice and work experience, additionally, the knowledge difference among categories of 
HCW specialties was taken into consideration and potential selection bias was treated by 
sample stratification in study design and multiple regression in analysis. 
One of the study limitations is that which corresponds to those inherent in multiple testing such 
as Bonferroni correction, which tends to the conservative often leading to a high rate of false 
negatives. However, no adjustments have been made for this, thus there could be a lack of 
association and an erring on the side on non-significance(335). Secondly, as results make sense 
of what has been tested, the P value should be interpreted with caution. 
Finally, findings cannot be projected to the general population as the military or HCW 
populations are likely to have different exposures e.g.: HCWs have one of the highest rates of 
occupational risk for HBV worldwide(1) and most soldiers often live in closed communities, 
and pursue activities that enhance close contacts and therefore the transmission of measles and 
varicella infection could occur(10-12). Additionally both groups are inherently more 
disciplined and predominantly healthy adult and specific age groupings. 
 
7.8 Generalisability  
The military training centre and KAMC are the largest military and medical centres in Jeddah 
for SANG, therefore, the results can be generalised to other military training centres and 
medical cities in country. However, it is possible that HBV, measles and varicella knowledge 
and epidemiological patterns of soldiers and multinational HCWs elsewhere may differ from 
patterns observed in Jeddah, the main seaport of the KSA and an industrial city attracting 
numerous expatriates, representing about 52.8% of the population(174). Contrariwise, findings 
cannot be projected to the general population as the military or HCWs population is likely to 
have different exposures and is characteristically more disciplined and predominantly healthy. 
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7.9 Chapter Summary  
This chapter has presented an overall discussion, a summary of the main findings, an 
explanation of how the results relate to expectations and to the literature, clearly stating why 
they are acceptable and how they are consistent or fit previously published knowledge on the 
topic, analysing strengths and limitations of the study. The next chapter discusses qualitative 
study findings. 
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Chapter 8. Discussion - Qualitative Research 
8.1 Summary of the Main Qualitative Findings 
This research identified key issues related to vaccine barriers and vaccination programme 
acceptability among HCWs and soldiers (service users) and HCW staff providing vaccines 
(vaccine providers) in MNG-HA. Five main barriers are identified: First, individual related 
barriers such as vaccine belief, negligence, low level of awareness about adult vaccines, 
personal experience, education level, occupational positional role and psychological reasons. 
Secondly, vaccine related barriers such as risk perception of vaccine side effects, perceived low 
efficacy vaccine, and concern about the vaccine entailing several visits. Third, HCWs providing 
vaccine related barriers, such as medical error concern, communication skills, lacking 
experience, workload and understaffing, stressed work life, and negative role-play. Next are 
organisational related barriers such as concerns about military work nature or vaccination 
clinics. Finally, social and cultural related barriers such as rumours, media effects, social 
context (such as Bedouin or village background), religion concerns, nationality and ethnicity. 
These barriers could influence decisions to be vaccinated, in both healthcare and military 
settings. 
 
8.2 Vaccine Barriers (Providers and Service Users views) 
For vaccine compliance in SANG , to the best of investigator’s knowledge, no available data to 
local setting and soldiers studies had been done. 
8.2.1 Individual related barriers 
Soldiers and HCWs reported individual related barriers such as listed above. This study found 
that the impact of information on increasing uptake of immunisation services remains a matter 
of agreement among HCWs and soldiers as the general knowledge of the benefits of 
immunisation encourage vaccination, as reported in a qualitative study in Uganda among 
service users(155). This study found that new HCWs and soldiers had limited or no knowledge 
about adult vaccines and explained how their colleagues have this limitation and weakness. In 
a qualitative study amongst Kenyan women, little knowledge was reported, as in Laos for 
measles vaccine knowledge; in both causing low vaccine compliance(157,336). HCWs and 
soldiers appear to have low knowledge about the benefits of immunisation and lack accurate 
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knowledge of the target diseases, the respective vaccines, and recommended doses, which may 
continue to have significant impact, especially in terms of the completion of recommended 
doses. However, among new soldiers, knowledge deficits appear widespread and a lack of 
advice about optional vaccines from health professionals was commonly reported. This has 
been also reported among Saudi medical students when assessing influenza vaccination 
awareness(337). In an Australian study, vaccine programme awareness was high among 
Australian HCWs, this affect in their adherence and vaccine compliance(338). 
Generally, HCWs and soldiers strongly welcomed vaccines believing in them. These findings 
were similar to qualitative studies in developing countries such as Kenya and Ghana on vaccine 
acceptability, and among developed countries, Australia, where many HCWs reported a sense 
of responsibility on vaccinating(336,338-340). However, in a measles outbreak in California, 
personal belief was a negative, stopping vaccinations(163,164). Additionally, low HBV 
coverage in Georgia is partially explained by negative attitudes(8). HCWs are expected to be 
more knowledgeable than the general population and should be perceived as role models for 
health behaviour(8). 
Soldiers usually accepted vaccines as necessary, reflecting trust in medical authority. However, 
there was some concern among HCWs about certain vaccines such as varicella and influenza 
who relied on risk-benefit evaluations based on previous own experience or peers’ 
experience(341). Although compliance to authority is unusual in vaccine studies(342-344), the 
military culture promotes respect for professional order, status hierarchies, and government 
policies, explaining soldiers higher compliance than HCWs. 
It was common for HCWs and soldiers to express a lack of confidence in being vaccinated, 
particularly HCWs around the uncertainty and ambiguity surrounding vaccines such as for 
influenza during yearly campaigns. Both often relied on two powerful psychological principles 
to aid deciding and confidence, authority and social validation(345). To overcome this, a 
structured comprehensive vaccination programme could improve service and vaccine 
compliance. In the absence of these, conforming to peers’ behaviour utilises social validation 
to inform choice. Therefore, a defined vaccination programme, to be mandatory for recruitment 
requirements, removed much ambiguity(346).  
The structured vaccination program should consider culture-centric narrative theory, defined 
thus as to “embed cultural knowledge in both the process and the content of the 
communication”(347), to address cultural values through culturally adapted messages among 
HCWs and soldiers(348). This theory will guide the development of interview protocols to 
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explain how HCWs and soldiers process(ed) their decisions to vaccinate. Collecting decision 
narratives was critical to gaining insight into service users’ experiences and how these 
experiences shaped their decisions(348). Although individuals might not be able to explain why 
they behave in a certain way, they can help understanding of their interpretation of events and 
their reasoning processes(349,350). 
Vaccination is still perceived by many as a considerable risk that is not worth taking and 
interviewees revealed that newly recruited HCWs relied on educational background or family 
messages to make vaccine decisions and soldiers on colleagues’ advice. In a Vietnamese 
vaccination’s study, the vaccination decision-making process was based on 'active decision-
making’ by consulting friends, family, and opinion leaders for guidance prior to making their 
decision(156). Vaccine campaigns need to include messages that reassure the public of vaccine 
safety and its necessity, while minimising perceptions of vaccine risk. The goal of this study 
was to characterise the meanings that newly recruited HCWs and soldiers ascribed to health 
care providing vaccines and their impact on the vaccine decision making process. 
Some HCWs reported avoidance of MMR because of misconceived historical links to autism, 
although investigations were made to understand if this was an isolated reason. In a UK study, 
parents' decision-making after the MMR-autism controversy has been investigated(95), several 
parents mentioned Andrew Wakefield (author of a fraudulent 1998 research paper in support 
of the now-discredited claim that there was a link between the administration of the MMR 
vaccine, and the appearance of autism and bowel disease, later withdrawn by The 
Lancet)(165,351,352), and though the quality of this original paper was criticised across 
decision groups, this affected their decision making to vaccinate or not. Some parents have a 
sense that MMR is simply an unsafe vaccine, but exactly why it is unsafe is unknown. Some 
MMR-rejecting parents applied quite general anti-vaccination arguments to their decision, 
including doubts about necessity (e.g. feeling not all the diseases against which MMR protects 
actually warrant vaccination), worry about vaccine additives, and concerns about creating new 
disease strains by controlling current strains; rejection of combined MMR motivated by MMR-
specific concerns appeared less common(95). 
8.2.2 Vaccine related barriers 
Soldiers and HCWs reported vaccine related barriers such as risk perception of vaccine side 
effects, perceived low efficacy, the entailing of several visits conflicting with busy schedules, 
clinic crowdedness, and low awareness about follow up. 
  
392 
HCWs and soldiers reported concerns and misconceptions regarding the safety and potency of 
vaccines used, particularly during mass campaigns. Not unique to staff at MNG-HA, it has been 
reported in a Nigeria, Vietnamese, Australian and Sweden immunisation 
studies(16,156,338,353). Most interviewees expressed fears of adverse reactions, and coupled 
with fear of the unknown and lack of knowledge surrounding the risk of disease and risk of 
vaccination, these resulted in not being vaccinated. The rather forced approaches used to 
mobilise HCWs and soldiers for immunisation further exacerbate their suspicions. These 
concerns have implications for vaccine uptake and completion of dosages(155). Lack of 
information has been associated with vaccine safety concerns and higher levels of distrust 
toward medical professionals(337,354,355). However, it appears that communities accept 
vaccination despite limited knowledge(356). 
People may object to imported foreign drugs and new medical interventions(357,358); knowing 
that all vaccines have already been administered in KSA and were approved by the Saudi Food 
and Drug Authority, WHO and CDC was thought to be persuasive by many respondents. Beliefs 
about the safety of vaccines, likelihood of occupational infection, as well as doctor’s 
recommendations, have been associated with increased vaccine acceptability(357). An 
Australian study among HCWs to explore key drivers and HCW decision making related to 
recommended vaccines, found that the main barriers seemed to stem from the vaccines not 
being considered to be ‘natural’ products. Additionally, it was believed to stem from 
individual’s risk-benefit assessment and not wanting to potentially feel slightly unwell 
following vaccination(338). 
Additionally, HCWs and soldiers reported novel or unfamiliar diseases such as Middle East 
respiratory syndrome coronavirus (MERS-CoV), swine flu and using flu vaccines to possibly 
control these diseases. The virus appears to primarily circulate in KSA, as the SMOH has been 
notified of 1,326 confirmed cases and 559 deaths since 2012(359) and there are fears that 
soldiers and HCWs may be picking up MERS-CoV and swine flu (especially) during Hajj 
seasons. The WHO identified how, from the first week of July until 31 August 2015, a total of 
112 cases of MERS-CoV including 38 deaths were reported to have been linked to an MNG-
HA outbreak in Riyadh(360). Representative undefined risks and benefits make vaccination 
decisions more difficult, consequently, lay responses revert to reliance on heuristics, of which 
“imitate the majority”(341,361). No participants among HCWs mentioned herd immunity or 
adopted the heuristic of “free-riding” to guide vaccination, although all participants were 
nursing qualified(362).  
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Most of soldiers reported low knowledge about vaccine safety citing colleagues being 
vaccinated without issue as their motivation. By observing peer group actions, soldiers 
assimilated relevant information and assessed the safety, effectiveness and necessity of 
vaccination. This may have resulted in adopting a “wait-and-see-approach” which can 
significantly impair the value of prophylactic vaccination programmes. Chinese research found 
this approach was a key motivating factor for parents adopting vaccination(346). 
Numerous previous studies on disease risk perceptions examined perceived severity and 
susceptibility to the diseases(337,363,364). This study found that HCWs and soldiers 
perceptions of vaccines relied on perceived susceptibility and severity, but also emphasised 
controllability, and anticipation of consequential affective elements as important influences. In 
particular, hepatitis B and meningitis vaccines related worry or anxiety was a key factor 
motivating service users to be vaccinated. Anticipated anxiety reduction after vaccination is a 
clear secondary benefit reinforcing vaccination uptake(365), similarly reported in a Chinese 
report(346). 
This study showed that experiences with AEFI and vaccine concerns in general affect service 
users’ propensity to accept vaccination, particularly in healthcare settings. Immunisation 
coverage figures in the year preceding the study for healthcare settings for flu vaccine were 
50.0%, however, MNG-HA targets 90.0%(27). This finding clarifies how disturbing or 
hindering side effects are to accessing immunisation services. This misconception has similarly 
been raised as a concern among HCWs in Australian emergency departments when influenza 
vaccine uptake was assessed and about 71.4% of HCWs were vaccinated in 2008(340). 
However, despite these concerns, most soldiers continue to be vaccinated, probably because of 
the strict military measures adopted. Laws requiring vaccination for newly recruited staff, as 
well as fears of the consequences of not immunising, have been documented as a primary reason 
for immunising; a similar reaction having been seen in Uganda(155). Additionally, under-
reporting of AEFI and knowledge of the side effects and how to handle them have been noticed, 
possibly further explaining the under-reporting of AEFI observed by those interviewed. Similar 
findings have been reported in Europe regarding concerns about vaccines’ adverse 
effects(95,158,366). 
8.2.3 Vaccine –providers related barriers 
Interviewees reported some vaccine provider related barriers, such as medical error concern, 
poor communication skills, having little experience, workload and understaffing, stressed work 
lives and negative role-play. Poor interaction between service users and staff providing vaccines 
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such as poor communication skills could impact negatively on coverage(367). Qualitative 
studies in Kazakhstan, Uzbekistan and Australia have reported high levels of trust in service 
delivery being vital for uptake(368,369) 
The results from this study offer insight into providers’ perceptions of both barriers and 
facilitators to improving uptake and adherence among newly recruited HCWs and soldiers. 
Among the many valuable suggestions provided by participants, there are specific 
recommendations for practice that are worth highlighting. Vaccine providers may need to be 
more proactive about recommending the vaccine to all appropriate service users. Improvements 
in targeting all service users for the vaccine must be coupled with communication emphasising 
the importance of the vaccine and the commitment to complete the two/three-dose series. This 
improvement in communication skills could assist the vaccine provider’s capacity to educate, 
playing a positive role. The lack of understanding of the importance of this preventive health 
measure was prevalent in the providers’ perceptions of barriers to vaccine uptake and 
adherence(370). A similar study suggested vaccine providers, especially nursing professionals, 
have a role in not only helping service users make an informed decision about starting the 
vaccine, but also encouraging completion of the entire series(371). 
As reported by interviewees, impaired information communication between vaccine providers 
and new HCWs and soldiers probably discourages service users from recommended action and 
encourages reliance on observing peer behaviour. Empirical studies suggest that people trust 
formal information (e.g. from government, health professionals) and more likely then to adopt 
active health-protective behaviours in vaccines(372,373). 
Newly recruited HCWs and soldiers in some cases, reported vaccine providers not raising the 
issue of vaccination, and sometimes stating negative opinions, associated with vaccination 
inhibition. Active support through informed vaccination cannot be exaggerated sufficiently, as 
supported by a recent independent report stating the critical importance of explicit vaccine 
providers discussion among 18- to 26 year olds(374). Vaccine providers play an important role 
in public health efforts and need to do a better job of clearly explaining the facts about, and 
benefits of the vaccines(375). Therefore, training of health care professionals, may contribute 
to increased vaccination uptake. 
8.2.4 Organisational related barriers 
Soldiers and HCWs reported organisational related barriers such as military work nature 
concern, hospital work concern and vaccination clinic concern (such as, vaccine layout and 
privacy, location, no effective reminder system, vaccine accessibility and clinic times). These 
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barriers were either shared between the two groups; no effective reminder systems, vaccine 
accessibility, or specific barriers to multicultural HCWs (overly busy schedules or no 
vaccination sick leave); or specific to soldiers, in privacy concerns, low number of vaccinators 
and inadequate resources. 
In the case of the military vaccination programme, interviewees reported the low number of 
vaccinators, inadequate resources and problems in transport for vaccines storage and delivery 
affecting vaccination compliance as indicating an administrative problem. Similar results 
reported in a qualitative study in Laos about measles vaccination identified main problems in 
the provision of services as; lack of vaccine supply, difficulty in maintaining the cold chain, 
lack of availability and competence of HCWs, and lack of coordination(157). 
Policy makers in MNG-HA recognised these obstacles as a challenge to consolidation and 
sustainability of the immunisation programme, such as in recruitment and properly prepared 
vaccination clinics, however, because of difficulties in creating new jobs and logistics, the 
service provided is understaffed with vaccine logistic difficulties, and therefore this problem 
could affect compliance and functionality, greatly affecting attitudes towards immunisation. 
This was reported in similar studies in industrialised and developing countries(155,376,377). 
Many interviewees reported vaccine accessibility as barriers, such as waiting, appointment 
times and clinic location, a systematic review reporting how access to services could affect 
compliance through juggling schedules for appointments, travelling to appointments, lost time 
from work, stress from dealing with vaccination appointments, including distance, convenience 
of health centre locations, and transportation(378). 
Access to health care is complex and requires multiple resources being coordinated(379,380), 
Andersen and colleagues defining access as “those dimensions which describe the potential and 
actual entry of a given population group to the health care delivery system”(381), amongst 
which are subjective indicators for convenience such as, travel time and costs, waiting and 
appointment times and visit costs(381). HCWs and soldiers reported difficulty with clinic 
appointments during work time, soldiers similarly commenting duties and hours in which 
vaccination services were available, as possible causes of failure to return for doses two and 
three such as for hepatitis B, MMR, or varicella vaccine is because they do not want to make 
an appointment and wait at the clinic for the simple act of receiving an injection. 
Additionally, the availability of transportation may be time inconvenient due to schedules and 
time constraints and, therefore, it is important to emphasise the convenience of having 
vaccinations in their own department or battalions. HCWs and soldiers in this study reported 
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that doing this would reduce demand on resources and access barriers, also suggesting that 
addressing these factors could encourage completing the two/three-dose series to increase 
vaccine uptake. Similar results were reported in Canada in improving temporal access to 
improve influenza vaccination uptake(382). Regular visits to medical departments or battalions 
when enough manpower is available could improve uptake - a USA study investigating low 
compliance and increased uptake suggested advertising subsequent doses may not require an 
actual physician appointment, but rather a nurse-only visit, thus encouraging service users to 
return for the follow-up doses(371). 
Many interviewees reported privacy concerns. Receiving the vaccine required unbuttoning and 
for some, removing the shirt. This lack of privacy is due to the non-availability of a vaccination 
clinic or on some occasions, inability to find a room with high health standards. As suggested 
by HCWs and soldiers, changes to the vaccination program should be made to be more 
respectful of privacy. An Australian study among HCWs to explore key drivers and HCW 
decision making related to recommended vaccines acknowledged this perceived disregard for 
privacy and expectation that they should line up for the vaccine in a public place impinged 
privacy making them feel like they were ‘lining up like cattle’(338). Privacy has similarly been 
raised as a concern for adolescent vaccination programs(383). 
Among the many valuable suggestions provided by study participants, more synchronised and 
effective reminder systems were deemed essential to vaccine take-up and dosage completion, 
many mentioning an appointment card or phone call as a reminding device, however, these 
remain ineffective, as adherence is low. Perhaps the most important tool in a reminder system 
is the patient-centred approach. Simply asking service users which reminder method is 
preferred could help increase adherence, especially with today’s variety of technological 
options. Both HCWs and soldiers recommended cell phone (specifically, text message) which 
seems easily implementable. Appalachian Kentucky vaccine providers suggest a similar 
approach(371). 
8.2.5 Social and culture related barriers 
Soldiers and HCWs reported social and culture related barriers such as rumours, media effect, 
social context (such as Bedouin or villages background or medical culture), religion-based 
concerns, nationality and ethnicity. 
Rumours were raised as a potential issue and are widespread, including being about experience 
of previous hospital/community such as broken needle, lack of knowledge about infection 
diseases or vaccine efficiency would cause immunity weakness or side effects, and safety in 
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targeted communities such as vaccinations against swine and bird flu infections causing death 
or paralysis. These reflect underlying suspicions and could be a potential challenge to vaccine 
uptake. As reported by an Australian study, hearing accounts of previous adverse reactions had 
a powerful impact in decision making to accept vaccination, even when these accounts were 
based on second or third hand descriptions(338). It will therefore be essential that correct 
information about vaccination be provided to HCWs, soldiers, and key personnel (leaders and 
commanders) to help prevent the emergence and/or spread of rumours before and during 
vaccination programmes(357). A study discussing health interventions such as vaccines and the 
persistence of rumour in African public health campaigns, mentioned an obstacle being a 
rumour claiming vaccines had been contaminated, affecting uptake(358). 
HCWs and soldiers in this study believed a more tailored occupational specific promotional 
campaign on media for newly recruited HCWs or soldiers is needed. Subsequently, many 
vaccine providers felt a different approach is needed. A heavier reliance on local media, such 
as billboards, radio, and community events may emphasise the benefits of receiving the vaccine 
for this catch-up group and make the issue more salient for newly recruited HCWs and soldiers 
who have little to no vaccine awareness(371). This has been also reported among Saudi medical 
students when assessing influenza vaccination awareness and barriers(337). Moreover, 
soldiers’ emphasis was on providing culturally appropriate health information accepted before 
the vaccination. Using medical jargon could be difficult; the information should be in simple 
lay language. 
Many interviewees suggested involving seniors and commanders in campaigns, thus increasing 
uptake. There was strong senior/management support for fostering a positive culture toward the 
vaccination program among Australian HCWs(338,384). Some interviewees suggested 
involving “champions” to increase participation, previous studies having documented this 
increasing seasonal influenza programme efficacy(384). 
Religious concerns were discussed when queried, some participants using these to escape 
vaccination. According to a “destiny” belief, a person's action is caused because God already 
knows all occurrences without any restrictions of time, affecting compliance to vaccination. 
Local religious bias against the oral polio vaccine was reported in some Islamic countries such 
as Nigeria in 2003, Indonesia in 2004 and Pakistan 2014(358,385), as against the Hadith and 
the fate determined by God. However, international Islamic authorities are generally supportive 
of EPI(386). However, some HCWs and soldiers state that Islam supports preventive care 
and/or medicine to improve health, such finding reported among Somali mothers(387). 
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This concern is not only in Islamic countries, a mumps virus strain indistinguishable from the 
Dutch epidemic strain was detected in 2008 among orthodox Protestants in Canada with 
historical and family links to the affected community in the Netherlands, suggesting that spread 
to Canada had occurred(388). Also, a measles outbreak in 2014 occurred in the Netherlands 
among a Reformed Orthodox Protestant community. This community is known to object to 
vaccination(389). 
There are different religious and philosophical beliefs related to the acceptability of the 
MMR(390). In Roman Catholicism, objections arise due to the rubella virus component 
originating from aborted human foetus tissue. In Islam, the primary concern is the use of a 
porcine-based gelatine in vaccine production. Hindus may object to its derivation from foetal 
cells or containing bovine components(390). These groups represent opportunities for 
education to improve vaccination rates and reduce risks among unvaccinated societies. 
 
8.3 Research Strengths and Limitations 
The strength of the study centres on interviewing all staff providing vaccine in IPCD face to 
face, providing high levels of data accuracy. However, these findings have some limitations. 
First, it is difficult to generalise from the results, as it employed a specific population being 
designed to probe their knowledge and attitudes. However, it should be noted that those 
interviewed, where they are employed, actually represent a substantial portion of the newly 
recruited vaccination program. In addition, they were able to offer detailed and meaningful 
insight into the low vaccine uptake and adherence rates for the newly recruited HCWs and 
soldiers. 
Second, once in the field and before receiving written consent, there were difficulties in 
recruiting non-Saudi nurses as they may have had concerns about recording their opinions 
possibly affecting their recruitment. Third, difficulties were also presented in recruiting male 
nurses, because most nursing recruitment is female which is the acknowledged nature of the 
industry (about of 90.0% in 2014) so, as such, a decision was made to interview Saudi female 
nurses, representing perspectives and views of Saudi female nurses. Fourth, for the in group 
interviews, participants were given unique identifier numbers, used for discussion 
identification. However, most members, in both groups, refused to use these, claiming this 
would affect their frankness and honesty in the interview, despite the researcher ensuring 
privacy. Nevertheless, members of each group were homogenous in terms of sociodemographic 
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and occupational characteristics; participants in military-focus group discussions were all Saudi 
male, Muslim, born in KSA, single, secondary school certificate holders, between the ages of 
20-24 years, had 12- 14 years in formal education and no previous experience in the military 
field. The participants in HCWs-focus group discussions were all Saudi female, Muslim, born 
in KSA, single, bachelor nursing holders, between the ages of 22-25 years, had 16- 17 years in 
formal education, no previous experience in the healthcare field and were working at KKH. 
Next, although information collected through the study represents views from both newly 
recruited nurses and soldiers, the study was limited in coverage to only two groups and did not 
include military commanders or officers in military settings, or medical department directors 
and other different occupations in HCW setting. This could not represent all staff categories in 
the MNG-HA and all soldiers in the SANG. 
 
8.4 Chapter Summary  
This chapter has presented a discussion of qualitative research through summarising the main 
findings, explaining how the results relate to expectations and to the literature, clearly stating 
why they are acceptable and how they consistently fit previously published knowledge on the 
topic and an analysis of strengths and limitations, The next chapter will discuss supplementation 
and complementarity of quantitative and qualitative studies followed by the conclusion and 
recommendations. 
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Chapter 9. Conclusions and Recommendations 
9.1 Supplementation and Complementarity of Quantitative and Qualitative Studies 
The results of the qualitative approach signify underlying reasons to the pattern of local 
variables and barriers regarding low vaccine compliance in MNG-HA. These barriers are shared 
between the two groups in: low awareness about vaccines and risk perception of vaccine side 
effects, specific barriers to multicultural HCWs such as in; busy schedule and perceived low 
efficacy of vaccines, or specific to soldiers such as in; privacy concerns, low numbers of 
vaccinators and inadequate resources, or specific to Saudi participants in; rumours and religion-
based concerns. Understanding these barriers could help to explain vaccine compliance patterns 
among both groups. Addressing these can help to improve these factors and improve 
vaccination rate. 
The quantitative findings provide important comprehensive assessment of the research aims in; 
variation in knowledge and sero-immunity, reported on intermediate knowledge level among 
HCWs, and low knowledge level among soldiers and low immunity coverage rate among both 
groups. These suggest the need for targeted educational programmes and vaccination 
campaigns. 
However, it would have been difficult to elaborate on these finding using a singular 
methodological approach. For this reason both quantitative and qualitative approaches took 
place concurrently as complementary to each other in order to identify related aspects of HBV, 
measles and varicella infection diseases and vaccine compliance of all in the MNG-HA 
vaccination programme in the healthcare and military settings. Addressing the mixed method 
approach facilitates appropriate preventive tool design and implementation for better public 
health interventions. 
Generally, increasing awareness among HCWs and soldiers could build knowledge, skills, and 
positive attitudes about vaccine preventable diseases particularly HBV, measles and varicella. 
It motivates targets to improve and maintain their health, prevent disease, and reduce potential 
risky behaviours(172). Additionally, increasing immunisation rates and reducing barriers to 
vaccination could improve awareness to more effectively allay fears and build trust(173). These 
strategies have been demonstrated as successful and effective tools in reducing the spread of 
infectious diseases in a population, particularity in risky groups such as HCWs and 
soldiers(28,38). 
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9.2 Implications 
The findings in the current study offer useful information to the health policy makers in MNG-
HA , which considers employee safety as the priority to prepare HCWs and soldiers to provide 
services either in hospitals or military battalions respectively(3). Moreover, it is expected that 
the findings will be of importance for IPCP in MNG-HA, who will be able to access a copy of 
this study. 
Policy makers need the credible data of these findings to properly plan policy and allocate 
resources efficiently, where currently, no specific surveillance military programme exists. 
Additionally, employing multinational HCWs presents unique challenges demanding planning 
for unusual viral susceptibility profiles(4). 
Implementation of a work site medical surveillance programme might help identify vaccine 
preventable diseases at an early stage in the military field and provide a revised view of the 
HCWs’ surveillance system. However, there are a number of practical considerations rendering 
this difficult, such as, the requirement for competent technicians and medical supervision. 
This study demonstrates that sero-immunity was low among HCWs and soldiers. Waning 
immunity is widely observed and little is known about the re-emergence of cases such as 
measles in highly vaccinated populations. Therefore, it is important to monitor levels of 
vaccine-induced antibodies in the population and to continue epidemiological surveillance in a 
period of decreasing opportunity for natural boosting. 
Additionally, the EPI for all Saudi military personnel regarding HBV and measles provokes 
issues, one of which is related to and jeopardising the efficacy of the received vaccine. The 
other issue is related to the lack of knowledge of the recipient about their immunisation status, 
even of their parents, which draws the conclusion that the mass immunisation campaign was 
not accompanied by proper health education. 
Furthermore, this study has revealed generally poor knowledge about HBV, measles and 
varicella among soldiers and only moderate among HCWs, demonstrating the need for a 
structured health education programme, pre-supposing that well designed educational 
interventions and materials that are both contextually and linguistically appropriate are key 
factors, to increase these communities’ knowledge about these infections and increase the 
chance of compliance with the recommended preventive practices such as vaccination. This 
should be targeting new soldiers and HCW recruits which may ensure earlier education and, 
most likely, protection before starting their work duties. 
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The qualitative study sought to understand soldiers’ and HCWs’ perspectives on low vaccine 
compliance and adherence rates, where findings are potentially useful to policy planners in, for 
instance, addressing vaccine barrier awareness. Study participants have provided tangible 
examples of strategies that could facilitate improved vaccine receipt and compliance, offering 
important, practical implications that could influence soldiers and HCWs in; improving 
knowledge, privacy concerns, and programme accessibility particularly for staff working part-
time or night duty. As articulated, vaccine providers need to be proactive and creative in their 
education efforts in the vaccination programmes and their full value (full vaccine series). 
Furthermore, messages about vaccines need tailoring to meet unique characteristics of HCW 
and military cultures. 
Health professionals and policymakers should continue to inform service users about disease 
risks (perhaps, particularly concerning are the recent outbreaks in MNG-HA of MERS-
CoV(391), or other possible infections in Hajj and Umra given the concerns observed here 
about non-Saudi sources of infection), and continue to highlight how accepting vaccines could 
remove or reduce their anticipated regret about these infections. HCWs and soldiers who 
perceive the threat of communicable disease and the benefits of vaccination, in addition to the 
provider’s strong recommendations and vaccine accessibility, were likely to take action to 
reduce that threat. These factors may also influence their future decisions regarding being 
vaccinated. 
Policy makers should support awareness of the potential risk and prevention measures of 
vaccine preventable diseases among HCWs and soldiers. Preventive measures in general are 
aimed at reducing vaccine preventable diseases at an earlier stage. It has been found that sero-
immunity of vaccine preventable diseases could be improved if effective primary preventive 
measures are applied in health education and improvement of vaccine compliance(28,29). 
Vaccination of susceptible soldiers and HCWs may prevent disease transmission, limit 
outbreaks, and reduce resulting costs incurred (i.e., worker compensation, lost work days, and 
economic burden on the healthcare facility). 
Generally, this study seeks to serve as a starting point for subsequent studies to further examine 
its stated research aims in and for MNG-HA, comparing different policy targets suggested here 
and determining the most suitable/feasible based upon their local experience and existing 
financial and other resources. The progress towards achieving the applied policy target should 
be monitored periodically through representative population-based surveys. 
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9.3 Recommendations 
Based on the results and conclusions, the following recommendations are suggested: 
9.3.1 Recommendations related to health education 
This study suggests that factors affecting the knowledge of the individual should be addressed 
and all efforts should be made to increase awareness and knowledge. 
1- Knowledge alone is not sufficient to bring behavioural change. Therefore, deliberate 
efforts are needed to develop and implement targeted educational campaigns to reduce 
exposure to risks of HBV, measles, varicella and other infectious diseases. This should 
be a novel continuing medical education and a pre-employment awareness programme 
for HCWs and soldiers. 
2- A multifaceted health education approach could include soldiers, medical and nursing 
schools, other allied health professions’ schools, universities and university campuses, 
community health services, public health departments, health leaders and planners. This 
should include multidisciplinary efforts using the mass media and multimedia 
communication approaches such as social media, text messaging for effective education 
of service users, and to ensure proper immunisation. 
3- Based on quantitative research findings, the message should be tailored and consider 
different knowledge levels of HCWs and soldiers and possible potential risks among 
each group. This message could cover the importance of screening, hazard of possessing 
the infection, and different ways of infection transmission. 
4- Based on qualitative research findings, service users’ knowledge of vaccine risks and 
benefits should be improved by educating HCWs and soldiers about vaccination and 
strategies for disease control. Additionally, rumours, misconceptions and vaccine 
concerns should be addressed. 
5- Soldiers and commanders should be educated to reduce HBV morbidity risks especially 
in the proper utilisation of daily personal instruments in military battalions such as, 
razors, nail clippers and toothbrushes, and compliance with recommended preventive 
practices, such as using disposable products. 
6- Based on qualitative research findings, current health college curricula do not take into 
account possible risks of occupational safety. This should be upgraded to address these 
issues; in particular, targeting blood-borne diseases transmitted occupationally, standard 
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precautions to prevent occupationally transmitted blood-borne infections, airborne 
infections and safe injection practices. 
7- Vaccine providers should have the capacity to provide adequate vaccine awareness in 
vaccine clinics and/or community meetings and mass media, and should play a positive 
role. 
9.3.2 Recommendations for prevention and control  
1- An occupational vaccination and screening programme for infection and antibodies 
should be mandatory and start as early as possible in the careers of trainees and 
students(109), particularly before HCWs begin to conduct clinical procedures with 
patients. 
2- An immunisation campaign should be empowered by health education under 
supervision of specialised teams, targeting the soldiers and HCWs. 
3- Establish specialised daily adult vaccination clinic in MNG-HA concerned with the 
follow up of the cases and their contacts. These should be accessible and designed to 
guarantee privacy and safety, providing all equipment necessary for administration, 
documentation, and disposal. 
4- Considering the widespread usage of technologies, a reliable reminder system such as 
text messaging or emails, should be initiated to remind service users to book and follow 
up their vaccinations to improve vaccine compliance. 
5- Vaccine providers should receive training on communicable diseases in occupational 
settings, vaccine handing and administration, vaccine safety and prevention strategies 
and vaccine cold chain, supervised by IPCD using effective techniques to prepare them 
with adequate knowledge and communication skills to deliver basic vaccination 
messages to service users. This training should be consistent considering the high 
turnover of HCWs. 
6- Vaccination cards should be provided for soldiers and HCWs; to be checked to assess 
their clinical and occupational history in different situations and vaccine coverage 
characteristics including vaccination status, number of doses received, and age at the 
time of vaccination. 
7- Initiate a secure computerised system to manage HCWs and soldiers’ records of 
immunisation status, vaccination history, or any documented AEFI. 
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8-  The HCW and soldier communities should be involved positively in compliance with 
the rules governing screening for infection prevention and control in work settings. 
9- Engaging military commanders, medical directors, cultural and religious leaders in 
discussion with communities to enhance community confidence about the importance 
of vaccination and prevention measures. Participation of role models at the outset of 
vaccine campaigns could motivate the acceptance and completion of vaccine dose 
schedules and have a correspondingly positive impact on individuals or community. 
10- All HCWs should be trained in cross-infection control methods and adhere to standard 
prevention and precautions including use of personal protective equipment (such as; 
gloves and masks) and addressing AEFI incidents by providing a clear explanation and 
reassurance to staff about the incident. 
11- Proper design for general ventilation systems should be considered to prevent the spread 
of infections especially diseases that spread easily through air (e.g. measles and 
varicella)(392), either in waiting common areas in hospital (e.g. waiting room, 
emergency departments) or large dormitories in battalions. 
9.3.3 Recommendations for future clinical practice and policy 
 
1- Standard precautions are recommended in the care of all hospitalized patients to 
reduce the risk of transmission of infection between patients and HCWs. These 
precautions comprise:  
a. Hand hygiene, use of gloves, gowns and eye protection, and safe disposal of 
sharp instruments in impervious containers. 
b. HCWs within six to ten feet of patients on droplet precautions should wear a 
facemask. 
c. Patients placed on airborne isolation precautions as result of measles or varicella 
should be placed in an airborne infection isolation room, a private room with negative air 
pressure and a minimum of 6 to 12 air changes per hour. Doors to the isolation rooms 
must remain closed, and all persons entering must wear a respirator with a filtering 
capacity of 95 percent that allows a tight seal over the nose and mouth. 
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2- Those who have a high risk exposure to HBV and are negative for HBsAg are 
suggested to screened by PCR for the presence of detectable HBV DNA to exclude 
occult HBV infection. 
3. Testing for HDV should be performed in HBV patients who emigrated from countries 
with a high prevalence of HDV infection (such as MER). 
4. All susceptible HCWs should be vaccinated, unless there is a contraindication to 
immunisation, as advised by the ACIP. 
5. Post-exposure prophylaxis with HBIG and/or vaccine should be used when indicated 
(eg, after percutaneous or mucous membrane exposure to blood known or suspected to 
be HBsAg-positive). Incidences of needle stick or other percutaneous exposures of 
unvaccinated HCWs should lead to initiation of the HB vaccine series, regardless of the 
HBV status of the source patient. 
6. All susceptible HCWs exposed to varicella-zoster require post-exposure prophylaxis, as 
suggested by the ACIP guidelines. 
7. Exposed susceptible HCWs to measles or varicella should be furloughed from work, 
regardless of the type of prophylaxis they received. 
8. The infrastructure for vaccines delivery requires simplification, the vaccine tracking 
systems should be improved and continue to provide the necessary support to the 
stakeholders of vaccine providers at MNG-HA. 
9. A careful assessment should be carried out on the level of high authority regarding 
prevention and control strategy at the MNG-HA, including consideration of priorities, 
predicted impact and cost-effectiveness, affordability and budget impact. 
9.3.4 Recommendations to improve diagnosis 
1-  Pre-recruitment blood screening for all soldiers and HCWs should be compulsory with 
strict vaccination of susceptible individuals. Those who are proven to be positive for 
HBV should be referred to IPCD for appropriate management. 
2- Based on quantitative findings, those HCWs originating from the MER, working in 
administration or the peripheral health centres and males recording the lowest immunity 
status and effort, should be the focus of attempts to increase vaccination coverage and 
awareness. 
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3- This study has found low seroprevalence of antibodies among soldier recruits. The 
detection of antibodies is not yet introduced into SANG incorporation screening. Based 
on these findings, IPCD could justify implementing a new policy of screening testing 
for HBcAb, HBsAb, IgG measles and IgG varicella which should be included in blood 
screening tests at pre-recruitment, as is already applied to HCWs. 
4- The low vaccine coverage among SANG susceptible population may suggest the need 
for periodic testing to check their immunity status and strict vaccination of susceptible 
individuals. 
9.3.5 Recommendations to the public health planners and policy makers 
1- Implementation of effective intervention programmes that include strict policy 
implementation and regular in-service behavioral-based training. 
2- The vaccines should be administered continuously to achieve more than 95.0% 
coverage, with administrative support in a multidisciplinary approach. 
3- Based on qualitative findings, vaccination service delivery should be improved by 
sustaining resources to ensure constant delivery, transport, incentive and rewards for 
staff and community. 
4- Vaccination clinics should be prepared with adequate and functional cold storage 
equipment, taking into account layout and privacy concerns. 
5- Scrutinised screening for all non-Saudi HCWs willing to be employed in Saudi should 
be conducted in private and public sectors with only HBsAg, HCV and HIV negative 
subjects permitted to work. 
6- Proper hygienic practices in barbers shops and traditional therapy settings such as wet 
cupping (Hijama) should be assured to be hygienic, clean and cautious, and only in 
licensed, qualified practitioners. 
7- Based on qualitative findings, early consultation with military battalions can result in 
better planning and implementation of the vaccination programme. This can also 
improve soldiers' compliance and minimise or even help avoid administrative issues 
that could cause soldiers to refuse being vaccinated. 
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9.3.6 Future research 
Based on the above data, a number of recommendations for future research are made: 
1- It has been discussed that majority of Saudis in this study had been vaccinated against 
HBV, measles under EPI(94). However, low immunity against these diseases was 
reported. Therefore, it may be useful to conduct well designed and monitored 
prospective studies to assess the efficacy of these vaccines and EPI efficacy. This may 
provide a better understanding of vaccine and programme effectiveness. 
2- It has been discussed that HCWs and soldiers should have a booster dose(286,287). 
Therefore, it may be useful to carry out clinical research based on population specific 
evidence of immunity and incidence of infection on whether one or more booster dose 
should be provided. 
3- The quantitative findings of this research uncovered factors that could affect immunity 
responses especially to HBV, such as being overweight, tobacco smoking, freezing of 
vaccine, and accelerated scheduling(14,393). Therefore, it may be useful to investigate 
the potential role of factors in future quantitative surveys. 
4- The infection of HBV was estimated by HBsAg only. It may be better to do this with 
other markers, including LFT, HBeAg, and HBeAb. This could help to link any 
possibilities of acute or potential risk of transmission to colleagues in the working 
settings. 
5- This study assessed seroimmunity and knowledge of newly recruited soldiers and 
HCWs in the SANG. As per MNG-HA policy, vaccinations were given after 
seroimmunity results. Therefore, this finding could be used to benchmark prospective 
studies to follow up seroimmunity and knowledge level to these groups. This may 
provide a better understanding of occupational risks and find any associated possible 
risk to HCW and military settings. 
6- In order to convince decision makers to continuously support military vaccination 
programmes and screening tests, it may be very useful to conduct cost-effective research 
to assess policy on screening and vaccination and compare findings. 
7- The interviewees do not include leaders, higher and different military ranks, medical 
directors, different HCW occupational positions and non-Saudis HCWs. These probably 
have different perceptions and concerns regarding vaccine barriers. So, a qualitative 
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study exploring the distribution of perceptions about vaccinations in the population and 
a greater understanding of the barriers could be useful. 
8- Different strategies have been suggested to improve knowledge and awareness of HCW 
and soldier vaccines uptake. Therefore, well designed studies may be useful to assess 
the efficacy of these interventions. 
9- A single dose vaccine has been developed in which HBsAg has been encapsulated in 
microparticles(394). These vaccines remain to be tested in humans and clinical research 
should be encouraged to improve vaccine compliance. 
10- The gene coding for HBsAg has been inserted into a virulent strain of recombinant 
Salmonella, which can be administered orally(395). These vaccines remain to be tested 
in humans and clinical research should be encouraged to improve vaccine compliance. 
11- Novel strategies and well-designed studies should be developed to improve delivery and 
increase coverage among difficult to reach populations such as deployed soldiers, 
including inaccessible areas and nomadic populations. 
12- In order to measure vaccine coverage, studies should be developed to increase vaccine 
coverage such as evaluation of vaccination registries, population-based sero-surveys, 
and lot quality assurance sampling. 
 
9.4 Conclusion 
Vaccine preventable diseases are a public health risk in occupational settings among HCWs 
and soldiers, imposing a massive burden on individuals and organisational health care. 
Information on the seroprevalence and seroimmunity rates and patterns in vaccine preventable 
diseases and its risk factors among newly recruited HCWs and soldiers in KSA are currently 
limited. The mixed methods approach in this research was useful to estimate and report the 
seroprevalence, seroimmunity and knowledge of HBV, measles and varicella and explore 
underlying reasons of low vaccine compliance. It was useful to learn about a number of aspects 
of the quantitative and qualitative research whilst carrying out this study. This permitted 
learning from the perceptions and views about vaccine compliance of the target communities 
leading to an awareness of the seroimmunity of the studied diseases. However, considering the 
current study as a whole it is clear that it is, without doubt, a work-in-progress endeavour. 
The low levels of overall seroimmunity observed and perceptions explored the low vaccine 
compliance among soldiers and HCWs reflect current MNG-HA figures, highlighting the 
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urgent need for effective vaccine promotions. Current local policy should incorporate research 
to achieve high seroimmunity and vaccine compliance awareness in both risk groups. 
Importantly, as far as I am concerned, this research endeavour has enabled an enhanced 
understanding of what I regard as an essential element of health education and vaccine uptake 
improvement. As mentioned at the beginning of this thesis, this issue has not been addressed 
by Saudi researchers who have previously largely focused on HCWs and seroimmunity 
estimation. Hence, by focusing on this phenomenon in the Saudi soldiers and multinational 
HCWs, I hope that this study has developed policies and reliable public health interventions to 
prevent and control vaccine preventable diseases in the SANG.  
Overall, this research highlights the need for urgent action to ensure effective implementation, 
monitoring and maintenance of the existing policy. Appropriate and effective preventive 
measures should be aggressively implemented at employee level to promote vaccine 
compliance and health awareness. 
To conclude, military and HCW employees’ safety involves considerable effort and time on the 
mission and vision of MNG-HA. However, it is the responsibility of IPCP to make every 
possible effort to better understand and provide preventions against infection diseases in work 
settings among soldiers and HCWs, as this would serve to make the occupational settings a 
more safe and effective environment for personnel productivity should this research finding and 
recommendation be put into practice,Appendix O. Therefore, I have been (and I would be) very 
happy to participate in endeavours which could help to increase understanding of vaccine 
preventable diseases in occupational settings in MNG-HA. 
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 Executive Report 
 
It is the responsibility of IPCP in MNG-HA to make every possible effort to better understand 
and provide preventive measures against infectious diseases among soldiers and HCWs in their 
work settings to ensure that the occupational settings are as safe and effective a working 
environment for personnel and, therefore, productivity. Should the research findings and 
recommendation of this study be put into practice, these aims would be further targeted. 
 
1. Monitoring and maintenance of the existing policy 
Overall, this research highlights the need for urgent action to ensure effective implementation, 
monitoring and maintenance of the existing policy with specified enhancements (detailed 
below). Appropriate and effective preventive measures should be aggressively implemented at 
employee level to promote vaccine compliance and health awareness. 
The low levels of overall seroimmunity observed and perceptions explored concerning reduced 
vaccine compliance among soldiers and HCWs reflect current MNG-HA figures, highlighting 
the urgent need for effective vaccine promotions. This study finds low seroprevalence of 
antibodies among soldier recruits. The detection of antibodies has not yet been introduced into 
SANG incorporation screening. Based on these findings, IPCP could justify implementing a 
new policy of screening testing for HBcAb, HBsAb, IgG measles and IgG varicella which 
should be included in blood screening tests at pre-recruitment stages, as is already applied to 
HCWs. IPCP should emphasise the need for this at pre-recruitment blood screening for all 
soldiers and HCWs and should make it compulsory with strict vaccination of susceptible 
individuals. Those who are proven to be positive for HBV should be referred to IPCD for 
additional appropriate management. 
Current local policy should incorporate this research and other related research to achieve high 
seroimmunity and vaccine compliance awareness in both risk groups. Policy makers at IPCP 
need the credible data of these findings to appropriately plan policy and allocate resources 
efficiently, where currently, no specific surveillance military programme exists. Additionally, 
employing multinational HCWs presents unique challenges demanding planning for unusual 
viral susceptibility profiles (4). 
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2. Monitoring and assessing immunisation systems 
Implementation of a work site medical surveillance programme might help identify vaccine 
preventable diseases at an early stage in the military field and provide a revised view of the 
HCWs’ surveillance system. Therefore, it is important to monitor levels of vaccine-induced 
antibodies in the population and to continue epidemiological surveillance in a period of 
decreasing opportunity for natural boosting. This could be achieved by establishing specialised 
preventive medicine clinics for follow-up of the cases and their contacts. These should be 
accessible and designed to guarantee privacy and safety, providing all equipment necessary for 
administration, documentation, and disposal with a secure computerised system to manage 
HCWs and soldiers’ records of immunisation status, vaccination history, or any documented 
AEFI. Additionally, IPCP should provide vaccination cards for soldiers and HCWs; to be 
checked in order to assess their clinical and occupational history in different situations and 
vaccine coverage characteristics including vaccination status, number of doses received, and 
age at the time of vaccination. 
Where findings are potentially useful to policy planners in IPCP vaccine barrier awareness, for 
instance, should be addressed. Study participants have provided tangible examples of strategies 
that could facilitate improved vaccine receipt and compliance, offering important, practical 
implications that could influence soldiers and HCWs in, improving knowledge, privacy 
concerns, rumours and programme accessibility particularly for staff working part-time or night 
duty soldiers through regular visits to medical departments or battalions. As articulated, IPCP 
need to be proactive and creative in their education promotion efforts for the vaccination 
programmes and their full value (full vaccine series). Furthermore, messages about vaccines 
need tailoring to meet unique characteristics of HCW and military cultures. Moreover, in 
consideration of the widespread usage of technologies, a reliable reminder system, such as text 
messaging or emails or phone calls, should be initiated by IPCP to remind service users to book 
and follow up their vaccinations to improve vaccine compliance. 
 
3. Strengthening public health education among HCWs and soldiers 
IPCP should support awareness of the potential risk and prevention measures of vaccine 
preventable diseases among HCWs and soldiers. This study has revealed generally poor 
knowledge about HBV, measles and varicella among soldiers and only moderate levels among 
HCWs. IPCP should consider a structured health education programme and campaigns, pre-
supposing that well designed educational interventions and materials that are both contextually 
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and linguistically appropriate are key factors. These should target the increase of relevant 
communities’ knowledge about these infections and increase the chances of compliance with 
the recommended preventive practices such as vaccination. This should be targeting new 
soldiers and HCW recruits which may ensure earlier education and, most likely, protection 
before starting their work duties. 
So, any immunisation campaign carried out by IPCP should be empowered by health education 
under supervision of specialised teams, targeting the soldiers and HCWs. These campaigns 
should engage military commanders and medical directors in discussion with HCWs and 
soldiers, in order to enhance confidence about the importance of vaccination and prevention 
measures. Participation of role models at the outset of vaccine campaigns could motivate 
individuals to accept and complete vaccine dose schedules and have a correspondingly positive 
community impact. 
 
4. Improving the working environment and continuous training of the qualified staff 
providing the services in IPCP programmes 
IPCP should revise knowledge capacity among staff providing vaccines and recruit sufficient 
manpower to facilitate this and carry out planned vaccination programmes. Vaccine provision 
staff should receive training on communicable diseases in occupational settings and prevention 
strategies, vaccine handing and administration, vaccine safety and the vaccine cold chain. Such 
training should be consistent considering the high turnover of HCWs being supervised by IPCP 
using effective techniques to empower them with adequate knowledge and communication 
skills to play a positive role in the delivery of basic vaccination messages to service users such 
a HCWs or soldiers in vaccine clinics and/or community meetings and mass media. 
 
5. Improving inter-sectoral and departmental collaboration 
In terms of coordination with other sectors, IPCP should work thoroughly with different 
stakeholders having a role in the vaccine process such as, logistic, health authority, military 
medicine, employees health, PHCs departments in MNG-HA, in order to improve the 
vaccination service delivery by sustaining resources to ensure appropriate utilisation, 
coordination, adherence to guidelines, consistent delivery and transport. Additionally, IPCP 
should provide advice to MNG about the effective and appropriate design of general ventilation 
systems for building structures, which should be considered urgently so as to reduce and 
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optimally prevent the risk of the spread of infections, especially diseases that spread easily 
through air (e.g. measles and varicella)(393), either in common waiting areas in hospital (e.g. 
waiting room, emergency departments) or large dormitories in battalions. 
 
6. Continuous monitoring and evaluation 
Generally, this study seeks to serve as a starting point for subsequent studies to further examine 
its stated research aims in and for MNG-HA, comparing different policy targets suggested and 
determining the most suitable/feasible based upon their local experience and existing financial 
and other resources. The progress toward achieving the applied policy target should be 
monitored by IPCP periodically through representative population-based surveys, interviews 
and chart reviews. 
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